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INFLAMMATORY BOWEL DISEASES AND LIVER FUNCTION:
FREQUENCY OF SUB CLINICAL SCLEROSING CHOLANGITIS
Imerio Angriman1, Marco Scarpa, Cesare Ruffolo, Teresa Filosa, Lino
Polese, Giovanna Romanato2, Silvia Basato, Fabio Pilon, Annamaria De
Pellegrin2, Elena Ossi2, Davide F. D’ Amico
1Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenter-
ologiche, University of Padova, Italy; 2Clinica Medica I, Dipartimento di
Scienze Mediche e Chirurgiche, University of Padova, Italy
Introduction. The strict association between inflammatory bowel diseases
and sclerosing cholangitis has been described by several studies. Sclerosing
cholangitis is characterised by recurrent episodes of cholangitis with the
presence of pANCA. Inflammatory bowel diseases (IBD) are associated in
the 10% of cases. The aim of this cross-sectional study was to assess liver
function in a group of IBD patients to investigate the possible sub clinical
presence of liver involvement.
Method. Seventy-four consecutive patients who were admitted for Crohn’s
disease (CD) or ulcerative colitis (UC) surgery between December 2004 and
April 2006 were enrolled. Patients who presented a history of liver disease
were excluded. Demographic data, disease activity, inflammatory parameters
were collected. Each patients had his/her liver function assessed as well as
pANCA level. Data were expressed as mean (95% CI) and Fisher’s exact test,
Mann-Whitney and Spearman correlation rank tests were used where
appropriated.
Result. In patients with IBD total bilirubin was 11,4 (9,413,4) mmol/l,
AST 25,4 (20,130,6) IU/L, ALT 25,6 (18,932,3) IU/L, GGT 31,5
(17,545,5), ALP 89,5 (74,8104,2), Albumin 39,1 (37,540,6) mg/L and
PT 80,3 (76,584,1)%. Twenty-one patients were pANCA positive. Five
patients (6.3%) showed an altered liver function with rise of transaminases
and cholestatic enzymes. Only one of them had been diagnosed with
sclerosing cholangitis but all of them were affected by UC and were pANCA
positive (p0.02 and p0.01, respectively). The presence of pANCA
showed a trend to correlation to ASTand ALT levels (R0.25, p0.05). No
other differences were observed between UC and CD patients.
Conclusion. In our UC cohort, 14.3% of patients showed an altered liver
function even if only one patient had a definite diagnosis of sclerosing
cholangitis. The frequency of liver involvement in UC is remarkable therefore
pANCA positive patients with UC should be monitored in their liver function
for possible sclerosing cholangitis diagnosis.
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HEPATOCELLULAR CARCINOMA WITH MAJOR PORTAL OR
HEPATIC VEIN TUMOR THROMBOSIS: RESULTS OF LIVER
RESECTION
Francesco Ardito1, Alexis Laurent, Claude Tayar, Jeanne Tran Van Nhieu2,
Alain Luciani3, Daniel Cherqui
1Department of Digestive Surgery; Henri Mondor Hospital; University Paris
12; 2Department of Pathology, Henri Mondor Hospital; University Paris 12;
3Department of Radiology, Henri Mondor Hospital; University Paris 12
Background. Short- and long-term results after liver resection for hepato-
cellular carcinoma (HCC) with major vascular invasion.
Study Design. From 1990 to 2005, 222 patients with HCC underwent
hepatectomy in our unit. Twenty (9%) had major vascular invasion, including
13 (65%) portal and 7 (35%) hepatic vein thrombosis and they are the
subject of this study. Extent of thrombosis was intraoperatively studied by
ultrasound for portal vein and by transesophageal echocardiography for
hepatic veins. Patients were divided into two groups: patients who had tumor
thrombus totally included in the resection specimen (group 1) and those who
required vascular procedures to remove thrombus outside the site of the
resection (group 2). Short- and long-term results were studied according to
the extent of thrombosis.
Results. Nineteen patients (95%) underwent major hepatectomy. Compared
to resected patients of our series without major vascular invasion, hepatect-
omy in these 20 patients was associated with significantly higher rates of total
vascular exclusion (35% vs. 10.4%; pB0.05) and of blood transfusions (50%
vs. 13.4%; pB0.001). Mortality and morbidity rates were 15%. Combined
risk of intraoperative blood transfusions and postoperative mortality was
significantly higher in group 2 (respectively 63.6% and 27.3% vs. 33.3% and
0; p0.02). Median survival was 16 months. The 3- and 5-year overall and
disease free survival rates were 25%. Alpha-fetoprotein level B1,000 ng/mL
and minimal fibrosis were associated with a 5-year survival rate higher than
40%; poor tumoral histologic differentiation and invaded surgical margins
were associated with no 5-year survival. The 5-year overall and disease-free
survival rates in group 1 were not significantly different than that in group 2
(respectively 25% vs. 26%; pns).
Conclusions. Liver resection for HCC with macroscopic vascular invasion is
associated with significantly higher operative risk but long-term survival may
be achieved in these patients and should be recommended when curative
hepatectomy can be preoperatively anticipated.
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EARLY EXPERIENCE OF LIVER RESECTION FOLLOWING
DOWNSTAGING CHEMOTHERAPY OF INITIALLY UNRESECT-
ABLE COLORECTAL LIVER METASTASES
Glen Irving1, Andrew Cresswell, Chris Briggs, Mark Peterson, Iain Cameron,
James Tiernan, Ali W Majeed
1Sheffield Teaching Hospitals NHS Trust
Introduction. Published data suggests that 5 year survival of up to 35% is
achievable following resection of initially unresectable colorectal liver
metastases downstaged by neoadjuvant chemotherapy. In the United King-
dom, the use of oxaliplatin and 5-fluorouracil for downstaging patients with
inoperable liver metastases but no extra-hepatic disease was sanctioned in
2002.
Methods. We have prospectively audited all patients in whom downstaging
of unresectable liver metastases has been attempted. Following chemotherapy
patients underwent restaging with both CT and MRI imaging, and the
feasibility of liver resection was assessed.
Results. 70 patients had attempted downstaging chemotherapy. A median of
8 cycles of chemotherapy were given (range 4 14), and 28 patients (40%)
were deemed suitable for liver resection following restaging. 25 underwent
hepatic resection and 3 were found to be inoperable at laparotomy. 17
patients underwent R0 resection and 8 patients had an R1 resection.
Operative mortality was nil, with 13 patients remaining disease free at a
median of 12 months post surgery (range 436). 7 patients are alive with
recurrent disease and 5 have died. Those who developed recurrent disease
did so in a median time of 6 (318) months after surgery. The median
survival after commencing treatment is currently 27 months in the group
having a liver resection compared to 17 months in the group not undergoing
liver surgery.
Discussion. Our R1 resection and early recurrence rates are slightly higher
than some published data. It is therefore possible that we are being too
aggressive in the selection of patients for liver surgery. However, the increased
median survival in the group undergoing liver surgery indicates that liver
resection may alter the natural history of this disease, even in patients who
develop recurrent disease.
*We would happily present this as a poster if not acceptable for oral
presentation.
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TREATMENT STRATEGY FOR PRIMITIVE OR SECONDARY
LIVER MALIGNANCIES IN UNFIT ELDERLY PATIENTS
Stefania Brozzetti1, Mario Bezzi2, Monica De Angelis, Diletta Cassini,
Gianmarco Andreoli2, Adriano Tocchi, Antonino Cavallaro
1Surgeon; 2Radiologist
Surgical resection of HCC in patients not suitable for liver trasplantation and
surgical resection of colorectal cancer hepatic metastases, still provides the
best opportunity for long term, disease-free and overall survival.
The advanced age cannot be considered by itself a factor precluding hepatic
resection. However elderly patients with significant co-morbidities tend to
have more postoperative complications that may be at high risk for an
unfavourable post-operative outcome. Age decreases organ functional
reserve. The functional reserve represents a safety margin that may be
needed to meet increased demands for cardiac output, carbon dioxide
excretion, protein synthesis, immune responsiveness, etc. Therefore age
places the elderly popolation at risk for morbidity and mortality. Patients with
coexistent morbidity who are not suitable for surgery are often able to
undergo radiofrequency ablation (RFA).
In general, RFA represents an effective technique for minimally invasive
tissue destruction for tumor 3 cm or smaller in diameter.
From March 2004 to June 2006, a team of hepatobiliary surgeons
and interventional radiologists at the Surgical Department ‘‘P. Valdoni’’ of
the University of Rome "La Sapienza" Medical School, performed an
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intraoperative RFA in 32 patients aged 65 to 81 years. Among them, 22
patients were treated for hepatocellular carcinoma and 10 for liver metastases
from colorectal cancer. All RFA were performed with a standard protocol by
using a cool-tip RF system. A minor hepatic resection was also performed in
12 patients. Patients with an ASA Score of III not suitable for major
hepatectomies and patients not suitable for percutaneous ablation approach,
with esophytic or paracaval or sub-glissonian lesions were included into this
protocol. A total of 67 lesions were treated. Intraoperative ultrasonography
allowed detection of 15 nodules missed at CT. Forty-nine lesions were
ablated with RF and 18 resected.
All elderly patients were not managed postoperative in the ICU and
discharged after 915 days from the hospital.
There was no mortality at 30 days after the operation and as well there was no
major medical complication. There was modest pleural effusion in the
18.75% of the cases and in two patients (6.25%) a partial portal vein
thrombosis was observed for 36 months. An overall complete ablation rate
was achieved.
All patients are alive without recurrence. The median follow-up is 14.1
months (range 327 months). The combined use of intraoperative RF with
minor liver resection can be considered, in elderly unfit patients, a good
treatment strategy for primary and secondary liver malignancies.
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LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA
(HCC): OUR EXPERIENCE
Roberta Molaro1, Enrico Benzoni, Alessandro Favero, Aron Zompicchiatti,
Federico Cattin, Sergio Intini, Alessandro Uzzau, Dino De Anna
1Clinica Chirurgia generale, University of Udine
Background. Liver resection rapresents the treatment of choice for hepato-
cellular carcinoma, the only that provides improvement in survival. We
retrospectively analysed our personal experience in liver resection for HCC.
Methods. From September 1989 to January 2007, 122 patients underwent
liver resection for HCC at our department. Their age ranged from 36 to 82
years (mean age 63 years) and the large part of them were men (94 male vs 28
female, M:F3.4:1). In 84 patients (69%) there was one single lesion and in
38 patients (31%) there were multiple nodules (up to five lesions). The size of
the nodules ranged 1-18 cm, in 50 cases (41%) they were smaller than 5 cm
and in 72 cases (59%) they were equal or larger than 5 cm. Limited
resections, single segmentectomies and bisegmentectomies were performed
in 98 cases and major hepatectomies were performed in 24 cases.
Results. Postoperative mortality and mobidity rates were 6% and 47%
respectively. The mean survival rate recorded was 32 months and the 1-,3-,5-
and 10-years survival rate were 76%, 41%, 22% and 4% rispectively. Number
of lesions, tumor size, Pringle manoeuvre lenght and Child-Pugh class were
not proved to influence significantly survival rates. Recurrence was observed
in 27% of the cases during the follow up.
Conclusions. Liver resection is an effective treatment for hepatocellular
carcinoma but further trials are necessary to detect and analize all the
possible variables that could affect mortality, morbidity, survival and
recurrence, in order to define clearly the patients eligible for resection.
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THE PROGNOSTIC PREDICTIVE VALUE OF HEPATIC AGO-
BIOPSY IN A GROUP OF PATIENTS UNDERGONE HEPATIC
RESECTION FOR HEPATOCELLULAR CARCINOMA
Federico Cattin1, Alessandro Favero, Roberta Molaro, Aron Zompicchiatti,
Alessandro Uzzau, Dino De Anna
1Clinica Chirurgia generale, University of Udine
Introduction. Hepatocellular carcinoma represents 8090% of liver neo-
plasms, with an incidence growing together with age, reaching the maximum
during the 7th decade. In more than 90% of cases, liver cirrhosis is present.
Only 30% of hepatocellular carcinomas is nowadays resectable with radical
aim, and this is due to the fast growth of the neoplasm and to the state of liver
function in cirrhotics. Liver agobiopsy could offer a rapid diagnosis in any
case of suspect nodule, and in this way improve the disease prognosis in those
cases in which the combined study of CT images and serum aFP is not
enough to get a diagnosis.
Aim of this study is to discover if agobiopsy performed in hepatocellular
carcinoma predicts the real grade of the whole nodule, giving the surgeon the
possibility to choose the best therapeutical strategy among a large number of
possibilities.
Materials and Methods. We have considered for this study a group of 30
patients, 23 males and 7 females of an age 50-79 years old, who underwent a
liver resection for hepatocellular carcinoma. In every case an agobiopsy was
taken from the malignant nodule before the resection, and a complete study
of the neoplasm was performed after surgery. A microscopic study of those
pieces was taken, and a grade according to the Edmonson and Steiner
grading classification was given. Also other informations, like surgical
technique, characteristics of the neoplasm, serum parameters and mortality
rates were considered. We matched the grade given through the agobiopsy
and that given through a post surgical complete study, to understand whether
this technique is predictive or not.
Results. About the grading, our results were as follows:
Agobiopsy Post surgery
G1 0 0
G2 26 (86.7%) 12 (39.9%)
G3 4 (13.3%) 17 (56.8%)
G4 0 1 (3.3%)
We have found neither correlation between agobiopsy grading and post
surgical one (significance of the correlation: 0.348), nor between agobiopsy
grading and other certificated prognostic factors.
Discussion. It is impossible to confirm the hypothesis according to which
agobiopsy is predictive of the grading of hepatocellular carcinoma. This is
due to many reasons. The first is the typical characteristic of this neoplasm to
express different grades in different places into the same nodule: the fine
needle agobiopsy takes just a small piece of it, and is not able to give the
surgeon a real image of the tumour. The second are the criteria of Edmonson
and Steiner grading classification, which are just morphological and
subjective. In this way, different pathologists-as demonstrated by many
studies  may give different grades to the same specimen, which contributes
to confusion and misunderstandings. It has been demonstrated that it is very
difficult to find differences between G1 hepatocellular carcinomas and benign
liver diseases, and between G4 carcinomas and other injuries, like metastases
or sarcomas. Among primitive liver neoplasms, it is difficult to separate G2
and G3 grades.
Anyways, even with this limit, agobiopsy in hepatocellular carcinomas
remains an important diagnostic technique, because it is fundamental in
controversial cases, and because it is the only way to study without the risk of
mistakes other elements, like the tumour molecular profile, factor which is
very important for prognosis and malignancy.
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INTRAOPERATIVE RADIOFREQUENCY ABLATION FOR HEPA-
TIC TUMORS: OUR EXPERIENCE
Aron Zompicchiatti1, Roberta Molaro, Alessandro Favero, Federico Cattin,
Gaetano Filippone, Luigino Noce, Dino De Anna, Alessandro Uzzau
1Clinica Chirurgia generale, University of Udine
Introduction. Ablative treatments for hepatic tumors such radiofrequency
ablation (RFA) have been the subject of ongoing research. Herein we analyse
our experience in intraoperative radiofrequency ablation for HCC and
colorectal liver metastases.
Methods. From 2001 to 2006, nine patients affected by hepatic metastases
from colorectal cancer and 8 patients affected by HCC underwent intrao-
perative RFA under US guidance. All RFA treatments were performed by
using a cooled-tip RFA system (Radionics Inc., Burlington, MA). Single-
needle electrodes were used for lesions smaller than 5 cm in diameter,
whereas cluster of 3 parallel electrodes were used for tumors larger than 5 cm
(4 patients). Medium diameter of ablated lesion: 27 mm (diameter of the
largest lesion ablated 70 mm). RFA was used alone or in conjunction with
surgery in order to reduce the extension of hepatic resection avoiding hepatic
failure and for previously unknown lesions discovered during intra operative
US and not resectable. In two patients RFA was associated with ethanol
injection. Four patients affected by metachronous metastases were treated
with RFA and hepatic wedge resection, three patients affected by synchro-
nous metastases were treated with RFA alone and 1 in association with wedge
resection. One patient affected by colorectal liver metastases was treated two
times with intraoperative RFA. Three patients affected by HCC (more than 1
lesion) were treated with hepatic resection associated with RFA; the
remaining 5 with intraoperative RFA only.
Results. One patient died because of liver failure and hemoperitoneum 5
days after surgery. We observed complications in 9 patients (50%): hepatic
abscesses (3 patients), biliary fistula (1 patient), anemia (3 patients), fever (4
patients), pleural effusion (1 patient). None of these patients required
surgical treatment for these complications. Three patients developed
recurrence at the site of previous RFA. Median survival rate was 24 months
(range 167 months). At the end of the follow-up period 11 patients (65%)
are still alive.
Conclusion. In our experience RFA is a relatively easy to perform, replicable
and well tolerated procedure . On the other hand our study shows
preliminary results: the limited number of cases and the short extension of
the follow-up make difficult to clearly establish the role of RFA in the
treatment of liver tumors.
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DISRUPTION OF THE WNT 1 PATHWAY (APC-BETA-CATENIN)
AND MICROSATELLITE INSTABILITY IN LIVER TUMORS
Armando Dhamo1, Maria Cristina Curia2, Alessandro Cama2, Giuliana
Malagnino, Francesco Cetta
1Department of Surgery, University of Siena, Italy; 2Department of
Pathology, University of Chieti, Italy
Liver tumors include a wide range of histotypes: hepatocarcinoma (HCC),
hepatoblastoma (HB), fibrolamellar carcinoma, adenoma and multiple
adenomatosis, cholangiocellular adenoma and carcinoma and mixed hepa-
tocholangiocarcinoma.
Hepatoblastoma (HB) is an embryonic tumor usually consisting of epithelial
and mesenchymal components, which mainly occurs in the first years of life.
The vast majority of hepatocellular carcinoma (HCCs) develop in cirrhotic
livers and are frequently virus related; nevertheless, a small percentage of
4 Abstracts
these tumors occurs in the absence of HBV/HCV infection and cirrhosis.
APC and beta-Catenin are part of the WNT-Wingless pathway. Beta-Catenin
mutation and its nuclear overexpression seems to be involved in tumorigen-
esis and cell differentiation. We report a multicentic study including 20
sporadic HBs and 11 non virus-related HCCs. In the HB group the mean age
was 1 year and 7 months, whereas in the HCC group all the patients were less
than 40-years-old and the tumor had developed in the absence of cirrhosis.
Mutational analysis of a part of the exon 3 (from nucleotide 214 to nucleotide
364) of the beta-Catenin gene, as well as the research of microsatellite
instability were performed in all HBs and HCCs. SSCP analysis and
sequencing of genomic DNA showed a mutation of the beta-Catenin gene
in 2 HBs (10%) and 2 HCCs (18%). A missense mutation in the codons 32
and 38 was discovered in 2 Hbs, while a nonsense mutation in the codon 27
and a missense mutation in the codon 32 were found in 2 HCCs.
Microsatellite instability was also found in 11 HBs. Present data confirm
the previously suggested involvement of beta-Catenin in liver carcinogenesis .
Interestingly, hepatoblastomas (HBs) showed a high percentage (55%) of
microsatellite instability. This could suggest a possible role for both
deregulation of the WNT 1-Beta-Catenin signaling and microsatellite
instability in the occurrence of liver tumors, even if in different types of
tumors.
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RESULTS OF YTTRIUM-90 MICROSPHERE TREATMENT IN
THE MANAGEMENT OF UNRESECTABLE LIVER CANCER
Osama Damrah1, Hapreet Wasan2, Ruben Canelo2, Nagy Habib, Long Jiao
1Hammersmith Hospital-Imperial College London; 2Hammersmith Hospital
Introduction. Selective internal radiation therapy (SIRT) is emerging as a
new therapeutic modality in recent years for management of non-resectable
hepatic metastases. Our initial experience in clinical application of this
treatment is reported here.
Methods. From November 2004, patients whose liver tumour was no
longer amenable for any conventional treatment with either chemotherapy
or surgery were considered for yttrium-90 microspheres treatment after
discussion at our multidisciplinary meeting. None of the patients had
extrahepatic disease. A pre treatment planning was carried out with visceral
angiography and technetium-99m macroaggregated albumin (MAA) for
assessment of both tumour volume and extrahepatic shunting in addition to
a baseline PET and CT scan respectively. Two weeks later, a second visceral
angiography was performed to deliver the calculated dosage of microsphere
into the arterial system supplying the tumour. Patients were then followed
up with repeat PET and CT scans of abdomen at 6 weeks, and 3 monthly
thereafter.
Results. A total of 19 patients with a mean age of 59 years received
yttrium-microspheres treatment, consisting of cholangiocarcinoma (n3)
and liver metastases from colorectal carcinoma (n10), pancreas (n2),
GIST (n1), breast (n1), squamous cell carcinoma of anus (n1) and
adenocarcinoma of an unknown primary (n1) respectively. The average
dosage of microspheres delivered was 1.990.3 GBq. Injection of micro-
spheres had no immediate effect on either clinical haematology or liver
function tests. At follow up, 17% of patients showed a radiological
response of a reduction in the size of tumour measured on CT scan at 3
months and 33% of a decreased PET activity on PET scan at 6 weeks. For
patients with colorectal liver metastases, there was no significant reduction
in CEA level (1279115 vs 759.72, p0.39). Four patients died at follow
up of pancreatic (n1) and colorectal primaries (n3). Others remained
alive with a stable disease. The total cost of this procedure was £11,000/
patient.
Conclusion. Microspheres treatment should be considered as a last option
for patients with liver cancer. Its use should be balanced against its cost/
effectiveness.
10
A PROSPECTIVE STUDY TO BETTER DEFINE CURABILITY
OF LIVER RESECTION FOR COLORECTAL METASTASES
BY PERIOPERATIVE CARCINOEMBRYONIC ANTIGEN (CEA)
MEASUREMENTS
Oussoultzoglou Elie1, Rosso Edoardo, Diop Bala, Giraudo Giorgio, Bachel-
lier Philippe, Jaeck Daniel
1Hopital de Hautepierre
Background. Despite a curative liver resection for colorectal metastases the
majority of the patients do not reach long term survival. Therefore, there is a
need for a new definition of radicality after liver resection.
Objective. The aim of the present prospective study is to evaluate the impact
of perioperative trend of CEA blood level as a predicting factor of R0 liver
resection for colorectal liver metastases.
Patients and Methods. Between January 2000 and December 2004,
among 233 patients treated for colorectal liver metastases in our depart-
ment, 213 patients underwent a curative R0 resection and constitute the
study population. The CEA blood level was routinely measured one week
before and 6 weeks after liver resection. These 213 patients were divided
into three groups : Group A, patients with normal pre- and post-operative
CEA blood level (n69); Group B, patients with high preoperative and
normal postoperative CEA blood level (n111); and Group C, patients
with abnormal pre- and persistent high post-operative CEA blood level (n
33). The significant accuracy value of the perioperative CEA blood level
evolution was investigated by univariate and multivariate analysis of
survival.
Results. No patient was lost during the follow-up. The clinicopathologic
features were similarly distributed among the three groups of patients. The
Fong clinical score (Ann Surg 1999; 230: 309321) was 0 or 1 in 44
patients, 2 or 3 in 135 and 4 or 5 in 34 patients. The overall 1-, 3- and 5-
year survival rates were 92.0%, 66.3% and 35.8% respectively with a
median survival of 32.2 months. The univariate analysis showed that
persistent increased perioperative CEA blood level (PB0.0001), multiple
liver metastases (P0.0073), large liver metastases (3 5 cm, P0.0015),
advanced Fong clinical score (PB0.0001), bilobar distribution of liver
metastases (P0.0082) and patients requiring major hepatectomies (P
0.0067) or a two-stage hepatectomy procedure (P0.0186) were associated
with a worse overall survival. These prognostic factors also significantly
affected disease-free survival. Indeed, the 5-year overall and disease-free
survival rates were significantly higher in Group A and B patients compared
to Group C (50.2% and 21.9% ; 38.5% and 18.3% versus 0% and 0%
respectively, both PB0.0001). The multivariate analysis demonstrated that
the perioperative trend of CEA blood level and number and size of liver
metastases were independent prognostic factors for overall survival. More-
over, the 5-year survival rate among patients presenting a Fong clinical
score of 2 or 3 is significantly affected by the perioperative trend of CEA
blood level (45.0%, 40.2% and 0% in Group A, B and C respectively, PB
0.0001).
Conclusion. These results suggest that long term outcome could be better
predicted by the perioperative evolution of CEA blood level than the Fong
clinical score alone or other characteristics of the primary tumor or liver
metastases. The decision to treat a patient with adjuvant chemotherapy
should be discussed also after considering the perioperative evolution of the
CEA blood level.
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PERIOPERATIVE USE OF THE LIMON METHOD OF INDOCYA-
NINE GREEN ELIMINATION MEASUREMENT TO DETECT
POST-HEPATECTOMY LIVER FAILURE
Nicola de Liguori Carino1, Derek A. O’Reilly, Paula Ghaneh, Graeme J
Poston, Andrew Wu
1Liverpool Supra-Regional Hepato-Biliary Center, University Hospital
Aintree, Liverpool University
Introduction. There are few practical and reliable tests for the estimation of
hepatic functional reserve in patients being assessed for hepatic resection.
Recently, a non-invasive liver function monitoring system, the LiMON
(Pulsion Medical Systems, Munich, Germany), has been developed that
measures indocyanine green (ICG) elimination by pulse spectrophotometry.
The aim of this study was to assess the utility of the LiMon system in the
prediction and early detection of liver failure post-hepatectomy.
Methods. Indocyanine green elimination, using the LiMon system, serum
liver function tests and Child-Pugh score were assessed in 21 patients
undergoing major liver resection (50% or more) pre-operatively and at days
1, 5 and 10 post-operatively. Post-operative course, complications and final
outcome were recorded.
Results. There were 16 men and 5 women with a median age of 68 years
(range 3976), all of whom were Child score A preoperatively. On days -1,
1, 5 and 10, the median ICG 15-min retention rates (R15) were 1.9, 2.8,
3.0 and 4.3 in those who remained Child A postoperatively (Group A) and
7.6, 17.5, 11.5 and 7.8 in those who became Child B or C post-operatively
(Group B), p0.4, 0.04, 0.02, and 0.03 respectively, Mann-Whitney U test.
On day 1, median R15 for Child A, B and C patients were 7.4, 7.6 and
19.5, respectively, ANOVA pB0.001.
Conclusions. LiMON ICG elimination by pulse spectophotometry is a
quick, non-invasive and reliable liver function test in patients undergoing
liver resection that aids in the early identification of post-hepatectomy liver
failure.
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THE ROLE OF IMMUNOGLOBULIN M, C-REACTIVE PROTEIN
AND COMPLEMENT IN LIVER ISCHEMIA-REPERFUSION IN-
JURY
GMP Diepenhorst1, W de Graaf, HW Niessen2, AK van Vliet, TM van Gulik
1Surgical Laboratory, Academic Medical Center; 2Department of Pathology,
Vrije Universiteit Medical Center ICAR-VU
Introduction. A role for C-reactive protein (CRP) and Immunoglobulin M
(IgM) in the initiation of I/R injury via complement activation has been
established in various I/R models. Both CRP and IgM can bind to
neoantigens in the damaged cell membranes leading to the activation of
complement. However, the time course in which IgM and CRP activate
complement in liver I/R remains unknown.
Aim. The aim of this study was to assess the relationship in time of IgM and
CRP binding in comparison to complement activation in a hepatic I/R rat
model.
Method. Male Wistar rats (n60) were divided into eleven groups: 60
minutes of partial ischemia (70%) followed by 0, 3, 6, 12 or 24 hours of
Abstracts 5
reperfusion (each n6). Partial ischemia was induced via clamping of the
afferent vessels and bile duct to median and left lateral lobes. Sham
laparotomy groups with corresponding reperfusion times were included, as
well as a control group sacrificed before ischemia (each n5). Hepatocellular
injury (plasma aminotransferases and histopathology), inflammatory re-
sponse (neutrophil influx), prothrombin time (PT), rat IgM content in
ischemic hepatic tissue homogenates and immunohistochemical depositions
of CRP, IgM and C3 on frozen tissue sections were assessed during each
reperfusion time. The Mann-Whitney test and the Spearman rank-correla-
tion test were used for statistical analysis.
Results. Aspartate aminotransferase (AST) and alanine aminotransferase
(ALT) significantly increased after 3 hours, peaking at 6 hours (530091000
and 31009800 U/L, respectively) and remained elevated up to 24 hours (pB
0.01 versus sham). Hepatic neutrophil influx significantly increased from 3 to
6 hours of reperfusion (pB0.01), peaking at 12 hours (1.190.2 U/mg
protein). A progressive increase in prothrombin time (PT) was observed
throughout reperfusion (pB0.05 versus sham). Histopathological injury
increased from 3 to 12 hours of reperfusion (pB0.01) and remained elevated
thereafter (pB0.01 versus sham). Rat IgM content in ischemic tissue
homogenates demonstrated a progressive increase throughout reperfusion
up to 24 hours. Immunohistochemical analysis showed a similar staining
pattern of IgM and CRP, in which depositions increased from 0 to 3 hours of
reperfusion, peaked at 12 hours and decreased thereafter until 24 hours (pB
0.05 vs sham). C3 depositions followed the IgM and CRP staining pattern,
demonstrating a considerable increase from 3 to 6 hours, peaking at 12 hours
of reperfusion and significantly decreasing from 12 until 24 hours (pB0.01).
Positive correlations existed between the staining of CRP and C3 (Spearman
rank-correlation test r(S)0.87, pB0.01) and IgM and C3 (Spearman rank-
correlation test r(S)0.80, pB0.01)
Conclusion. These data show a parallel binding pattern in time of IgM and
CRP to ischemic liver tissue which precedes the activation of C3. Hence, this
study suggests CRP and IgM to be mediators of of hepatic I/R-induced
complement activation in rats.
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THE USE OF VASCULAR CLAMPING IN HEPATIC SURGERY:
THE LESSON LEARNED FROM 1260 LIVER RESECTIONS
Giorgio Ercolani1, Matteo Ravaioli2, Gian Luca Grazi2, Matteo Cescon2,
Massimo Del Gaudio, Gaetano Vetrone, Matteo Zanello, Francescon Tuci,
Alessandro Cucchetti, Antonio Daniele Pinna
1Department of Surgery and transplanation-University of Bologna; 2Depart-
ment of Surgery and Transplantation-University of Bologna
Objective. To minimize intraoperative bleeding several techniques have
been introduced. Ischemia-reperfusion injuries and intestinal congestion are
the main drawbacks of vascular clamping. We evaluated the possible
negative effects on early postoperative outcome of different type of vascular
clamping during liver resections and how attitudes have changed in the last
20 years.
Patients and Methods. The study group included 1260 consecutive liver
resections, 338 (26.8%) of them in cirrhotic patients. Postoperative compli-
cations and mortality were analyzed in relation to the use of vascular
clamping, blood transfusion, liver disease and type of liver resection.
Results. Vascular clamping was applied in 594 (47.1%) cases. Operative
mortality was 3.2% in the vascular clamping group and 2.0% in the non-
clamped group (pn.s.). At multivariate analysis, blood transfusion, major
hepatectomies and presence of cirrhosis were significantly related to post-
operative complications. There was a significantly reduced used of vascular
clamping during the last 20 years as well as of blood transfusion, in the whole
group and among cirrhotic patients. The lowest incidence of severe
complications was in the case of continuous or hemi-hepatic vascular
occlusion. Among the 338 cirrhotic patients, 155 (54.1%) received some
type of vascular control. Morbidity and mortality rates were similar between
the 2 groups. At multivariate analysis, only blood transfusion was significantly
related to postoperative morbidity. Postoperative complications were sig-
nificantly reduced in the group receiving intermittent compared to contin-
uous clamping.
Discussion. Vascular clamping can be applied without additional risk during
partial hepatectomy. Intermittent or hemihepatic vascular occlusion is
preferable in cirrhotic patients.
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THE ROLE OF PARTIAL HEPATECTOMY FOR LIVER METAS-
TASES FROM BREAST CARCINOMA
Giorgio Ercolani1, Gaetano Vetrone, Gian Luca Grazi2, Matteo Ravaioli2,
Matteo Cescon2, Massimo Del Gaudio, Matteo Zanello, Francescon Tuci,
Alessandro Cucchetti, Antonio Daniele Pinna
1Department of Surgery and transplanation-University of Bologna; 2Depart-
ment of Surgery and Transplantation-University of Bologna
Background. To evaluate the role of liver resection for hepatic metastases
from breast carcinoma, early and long term results were retrospectively
reviewed in 38 resected patients.
Methods. Among 528 liver resection for metastases, 38 (7.2%) were
performed for metastases from breast cancer; 381 (72.2%) were performed
for colorectal liver metastases. Mean age was 56.1910.8 year old (varying
from 37 to 76 year old). Mean number of metastases was 1.4 (varying from 1
to 4); single metastases was present in 21 (55.3%) patients. Mean diameter of
the nodules was 4.7 cm (varying from 2 to 11 cm). Only one patient had
synchronous metastases and in 90% of patients primary tumor was ductal
carcinoma. All patients received adjuvant chemotherapy after resection of
primary tumor.
Results. Major hepatectomies were performed in 18 (47.4%) patients, while
minor resections were performed in the remaining 20 (52.6%) cases.
Operative mortality was 0. Postoperative morbidity was 18.4%. Median
postoperative stay was 11.8915.9 days (varying from 3 to 91). The 1, 3 and
5-year actuarial survival rate was 88%, 61% and 31%, respectively. Tumor
diameter and number of metastases did not affect long term survival. The 1,
3 and 5-year survival among the 381 colorectal liver metastases were 89%,
53% and 37%, respectively. No statistical significant difference was found in
survival curve between the 2 groups. Five patients (13.1%) survived longer
than 5 years.
Conclusions. Liver resection is an effective treatment for metastases from
breast cancer; satisfactory long term survival, similar to hepatectomy for
colorectal metastases, can be obtained with an acceptable operative risk.
Patients’ selection is the key point to achieve encouraging results.
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HEPATIC RESECTION FOR METASTASES FROM NON-
COLORECTAL NON-ENDOCRINE TUMORS: EXPERIENCE OF
A SINGLE INSTITUTION
Alessandro Favero1, Roberta Molaro, Aron Zompicchiatti, Enrico Benzoni,
Federico Cattin, Vittorio Bresadola, Dino De Anna, Alessandro Uzzau
1Clinica Chirurgia Generale, University of Udine
Backgrounds. the significance of surgical therapy for hepatic metastases
originating from primary non-colorectal non-neuroendocrine (NCNE)
tumors is yet to be completely clarified. We want to evaluate the role of liver
resection for NCNE metastases from our experience in our institution.
Materials and Methods. Between 1989 and 2006 56 patients with NCNE
hepatic metastases underwent liver resection at Surgical Department of the
University of Udine. 28 were female and 28 male, with a mean age of 60.2
years (range 3779) at the time of surgery. In 22 patients (39.3%), the
metastases were synchronous.
Results. In most cases (80.3%), were performed minor resections. In 8 cases
(14.3%), the main procedure was complemented by a wedge resection, and
in other 7 cases (12.5%) by alcohol or radiofrequency ablation of one or more
deep lesions The median survival rate for the entire group was 20 months,
while actuarial survival at 5 years was 28.9%. Survival was better for non-
gastrointestinal tumors (p0.003), and for patients affected by metachro-
nous metastases with a disease-free interval longer than 24 months (p
0.01).
Conclusions. Hepatic resection for NCNE metastases may be considered as
a viable therapeutic modality such, as showed in this study, in the cases of
metastases originating from non-gastrointestinal tumors, such as sarcoma,
renal and breast cancer.
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SURGICAL TREATMENT OF LIVER METASTASES OF COLOR-
ECTAL CANCER
Alessandro Favero1, Federico Cattin, Roberta Molaro, Enrico Saccomano,
Gaetano Filippone, Giovanni Terrosu, Dino De Anna, Alessandro Uzzau
1Clinica Chirurgia Generale, University of Udine
Introduction. Surgery is currently the only available treatment option which
offers the potential for cure for patients with liver metastases from colorectal
cancer: hepatic resection may offer long-term survival.
Materials and Methods. One hundred and forty-four patients, who
underwent hepatectomy for colorectal cancer metastases at Surgical Depart-
ment of the University of Udine, from 1989 to 2006, were enrolled in this
retrospective study. In 105 (72.9%) cases metastases originated from colon
cancer and in 39 (27.1%) from rectal cancer. 101 (70.1%) were male and 43
(29.9%) female, with a mean age of 61.41 years (range 2582) at the time of
surgery. In 56 patient (38.9%), the metastases were synchcronous.
Results. The median survival rate for the entire group was 30 monthes,
while the overall 5-year survival rate was 28.7%; 5-year survival rate of
hepatic resections performed until 1999 was 20.8% (78 cases) and 46.2%
from 2000 (66 cases) (p0.003). There was no significant 5-year survival
rate difference between patients with colon cancer (26.2%) and rectal cancer
(36.3%). Hospital death was 1.4% (2 cases) and morbidity was 24.3% (35
cases). The survival rates for synchronous and methacronous metastases,
partial resection and hemiepatectomy, single and multiple metastases,
monolobar and bilobar metastases, surgical margins B10 mm or 10mm,
metastases diameter B5cm or 5cm were not statistically significant.
Conclusions. These results show that hepatectomy may offer long survival,
even in patients with multiple or bilobar metastases. Neither the operative
procedure nor the size of the surgical margin had any influence on survival
6 Abstracts
after hepatectomy. This study suggest that liver resection should be indicated
in patients with expanded indications.
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BILIARY DRAINAGE AND INFECTIOUS COMPLICATIONS
AFTER HEPATECTOMY FOR PROXIMAL BILE DUCT TUMOR
OBSTRUCTION
Alessandro Ferrero1, Roberto Lo Tesoriere, Luca Vigano’, Luisa Caggiano,
Roberto Polastri, Lorenzo Capussotti
1Department of Surgery, Ospedale Mauriziano ‘‘Umberto I’’
Background. The role of preoperative biliary drainage before liver resection
in jaundiced patients remains controversial.
Aim. To compare perioperative outcome of liver resection for carcinoma
involving proximal bile duct in jaundiced patients with and without
preoperative biliary drainage.
Patients and Methods. Seventy-four consecutive jaundiced patients under-
went hepatectomy for carcinoma involving proximal bile duct from January
1985 to June 2006 and their data were retrospectively analysed. Fourteen
patients underwent biliary drainage before portal vein embolization because
of small remnant liver and were excluded from the study. Thirty patients
underwent preoperative biliary drainage and thirty underwent liver resection
without preoperative biliary drainage. All patients underwent resection of
extrahepatic biliary tree. Obstruction was due to hilar cholangiocarcinoma
(44 patients), gallbladder cancer (9), intrahepatic cholangiocarcinoma (3),
hepatocellular carcinoma (2), colorectal metastasis (1) and bile duct
polyposis (1). Outcome measures were postoperative liver function tests,
incidence of postoperative infectious and non-infectious complications,
length of hospital stay and overall mortality.
Results. Groups were equivalent for age, sex ratio, cause of jaundice, type of
hepatectomy and number of resected hepatic segments. Preoperative
bilirubin level was lower in preoperative drainage group (3.1 vs 13.2 mg/dl,
pB0.0001). Liver function tests were similar in postoperative day 3 and 7,
while bilirubin level became similar after postoperative day 10. Overall
operative mortality and morbidity rates were similar in the two groups (3.3%
vs 10%, p 0.612 and 70% vs 63.3%, p 0.583, respectively). Patients with
preoperative biliary drainage had significantly increased rates of infectious
complications (40% vs 16.6%, p 0.044). Considering both drainage related
and operative complications, infectious complication rates were even higher
in the drainage group (53.3% vs 16.6%, p 0.002). Multivariate analysis
identified the presence of biliary drainage as the only independent risk factor
for the onset of infectious complication in the postoperative course (RR
4.412, CI95% 1.21616.002, p 0.024). The incidence of non-infectious
complications was similar in the two groups. There was no difference in
hospital stay between the two groups.
Conclusions. Overall mortality and morbidity after liver resection are not
improved by preoperative biliary drainage in jaundiced patients. Pre-
hepatectomy biliary drainage increases the incidence of infectious complica-
tions.
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SALVAGE SURGERY AFTER NEOADJUVANT CHEMOTHERAPY
WITH BEVACIZUMAB IN UNSELECTED PATIENTS WITH
ADVANCED COLORECTAL CANCER AND UNRESECTABLE
SYSTEMIC METASTASIS. RESECTABILITY RATE AND POST-
OPERATIVE OUTCOME
Joan Figueras1, Santi Lopez-Ben, Antoni Codina-Barreras, Inaki Juez2,
Maite Albiol, Xavi Hernandez2, Bernat Queralt2, Jordi Soriano3, Rosa
Ortiz*, Antoni Codina-Cazador
1Dept. of Surgery; 2Oncology; 3Radiology; *Pathology
Background. Surgical resection of liver metastases (LM) from colorectal
cancer (CRC) remains the only therapy with potential for cure. However,
only 1520% of patients are candidates for surgery. Neoadjuvant chemother-
apy has been reported to be effective for initially unresectable liver
metastases.
Objective. The primary objective was to determine the rate of salvage
surgery after neoadjuvant chemotherapy with Bevacizumab in unselected
patients with advanced CRC and unresectable systemic metastasis. The
secondary objective addressed the post-operative outcome (particularly the
development of complications), the frequency of reoperations (owing to
bleeding or biliary leakage) and the postoperative mortality.
Patients and Methods. Study design: Retrospective. However in operated
patients, the data collection was prospective. Period of inclusion: January-
2005 / February-2007. Inclusion Criteria: Biopsy proved CRC. Stage IV
disease with unresectable LM and/or other associated systemic metastases.
Fifty eight patients received neoadjuvant chemotherapy with Bevacizumab as
a first treatment due to LM in 47 cases (80%), lung metastasis in 18 (31%),
peritoneal carcinomatosis in 14 (24%), pedicular lymph nodes in 8 (14%)
and loco-regional recurrence in 13 (22%). Thirty four patients (59%)
presented LM with simultaneous extrahepatic deposits. Extrahepatic disease
was in multiple sites in 13 patients (22%).
Results. There were 42 males (72%) and 16 females (28%). Mean age
was 59Aˆ910 years (range 4077). Median (range) CEA levels before
chemotherapy were 20 (1.23253) ng/mL, and after chemotherapy 5
(0.92143) ng/mL (p0.0001). Median (range) Ca19.9 levels before
chemotherapy were 39.4 (0.64728) ng/mL, and after chemotherapy 15.6
(0.63800) ng/mL (p0.004). Fourteen patients have not completed
therapy, so there are 43 patients for evaluation. The resectability rate was
56% (24/43). Two patients have been operated two times due to recurrence.
Five patients underwent simultaneous surgery of the primary and LM. CEA
levels before surgery were 8.2Aˆ911 (0.9-40) ng/mL, and Ca 19.9 levels
before surgery were 22.8Aˆ916 (0.652) ng/mL. Operations performed
were: Left extended hepatectomy, left or right hepatectomy with contralateral
metastasectomy (n4), right hepatectomy (n2), left hepatectomy (n2),
bisegmentectomy (n2), limited resection (n9), radiofrequency ablation
(n7), lung resection (n2), and peritonectomy. Pathology: Mean number
of LM was 4.75 Aˆ9 2.3 (range 19), 16 (76%) patients had 4 LM and 14
(67%) presented bilobar LM. Median postoperative stay was 7 days (range
058). No patient needed intraoperative transfusion. Mortality and morbid-
ity: Postoperative mortality was nil. Twelve patients (57%) experienced
postoperative complications: intrabdominal collection (n1), ascitis (n3),
hemoperitoneum (n3), hepatic insufficiency (n2), wound infection (n
1), biliary fistula 0% and 5 patients (23%) need a reoperation. However,
according to Clavien’s, classification only 7 patients (33%) were classified by
degree 3 or higher.
Conclusions. Chemotherapy with Bevacizumab has a high surgical rescue
rate (56%). Blood loss, transfusion, incidence of biliary fistula, and infection
is comparable to patients without Avastin. Results about haemorrhage and
reoperation rate need further confirmation.
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TREATMENT OF BILIARY FISTULAS AFTER LIVER RESEC-
TIONS WITH ERCP
Fausto Fiocca1, Vincenzo Ceci2, Gianfranco Donatelli, Alessio Santagati
1University ‘‘La Sapienza’’ of Rome; 2University ‘‘La Sapienza’’  Rome
Biliary fistulas after liver resections or liver trauma are not so infrequent after
this kind of surgery. Often they will close spontaneously but, when a big
peripheral duct is involved, new treatment is required. We report the
successfull treatment of biliary fistulas, both after surgery or after liver
trauma, wirh endoscopic sphincterotomy (ES) and naso-biliary drainage.
Patients and Methods. 15 patients were treated: 12 after liver surgery and 3
after liver trauma previously treated with surgical repair. All patients had a
high flow biliary leak, 300 ml/24 hours, through the surgical drain. All
patient were treated with ERCP that showed the site of biliary leakage, ES
and a naso-biliary tube was left in place with the tip near the main damaged
duct.
Results. ERCP was successfull in all the cases and it clearly showed the main
duct responsible for the bile leak. The day after the procedure the biliary leak
reduced and stopped after a mean of four days.
Conclusions. biliary leak after liver surgery is an annoying complication that
sometimes stops spontaneously which depends on the gradient pressure from
the biliary tree and the papilla and the duodenum. ES with a naso-biliary
drainage reduces the pressure between the biliary tree and the duodenum
allowing the correct biliary outflow.
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REVISED CONSIDERATION OF SURGICAL INDICATIONS FOR
BENIGN TUMORS OF THE LIVER OVER TIME
Gaetano Vetrone1, Gian Luca Grazi, Matteo Cescon, Matteo Ravaioli,
Giorgio Ercolani, Massimo Del Gaudio, Antonio Daniele Pinna
1University of Bologna
Surgical treatment of benign tumors of the liver still represents a challenge.
We reviewed the experience gained in a 20 year period with particular
attention to the indication for surgery.
Two hundred sixty patients were surgically treated: there were 54 (20.8%)
male and 206 (79.2%) female. Mean age was 46.3A˜Aˆ,A˜,Aˆ913.8 (range 18-
75) years. There were 93 (35.8%) pts. carrying hemangiomas (LH), 77
(29.6%) with cystic lesions (CL), 51 (19,6%) with focal nodular hyperplasia
(FNH), 30 (11.5%) with adenoma (LA) and 9 (3.5%) with other different
lesions. One hundred thirty-six (52.3%) pts. were operated before ’95 and
124 (4.77%) thereafter.
There was no difference in the indication for surgery for LH, FNH and LA.
The number of pts. carrying CL decreased from 54 (39.7%) to 23 (18.5%)
(pB0.001) of the more recent years. We observed a slight increased of pts
operated on for reasons different from symptoms (45.9% vs. 54.3%, pNS)
Surgical indication for reasons other then symptoms increased over the year
from 28.1% to 71.9% (pB001). On the other hand, formal indication for
surgery increased from 2.9% to 9.1% (pB0001) and those for tumors that
grew from 5.1% to 26.4% (pB0001). The percentage of patients submitted
to surgery based only on the diameter decreased from 11.8% to 2.5% (pB
0.001). There was no difference in patients operated for diagnostic dilemma.
There were 42 (16.8%) major hepatectomy, 162 minor hepatectomy
(64.8%), 39 (15.6%) cystic drainage, 7 (2.8%) pericystectomy. Mean
hospital stay in liver resection was 17.15 A˜Aˆ,A˜,Aˆ910.5 days. Overall
mortality and morbidity was 0 and 11.6% respectively. Indications for liver
transplantation were 5 symptomatic polycystosis, 3 angiomatosis, 1 adeno-
matosis and 1 nodular regenerative hyperplasia. Mean hospital stay in liver
transplantation was 24.43 A˜Aˆ,A˜,Aˆ914.69 days. Overall mortality and
morbidity was and 30% and 30% respectively.
Abstracts 7
Benign liver lesions represent a consistent indication for hepatic surgery. The
increased knowledge of these diseases led to a substantial change in their
indication for removal. Futile liver resection in this field should be avoided.
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THE IMMUNOSUPPRESSANT DRUG FTY720 INHIBITS PDGF-
BB-INDUCED HEPATIC STELLATE ACTIVATION
Amedeo Carraro1, Enrico Gringeri, Elena Tibaldi2, Giacomo Zanus, Patrizia
Boccagni, Paola Violi, Domenico Bassi, Francesco Jr D’Amico, Anna Maria
Brunati2, Umberto Cillo
1Hepatobiliary Surgery and Liver Transplant Unit  University of Padova;
2Department of Chemical Biology ‘‘A. Vallisneri’’  University of Padova
Introduction. Liver fibrosis is the common response to chronic liver injury,
characterized by the accumulation of Extra-Cellular-Matrix (ECM) proteins.
It is widely recognized that activated Hepatic Stellate Cells (HSCs) play a
pivotal role in the development of liver fibrosis.
Platelet-derived growth factor (PDGF)-BB actually represents the most
vigorous mitogen and stimulator of chemotaxis for HSCs. Furthermore
sphingosine-1-phosphate (S1P), released from activated platelets, has been
recently shown to increase the proliferation of cultured HSCs (i.e. trans-
activation of PDGF receptor). A relevant issue has been recently led to the
hypothesis of a possible interference of SP1 receptors with FTY720, which is
a potent immunomodulator. The aim of this study is to investigate the
potential anti-fibrotic role of FTY720 in the liver.
Results. Our work demonstrated the FTY720 can interfere in the signalling
pathways of HSCs activation, with a reduced mitogenic effects. Furthermore,
our data support that the phosphorylated form of the drug contributes to its
action, but not exclusively, suggesting that FTY720 is effective also in the
not-phosphorylated form.
HSCs treatment with FTY720 resulted in a significant inhibition of PDGF-
induced proliferation in a concentration-dependent manner, without cito-
toxic effects. However, since FTY720 exerts a more powerful effect on
PDGF stimulation than a standard Gi-protein inhibitor, we can suppose that
the drug might act not only through receptors but also through intracellular
targets.
Finally, the evalutation of chemotaxis confirmed the 50% decrease of cell
migration when the cells, stimulated by PDGF, were pre-treated with
FTY720
Conclusion. Our results suggest the validity of this molecule as a potential
novel anti-fibrogenic drug, and further reinforce and extend its role for other
potential clinical applications.
22
MITOCHONDRIAL SRC-DEPENDENT PHOSPHORYLATION IN
A RAT MODEL DURING HEPATIC REGENERATION
Enrico Gringeri1, Amedeo Carraro, Francesco Jr D’Amico, Alberto Brolese,
Daniele Neri, Nela Srsen, Paola Violi, Domenico Bassi, Anna Maria
Brunati2, Umberto Cillo
1Hepatobiliary Surgery and Liver Transplant Unit  University of Padova;
2Department of Chemical Biology ‘‘A. Vallisneri’’  University of Padova
Introduction. Hepatocytes are highly differentiated cells with a potential
capacity of proliferation under particular circumstances such as liver injuries.
Hepatic proliferation in vivo is controlled by several cellular stimuli including
growth factors, hormones ect. Besides, mitochondria have been recently
recognized to have a pivotal role in the signalling pathway. Our aim is to
demonstrate the mitochondrial involvement in the tyrosinic signalling during
liver regeneration.
Materials and Methods. 20 Winstar rats underwent 70% liver resection.
Sub-cellular fractions of liver were purified in different times after surgery.
Hence some aliquots of them were used to verify the immunoreactivity to the
anti-phosphotyrosin antibodies, anti-Lyn, anti-Jak, anti-ERK1/2 and phos-
phorylated forms, and some other proteins usually considered markers for the
cellular cycle. Tirosin kinase Src dependent activity was evaluated using a
specific substrate for Src kinases.
Results. Our data showed an increased activity in terms of tyrosinic
phosphorylation for several mitochondrial proteins along with an highly
activity of mitochondrial Lyn kinase, which is the most expressed protein of
Src family in liver during regeneration.
Even though it is widely recognized that Src family is involved in the cellular
signalling in the plasmatic membrane, however its presence has been recently
shown also in other cellular compartments such as mitochondria, together
with phosphotyrosin phosphatase.
Specifically, our results showed that a tyrosin-kinase Src-dependent activity
exists and it is highly expressed in the mitochondria between G1 and S phase
during hepatic regeneration. Therefore, immunoreactivity assay of Lyn
protein and its mRNA level (real time PCR) showed that the increased
activity of the mitochondrial tyrosin kinase has been due to its translocation
from the cytoplasm to the mitochondria.
Conclusions. Mitochondrial translocation of Lyn tirosin kinase highlighted
the potential role of the phosphotyrosinic signalling during proliferative
phase. A further investigation of Src family might help us to better
understand molecular mechanisms of diseases related to mitochondrial
disfunctions.
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ELEVATED PREOPERATIVE NEUTROPHIL TO LYMPHOCYTE
RATIO CONFERS POOR OUTCOME AND INCREASED RECUR-
RENCE RATE AFTER RESECTION FOR COLORECTAL LIVER
METASTASES
Karim J Halazun1, Amer Aldoori2, Hassan Z Malik3, Ahmed Al-Mukhtar*, K
Rajendra Prasad, Giles J Toogood, J Peter A Lodge3
1HPB and Transplant Unit St. James’s University Hospital, Leeds UK; 2HPB
and transplant Unit St. James’s University Hospital, Leeds UK; 3HPB and
Transplant Unit, St. James’s University Hospital, Leeds UK; *HPB and
Transplant Unit St. James’s university Hospital, Leeds UK
Background. The neutrophil-lymphocyte ratio (NLR) provides an indictor
of inflammatory status, and an elevated NLR has been shown to be a
prognostic indicator in primary colorectal cancer. The immunological
response to malignancy is primarily lymphocyte mediated, therefore the
relative lymphocytopaenia that occurs in patients with raised NLR may incur
a higher risk of recurrence and a poorer prognosis. The aim of this study is to
establish whether NLR can predict outcome in patients undergoing surgery
for colorectal liver metastasis.
Methods. Retrospective analysis of the white cell and differential counts for
440 patients undergoing liver resections for colorectal liver metastasis
between January 1996 and January 2006. An NLR 5:1 was considered to
be elevated.
Results. White cell counts were available for 440 patients. 289 males and
151 females were included with a mean age of 64.1910.7 years and mean
follow up of 30919 months. 78 patients (18%) had elevated NLR, and of
these 55 died, therefore giving elevated NLR a positive predictive value for
death of 71%, while 60 of the 78 had recurrent disease giving raised NLR a
positive predictive value for recurrence of 78%. The 5year survival for
patients undergoing resection with high NLR was significantly worse than
that for patients with normal NLR (5 year survival High NLR 22%, Normal
NLR 43%, Log Rank Test pB0.0001). Univariate analysis of factors
affecting survival revealed that raised NLR, number of metastases (8),
tumour size 5cm and age (70) significantly affected outcome. All factors
except tumour size remained significant predictors of term survival on
multivariate analysis (pB0.0001, HR2.261 CI1.654 3.129 (NLR), p
0.047, HR1.611 CI1.006 2.579 (Mets 8), p0.027, HR1.418
CI1.049 1.930 (Age 70)). On univariate analysis of factors affecting
recurrence, elevated NLR was found to be the sole positive predictor of
recurrence (pB0.0001, HR4.521 CI2.4758.257).
Conclusion. Elevated NLR increases both risk of death and the risk of
recurrence in patients who undergo surgery for colorectal liver metastases.
Preoperative NLR measurement in such patients may provide a simple
method of identifying patients with poorer prognosis.
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A SIMPLE PRE-OPERATIVE PROGNOSTIC SCORE FOR
PATIENTS WITH COLORECTAL LIVER METASTASES
Hassan Z Malik1, Karim J Halazun2, Ahmed Al-Mukhtar3, K Rajendra
Prasad2, Giles J Toogood2, J Peter A Lodge
1HPB and Transplant Unit, St. James’s University Hospital, Leeds UK;
2HPB and Transplant Unit St. James’s University Hospital, Leeds UK; 3HPB
and Transplant Unit St. James’s university Hospital, Leeds UK
Background. With improvements in outcome from liver resection, the
indications for resection of colorectal liver metastases (CRLM) have
expanded. However, debate continues about identifying those patients that
benefit from surgery.
Methods. Clinico-pathological data from a total of 687 patients who
underwent resection for CRLM between January 1993 and January 1996
were reviewed from a prospectively gathered dataset.
Results. The median age of patient was 64 years and 36.7% of patients had
synchronous disease. The presence of an inflammatory response to tumor
(IRT) was noted in 25.2% of cases. The overall 5-year survival was 45%.
Only the presence of 8 or more metastases and an IRT influenced both
overall and disease-free survival on multivariable analysis. A pre-operative
score: 0 less than 8 metastases & absence of IRT; 1 8 or more metastases
or an IFT and 2 8 or more metastases & an IRT- was derived from the
results of the multivariable analysis. This "Leeds criteria" correlates with both
overall and disease-free survival.
Conclusion. This study amounts to the second largest single centre
experience in the surgical management of CRLM. We have validated
previously published results as well as developed a simple pre-operative score
that allows the clinician to stratify patients according to long-term prognosis.
25
LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA
ARISING IN NON-CIRRHOTIC LIVERS
Hauke Lang1, Georgios C. Sotiropoulos, Irene Brokalaki, Christian Ber-
tona2, Klaus J. Schmitz3, Andreas Paul, Massimo Malago’, Christoph E.
Broelsch
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1Department of General-, Visceral and Transplantation Surgery, University
of Essen; 2Hospital Italiano, Buenos Aires; 3*Department of Pathology,
University of Essen
Introduction and Aim. Liver cirrhosis is by far the most frequent risk factor
for HCC but about 1015% of HCC occur non-cirrhotic livers. While there
are numerous reports on liver resection for HCC in cirrhosis the outcome
after hepatectomy for HCC arising in non-cirrhotic livers is not well
documented. It is the aim of this study to analyse surgical treatment and
results as well as to determine prognostic factors for overall and disease-free
survival in a current series of 80 patients after hepatectomy for HCC in non-
cirrhotic liver.
Patients and Methods. Between 06/1998 and 05/2005, 83 patients
underwent liver resection for hepatocellular carcinoma in non-cirrhotic
livers. Data and follow-up of 80 patients were available for analysis with
regard to preoperative treatment, intraoperative details, pathologic findings
and outcome measured by tumor recurrence, treatment of recurrence and
survival.
Results. There were 28 trisectionectomies, 22 left or right hepatectomies, 1
mesohepatectomy and 32 mono- or bi- or multisegmentectomies. In 5
patients, additional atypical resections were performed to remove satellite
lesions or other tumors. In 19 patients the following 20 procedures were
performed in addition to hepatectomy: resection of hilar bifurcation (n3),
bile duct reconstruction (n1), partial resection of diaphragm (n4),
partial resection of the inferior vena cava (IVC; n5), reconstruction of
segment-VI-vein (n1), resection of portal vein (n2) or hepatic artery
(n1), gastrectomy (n1), thoracotomy (n1), adrenalectomy (n1).
There were 66 R0-resections. Following resection, the 3- and 5-year-survival-
rates are 48% and 30%. Survival was significantly better after R0-resection
with a calculated 3- and 5-year-survival of 54% and 39% compared to 23%
and 0% after incomplete resection (pB0.005). So far, after a median follow-
up of 25 months tumor recurred in 40/66 (63%) patients after R0-resection.
In univariate analysis, UICC-stage, vascular invasion and tumor grading were
identified to be significantly associated with recurrence and worse survival
after R0-resection. In tumors without vascular invasion (n39) the 3- and 5-
year-survival was 79% and 65% compared to 21% and 7% with vascular
invasion (pB0.0001). Similarly, R0-resection of G1-tumors (n19) resulted
in significantly better 3- and 5-year-survival (95% each) compared to
resection of G2 and G3 tumors.
Conclusions. The presented data show that an R0-resection offers a chance
for cure in HCC arising in the non-cirrhotic but long-term results are
hampered by a high rate of recurrence. UICC-stage, vascular invasion and
tumor grading are predictive of tumor recurrence and survival. This might
help for a better patient selection and to identify candidates for probable
adjuvant therapy.
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COMPUTER-ASSISTED OPERATION IN MAJOR HEPATECT-
OMY
Hauke Lang1, A. Radtke, M. Hindennach2, Georgios C. Sotiropoulos, H.
Bourquain2, Massimo Malago’, H. O. Peitgen2, Christoph E. Broelsch
1Department of General-, Visceral and Transplantation Surgery, University
of Essen; 2MeVis, Center for Medical Diagnostic Systems and Visualization,
Bremen
Introduction and Aim. Standard planning of hepatic resection is based on
two-dimensional (2-D) imaging of the liver. Recent developments in CT-
techniques allow an improved three-dimensional (3-D) visualization of the
distribution of intrahepatic vascular branches and a precise calculation of
their depending territories. We evaluated the impact of 3-D-reconstruction
and computer-assisted risk analysis on operation planning and intraoperative
strategy in 55 patients considered for major hepatectomy.
Patients and Methods. In the first 25 patients, operation planning and
measurement of the future liver remnant was performed at 2-D-CT.
Thereafter, calculation of the volume of the remaining liver tissue was
repeated with a computer-assisted risk analysis. This volume was defined as
the amount of tissue not being devascularized, but having portal venous
blood supply and hepatic venous drainage after resection. The results of
remaining liver tissue in 2-D-CT and after computer-assisted risk analysis
were compared.
In patient 26 to 61, operation planning was made directly at the 3-D-
reconstructed liver.
Results. The deviation of 2-D-CT and computer-assisted risk analysis was
below 20% (n17/25), between 2030% (n4/25), and between 3040%
and 4050% in two patients, each. Most extensive deviations were found in
extended left hepatectomies. In 8 patients, the results of computer-assisted
risk analysis led to a change of operation planning with regard to extend of
resection or need for vascular reconstruction.
Conclusions. By use of computer-assisted analysis areas at risk for either
devascularization or venous congestion can be calculated precisely prior to
liver resection. In selected cases with small liver remnants or large anatomic
variations, operation planning may be improved substantially by this
technique.
27
SURGICAL TREATMENT OF INTRAHEPATIC CHOLANGIOCEL-
LULAR CARCINOMA
Hauke Lang1, Georgios C. Sotiropoulos, Klaus J. Schmitz2, Andreas Paul,
Massimo Malago’, Christoph E. Broelsch
1Department of General-, Visceral and Transplantation Surgery, University
of Essen; 2*Department of Pathology, University of Essen
Introduction and Aim. Intrahepatic cholangiocarcinoma (CCC) is asso-
ciated with a poor prognosis. Since CCC is currently considered a contra-
indication for liver transplantation and results of chemotherapy are poor
surgical resection remains the only chance for cure. Therefore, since 04/1998
we have adopted an aggressive surgical approach to CCC.
Patients and Methods. Data of 142 patients who underwent explorative
laparoscopy/laparotomy for CCC between 1998 and 2005 were evaluated.
There were no data of hilar cholangiocarcinoma or gall bladder carcinoma
within this analysis.
Results. In 70 patients liver resection was performed (resectability rate
49%). There were 48 trisectionectomies, 14 left or right hepatectomies and 8
mono- or bi- or multisegmentectomies. In addition the following procedures
were performed: resection of hilar bifurcation (n26), partial resection of
Vena Cava (n5), portal vein (n9), major hepatic vein (n2) or hepatic
artery (n1). Median blood transfusion was 2 EK (range: 012 EK). There
were 43 R0-, 23 R1- and 4 R2-resections. Thirty-day-mortality was 6/70
(8.6%). Morbidity requiring operative or interventional/medical treatment
was 40%. There were 34 solitary tumors. Median tumor diameter was 8 cm
(range: 218cm). In 23 patients, there was tumor involvement of locor-
egional lymphnodes. Vascular invasion was found in 33/70 cases including
macrovascular tumor invasion in 10 CCC. Following resection the calculated
5-year-survival is 27% with a median survival of 26 months. After R0-
resection the calculated 5-year-survival is 48% compared to 0% after
incomplete resection (pB0.0001;LogRank).
Conclusions. The presented data show that an R0-resection offers a chance
for long-term survival even in large intrahepatic cholangiocarcinoma. This
justifies an aggressive surgical approach which often requires additional
vascular or biliary reconstructions. On contrast, with regard to the poor
results after incomplete (R1-/R2)-resection there is hardly an indication for
palliative tumor resection in CCC. The high rate of irresectability under-
scores the use of diagnostic laparoscopy.
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EVOLUTION IN OPERATIVE AND NON-OPERATIVE MANAGE-
MENT OF HEPATIC TRAUMA: A 20-YEAR SINGLE-CENTER
EXPERIENCE
Petrowsky Henrik1, Perez Daniel, Keel Marius2, Trentz Otmar2, Clavien
Pierre-Alain
1Swiss HPB Center, Dept. of Visceral and Transplant Surgery, University
Hospital Zurich; 2Dept. of Trauma Surgery, University Hospital Zurich
Objective. To assess the evolution in operative (OM) vs. non-operative
management (NOM) of hepatic trauma in a large consecutive single-center
series over a 20-year period.
Background. Advances in diagnostic imaging and emergency management
during the past two decades as well as the introduction of ‘‘damage control’’
strategies in trauma patients have influenced the practice of liver trauma
management. Therefore, we investigated the impact of these factors on the
management of hepatic trauma with special emphasis on OM and NOM.
Methods: Patients with liver trauma who were treated at our center during
the 20-year study period (19852005) were reviewed. The following data
were collected: demographics, mechanisms of injury, diagnostic imaging,
hepatic and associated injuries, management of hepatic injury (OM vs.
NOM), and outcome. The degree of hepatic trauma was graded either
operatively or by CT scan according to hepatic injury scale (Moore et al. J
Trauma 1989). The analysis was performed for the early (1985 1995) and
late (19962005) study period.
Results. 322 patients (M/F: 216/106, median age 31 yrs, R: 1681 yrs) were
treated for liver trauma during the entire study period. Blunt liver trauma was
present in 254 patients (79%) and penetrating liver trauma in 68 patients
(21%). OM was performed in 203 patients (63%) and NOM in 119 patients
(37%) during the study period. There were no apparent differences in the
severity of liver damage or associated injuries between both periods. The
mortality rate was 35% for the early period and improved to 23% in the late
period. While only the minority of patients was treated non-operatively
during the early period (OM 95%, NOM 5%), there was a significant shift to
NOM in the later period (OM 52%, NOM 48%). The increase in NOM over
the study period directly correlated with the increased use of CT scan as
diagnostic modality (R20.96). Non-operative treatment was successful in
93% of patients (failure rate 7%) and was associated with a low mortality rate
(7%). Also, a shift to significantly shorter operation times (OM group) was
observed between the early and late study period (154 vs. 242 min, pB0.01).
Multivariate analysis revealed that age, operative therapy, transfusion
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requirement, as well as associated head and pelvic injuries were independent
predictors of poor outcome.
Conclusion. During the last decade, there was a significant change in the
management of hepatic trauma which resulted in improved survival. Non-
operative management of hepatic trauma became the treatment of choice in
hemodynamically stable patients and is associated with a high success rate.
For patients requiring OM, the duration of initial surgery should be kept as
minimal as possible.
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ISOLATED TOTAL CAVAL CLAMPING WITH ‘‘REMNANT LIVER
SHUNT’’ FOR COMBINED HEPATIC AND VENOCAVAL RESEC-
TION IN TUMORS INVOLVING VENACAVA
Belghiti Jacques1, ANDRAUS Wellington, VARMA Deepak, Ogata Satoshi
1HPB Surgery  Hospital Beaujon
Hepatic vascular exclusion procedures, ranging from total vascular exclusion
(TVE) to selective hepatic vascular exclusion, have extended the indication
for complex hepatic resections. TVE is indicated in major tumor involvement
of hepatocaval confluence, but imparts major hemodynamic consequences
and morbidity in a significant number of patients.
We describe herein, a new technique of isolated total caval clamping with
preservation of portal flow through the remnant liver used as a shunt. We
experienced 10 patients with right sided tumor involving the right hepato-
caval confluence underwent right hepatic resection associated with recon-
struction of vena cava. After division of the liver parenchyma the superior
clamp was applied obliquely below the common trunk of middle and left
hepatic veins while the inferior clamp was totally occluding the venacava
above the renal veins. The left remnant liver continued to be perfused during
caval reconstruction. This perfusion using the remnant liver as a shunt
maintained the hemodynamic stability of all patients resulting in good
postoperative outcome. This procedure would reduce the indications of
TVE to exceptional cases with the involvement of the three hepatic veins.
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SINGLE AND MULTIPLE HEPATOCELLULAR CARCINOMA: A
SINGLE CENTRE SURGICAL EXPERIENCE OF 120 CASES
Belghiti Jacques1, Dokmak Safi2, Paradis Valerie3, Vilgrain Valerie*, Farges
Olivier2, Sauvanet Alain2, Valla Dominique$, Lesurtel Mickael2, BEDOSSA
Pierre3
1HPB Surgery-Hospital Beaujon; 2HPB Surgery-Hospital Beaujon; 3Pathol-
ogy-Hospital Beaujon; *Radiology-Hospital Beaujon; $Hepatology-Hospital
Beaujon
Aims. Hepatocellular adenoma (HA) is a rare benign liver tumor with a
significant risk of bleeding and malignancy justifying resection. The aim of
this single centre study including 120 patients who underwent a surgical
resection for single and multiple HA, was to clarify the indications of liver
resection and to study the long-term outcome.
Patients and Methods. Between 1990 and 2004, 120 patients (109 females)
mean aged 37.5 yrs (range 1662) with a definite diagnosis of HA established
on surgical specimen, were included. Among the 59 patients who had a
multiple adenoma, 3 patients underwent a liver transplantation and 13
patients (22%) had a complete resection, while every cases with a single
adenoma (n61) underwent a complete resection. In the group with multiple
HA in whom surgical excision of all tumors was not possible, only tumors
5cm were resected. Bleeding HA was present in 25 (21%) patients and
malignancy in 12 (10%). The mean follow-up was 74 months (range 18192).
Results. There was no significant difference between the group with single
HA and the group with multiple HA concerning age (37 yrs vs 38 yrs), use of
oral contraceptive (92% vs 92%), bleeding (24% vs 17%) and malignancy
(11% vs 8.5%). Tumor size was  5cm in case of malignancy and in 24/25
(96%) patients with bleeding HA. There was a malignant HA in 5 of the
11(45%) males and in 7 of the 109 (6%) females (pB0.001). All patients
with multiple malignancy (n3) were transplanted but died due to
malignant recurrence within 2 years. The other 9 patients with malignancy
who underwent resection were alive without recurrence with a mean follow-
up of 54 months (18132). Among the 43 patients with multiple HA
incompletely resected, 5 (12%) experienced tumor progression requiring
systematic re-resection in only 2 with HA5cm, while 4 (9%) patients
experienced tumor regression.
Conclusions. Whatever the number of hepatocellular adenoma, the risk of
bleeding and malignancy is quite exclusively observed in large tumors (
5cm). Resection of HA5cm, including those with malignancy is necessary
and sufficient. There is no indication of liver transplantation for multiple HA.
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PROGNOSTIC FACTORS IN HEPATIC RESECTIONS FOR THE
COLORECTAL CANCER METASTASES
Aleksandar Karamarkovic1
1University Center for Emergency Surgery, School of Medicine Belgrade
Background. Liver resection currently serves as the only one curative
therapy for liver metastases from colorectal carcinoma. Appropriate criteria
for surgical resection are controversial.
Aim. The aim of this study was to determine the caracteristics of the disease
which affected prognosis.
Methodology. Between March 2002 and December 2006, 135 patients with
hepatic metastases from colorectal carcinoma underwent anatomical liver
resection at our institution. There were 77 men and 58 women, with a mean
age of 56.9 years (range 2274). The follow-up period ranged from 2 to 69
months. The survival rate was estimated by the Kaplan-Meier method and
compared by log-rank test.
Results. 76 of the primary lesions were located in the colon and 59 in the
rectum. There were 42 Dukes B, 54Dukes C and 39 Dukes D. Liver
metastases were detected synchronously in 45 and metachronously in 90
patients at the time of diagnosis. The operative mortality rate within 30
postoperative days was 3.1%. During the follow-up period we registered
tumor recurrence rate of 14.1%. The overall 5-year survival rate was 31.8%.
Multivariate analysis shows a significant correlation between 5-year survival
and solitary (pB0.05) and unilobar (pB0.01) metastases. The survival rate
did not significantly correlate with gender, age, location of primary tumor,
Dukes classification, time of diagnosis or CEA level.
Conclusions. According to our results, number and localization of meta-
static liver lesions represents the prognostic factors of significant importance.
Without an effective therapeutic alternative, liver resection is still recom-
mended and represent a ‘‘gold’’ standard in the treatment of colorectal liver
metastases.
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SURGICAL TREATMENT OF HYDATID LIVER DISEASE
Aleksandar Karamarkovic1, Pavle Gregoric2, Nenad Ivancevic2, Ivan Blazic2,
Krstina Doklestic2
1University Center for Emergency Surgery, School of Medicine Belgrade;
2University Center for Emergency Surgery
Background. Surgery remains the main treatment modality of hydatid liver
disease. There still debate about the best approach, conservative surgery
(marsupialization, drainage, partial cystectomy) has opposed to radical
surgery in which the cyst is totally removed including the pericyst by total
pericystectomy or partial hepatectomy.
Aim. This study aims to show that radical surgery resection of the hepatic
hydatid cysts is a safe and effective technique.
Patients and Methods. A series of 49 consecutive patients operated on for
liver hydatid disease between January 2003 and December 2006 was
analyzed. The most common compliant were pain (62%), hepatomegaly
and abdominal mass (39%). Diagnostic assessment was obtained with
serology (ELISA) and radiology (US and CT scan). Surgery comprised
conservative methods like partial cystopericystectomy with intracavitary
placed drainage and omentoplasty of residual cavity (21 pt.), and radical
surgical methods like total cystopericystectomy (5 pts.) and liver resection
(segmentectomy, lobectomy, hemihepatectomy) (23 pts.).
Results. In the entire series, morbidity was 19% of which 28% was seen with
conservative surgery and 11% with radical methods (pB0.05). Biliary fistula
was more frequent complication in both groups: 15.9% vs. 4.2% (pB0.01) in
patients that underwent conservative methods and radical methods, respec-
tively. There was no operative and postoperative mortality in our studied
group. Long-term follow-up showed that hydatid disease relapsed frequently
in patients who underwent conservative treatment than in those who
underwent radical surgical approach: 4 pts. Vs. 0 pts.
Conclusion. According to our results, radical surgery of the hydatid liver
disease represents the method of choice over others such as partial
pericystectomy.
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NEW INSIGHTS INTO THE REGENERATIVE RESPONSE FOL-
LOWING MAJOR HEPATECTOMY, PORTAL VEIN EMBOLIZA-
TION AND LIGATION
Furrer Katarzyna1, Tian Yinghua, Pfammatter Thomas2, Jochum Wolfram3,
Graf Rolf, Clavien Pierre-Alain
1Swiss Hepato-Pancreato-Biliary (HPB) Center, University Hospital Zurich,
Department of Surgery; 2University Hospital Zurich, Department of Radi-
ology; 3University Hospital Zurich, Department of Pathology
Objective. To compare the impact of portal vein embolization (PVE), portal
vein ligation (PVL) and anatomic major hepatectomy on liver regeneration.
Background. Liver resection is the only cure for a number of malignant or
benign diseases. Preoperative induction of hypertrophy of the healthy part of
the liver increases the resectability rates of large tumors. Two strategies are
clinically available to induce selective hypertrophy of the liver; PVE and PVL.
There are persistent controversies about which strategy is the most effective.
Methods. Male Wistar rats (n5 in each group) were subjected to selective
70% PVL, 70% PVE, as well as 70% partial hepatectomy (PH) (positive
control) or sham operation (negative control). PVE of liver segments was
validated by angiography and histological staining demonstrating permanent
obstruction of the involved portal branches. The hepatic artery remained
patent in each group. Liver weight and a variety of markers and mediators of
regeneration were assessed at 24hr, 48hr, 72hr, and 7 days after surgery.
Results. The weight of the regenerating liver segments increased continu-
ously in all groups reaching the highest values after PH. This group also
disclosed the strongest proliferative activity. For example, Ki67 staining at
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48h disclosed 280 positive cells per visual field (VF) vs. 10 in the sham group
(p0.0001). PVL displayed also a high regenerative response (190 cells/VF),
which was significantly more pronounced than PVE (100 cells/VF) (p
0.01). The ispilateral part of the liver atrophied in both groups with smaller
volumes observed in the PVE group. For example, at 48hr the ipsilateral
segment was 7.5g in the PVL group vs. 5g in the PVE group (p0.001).
Focuses of necrosis were 60% more prevalent in the PVL group (p0.008).
Transcript levels of cytokines (Il-1beta, TNF-alpha, IL-6) peaked at 24hr and
were highest after PH. Hepatocyte growth factor (HGF) expression appeared
delayed in PVL and PVE compared to PH group.
Conclusion. Selective induction of liver hypertrophy is highly dependent on
the type of intervention, with PH associated with the strongest regenerative
response. PVL was superior to PVE in the regenerative response of the
contralateral segment. PVE resulted in higher atrophy of the ipsilateral part of
the liver compared to PVL. These findings may trigger the search for novel
strategy in patients.
34
BILIARY DRAINAGE ATTENUATES POST-ISCHEMIC REPER-
FUSION INJURY IN THE CHOLESTATIC RAT LIVER
J.J. Kloek1, H.A. Marsman, A.K. van Vliet, D.J. Gouma, T.M. Van Gulik
1Department of Surgery, Academic Medical Center, Amsterdam
Background. Oxidative stress plays an important role in cell death and has
been identified as a pathogenic feature of parenchymal injury in cholestasis.
During major liver resections, vascular inflow occlusion can be applied to
reduce intraoperative blood loss. The combination of ischemia and oxidative
stress potentially enhances post-ischemic reperfusion injury and increases the
risk of remnant liver failure in cholestatic patients requiring extended liver
resection. Biliary decompression relieves oxidative stress in cholestasis.
Therefore, preoperative biliary drainage seems a worthwhile intervention in
cholestatic patients undergoing major liver resection, although this is
debatable in distal tumors which are resected without partial liver resection.
The aim of this study was to assess the influence of cholestasis on
hepatocellular injury after hepatic ischemia and reperfusion (I/R) injury in
a bile duct ligation (BDL) model in the rat. In addition, the effect of biliary
decompression prior to I/R was studied.
Methods. Male Wistar rats were randomized into three groups: The first
group (n6) underwent partial liver ischemia after 7 days BDL. Partial liver
ischemia was induced by clamping of the segmental portal triad to the
median and left lateral lobes (970%) for 30 minutes. The second group (n
6) underwent internal drainage (ID) after 7 days BDL and following 5 days,
was subjected to ischemia. Control animals (n6) underwent two sham
laparotomies at 7 and 12 days, respectively, and subsequently ischemia. A
reperfusion period of 24h was applied in all groups after which the rats were
sacrificed. To assess the effects of BDL, ID and sham operations, rats (n6
per group) were sacrificed before inducing liver ischemia. Blood was collected
before ischemia, and after 30min, 6h and 24h of reperfusion, respectively.
The following outcome parameters were assessed: plasma AST and ALT,
hepatic oedema, lipid peroxidation, histopathology, hepatic synthetic func-
tion (albumin and prothrombin time), inflammatory response {plasma IL-6,
IL-10, IFN-y and GRO/KC (a chemoattractive cytokine in rodents), hepatic
myeloperoxidase (MPO) activity} and the total antioxidant activity (a marker
of antioxidant status) of the liver.
Results. Peak levels of AST and ALT were significantly higher at 6h
reperfusion as compared to the control and ID group (BDL group:
AST:159794595U/L; ALT:398791560U/L control group: AST:13289
429U/L; ALT:11409329U/L and ID group: AST:275091508U/L;
ALT:10979497U/L (pB0.01). Plasma IL-6, IL-10 and GRO/KC were all
significantly increased in the cholestatic group over 24 hour reperfusion (pB
0.05 for control and ID). Prothrombin time, MPO, necrosis, lipid peroxida-
tion and oedema were all significantly increased in the BDL group after 24h
reperfusion (pB0.05 for control and ID). Moreover, the antioxidant activity
was strongly decreased in the cholestatic group (pB0.01 for control and ID).
No significant differences for most parameters were seen in the ID group as
compared to the control group.
Conclusion. The cholestatic rat liver is more susceptible to post-ischemic
reperfusion injury, probably mediated by decreased antioxidant activity and
an increased inflammatory response. These injurious effects were attenuated
by biliary decompression. The results of this study suggest an increased risk
of inflammatory events, such as clamping of the portal triad during liver
resection, in the presence of cholestasis.
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CAN BARCELONA CLINIC LIVER CANCER SYSTEM IMPROVE
OUR APPROACH IN THE TREATMENT OF HEPATOCELLULAR
CARCINOMA?
Gaetano La Greca1, Rosario Lombardo, Maria Sofia, Francesco Barbagallo,
Rosario Vecchio2, Domenico Russello, Stefano Puleo2
1Department of Surgical Sciences, Organ Transplantation, and Advanced
Technologies, University of Catania, Cannizzaro Hospital, Catania, Italy;
2Department of General Surgery, Vittorio Emanuele Hospital, Catania, Italy
Background/Aims. The Barcelona Clinic Liver Cancer (BCLC) classifica-
tion has been recently validated as the best system for treatment guidance for
hepatocellular carcinoma (HCC) in relation to tumor stage, liver functional
status and physical status. The BCLC linking these variables divides patients
in four stages combinated with a treatment algorithm. In spite of this the
BCLC system doesn’t consider other important variables for the choice of the
best treatment in early and very early stage (indocyanina green clearance
retention, future liver remnant percentage, grade of liver fibrosis, presence of
active hepatites). The aim of this retrospective study is to evaluate the
usefulness of BCLC for hepatic surgeons comparing our treatment decision
and BCLC algorithm indications.
Materials and Methods. A retrospective analysis of 102 patients with HCC
observed from 1991 to 2002 was performed. Age, sex, Child-Pugh
classification, Okuda stage, tumor size, and IGC test according to Makuuchi
algorithm, were analysed. The choice of treatment was compared with the
treatment schedule proposed by BCLC.
Results. Of 102 patients, in 44 (43.1%) cases our treatment and BCLC
system were in agreement, while in the remnant 58 (56,9%) cases, there was
an undertreatment in 47 (81.1%) patients and an overtreatment in 11
(18.9%). About the undertreatment cases in 21 (44.7%) patients we didn’t
perform hepatic resection such as BCLC suggests because of advanced age
and/or high level of IGC; in 20 (42.5%) patients in which BCLC suggests
chemoembolization, we supposed this treatment an high risk therapy and
contraindicated it because of sieric bilirubin level 3 mg/dl, the prevalence of
patients in Child B class and difficult anatomical site for selective emboliza-
tion. About the overtreatment in 4 (36.4%) patients we choose hepatic
resection, even if BCLC would suggests ablative treatment or chemoembo-
lization, because early Child B class and good liver functional status.
Conclusions. Analysing our conduct in the treatment of HCC during ten
year before introduction of BCLC classification, we can conclude that even if
the disagreement was not neglectible, the BCLC system wouldn’t changed
our decision expecially in surgical indication. In fact to perform an hepatic
resection the presence of a single node in a patient in good health condition
couldn’t be enough for a safe surgery and an estimation of liver function
reserve, like IGC test, is advisable. In conclusion the BCLC system is a good
tool for a first selection of patients, but not adds any specific data for the
security in the choice of the best treatment for each patient.
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LIVER RESECTION FOR NON-COLORECTAL NON-NEUROEN-
DOCRINE METASTASES: ANALYSIS OF A MULTICENTER
STUDY FROM ARGENTINA WITH 106 PATIENTS
Javier Lendoire1, Mariano Moro2, Oscar Andriani3, Jorge Grondona*,
Octavio Gil$, Ricardo Bracco*, Jorge Silva3, Carlos Valenzuela$, Oscar
Imventarza, Eduardo de Santibanes2
1Hospital Dr C Argerich; 2Hospital Italiano; 3Fundacio´n Favaloro; *Centro
Me´dico Martı´n y Omar; $Sanatorio Allende
Resection of colorectal liver metastases has become a standard of care.
However, the value of this procedure in non-colorectal non-neuroendocrine
(NCRNNE) metastases remains controversial and is still debated.
Objective. To determine the utility of liver resection in the long term
outcome of patients with NCRNNE metastases.
Methods. Records of 106 patients who underwent liver resection for
NCRNNE metastases from 1989 to 2006 in 5 HPB Centers of Argentina
were analyzed.
Patient demographics, tumor characteristics, type of resection, long term
outcome and prognostic factors were analyzed. According to primary tumor
sites a comparative analysis of survival was performed.
Results. Mean age was 54 (1776) Hepatic metastases were solitary in 62%
and unilateral in 86%. Primary tumor sites were: Urogenital (37,7%),
Sarcomas (21,7%), Breast (17,9%), Gastrointestinal (6,6%), Melanoma
(5,7%) and others (10.4%). 51 major hepatectomies and 55 minor resections
were performed. 24 patients underwent synchronous liver resection. In
89,6% an R0 resection could be achieved. There was no surgical mortality.
Overall 2 and 5 year survival rates of 46% and 18% were observed. Survival
was significantly longer for metastases of urogenital (p0.0001) and breast
(p0.003) origin. Curative resections (p0.04) and metachronous disease
(p0.0001) were predictors of better survival. The disease free interval from
time of original disease to presentation with liver metastases and the extent of
resection were not predictive of outcome. We conclude that liver resection is
an effective treatment for NCRNNE liver metastases; it allows a satisfactory
long term survival especially in metachronous disease, in patients with
metastases from urogenital and breast tumors and when R0 procedures can
be performed.
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RIGHT PORTAL VEIN LIGATION IS AS EFFICIENT AS PORTAL
VEIN EMBOLIZATION TO INDUCE HYPERTROPHY OF THE
LEFT LIVER REMNANT
Beatrice Aussilhou1, Mickael Lesurtel, Safi Dokmak, Reza Kianmanesh,
Olivier Farges, Alain Sauvanet, Annie Sibert2, Valerie Vilgrain2, Jacques
Belghiti
1Department of HPB Surgery BEAUJON HOSPITAL, Clichy, France;
2Department of Radiology BEAUJON HOSPITAL, Clichy, France
Background and Aim. Right Portal Vein (PV) obstruction induces
hypertrophy of the future left liver remnant. Right Portal Vein Ligation
(PVL), which is supposed to result in an incomplete and transient occlusion,
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has been considered to be less efficient than right Portal Vein Embolization
(PVE) before a right hepatectomy. The aim of this study was to compare PVL
and PVE before right hepatectomy in terms of efficacy for induction of left
liver hypertrophy.
Methods. Between 1998 and 2003, 35 patients with liver metastases
underwent a right portal branch obstruction before ‘‘high risk’’ right
hepatectomy because of a future remnant liver volume less than 30% of
the total liver volume or because of a postchemotherapy liver parenchyma.
PVE was performed percutaneously in 18 patients, while 17 patients
underwent a PVL during a first stage laparotomy for resection of the primary
tumor (n10) and/or resection of left liver metastases (n16).
Results. Right portal vein occlusion was complete in all the cases in both
groups except for one patient in group PVE. Interval time between portal
vein occlusion and liver resection was similar in both groups (793 weeks
after PVE vs. 893 weeks after PVL, p0.6) There was no complication
following PVE and postoperative hospital stay was 291 days. In group PVL,
6 patients had postoperative complications which were related to primary
tumor resection and postoperative hospital stay was 1396 days. The left liver
volume increased from 5099222 ml to 6419220 ml after PVE (pB0.001),
and from 4779179 ml to 6389192 ml after PVL (pB0.001). After PV
occlusion, the increase of the left liver volume was not significantly different
between the two groups (35938% after PVE vs. 38926% after PVL, p
0.7). After PVE, 6 patients were not eligible for right hepatectomy because of
insufficient hypertrophy of the left liver (n2) or tumor progression (n4).
After PVL, 3 patients were not eligible for resection because of tumor
progression (n2) or death (n1). Prior to resection, CT-scan showed a
portal cavernoma in 3 patients of each group. Technical difficulties during
surgical procedure were similar in both groups according to duration of
procedure (6.491 hours vs. 6.791 hours, p0.7) and transfusion rates
(33% vs. 28%, p0.7) after PVE and PVL, respectively.
Conclusion. Right PVL and PVE result in a comparable hypertrophy of the
left liver. During the first laparotomy of a two-step liver resection, PVL can be
efficiently and safely performed.
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SEQUENTIAL PREOPERATIVE IPSILATERAL PORTAL AND
ARTERIAL EMBOLIZATION IN PATIENTS WITH LIVER TU-
MORS
Salvatore Gruttadauria1, Lucio Mandala`, Angelo Luca, Roberto Miraglia,
Luigi Maruzzelli, Bruno Gridelli
1ISMETT-UPMC Italy
Introduction. Preoperative portal vein embolization (PVE) induces ipsilat-
eral atrophy of the hepatic parenchyma to be resected, as well as contralateral
compensatory hypertrophy of the residual liver. However, there are two
potential problems with this technique: inadequate contralateral hypertrophy
and tumor progression while waiting for the non-embolized liver to
hypertrophy. We devised a strategy to deal with these two problems by
performing an ipsilateral hepatic artery embolization (HAE) 6 weeks after an
unsatisfactory PVE in an effort to accelerate the hypertrophy of the remnant
liver.
Material and Methods. Five patients underwent to this sequential
preoperative treatment in order to achieve resectability of their tumor. Two
patients had liver metastases from colorectal cancer, two patients had
hepatocellular carcinoma and the last one had a primary endocrine hepatic
tumor. In all patients percutaneous right PVE was realized using micro-
spheres (300500 mm) and metallic coils to increase the volume of the left
lobe. After 6 weeks a CT scan was obtained to evaluate the volume of the left
lobe and then selective right HAE was performed using microspheres (300
500 mm) and Gelfoam sponge, finally after 3 weeks a CT scan was repeated.
Result. Table 1 showed Volumes of the future remnant liver at different
stages calculated by CT scan.
This strategy allowed two patients to successfully undergo to a right
trisegmentectomy, two patients successfully received a standard right
hepaetcomy and in one case, resective surgery was not performed because
of diffusion of the disease in the remnant lobe, although the patient is still
alive waiting for a liver transplant.
Conclusion. We reserved this sequential combined ipsilateral embolization
for cases where the tumor was located in the embolized part of the liver,
because we do not know the effect of this approach on tumor overgrowth
when the tumor is located in the non-embolized part of the parenchyma.
Based on our observation in selected cases without cirrhosis or cholestasis, it
is worthwhile to pursue a sequential ipsilateral portal vein and hepatic artery
embolization if the remnant liver does not reach a satisfactory volume 6 weeks
after PVE.
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LIVER RESECTION FOR HILAR CHOLANGIOCARCINOMA:
LONG-TERM RESULTS AND PROGNOSTIC FACTORS
Andrea Muratore1, Alfredo Mellano, Enrico Sgotto2, Roberto Lotesoriere2,
Lorenzo Capussotti
1Istituto Per La Ricerca E La Cura Del Cancro; 2Ospedale Mauriziano
‘‘UMBERTO I’’
Aims. To analyze long-term results and prognostic factors of patients with
hilar cholangiocarcinoma who underwent extended surgical procedures
Patients and Methods. Single-unit, retrospective study analyzing 62
patients. Bismuth 1 four patients, Bismuth 2 ten patients, Bismuth 3 forty-
seven patients, and Bismuth 4 one patient.
Results. Bile duct confluence and liver resection were associated in 55
patients (82.1%); all but three had also caudate lobe resection. The mean
number of dissected lymph nodes was 7.2 (95% CI: 5.58.8). Fifty-three
patients (85.5%) had a radical resection. The in-hospital mortality and
morbidity rates were 4.839% and 62.903% respectively. Mean follow up was
22.6 months (95% CI: 15.329.8). The 1- and 3-year overall survival rates
were 71.781% and 32.977% respectively (median survival 19.8 months). The
1- and 3-year disease-free (DF) survival rates were 64.047% and 28.301%
respectively (median DF survival 14.6 months). Forty-three patients
(72.881%) developed a recurrence. In multivariate analysis, T stage and
the presence of regional lymph node metastases (Npos) were independent
predictors of survival (T1-2 vs T3-4: RR 0.275, p0.003; Npos vs Nneg: RR
4.838, p0.028). The presence of lymph node metastases was the only
independent predictor of worse DF survival (RR 1.888, p0.0535). By the
end of follow up, twelve patients were alive without recurrence (mean follow
up 50.4 months; 95% CI: 26.973.9): T1-2N0 eight patients, T3-4N0 three
patients, and T3N one patient.
Conclusions. Extended curative surgical procedures can be accomplished
with low mortally rates. Long-term survival is possible, mainly among node-
negative patients
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LONG TERM OUTCOME OF PORTAL VEIN EMBOLISATION
PRIOR TO MAJOR HEPATECTOMY FOR COLORECTAL CAN-
CER LIVER METASTASES
Viniyendra Pamecha1, Bahmans Nedjat Shokouhi2, George Glantzounis2,
Niel Davies3, Brian Davidson*
1HPB and Liver Transplantation Unit, Royal Free Hospital, London; 2HPB
and Liver Transplantation Unit, Royal Free Hospital,London; 3Department
of Radiology, Royal Free Hospital, London; *HPB and Liver Transplantation
Unit, Royal Free Hospital,London
Background. Preoperative portal vein embolisation (PVE) can be used to
increase the remaining liver parenchyma volume before major liver resection.
There are few reports on long term outcome of liver resection following
preoperative PVE for colorectal cancer (CRC) liver metastases.
Objective. To assess feasibility, risks and long term outcomes of preoperative
portal vein embolisation prior to major hepatectomy for colorectal cancer
liver metastases.
Methods. Over a period of seven years thirty six patients underwent
preoperative PVE before resection of four or more liver segments for CRC
liver metastases. PVE was performed when the future liver remnant (FLR)
assessed by MRI scan volumetry was less than 30%.
Results. PVE was feasible in all patients. PVE significantly increased the
FLR volume. The median FLR pre PVE was 295mls (range 110588) and
increased post PVE to 404mls (range 239653) pB0.0001. Liver
resection was performed after PVE in 22 patients (61%).The mortality and
morbidity was 4.5% and 27% respectively. The 1, 3, and 5 year actuarial
survival was 90%, 50%, 30% and survival after liver resection was 95%, 80%,
50%.
Conclusions. PVE allows patients with unresectable liver metastases to be
considered for resection. Long-term survival comparable to that of resection
without PVE can be achieved.
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YTTRIUM 90 MICROSPHERE THERAPY FOR HEPATIC MALIG-
NANCY: INITIAL CONSIDERATION
A. Percivale1, S. Baldo, A. Gandini, E. Azzola2, P. Gazzo3, N. Gandolfo3, O.
Serrato3, D. Venerucci3, P. Moresco*, M. Chianello*, C. Cananzi$, L.
Bertolazzi$, R. Pellicci
1Surgical Department of Santa Corona Hospital, Pietra Ligure (SV) Italy;
2Gastroentelogy of Santa Corona Hospital, Pietra Ligure (SV) Italy;
3Radiological Department of Santa Corona Hospital, Pietra Ligure (SV)
Italy; *Health Physic Units of Santa Corona Hospital, Pietra Ligure (SV)
Italy; $Nuclear Medicine of Santa Corona Hospital, Pietra Ligure (SV) Italy
Objective. Surgical resection remains the most effective methods for
enhancing survival in patient with primary or metastatic liver cancer: however
Table 1.
Patient
ID
Future remnant
liver volume
before PVE (cc)
Future remnant
liver volume after
PVE (cc)
Future remnant liver
volume after HAE
1 379 505 916
2 302 344 521
3 400 444 550
4 390 430 532
5 361 400 507
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primary and metastatic liver cancer are not suitable for surgical resection both
at initial manifestation and at recurrence.
In these patient palliative cytoreductive therapies favourably allow the control
of cancer progression.
Being demonstrated the principal hepatic arterial supply for tumor growth,
cytotoxic agents delivered by transarterial pathways may allow local treat-
ment therapy.
The hepatic transarterial injection of Y90 microsphere, unlike the well known
external beam hepatic radiation, deliver very high radiation dose to liver
tumors while radiation exposure to the whole remaining normal hepatic
parenchyma remains within tolerable limits.
Methods. We enrolled patients with primary and metastatic liver disease: all
patients were treated by infusion of SIR-Spheres (Sirtex, Sydney, Austarlia).
We enrolled patients using WHO performance score criteria. Bone metastasis
were not considered exclusion criteria. Baseline CT scan and PET CT scan
were performed. South West Oncology Group Criteria were used during the
follow up.
Results. Between December 2005 and December 2006 we treat 10 patients
consecutively with an average age of 55 (range 39 74). Bilateral lesions were
presents in all patients. Four patients were affected by HCC, three by breast
cancer metastases, two by CRC metastases and one by cholangiocarcinoma.
Three patients have bone metastasis. The average dose of radiation was 1,60
GBql. All patients reported moderate post hembolization pain and weakness,
four patients nausea and vomiting and one patient developed a gastric ulcer
resolved with conservative treatment.
Two patient affected by HCC died for progressive disease. There was one
treatment related death: the patient affected by chiolangiocarcinoma died for
hepatic radiation induced injury one month post treatment.
One patient affected by breast metastasis had a complete hepatic response:
the others patients are alive with stable disease.
Conclusion. Ours initial results with liver directed therapy with Y90
microspheres appear to be very promising including significant improvements
in response disease, improvement in the interval of disease progression and
maybe in survival: patients outcoming still remains a challenge being interval
from primary treatment too short for making decisive consideration about
overall survival.
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RADIOFREQUENCY ASSISTED LIVER RESECTION: RECUR-
RENCE EVALUATIONS
S. Baldo1, A. Percivale, A. Gandini, G. Saccomani, E. Azzola2, A. Vitale3, G.
Serafini*, A. Maritano*, R. Pellicci
1Surgical Department of Santa Corona Hospital, Pietra Ligure (SV) Italy;
2Gastroentelogy of Santa Corona Hospital, Pietra Ligure (SV) Italy;
3Pathology of Santa Corona Hospital, Pietra Ligure (SV) Italy; *Radiological
Department of Santa Corona Hospital, Pietra Ligure (SV) Italy
Objective. Forty-two patients undergoing curative hepatic resection for liver
cancer were analyzed retrospectively All patients were treated with liver
parenchyma transection technique using heat coagulative necrosis induced by
radiofrequency (RF). Final endpoint were: evaluation of recurrences on the
surgical margin of resection, blood loss and technical related complications.
Methods. Between September 2002 and September 2005, forty-two patients
underwent liver resection with the RF-assisted technique (18 HCC, 24
colon-rectal cancer metastases). Patients were divided into 3 groups: Group
A enrolled seven patients (16,67%) who underwent resection with no margin,
Group B included sixteen patients (38,1%) with a surgical margin B1 cm
and Group C included nineteen patients (45,23%) with a sufficient surgical
margin1 cm.
Results. At a median follow-up of 42 months, twenty-five patients (59.52%)
were alive and seventeen (40,48%) died. No local recurrence on the resection
line was diagnosed. Twenty-eight patients (66.67%) experienced recurrence
in the remnant liver. Extra-hepatic recurrence occurred in five patients
(7.93%).
While total operative time was 300 /100 minutes, intra-operative blood
loss was 175 /125 mL. Two patients (5%) received blood transfusion.
Nine patients (21.4%) developed post-operative complications, and no
mortality was observed. Mean hospital stay was 11 /8 days.
Conclusion. The RF-assisted technique is associated with minimal blood
loss, a low blood transfusion requirement, and above all the margin of
necrosis of this technique is adequate for a complete sterilization of the
resection site.
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ANATOMICAL STUDY OF RIGHT PHRENIC ARTERY BY MULTI-
DETECTOR COMPUTED TOMOGRAPHY IN RELATION TO
HEPATOCELLULAR CARCINOMA EMBOLIZATION
Antonio Basile1, Dimitrios Tsetis2, Giacomo Calcara3, Arturo Montineri*,
Filippo Fatuzzo*, Stefano Puleo$, Maria Teresa Patti3, Giancarlo Ettorre§
1Department of Diagnostic and Interventional Radiology, Ospedale Ferrar-
otto, via Citelli 14, 95124 Catania, Italy; 2Department of Radiology,
University Hospital of Heraklion, Medical School of Crete, Greece;
3Department of Diagnostic and Interventional Radiology, Ospedale Ferrar-
otto, via Citelli 14, 95124 Catania, Italy.; *Department of Infectious
Diseases, Ospedale Ferrarotto, via Citelli 14, 95124 Catania, Italy.;
$Department of General Surgery, Ospedale Vittorio Emanuele, via Plebiscito
125, 95124 Catania, Italy; §Department of Radiology, University Hospital of
Catania, Catania, Italy
Introduction. The purpose of this study was to prospectively assess the
anatomic variation of inferior phrenic arteries (IPAs) origin with Multi-
Detector Computed Tomography (MDCT) scans in relation to technical and
angiographic findings during transcatheter arterial embolization of hepato-
cellular carcinoma (HCC).
Materials and Methods. 100 patients with suspected or diagnosed
hepatocellular carcinomas were examined with 16-section CT during arterial
phase. The anatomy of IPAs with particular interest to their origin, was
recorded. All patients with subcapsular HCC located at VII and VIII
segments underwent arteriography of the right phrenic artery (RIPA) with
subsequent embolization if neoplastic supply was detected.
Results. The RIPAs originated from aorta (47%), celiac trunk (43%), right
renal artery (5%), left gastric artery (4%), proper hepatic artery (1%), with
13 types of combinations with left IPA. Twenty-three patients showed
subcapsular HCCs in the VII and VIII segment and all but one underwent
RIPA selective angiography, followed by embolization in 6 cases
Conclusion. MDCT well asseses the anatomy of the RIPA, fundamental for
planning subsequent cannulation and embolization of extrahepatic RIPA
supply to HCC.
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ULTRASONIC MEDIATED LAPAROSCOPIC LIVER TRANSEC-
TION
Carlo Pulitano?1, Luca Aldrighetti, Marcella Arru, Marco Catena, Eleonora
Guzzetti, Massimiliano Casati, Gianfranco Ferla
1Department of Surgery, Liver Unit, Scientific Institute San Raffaele, Vita-
Salute San Raffaele University
Background. Parenchymal liver transection represents a fundamental phase
of liver surgery. Several devices have been described for safe and careful
dissection of the liver parenchyma during laparoscopic liver surgery, but the
ideal technique has not yet been defined.
Objectives. This report describes the combined use of ultrasonic dissector
and the ultrasonic coagulating cutter for laparoscopic liver resection.
Methods. The ultrasonic dissector is used to fracture the parenchyma along
the line of proposed division, and the uncovered bridging structures are
sealed using the ultrasonic coagulating cutter.
Results. This method of hepatic transection has been used for 14 consecutive
laparoscopic liver resections. Type of procedure included 6 left lateral
sectoriectomy, 4 segmentectomy, 2 wedge resection, and 2 left hepatectomy.
Cirrhosis was present in four patients. No conversion to open surgery was
necessary. Intraoperative median blood loss was 150 ml (range, 100250 ml)
and median operative time was 340 minutes (range, 290 400 mninutes).
Resections performed for a malignant diagnosis resulted in a mean margin of
1.7 cm (range, 1.13.2 cm). There was no mortality and no morbidity in these
patients, in particular bile leak of any grade did not occur in any patient.
Conclusions. The combined use of ultrasonic dissector and harmonic
scalpel allows liver resection to be safely performed, with the advantage of
minimal surgical complication and low blood losses.
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A MODIFIED CLINICAL RISK SCORE TO PREDICT PROG-
NOSIS IN PATIENTS UNDERGOING LIVER RESECTION FOR
COLORECTAL CANCER
Carlo Pulitano?1, Francesco Ardito2, Maria Vellone2, Marco Catena, Luca
Aldrighetti, Felice Giuliante2, Gianfranco Ferla, Gennaro Nuzzo2
1Department of Surgery, Liver Unit, Scientific Institute San Raffaele, Vita-
Salute San Raffaele University; 2Unit of Hepato-Biliary and Digestive
Surgery, Catholic University of the Sacred Heart School of Medicine
Background. Hepatic resection has become the standard of care for
colorectal liver metastases, and currently remains the only potentially curative
therapy. A major challenge remains the selection of patients who may
benefit from liver surgery as well as the identification of patients at high
risk for recurrence after liver resection who may require perioperative
therapy programs. Several prognostic scores have been proposed to stratify
patients based on their survival. Previous reports have found the Memorial
Sloan Kettering Clinical Risk Score (CRS) to be highly predictive of
survival. The CRS takes into account five variables: disease-free interval
B12 months, tumour 5 cm, number of metastasis, node-positive primary
cancer, and preoperative CEA level  than 200 ng/mL. In spite of their
well known detrimental effect over both the overall and the disease-free
survival, surgical margin status and extrahepatic disease were not included in
the CRS point score system, since they had been considered specific
contraindications to surgery. However, over the last few years, several studies
have reported encouraging results for hepatic resection even in the presence
of resectable extrahepatic disease or minimal tumour-free surgical margins,
pushing towards an even more aggressive management of hepatic colorectal
metastases.
Aim of the Study. We hypothesized that the value of CRS in predicting
patient outcome after liver resection as well as identifying patients at high risk
for tumour recurrence, may be improved by adding two variables, the
presence of resectable extrahepatic disease and surgical margins status.
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Methods. Using a bi-institutional database, 313 patients who underwent
liver resection for colorectal metastases between January 2000 and December
2005 were identified. For each patient, the original 5-point score (CRS) was
calculated. Then a Modified CRS (M-CRS) was built including positive
surgical margin (defined as the presence of exposed tumour along the line of
transection or less than 1 mm tumour-free surgical margin or the presence of
tumour cells at the line of transection detected by histologic examination)
and extrahepatic disease, creating a 7-point score system with a minimum M-
CRS of 0 and a maximum of 7. Discriminatory ability for death at one, three,
and five years for CRS and M-CRS score were evaluated by receiver
operating characteristic curve (ROC) area.
Results. The calculated CRS and M-CRS were analyzed with respect to
patient survival and were found to be significantly predictive of long-term
outcome and diseases free-survival (PB 0.001). Five-year survival rates for
CRS of 0, 1, 2, 3 and 4 were found to be 61% 53%, 38%, 27.8%, and 21%
respectively and was 0% for CRS4. Five-year survival rates for M-CRS of
0, 1, 2, 3, and 4 were found to be 72%, 69%, 45%, 28%, and 7% respectively
and was 0% for M-CRS4. Discriminatory ability for death evaluated by
ROC curve area analysis, were higher for M-CRS compared with CRS at one
(0.872 vs 0.660), three (0.771 vs 0.640), and five years (0.786 vs 0.698).
Conclusions. The M-CRS may represent a better point score system than
CRS for the selection of patients at high risk for recurrence after hepatic
resection for colorectal liver metastases.
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IMPACT OF TYPE OF LIVER RESECTION ON THE OUTCOME
OF COLORECTAL LIVER METASTASES
Eleonora Guzzetti1, Carlo Pulitano’, Marco Catena, Marcella Arru, Massi-
miliano Casati, Luca Aldrighetti, Gianfranco Ferla
1Department of Surgery, Liver Unit, Scientific Institute San Raffaele, Vita-
Salute San Raffaele University
Background. Wedge resection (WR) for colorectal liver metastases (CLM)
has become more common in an attempt to preserve liver parenchyma.
However, some investigator have reported that WR is associated with a higher
incidence of positive margin and an inferior survival compared with anatomic
resection (AR).
Objectives. This study evaluated survival, margin status, and pattern of
recurrence of patients with CLM treated with WR or AR.
Methods. We identified 232 consecutive patients, in a single institutional
database from 1995 to 2004, who underwent either WR or AR. WR was
defined as a nonanatomic resection and AR was defined as single resection of
one or two contiguous liver segments. Patients with combined WR-AR and
patients requiring resection of more than two segments or radiofrequency
ablation were excluded from the analysis.
Results. 107 patients underwent WR and 125 patients had AR. There was no
differences in the rate of positive surgical margin (P0.236), overall
recurrence rates (P0.658), and patterns of recurrence between the two
groups (P0.235). The median survival was 42 months for WR and 32 for
AR, with 5-year survival rates of 35% and 33% respectively, with no significant
difference (P0.248). Morbidity was similar between the two groups.
Conclusions. WR is a safe procedure and does not disadvantage the patients
in terms of tumor recurrence and overall survival.
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LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCI-
NOMA: A NEW POLICY ON SELECTION CRITERIA AND ORGAN
ALLOCATION
Matteo Ravaioli1, Gian Luca Grazi, Matteo Cescon, Giorgio Ercolani,
Vivarelli Marco, Massimo Del Gaudio, Gaetano Vetrone, Alessandro
Cucchetti, Giuliano La Barba, Matteo Zanello, Lauro Augusto, Alessandro
Dazzi, Francesco Tuci, Chiara Zanfi, Antonio Daniele Pinna
1Liver and Multi-organ Transplantation, Sant ’Orsola-Malpighi Hospital;
University of Bologna,Italy
Background. The selection criteria for liver transplantation of patients with
hepatocellular carcinoma on cirrhosis and the liver allocation policies are
debated.
Methods. We evaluated prospectively the outcome of 173 patients listed for
liver transplantation with a pre-operative diagnosis of HCC during 2003
2006. Patients had a priority for liver transplantation according to MELD
score, waiting time and tumor stage.
Thirty eight patients had single HCCB3cm (H1); 94 patients had single
HCC 35 cm or 23 HCC53 cm (H2) and 41 patients had single HCC 5
6 cm or 2 HCCs 35 cm or multiple HCCsB6 with a diameter54 cm and a
sum diameter512 cm, who met H2 criteria after down-stage procedure
(H3).
Results. The competing risk analysis showed equal risk of transplantation
and drop-out on the list among the groups. The H2-H3 cases had a
significant higher risk of drop-out for tumor progression compared to H1
(12% vs. 0%, pB0.05), while the risk of death on the list was related to the
real MELD score (AUC0.725, pB0.01) and it was comparable among the
groups.
The 93 cases transplanted, after a median follow-up of 22 months, had a
tumor recurrence rate close to 13% and an actuarial survival rate of 80%,
without any difference among the groups.
Conclusions. The allocation policy adopted by our Center and the new
extended pre-operative selection criteria for HCC patients listed for liver
transplantation were equal and safe.
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IS LAPAROSCOPIC LIVER RESECTION COST EFFECTIVE?
Thomas Roe1, Mohammed Abu-Hilal, David Hou2, Bashar Zeidan, Amjad
Parvaiz3, John Primrose, Neil Pearce
1Southampton General Hospital; 2Queen Alexandra Hospital; 3Queen
Alexendra Hospital
Institution Hepatopancreatobiliary Surgical Unit, Southampton General
Hospital, SOUTHAMPTON, UK
Introduction. Laparoscopic liver resection (LLR) is now recognised as a
viable alternative to open liver resection (OLR). The economic implications
have never been assessed, although savings have been demonstrated for other
laproscopic procedures.
Aims. To assess the economic impact of the recent introduction of LLR to
our practice by comparison of costs relative to OLR.
Methods. 34 patients underwent LLR at Southampton General Hospital
between August 2003 and December 2006 (14 male, 20 female, median age
65 (2181) years). These were matched to 27 open resections performed
between 1998 and 2004 retrospectively identified as suitable for LLR (8
male, 17 female, median age 63 (2980) years). In hospital costs were
calculated using current NHS commissioning data.
Results. There were 5 complications in each group but no deaths.
Mean blood loss was 642/185ml (OLR) compared to 334/142ml
(LLR) (p0.005).
Median lenghts of stay were 7 (IQR 612) and 3 (25) days for OLR and
LLR respectively (p0.001).
Mean operating times of 201/30 minutes (OLR) and 220/37
minutes (LLR) were not significantly different (p0.361).
The mean cost of OLR was £5120/1760 compared to £4498/1405
for LLR (p0.13).
Resection margins were comparable (97% Ro resection).
Comparing the first 8 laparoscopic left lateral resections with the most recent
9, mean cost fell from £5105/733 to £3637/1069 (p0.005). The
equivalent open operation cost £4529/1349 (n.s., p0.1).
Conclusion. In experienced hands LLR is no more expensive than open
surgery. Improvement in performance in left lateral resection suggests that
increasing familiarity may eventually make the laparoscopic approach
cheaper.
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SURVIVAL AFTER SURGICAL RESECTION OF HEPATOCELLU-
LAR CARCINOMA ACCORDING TO TIME-TO-RECURRENCE
A. Ruzzenente1, S. Pachera, G. Piccirillo, M. Fontana, C. Zugni, C. Iacono,
A. Guglielmi
1Department of Surgery and Gastroenterology University of Verona
Objective. Evaluate survival among patients with hepatocellular carcinoma
(HCC) after surgical resection in relation to time-to-recurrence.
Methods. One hundred thirty patients with HCC submitted to surgical
resection from 1990 to 2006 were included in this retrospective study.
Surgical resection of HCC was the treatment of choice for Child-Pugh class
A patients with single HCC, surgery was applied also in a selected group of
patients with oligofocal HCC and/or with Child-Pugh class B7 cirrhosis.
Follow up protocol included clinical, laboratory and imaging evaluation at 6-
months intervals after surgery. All patients with recurrence were evaluated for
a new treatment with surgery, RFA, PEI, TACE or supportive therapy
according to stage of HCC and degree of hepatic decompensation.
Results. Median follow up time was 27 months. The overall median survival
was 44 months with actuarial 3 and 5-year survival rates of 59% and 43 %.
Fifty-nine patients showed intrahepatic recurrence of HCC with a median
disease free survival of 36 months, and an 3- and 5-years actuarial disease free
survival of 43 and 25%, respectively. According to time to recurrence 24
patients recurred before 1 year and 35 patients after 1 year. Survival analysis
showed that survival was significant related with time-to-recurrence with a
median survival of 12 and 64 months, respectively (p0B001). We
performed univariate analysis for factors related to early recurrence and we
identify the following negative prognostic factors: tumor size, higher serum
alfa fetoprotein level and histologic grading.
Conclusions. Surgical resection of HCC have good results in selected
patients, intrahepatic recurrence of the disease are frequent and prognosis
after resection is significant related to time of recurrence.
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INFLUENCE OF PERIOPERATIVE ALLOGENIC BLOOD TRANS-
FUSION IN SURGICAL RESECTION OF HEPATOCELLULAR
CARCINOMA
A. Ruzzenente1, S. Pachera, P. Nicoli, G. Piccirillo, T. Campagnaro, C.
Iacono, A. Guglielmi
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Objective. Evaluate the relation between perioperative allogenic blood
transfusions with the occurrence of postoperative complications, overall
survival and recurrence free-survival
Methods. One hundred thirty patients with HCC submitted to surgical
resection from 1990 to 2006 were included in this retrospective study. Blood
trasfusion during surgery and during the first postoperative week were
recorded and analysed.
Results. The post-operative mortality was 1.7% and the morbidity rate was
37%. 40.6% of patients received red blood cell transfusions. The units of
blood transfused varied from 1 unit to 13 units (mean 4.1 units). 30.5% of
patients were transfused during operation and 16.9% in the first week after
resection. A significant statistical relation was found between blood transfu-
sion and Child-Pugh’s class and the extent of liver resection. Blood
transfusions were significant related to occurrence of post-operative compli-
cations, 55% and 44%, respectively (p0.03). In univariate analysis we
observed that transfused patients had a significantly shorter survival (p
0.02). Further analysis with multivariate Cox’s regression analysis for survival
identified that the only independent factor for survival was Child-Pugh score
(odd ratio 1.5, p0,01) and did not confirmed that blood transfusion
influence long-term survival. Both univariate and multivariate analyisis did
not identify relation between blood transfusion and disease free survival.
Conclusions. Blood losses and blood transfusion were related to higher rate
of post-operative complications. In our study with univariate and multivariate
analysis we did not observed relation between blood transfusions with long-
term survival and disease free survival.
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ELECTROLYTIC DESTRUCTION IS AS EFFICENT AS RADIO-
FREQUENCY ABLATION IN THE TREATMENT OF ARTIFICIAL
LIVER METASTASIS IN A PIG MODEL
Hinz Sebastian1, Pauser Ursula2, Egberts Jan-Hendrik3, Schafmayer Clem-
ens3, Fandrich Fred3, Tepel Jurgen3
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Background. The best treatment option for liver metastasis is the complete
surgical resection. Unfortunately at the time of diagnosis, only a small
proportion of patients with liver metastasis are candidates for resection.
Electrolytic destruction is a novel non-thermal method of tissue destruction,
which was evaluated regarding its safety and efficiency compared to radio-
frequency ablation.
Methods. In a total of 8 pigs 37 tumor mimics were created by injecting
glycerol/ agarose gel in the liver. Two pigs served as a control without tumor
mimics. The volume of the lesions was measured with ultrasound before
treatment. Tumor mimics were treated either with RFA or electrolytic
ablation. In all cases correct placement of the electrodes was confirmed by
ultrasound. 48h after treatment the animals were sacrificed and the liver was
fixed in formalin and suspect to histological investigation.
Results. 18 lesions were treated with RFA. 8/18 lesions were localized near
the hepatic veins. In all cases the lesions were destructed completely.
Electrolytic destruction was applied on 19 Lesions. Histological investigation
confirmed that after treatment with electrolysis and RFA all lesions were
completely surrounded by necrosis, reflecting an efficient treatment of the
target lesion. Interestingly, histological investigation showed two different
types of necrosis. After RFA the cell membranes disapeared but the nuclei
were still intact. In contrast to this after electrolysis cell membranes and
nuclei were completely disrupted. Both types of necrosis resulted in an
irreversible necrosis. In addition, after electrolysis the necrosis was sur-
rounded by infiltrating lymphocytes in 13/19 cases. This inflammatory
reaction was not apparent after RFA.
Conclusion. Electrolysis produced a predictable and reproducible necrosis
in the pig liver and is as efficient as RFA in destructing a defined target lesion.
The type of necrosis was different in electrolysis and RFA. The local
inflammatory reaction after electrolysis may favour the development of a
systemic immune response. Taken together electrolysis is an alternative
treatment option for irresectable liver metastasis.
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A NEW LOOK AT INTRAOPERATIVE ULTRASONOGRAPHY IN
THE MODERN MANAGEMENT OF PATIENTS WITH LIVER
METASTASES-A PROSPECTIVE STUDY IN 110 PATIENTS
Breitenstein Stefan1, Petrovsky Henrik, Mu¨llhaupt Beat2, Hany Thomas3,
Clavien Pierre-Alain
1Swiss HPB Center, Department of Surgery, University Hospital Zurich;
2Swiss HPB Center, Department of Gastroenterology, University Hospital
Zurich; 3Swiss HPB Center, Department of Nuclear Medicine, University
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Objective. To evaluate the impact of intraoperative ultrasonography
(IOUS) on the detection and surgical management of liver metastases in
the area of specialized HPB surgery and modern imaging technology
including PET/CT.
Background. Accurate imaging is central to achieve curative resection in
many patients with liver metastases. IOUS is still considered by many as the
ultimate gold standard modality to detect and reliably localize liver tumors.
Sophisticated preoperative imaging modalities have emerged over the past
decade. For example, it has been demonstrated by several groups that PET/
CT influences therapy in about 20% of patients with liver tumors. Therefore
we designed a study to assess the current value of IOUS in the modern work-
up of patients for liver resection including routine PET/CT imaging.
Material and Methods. 110 patients operated for liver metastases between
1.1. 2004 and 31.12. 2005 were enrolled in the study. The standard
preoperative work-up included contrast-enhanced CT or MRI, and PET/
CT in each patient. All tests were performed within a month prior to
surgery. For the purpose of the study IOUS was performed by an
independent and experienced ultrasonographer unaware of the preoperative
staging. Mapping of the metastases through visualization and palpation by
the surgeon was also recorded. The resected specimen was examined by a
pathologist unaware of the previous findings. Endpoints included sensitivity
and specificity of IOUS, intraoperative mapping by the surgeon and PET/
CT, and eventually the impact of each respective modality on the surgical
management.
Results. Median age was 62 years (22yr-84yr). The primary origin of the
tumor was colorectal in 97 patients, and other sites in 13 patients. 34 patients
(31%) received preoperative chemotherapy within 3 months of surgery. The
final histological finding disclosed a solitary metastasis in 53 patients (48%),
two metastases in 17 patients (15.5%), three in 16 (15%), and  three in 15
(13.5%). In 9 patients (8%), a R0 resection could not be achieved.
Preoperative staging including PET/CT showed a positive correlation with
the definitive diagnosis in 96 cases (87%, CI: 78% 94%); intraoperative
inspection and palpation correlated in 104 (95%, CI: 8899%); and IOUS in
108 (99%, CI: 92100%). The preoperative work up combined with
intraoperative palpation correlated in 106 patients (96%, CI: 8999%).
Metastatic lesions exclusively diagnosed by IOUS were documented in only 4
patients (4%) resulting in a modification in therapy, and each of them had 4
metastatic nodules. Additionally, in 5 patients (7%), IOUS was helpful in
considering intrahepatic vessels and to better define the resection plane.
Conclusion. This study demonstrates that IOUS has a marginal impact on
the identification of liver metastases in the modern area of liver surgery and
imaging modality. We would recommend IOUS only in patients with multiple
tumors (e.g. 3 metastases) or for tumors in the vicinity of vessels, where
accurate evaluation of the anatomy may impact on surgery.
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STEREOTACTIC APPROACHES FOR SUPPORT DURING COM-
PLEX LIVER SURGERY
Weber Stefan1, Lang Hauke2, Radtke Arnold2, Markert Mathias, Prause
Guido3, Zidowitz Stephan3, Peitgen Heinz-Otto3, Broelsch Christoph E.2,
Lueth Tim C.
1MiMed-Technical University Munich; 2University Clinic Essen; 3MeVis
Research GmbH
Background. While computer based planning of surgical interventions
(CAS) on the base of CT imaging (MeVis) is becoming standard especially
for complex interventions at the liver, the intraoperative application of
computer assisted devices in the OR is still limited. To extend the existing
limitations, a navigation (stereotactic) system has been developed especially
for liver surgery. It bases on the fusion of CT-based planning information
(MeVis) with intraoperatively available 3D ultrasound imaging.
Aim. The goal of our current research is the clinical application of such a
navigation system during a study in liver surgery. The device has been applied
in 5 cases, an additional 10 cases are being carried out at present. The
contribution will discuss applicable clinical indication as well as advantages,
challenges and drawbacks of such technology.
Methods. The stereotactic system consists of a flat panel computer screen
(PaceBlade), as miniature ultrasound transducer (7.5MHz Terason) with a
localizer which is measured in its spatial position using a stereo camera (NDI
Vicra) and a six-dimensional computer mouse to control the system and the
depiction of image data. During the intervention, planning information is
together with the actual ultrasound image (see Figure System Setup ). The
surgeon fuses the both image modalities by using the 6D-mouse. Using the
stereo camera, movements of the tracked ultrasound probe are displayed as
movements of the ultrasound image within the planning model (see Figure
Screenshot ). This greatly enhances the surgeon’s orientation and its under-
standing of anatomical details. Additionally, navigated instruments (i.e.
CUSA) can be displayed within the planning data and serve for precise
orientation.
Results. Clinical integrability and ergonomical aspects of such a device are
essential for its later clinical success. During the first interventions (see Figure
Navigation in Liver Surgery ) we identified interesting application scenarios
(i.e. tumour resection) and advantages of the described technology. Since it is
still a long way until such systems might applicable in daily clinical routine, it
is necessary to constantly discuss actual clinical outcomes.
Conclusion. Navigation technology and concepts have been proven useful in
other clinical disciplines. The system presented is based on special concepts
and approaches for extending computer assistance into soft tissue surgery.
Only constant clinical application of such devices will help to identify and
precisely define useful scenarios. However, ongoing efforts have to be made,
to realize truly clinically suitable systems.
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PORTAL VEIN OCCLUSION AND CHEMOTHERAPY IN TWO
STAGE LIVER RESECTION
Kupcsulik Peter1, Bodoky Gyorgy2, Darvas Katalin, Szijarto Attila, Hahn
Oszkar3
1Semmelweis University 1st Department of Surgery; 2Dept. of Oncology
Szt. La´szlo´ Hospital; 31st Dept. of Surgery Semmelweis University
Aim of the Study. After portal vein ligation for regeneration of potential
remnant, 78 weeks are needed to achieve appropriate liver volume.
Conventionally no chemotherapy is given during this period. Effect of
systemic and selective right hepatic artery locoregional chemotherapy on
liver regeneration was studied.
Methods. Out of 578 patients operated for liver tumour between 2001
2006, 32 were unsuitable for primary extended resection because of
inadequate size of potential liver remnant. Colorectal metastasis: 19 pts,
HCC : 11, metastasis of gastric cc:2. Right portal branch ligation were
performed to promote regeneration of left lateral segment.3 patients were lost
after the first intervention. In a prospective study after ligation of right portal
branch (PVL) in 10 pts arterial port was inserted through gastroduodenal
artery into the right hepatic artery.(Group A). In 19 pts only PVL was
performed. 9 of them underwent systemic chemotherapy according DeGra-
mont (group B), in 10 pts no chemotherapy was applied.(Group C) Group A
patients were treated like pts in group B, but Adriamycin was admininistered
locoregionally into the right hepatic artery.
Results. All patients but one underwent second liver resection without
mortality.This patient (GroupA) with HCC missed readmission,but one year
later no tumour was found in the previously infiltrated right lobe.
Chemotherapy did not influence regeneration of left lobe. Group B
28.496.6% v.s. Group C26.699.5%. Surprisingly regeneration was
significantly better in Group A34.596.7%. No significant change of
volume of tumorous right lobe in groups B and C could be observed.
Contrary to this, in group A both right lobe and tumour volume diminished
significantly.
Conclusions. Chemotherapy does not interfere with liver regeneration after
portal vein ligation. Hepatic artery chemoperfusion might be recommended
as additional therapy before second stage liver resection.
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INDOCYANINE GREEN CLEARANCE FOR EVALUATING LIVER
FUNCTION FOLLOWING PORTAL LIGATION
Szijarto Attila1, Darvas Katalin, Kupcsulik Peter
1Semmelweis University 1st Department of Surgery
Background and Objectives. To predict and estimate the optimal time of
resection following portal vein ligation (PVL) with the aid of 3D CT
volumetry and indocyanine green (ICG) clearance in healthy liver. Following
right PVL, hypertrophy of the left liver lobe was induced prior to an extended
right hepatectomy. Methods: Fourteen patients with huge right lobe color-
ectal liver metastases underwent right PVL. Cut off points of ICG clearance
test were: R15B14% or PDR15%/min. A remnant liver volume of 25% of
the whole liver volume was assessed by CT scan prior to the procedures.
Postoperatively, repeated ICG clearance and 3D CT volumetry tests were
used to estimate the regeneration. Liver resections were performed as a
second stage.
Results. After PVL, ICG clearance increased significantly in some patients,
while in the rest, ICG clearance remained unchanged with borderline low
clearance values. Between the two operations, patients with high clearance
had less complications and a better regeneration rate.
Conclusions. ICG clearance has a significant prognostic value. Patients with
an apparently inoperable right lobe liver tumor can be successfully treated
using a two-stage hepatectomy. The 3D CT volumetry and ICG clearance
test were essential monitoring tools in these resections.
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THE GROWING INFLUENCE OF LAPAROSCOPIC SURGERY ON
THE MANAGEMENT OF PATIENTS WITH LIVER TUMOURS
Baki Topal1, Hilde Vandeweyer2, Raymond Aerts, Freddy Penninckx
1UZ.Leuven, Abdominal Surgery; 2UZ.Leuven, Department of Management
Information and Reporting
Introduction. Many centres are reluctant to implement laparoscopy in liver
surgery. The aim of the present study was to assess the effect of laparoscopic
liver surgery in a single academic centre.
Methods. Between 2002 and 2006, hepatic surgery was performed in 516
consecutive patients (M/F: 271/245; median (range) age 61 (1689) y.) with
primary (191 patients) or metastatic (325 patients) tumours. The majority of
patients scored ASA II (n 355) and ASA III (n 117). Cirrhosis was present in
78 patients, and chemotherapy within 3 months prior to surgery was given in
175 patients. Hepatic surgery consisted in resection only in 365 patients,
resection combined with radiofrequency ablation (RFA) in 38, and RFA only
in 113 patients. Laparoscopic liver surgery was performed in 171 patients.
Significantly more hepatic resections, RFA, and laparoscopic procedures
were performed in the course of the years (pB0.0001). Laparoscopy was
more frequently used in patients with severe comorbidity (31% vs. 18%;
The surgeon uses the 6D-mouse to align both the ultrasound image with the
planning model (MeVis). Here, an overlay of the middle hepatic vein is
shown.
Components of the navigation system.
Application of navigation device during surgical intervention.
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p0.001) and cirrosis (27% vs. 9%; pB0.0001). Major liver resections
(3 segments) were more frequently performed via laparotomy (p0.001).
Results. Postoperative complications occurred in 118 patients with subse-
quent mortality in 7. No significant changes with regard to the number or
severity of complications were observed in the course of the years (p0.159),
while median length of hospital stay and duration of the entire surgical
process were significantly reduced (pB0.0001). The short-term clinical
outcome with regard to the number and severity of complications, and LOS
were in favour of laparoscopy (pB0.0002).
Conclusions. Laparoscopic liver surgery can be performed with excellent
clinical outcome in selected patients. Extensive experience of the surgical
team in both open liver surgery and advanced laparoscopy, and the
availability of adequate equipment are indispensable.
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SHORT-TERM RESULTS OF LAPAROSCOPIC VS. OPEN RADIO-
FREQUENCY ABLATION OF HEPATIC MALIGNANCIES
Baki Topal1, Steffen Fieuws2, Raymond Aerts, Freddy Penninckx
1UZ.Leuven, Abdominal Surgery; 2KU.Leuven, Department of Biostatistics
Introduction. Surgical radiofrequency ablation (RFA) of hepatic malignan-
cies is associated with superior oncological outcome as compared to
percutaneous RFA. The aim of this prospective non-randomized cohort
study was to compare morbidity and mortality of laparoscopic (LRFA) vs.
open (ORFA) radiofrequency ablation of liver cancer.
Methods. Between October 1999 and November 2006, RFA was performed
in 154 consecutive patients (percutaneous 12, LRFA 93, ORFA 49) for a
total of 291 hepatic tumours (HCC 81, colorectal metastases 157, other 53).
Seventy-four patients simultaneously underwent additional surgery.
Results. Postoperative complications occurred in 25 patients with subse-
quent mortality in 2. Laparoscopic RFA was performed in 45/54 patients
with HCC and in 44/54 patients with cirrhosis. Laparotomy was performed
in 14/22 patients who underwent simultaneous colorectal resection and in 12/
22 patients with hepatic resection. As compared with LRFA, ORFA was
associated with significantly higher intra-operative blood loss (median 20
(range 01700) vs. 10 (0-900) ml; p0.0001), longer duration of surgery
(180 (25440) vs. 75 (30390) min.; pB0.0001), more postoperative
complications (17 vs. 8; p0.0001), and longer postoperative hospital stay
(8 (1127) vs. 4 (151) d.; pB0.0001). According to the therapy-oriented
severity grading system (TOSGS) classification, postoperative complications
in the ORFA-group were more severe than those in the LRFA-group (p
0.001). These findings were consistent in patients without simultaneous
colorectal and/or hepatic resection and in patients with liver tumours
measuring 3 cm or less. In univariate analysis the following factors were
significantly related to the presence of postoperative complications: simulta-
neous colorectal resection (p0.0003), laparotomy (p0.0004), duration of
surgery (p0.0006), tumour location in right liver (p0.002), liver segment
7 (p0.013), absence of cirrhosis (p0.021), liver segment 8 (p0.026),
and metastatic liver cancer (p0.041).
Conclusion. LRFA for hepatic malignancies seems preferable above ORFA,
provided good patient selection, surgical expertise, and long-term oncological
control.
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RECONSIDERING THE OUTPUT OF THE BARCELONA-
CLINIC-LIVER-CANCER CLASSIFICATION: A NEW ROLE FOR
SURGERY BASED ON AN INTENTION-TO-TREAT ANALYSIS
Daniele Del Fabbro1, Matteo Donadon, Matteo Marconi, Angela Palmisano,
Antonino Spinelli, Florin Botea, Marco Montorsi, Guido Torzilli
1University of Milan, IRCCS Istituto Clinico Humanitas
Background. For the Barcelona-Clinic-Liver-Cancer classification (BCLC),
hepatocellular carcinoma (HCC) patients with multiple and/or with vascular
invasion, palliation is the only feasible approach. However, some experiences
show benefit after surgery in more advanced patients. We prospectively
evaluated resectability, short and long-term outcome of HCC patients who
underwent surgery by means of an intention-to-treat algorithm in which the
BCLC intermediate and advanced stage were not contraindicated.
Methods. Among 142 consecutive HCC patients, 104 (73%) underwent
surgery and 98 patients of these were resected (94%). Of the 98 patients, 51
were BCLC stage 0-A, 21 were stage B, and 26 were stage C. BCLC C
classification was, in all patients, due to the concomitance of macroscopic
vascular invasion. Surgical strategy was based on the relationship between the
tumor and the intrahepatic vascular structures at intraoperative ultrasono-
graphy (IOUS). Mortality, morbidity and rate of cut-edge local recurrences
and long-term outcome were evaluated.
Results. Hospital mortality was 1%. The overall morbidity rate was 27% and
major morbidity occurred in 4%. Surgical clearance was achieved in all cases
without local recurrence. For patient in the BCLC 0-A, B and C stages 1-
and 3-year overall survivals were respectively: 9880%; 8865%; 9287%.
Similarly, disease-free 1- and 3-year survivals were respectively: 8448%;
8545%; 6751%.
Conclusions. This study shows that hepatic resection may offer survival
benefits in patients with BCLC class B and C HCC when resection is feasible
and safe under strict IOUS guidance. These results should induce to revise
the BCLC treatment recommendations.
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ULTRASOUND GUIDED LIVER RESECTION: DOES THIS AP-
PROACH LIMIT THE NEED FOR PORTAL VEIN BRANCHES
EMBOLIZATION?
Matteo Donadon1, Daniele Del Fabbro, Matteo Marconi, Angela Palmisano,
Antonino Spinelli, Fabio Procopio, Marco Montorsi, Guido Torzilli
1University of Milan, IRCCS Istituto Clinico Humanitas
Background. To enlarge the feasibility and safety of hepatectomies for liver
tumors portal vein embolization (PVE) is often used. However, PVE has
some drawbacks. Our reported approach based on ultrasound guided liver
resection minimizes the need for major resections and therefore is alternative
to PVE. The aim of this study is to support this hypothesis.
Methods. One-hundred and sixty-nine consecutive patients who underwent
surgery for liver tumor were reviewed. Fifty-four patients with tumors in
relation with right-sided 1st/2nd order portal branches (Zone P) and the right
hepatic vein (Zone H) were selected as potential candidates for major
hepatectomy. Their indication to PVE was retrospectively categorized based
on background liver and remnant liver volume (RLV). Results in term of
postoperative outcome and rate of recurrence were revised.
Results. Thirty-four patients (63%) with tumors located in Zone H and P
resulted potential candidates to PVE, but none underwent PVE. Major
resections were performed in 4 patients (7.4%), with removal of more than 3
segments in just 1 patient (1.8%). No hospital mortality was seen. Morbidity
rate was 15% and major morbidity occurred in 1 patients. Blood transfusions
rate was 11%. Mean tumor-free margin was 4 mm (median 2; range 010).
None had local recurrence at 18 months of mean follow-up (median 15;
range 346).
Conclusions. These results underline that the ultrasound guided liver
resections allow us to perform alternative safe and effective surgical
treatment in patients generally submitted to major hepatectomy and
preoperative PVE.
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CONTRAST-ENHANCED INTRAOPERATIVE ULTRASONOGRA-
PHY DURING SURGERY FOR HEPATOCELLULAR CARCINOMA
IN LIVER CIRRHOSIS: IS IT USEFUL OR USELESS? A PRO-
SPECTIVE COHORT STUDY OF OUR EXPERIENCE
Angela Palmisano1, Daniele Del Fabbro, Matteo Marconi, Matteo Donadon,
Florin Botea, Antonino Spinelli, Marco Montorsi, Guido Torzilli
1University of Milan, IRCCS Istituto Clinico Humanitas
Background. Preliminary results showed that contrast-enhanced intrao-
perative ultrasonography (CEIOUS) could provide information not obtain-
able with conventional IOUS during surgery for hepatocellular carcinoma
(HCC). The aim of the study was to prospectively validate the role of
CEIOUS, based on a larger experience and a new classification of its findings.
Methods. Eighty-seven consecutive patients underwent surgery for HCC.
Those patients with new lesions at IOUS underwent CEIOUS. They received
intravenously 4.8 mL of sulphur-hexafluoride microbubbles. Pattern of
enhancement, and consequent treatment were classified in 4 categories: A1
(resection), A2 (resection), A3 (resection), and B (no treatment).
Results. Twenty-nine patients (33%) had 59 new lesions at IOUS, and
underwent CEIOUS. Twenty-seven nodules showed a B-pattern at CEIOUS,
and were not removed, while 32 resulted at CEIOUS, A1 in 5, A2 in 11, and
A3 in 16; they were removed, and at histology, 5 A1, 9 A2, and 6 A3
confirmed to be HCC. CEIOUS modified the operative decision making in
79% of the patients.
Conclusions. CEIOUS is certainly useful during surgery for HCC,
improving IOUS accuracy and surgical radicality. Specificity of CEIOUS
has to be further improved, although intrinsic drawbacks exist in the
diagnostic criterion of tumor vascularity.
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PROSPECTIVE RANDOMIZED COMPARISON OF MONOPOLAR
FLOATING BALL VERSUS BIPOLAR FORCEPS IN LIVER RE-
SECTION
Antonino Spinelli1, Matteo Marconi, Angela Palmisano, Daniele Del Fabbro,
Matteo Donadon, Florin Botea, Marco Montorsi, Guido Torzilli
1University of Milan, IRCCS Istituto Clinico Humanitas
Background. Intraoperative blood loss and blood transfusions are important
predictors of outcome in hepatic surgery. Dissection by Pe´an-clasia is a safe,
simple and low cost approach, while, methods for coagulation are still object
of debate. Monopolar floating ball (Tissuelink) (Figure 1) is proposed for
liver dissection, but blunt dissection with it may lead to a necrotic layer on the
cut surface possible source of postoperative morbidity. However, this method
seems more efficient for achieving the hemostasis. For this purpose, we
compared, in a prospective randomized trial, the traditional bipolar forceps
coagulation with the monopolar floating ball used only for coagulation
(Figure 2), both using Pe´an-clasia for liver transection.
Methods. Fifty-one consecutive patients (42 male, 9 female; mean age: 67.4
yrs) undergoing ultrasound guided liver resection for liver tumors were
randomized in two groups, according to transection device: Group A
(Tissuelink, n24) and Group B (bipolar forceps, n27). The two groups
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were homogeneous in terms of tumors and background liver features. Blood
losses, transection time, number of ligatures per cm2, overall red blood cell
transfusions, amount of drains discharges, drain discharge bilirubin levels at
3rd, 5th, and 7th postoperative day, postoperative morbidity and mortality
were prospectively evaluated. Resection area was calculated using strips of
paper of 10 cm in length as shown in Figure 3. Level of significance was set at
P0.05.
Results. Mean resection surface was 91.4 cm2; mean Pringle time was 102.8
minutes. Mean blood loss was respectively 8.9 ml/cm2 in group A and 6.9 ml/
cm2 in group B (n.s.). Mean transection time were respectively 1.3 min/cm2
in group A and 1.3 min/cm2 in group B (n.s.). Mean number of ligatures were
respectively 0.7 per cm2 in group A and 0.7 min/cm2 in group B (n.s.). Both
the transection methods resulted equally safe with no mortality and major
morbidity. Rate of patients transfused with blood were 12.5% in Group A
and 18.5% in Group B (n.s.). No bile leakage was observed in both groups.
No significance could be reached for the considered parameters among the
two groups.
Conclusion. Our preliminary data seem to indicate that Pe´an-clasia together
with monopolar floating ball liver dissection is safe and allows an adequate
control of blood loss during liver resections. However, these preliminary
results does not address to this new technique enough evidence for
substituting the Pe´an-clasia and bipolar forceps method based on.
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BILE LEAKAGE AFTER LIVER RESECTION: PREDICTIVE FAC-
TORS OF SPONTANEOUS HEALING
Luca Vigano?1, Alessandro Ferrero, Roberto Lo Tesoriere, Andrea Muratore,
Lorenzo Capussotti
1Department of Surgery, Ospedale Mauriziano ‘‘Umberto I’’
Background. Bile leakage after hepatectomy is usually managed by
conservative treatment, but some authors suggest early interventional
procedures.
Aim. To identify early predictive factors of bile leakage spontaneous healing
failure in order to avoid useless long waiting time.
Methods. Clinical data from patients who underwent liver resection from
January 1996 to January 2006 were analysed. Hepatectomies associated with
extra-hepatic biliary resection and reconstruction were excluded. Bile leakage
was defined as the drainage of 50 cc or more of bile from the surgical drain or
from drainage of an abdominal collection, over a period of 3 days or more.
Conservative management was the initial bile leakage treatment in all
patients. Failure of conservative management was defined as necessity of
interventional procedures because of sepsis and/or choleperitoneum or
because of prolonged drainage of high output.
Results. Postoperative bile leakage occurred in 34 out of 596 patients
(5.7%), from the surgical drain in 24 cases and from percutaneous drainage
of an abdominal collection in 10. Conservative approach was successful in
26 patients (76.5%) with a median healing time of 15 days (range 4 180).
In 8 patients interventional procedures were required because of sepsis in 2,
choleperitoneum in 1 and prolonged drainage of large amount of bile in 5
(mean output of 290 cc after mean waiting time of 36.5 days). At univariate
analysis, associated extra-hepatic resections, associated vascular resections,
drainage output in day 1, 3 and 10 were significant negative predictors of
spontaneous healing. With the ROC curve analysis the best drainage output
cut-off values were identified: 300 cc in day 1, 250 cc in day 3 and 100 cc
in day 10. At multivariate analysis drainage output higher than 100 ml in
day 10 was the only independent prognostic factor of failure of conservative
management (RR 55.985, CI95% 2.826 1108.956. p 0.008), with a 80%
sensitivity, 93.3% specificity and 90% accuracy.
Conclusions. Wait and see treatment for bile leakage after hepatectomy is
successful in most cases. Patients with drainage bile output higher than
100 ml 10 days after bile leakage diagnosis should be scheduled for
interventional treatments.
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QUANTIFICATION OF THE RISK OF A POSITIVE RESECTION
MARGIN (R1) FOLLOWING HEPATIC RESECTION FOR META-
STATIC COLORECTAL CANCER A MULTIFACTORIAL MODEL
Fenella Welsh1, Paris Tekkis2, Tim John, Tom O’Rourke, Merv Rees
1Hepatobiliary Unit, North Hampshire Hospital; 2Department of Biosurgery
and Surgical Technology, St Mary’s Hospital, Imperial College
Aims. The present study aimed to identify risk-factors and develop an index
for quantifying the likelihood of a positive resection margin (R1) for patients
undergoing hepatic resection for metastatic colorectal cancer.
Methods. Clinical, pathological and complete follow-up data were prospec-
tively collected from consecutive patients undergoing primary (n844) or
revisional hepatic resection (n67) for colorectal liver metastases with a
curative intent at a tertiary referral centre from 19872005. Patients with
extra-hepatic disease were excluded. Multivariate logistic regression was used
to identify independent predictors of margin involvement and to develop a
predictive index. The model was validated using measures of discrimination
and calibration.
Results. The positive resection margin (R1) was 8.8% (n80/911) with a
5-year cancer-specific survival for R0 and R1 hepatic resections of 39.7%
and 17.8% respectively; pB0.001. On multivariate analysis, five risk-factors
were found to be independent predictors of a positive resection margin,
ranked in the order of importance: number of hepatic metastases 3
involving 50% of the liver vs. B3 metastases (R131.7% vs. 6.6%, odds
ratio (OR)5.1, pB0.001); bilobar vs. unilobar disease (R119.0% vs.
5.6%, OR3.4, pB0.001); revisional vs. primary hepatic resection (R1
17.9% vs. 8.1%, OR3.4, p0.002); abnormal vs. normal pre-operative
liver function tests (R113.7% vs. 7.5%, OR1.8, p0.044); and wedge
excision or extended hepatectomy vs. left hepatectomy (R1 18.6.%,
16.7% vs. 4.5%, OR3.4, 2.6, p0.045, 0.165 respectively). Patients with
the best and worst prognostic criteria had an expected positive resection
margin ranging from 2.2% to 78.6%. When tested the model fitted the data
well, with an area under the receiver operating characteristic curve of 77.4%
(SE2.7%).
Conclusions. The present study describes a simple and accurate model for
quantifying the risk of a positive margin following hepatic resection for liver
metastases. The model may be used pre-operatively within the context of a
multi-disciplinary team for identifying patient who may benefit from neo-
adjuvant therapy prior to liver surgery, thus minimizing the risk of a positive
margin.
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ASSESSMENT OF PRE- AND POSTOPERATIVE LIVER REGEN-
ERATION IN COMBINATION WITH TUMOR GROWTH IN PA-
TIENTS UNDERGOING PREOPERATIVE PORTAL VEIN
EMBOLIZATION
W. de Graaf1, K. P. van Lienden2, A. K. van Vliet, R. J. Bennink3, T. M. van
Gulik
1Department of Surgery/Surgical Laboratory, Academic Medical Center,
University of Amsterdam, The Netherlands; 2Department of Radiology,
Academic Medical Center, University of Amsterdam, The Netherlands;
3Department of Nuclear Medicine, Academic Medical Center, University of
Amsterdam, The Netherlands
Preoperative portal vein embolization (PVE) is an option in patients
requiring major liver resection in whom estimated future remnant liver
(FRL) is considered insufficient. PVE induces atrophy of the embolized,
tumor-bearing lobe while compensatory hypertrophy occurs of the non-
embolized lobe, resulting in increased FRL volume and function. There is
evidence that tumor growth after PVE is accelerated, creating a dilemma in
terms of optimal waiting time between PVE and resection. It is also
uncertain whether postoperative liver regeneration is hampered after
preoperative PVE.
Time interval between PVE and resection is mainly determined by the time
required to reach sufficient FRL hypertrophy, as usually assessed by CT
volumetry. Safe resection can be performed if FRL exceeds 2530% of total
liver volume in patients with normal livers, or 40% in patients with
compromised livers. Few methods, however, are available to measure FRL
function after PVE. 99mTc- mebrofenin hepatobiliary scintigraphy (HBS)
enables the measurement of both total and regional liver function.
The aims of this study were to assess tumor growth as well as increase in FRL
volume and function after PVE, and to compare postoperative liver
regeneration in patients undergoing preoperative PVE with normal post-
operative liver regeneration using CT volumetry and HBS.
From 2005 until 2006, PVE was performed in thirteen patients. Preceding
PVE, total liver volume, tumor volume and FRL volume were measured by
CT volumetry. Total and FRL function were determined by HBS. Three to
four weeks after PVE, CT volumetry was performed to measure the increase
of FRL volume and tumor growth in the embolized lobes. HBS was used to
measure the increase of liver function. Three months after liver resection,
HBS and CT volumetry were repeated to assess postoperative liver
regeneration. A group of 7 patients who underwent a right (extended)
hemihepatectomy without PVE in the same period was used as postoperative
control group.
Of eight patients with measurable tumors in the liver, seven patients showed
increased tumor volume after PVE (23.5% increase). One patient with a
benign lesion had decreased tumor volume.
Increase of FRL function (41.8% increase) measured by HBS was
significantly (pB0,05) greater than increase of FRL volume (32.6%
increase), 34 weeks after PVE. Correlation between functional increase
and volumetric increase of the FRL was moderate (r0.63, p 0.03). In 9
patients, a partial hepatectomy was performed. In the PVE group, liver
volume regenerated up to 78918% of initial liver volume whereas liver
function increased to 85.5921% of preoperative values. In the control
group, liver volume and function recovered to 74.099.8% en 85.4912.6%
of initial values, respectively.
In this study, tumor load increased after PVE. Therefore, time interval
between PVE and resection is crucial and should be limited. Increase of
function is more advanced than increase of volume. Functional assessment of
the FRL after PVE using HBS might be more reliable than CT-volumetry to
determine the time period between PVE and liver resection. Preoperative
PVE has no negative effect on postoperative liver regeneration.
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LARGE HEPATOCELLULAR CARCINOMA: TIME TO STOP PRE-
OPERATIVE BIOPSY
Alastair L Young1, Hasan Z Malik, Mohammed Abu-Hilal, J Ashley
Guthrie2, Judy I Wyatt3, K Rajendra Prasad, Giles J Toogood, J Peter A
Lodge
1Hepatobiliary and Transplant Unit, St James’s University Hospital; 2Radi-
ology Department, St James’s University Hospital; 3Histopathology Depart-
ment, St James’s University Hospital
Introduction. In Western countries Hepatocellular Carcinoma (HCC) often
presents at a large size, which is seen as a contraindication to transplantation
and often resection. Although diagnosis by imaging and alpha fetoprotein is
usually straightforward, non-specialist units continue to use biopsy to prove
that diagnosis before transfer for specialist surgical opinion. We have looked
at the impact of this on our practice.
Methods. We retrospectively analysed all Large HCC’s resected in our unit
over the last 12 years. Survival data was calculated according to size and
univariate and multivariate analyses was carried out to determine impact of
preoperative, operative and histological factors affecting outcome.
Results. We identified 85 large HCC’s (3 cm) and classified 42 as giant
(10 cm). Overall survival at 1, 3 and 5 years was 76%, 54% and 51%. Size did
not influence survival, although more complex surgical techniques were re-
quired for giant tumours. Predictors of poorer disease free survivalwere positive
resection margin (pB0.001), multiple tumours (p0.003), macroscopic
vascular invasion (p0.015) and pre-operative lesion biopsy (p0.027).
Conclusion. Our data shows excellent outcomes after resection for large/
giant HCC. This supports the management of such patients in large volume
units which are fully equipped and experienced in the management of these
patients. Pre-operative biopsy must be avoided as this unnecessary man-
oeuvre has severely compromised our operative results.
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DO PREVIOUS ATTACKS OF ACUTE BILIARY PANCREATITIS
INCREASE THE RISK OF A FUTURE SEVERE ATTACK?
Ahmed Z Al-Bahrani1, Mohammed Al-Rashedy2, Nuha A Yassin3, Maria
Charalambous3, Basil J Ammori3
1Department of Surgery, Hemel Hempstead Hospital, Hemel Hempstead,
UK; 2Department of Surgery, Manchester Royal Infirmary, Manchester UK;
3Department of Surgery, Manchester Royal Infirmary, Manchester, UK
Introduction. The influence of previous attacks of acute biliary pancreatitis
(ABP) on the likelihood of a subsequent severe attack remains unclear.
Methods. Patients who underwent cholecystectomy for ABP between 1992
and 2004 were identified and their clinical data retrieved.
Results. There were 97 patients (67 female) with a median (range) age of 50
(1487) years. The final preoperative attack of ABP was mild in 64 patients
(66%) and severe in 33 patients (34%). The median (range) number of
previous attacks was 1 (07) and 78 patients (80%) had previously suffered
one or more acute attacks of pancreatitis. The median interval between first
attack and surgery was 65 days. Patients who had previously suffered more
than one attack of ABP were significantly more likely to develop a severe
attack compared with those who did not [15 of 23 patients (65%) vs. 18 of 74
patients (24%), pB0.0001]. Multivariate analysis identified the number of
previous attacks and not the interval between first and last attack, age or sex
as an independent predictor of severity (p0.001).
Conclusion. Previous attacks of ABP increase the likelihood of a future
severe attack. Definitive management of gallstones is required during the
index admission with ABP.
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IS LAPAROSCOPIC CHOLECYSTECTOMY MORE DIFFICULT
AFTER SEVERE ATTACKS OF ACUTE BILIARY PANCREATITIS
COMPARED WITH MILD ATTACKS?
Ahmed Z Al-Bahrani1, Mohammed Al-Rashedy2, Nuha A Yassin3, Maria
Charalambous3, Basil J Ammori3
1Department of Surgery, Hemel Hempstead Hospital, Hemel Hempstead,
UK; 2Department of Surgery, Manchester Royal Infirmary, Manchester UK;
3Department of Surgery, Manchester Royal Infirmary, Manchester, UK
Introduction. Although laparoscopic cholecystectomy (LC) following acute
biliary pancreatitis (ABP) may be associated with increased operative
difficulty and risk, it is unclear whether severe attacks had a greater influence
compared with mild attacks.
Methods. Patients who underwent LC for ABP were identified from the
theatre log and their clinical data retrieved. Severity was defined according to
the Atlanta criteria.
Results. Amongst 87 consecutive patients with a median age of 48 years, 29
patients (33.3%) suffered severe ABP. There was no difference between the
severe and mild groups with regard to age, sex, ASA scores, frequency of LC
performed during index admission (17% vs. 24%, p0.586) or within one
month of the attack (28% vs. 38%, p0.473), and the interval between onset
and LC (median, 78.5 vs. 61 days, p0.207). Severe attacks of ABP did not
significantly increase the operative time (median, 94 vs. 82 minutes, p
0.191), conversion rate (7% vs. 5%, p0.746), or postoperative morbidity
(17% vs. 14%, p0.800). There was a trend towards longer postoperative
hospital stay in patients with severe ABP (median, 3 vs. 2 days, p0.055).
Conclusion. Severe attacks of ABP do not appear to increase the operative
difficulty or risk of LC compared with mild attacks.
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MODIFIED CATELL’S PANCREATICO-JEJUNOSTOMY, BUT-
TRESSING AND ISOLATED BILIO-PANCREATIC LOOP
RESULTS IN BETTER OUTCOMES FOLLOWING PAN-
CREATICODUODENECTOMY
Mohammad Abu hilal1, Hamilton-burke Wurbena2, Karim Halazun2, Manal
Atwan2, Glenn K Bonney2, Krishna V Menon2
1St James’ University Hospital,; 2St James’ University Hospital
Introduction. Pancreatic leak following Pancreatico-duodenctomy (PD)
continues to be the most serious complication (1) accounting for up to 80%
of post- operative death (2).
Objective. To assess outcomes following PD adopting a combination of
reconstructive preventive techniques.
Patients and Methods. Over a 4 year period, between May 2002 and June
2006, 50 PDs were performed by a single surgeon performing a modified
Catell’s pancreatico-jejunostomy on an isolated bilio-pancreatic loop after
buttressing of soft pancreatic parenchyma.
Results. median pancreatic duct size 4mm (0.210mm) respectively. The
pancreas was found to be firm in 18 patients (36%), intermediate in 13
patients (26%) and soft in the remaining 19 patients (38%). Buttressing was
performed in 21 (42%) of patients. Median intra-operative blood loss was
300 mls.
There were no intra-operative and in-hospital mortalities in this cohort.
Major complications occurred in 7 patients (5 requiring relaparotomy and 2
managed conservatively). The re-operated group included bleeding from the
stapled jejuno-jejunal anastamosis (n4), bowel obstruction from internal
herniation (n1). Pancreatic leak occurred in one patient only (2%) and one
patient had biliary leak (2%). Both patients were managed conservatively.
Discussion. Since Codivilla Performed the first PD in 1904 the treatment of
the pancreatic stump has been the Achilles heel for pancreatic surgeons.
However the best reconstructive technique is still debatable. It appears that
different preventive measurements should be combined for a better outcome.
Conclusion. Our results suggest, modified Catell’s pancreatico-jejunostomy
on an isolated bilio-pancreatic loop after buttressing for soft pancreases to be
safety measures for better outcomes following Pancreaticoduodenectomy.
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INTRACTABLE ABDOMINAL PAIN IN PATIENTS WITH
CHRONIC PANCREATITIS AND PANCREATIC CANCER: RE-
SULTS OF BILATERAL THORACOSCOPIC SPLANCHNOTOMY
Saleh Baghdadi1, M H Abbas, B J Ammori
1Manchester Royal Infirmary
Background. Division of the greater and lesser splanchnic nerves is reserved
to patients with intractable upper abdominal pain after failed medical
therapy.
Method. Selected patients with opiate-dependent upper abdominal pain
secondary to chronic pancreatitis (CP) or malignancy underwent bilateral
thoracoscopic splanchnotomy (BTS). Response to surgery was assessed using
the visual analogue scale (VAS), and the analgesic requirements were
recorded.
Results. Between 2001 and 2006, 20 patients (male, 14) with a median age
of 50.5 years who suffered with CP (n12) or malignancy (n8) underwent
20 BTS procedures. The median (range) operating time was 30 (2075)
minutes. There were no conversions to thoracotomy, operative complications
or mortality. The median (interquartile range) postoperative hospital stay was
1 (12.5) days. At a median (range) follow up of CP patients of 36 (163)
months, the median VAS score declined from 7.5/10 preoperatively to 3/10
postoperatively, while opiates were discontinued in 3 patients, markedly
reduced in 5, unchanged in 2, and increased in 2 patients. At a median
(range) follow up of cancer patients of 2 (115) months, the median VAS
score declined from 8/10 preoperatively to 1.5/10 postoperatively, while the
opiate requirements were markedly reduced in 5 patients and increased in 2
patients (one patient was lost to follow up).
Conclusions. BTS is a safe and useful minimally invasive approach to
palliation of intractable upper abdominal pain with good short-to-medium
term results in patients with malignancy and those with CP.
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DELAYED GASTRIC EMPTYING AFTER PANCREATICODUO-
DENECTOMY CAN BE REDUCED BY A FAST-TRACK CLINICAL
PATHWAY
Gianpaolo Balzano1, Simona Irma Rocchetti, Alessandro Zerbi, Enrico
Ortolano, Roberta Varale, Francesca Gavazzi, Valerio Di Carlo
1San Raffaele Scientific Institute
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Background. Delayed gastric emptying (DGE) is a frequent postoperative
complication of pancreaticoduodenectomy (PD).
Aim. To evaluate if a fast-track clinical pathway is effective in decreasing the
incidence of DGE in a large series of patients undergoing PD.
Methods. A fast-track clinical pathway was introduced in our unit in July
2004. The protocol includes early removal of nasogastric decompression (day
1), early mobilization and early postoperative oral intake (liquid food from
day 3 and solid intake from day 4 or 5 when tolerated). Until December 2006
224 patients were prospectively evaluated (group A) and compared to an
historical group of 224 patients, treated from February 2001 to June 2004,
without fast-track pathway (group B). DGE was defined by the need for
nasogastric decompression or vomiting after 10 days from operation.
Statistical analysis was made with Chi-square and Mann-Whitney test.
Results. We observed 54 DGE in the group B (24.1%), 35 as single
complication (15.6%) and 19 in association with other intra abdominal
complications (IAC) (8.5%), and 30 DGE in group A (13.4%), 12 alone
(5.3%), and 18 with other IAC (8%) respectively. In both groups post-
operative pancreatic fistula was the most frequent complication associated.
The difference between the incidence of DGE non associated with other IAC
in the two groups was significant (pB0.001). Overall morbidity was
significantly reduced in group A (51.3% vs 62.9%, pB0.05), with no
significant difference in terms of mortality (3.1% group B and 2.7% group
A), re-laparotomy (8% B and 8.4% A) and re-recovery rate (6.2% in both
groups). The median postoperative hospital stay was 15 days (mean 18.5;
range 7102) for group B and 12 days (mean 16.3; range 7110) for group A
(pB0.01).
Conclusions. A fast track clinical pathway is feasible also in patients
undergoing major pancreatic surgery and is associated to a reduction in
postoperative DGE and postoperative stay.
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THE CHIMERA OF RADICALITY IN PANCREATIC CANCER
RESECTION
Gianpaolo Balzano1, Aldo Alberto Beneduce, Alessandro Zerbi, Michele
Reni, Marco Polese, Stefano Cereda, Luca Albarello, Valerio Di Carlo
1San Raffaele Scientific Institute
Backgroud. Pancreatic cancer has a dismal prognosis even in patients
undergoing resection. This is partially justified by the aggressive behaviour of
this cancer: 7080% of resected cases had metastatic lymphnodes, and
margin invasion is reported in up to 50% of cases.
Aim. To describe the frequency and pattern of relapse in pancreatic cancer
patients in which resection achieved an apparent radicality, namely patients
with either negative resection margins (R0) and negative lymphnodes (N0).
Methods. Retrospective evaluation of prospectively collected data. Between
1/1995 and 12/2004 we performed 354 pancreatic resections for ductal
pancreatic adenocarcinoma. Pathologic evaluation of resection margins was
made by multiple axial sections after inking the specimen margins. 45
patients (12%) resulted R0-N0, but.7 of them were excluded because they
had less than 10 nodes isolated in the surgical specimen (NX). Another
patient was lost at follow-up at 12 months. The remaining 37 patients were
the object of the study. Disease failure was assessed by CT scan performed
every 34 months after surgery, or when recurrent disease was suspected.
Survival analysis was made by the Kaplan-Meier curves and log-rank test.
Results. Patients were treated by 31 pancreaticoduodenectomies and 6 distal
pancreatectomies. 97% of patients (36/37) were T3N0, and 3% (1/37) was
T1N0. Despite the favourable histological pattern, only 38% of patients (14/
37) are still disease free with a median follow up of 58 m. (range 24130 m).
Disease-free survival and overall median survival (MS) were 25 and 29
months, respectively with 5-year survival of 32%. A recurrence of disease was
detected in overall 62% of patients: 11 pts (30%) had local relapse and 15 pts
(40%) had distant metastases (8% of them had both local and distant
metastases). Stratifying the study group by age, tumour size, grading and
adjuvant CT, tumour size B2.3 cm was a significant prognostic factor (MS 54
m. and 24 m, pB 0.05); and age 63 y was almost a significant favourable
factor (p0.07). When comparing the study group with the remaining
resected patients, there was a significant difference in disease-free and overall
survival (pB0.001), and in the overall recurrence rate (81% vs 62% pB0.05).
Conclusions. Radicality is a chimera in pancreatic cancer resection, since
most of R0N0 patients will die of the disease. Even an accurate pathologic
evaluation fails to certify the achievement of local radicality, since 30% of
R0N0 pts had local recurrence. Furthermore, 40% of R0N0 pts had occult
distant metastases at the time of resection.
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PREDICTION OF MALIGNANCY IN WELL DIFFERENTIATED
ENDOCRINE TUMOURS WITH UNCERTAIN BEHAVIOUR
Alessandro Zerbi1, Vanessa Capitanio, Luca Albarello, Gianpaolo Balzano,
Federica Milani, Giovanni Capretti, Claudio Doglioni, Valerio Di Carlo
1San Raffaele Scientific Institute
Background. Endocrine tumors classified as well differentiated with
uncertain behaviour (WDET-U) represent a poorly characterized clinical-
pathological entity; few information are available about their natural history.
Aim. To evaluate clinical behaviour and adequacy of surgical treatment in
WDET-U.
Methods. 40 patients (25 female and 15 male; mean age 47,3 years)
underwent pancreatic radical resection between 1987 and 2005 for unifocal,
non-MEN associated WDET-U ( according to WHO 2000 classification if
present at least one of these four parameters: size 2 cm, Ki-67 index 2%,
angioinvasion, mitoses/10HPF 2). An atypical pancreatic resection was
performed in 47% of cases (enucleation in 30%, middle pancreatectomy in
12%, distal pancreatectomy with splenic preservation in 5%) whereas a
typical resection in 53% (pancreatoduodenectomy in 28%, distal splenopan-
createctomy in 25%). 40% were non-functioning tumors and 60% were
functioning. Mean size was 3,8 cm (range 0,8 17,2 cm; 2cm in 67%). Ki-
67 index was B2% in 86% of cases, 25% in 11%, 5% in 3%.
Angioinvasion was present in 25% of cases. 13% of patients showed mitoses
2 10HPF. In 33 cases only one of the 4 pathological parameters was present,
in 6 cases two, in 1 case three. Mean follow-up was 87 months (range: 7223
mo).
Results. We observed distant relapse in 2 patients at 76 and 84 months, in
the first case in the adrenal gland and in the second case in the liver. The first
patient underwent a pancreatoduodenectomy; the pathological evaluation
showed a size of 3,8 cm and angioinvasion was present; in the second patient
a distal splenopancreatectomy was performed, tumor size was 4 cm,
angioinvasion and 2 mitoses/10HPF were present. In both cases relapse
was surgically removed; both patients are alive and disease-free at respectively
147 and 10 months after re-intervention. Recurrence was observed in 2/7
patients with more than one WHO parameters and in 0/33 patients with only
one parameter (pNS). Three patients died for reasons not related to the
disease; all the other patients are alive and disease-free.
Conclusions. Endocrine tumors classified as WDET-U, though very low,
have a malignant potential; the presence of 1 WHO parameter predicts a
higher risk of malignancy. Since no local recurrence was found, atypical
resection is indicated to treat WDET-U. A long-term follow-up (5 years) is
needed, because the onset of metastases occurred very late.
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UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AS A
NEW USEFUL MARKER IN PANCREATIC CANCER: PRELIMIN-
ARY RESULTS
Antonio Bonora1, Claudio Sorio2, Federico Furlan3, Gianluigi Maraia*,
Andrea Mafficini2, Stefano Crippa, Marco Della Peruta2, Claudio Bassi,
Paolo Pederzoli, Alvise Cavallini$
1Department of Surgical Sciences; 2Department of Pathology; 3Department
of Molecular Biology and Functional Genomics; *Department of Surgical
Sciences-Medical Research Laboratories; $Departement of Surgical Sciences
Urokinase plasminogen activator receptor (uPAR) has been recently reported
as highly expressed in various types of cancer (1) and above all thought as
potential prognostic indicator in pancreatic cancer (2).
In order to verify these data we collected serum and urine of 61 pts (28 males,
33 females; mean age 52.8 ys, range 1677) suffering from pancreatic
disease: 36 pancreatic cancer (59%), 12 inflammatory disease (20%), 9 cystic
tumours (15%) and 4 endocrine tumours (6%). Then uPAR were measured
both in plasma and urine, before and after correlating with creatinine levels.
The correspondence between uPAR values in plasma and urine was only 32%
in the upper case, but increased to 60% in the latter. Mean values in plasma
and urine were 50.8 pmol/l and 321.6 pmol/l respectively. Crossing both
plasma and urine levels, the difference among pancreatic cancer and the other
tumoral and inflammatory disease reached statistical significance, as showed
in the table (see attached files).
Whereas we did not report any significant relationship among uPAR levels,
tumoral markers, pathological features and survival in pancreatic cancer
patients, probably owing to the relative narrowness of our series.
In conclusion, uPAR appeared to be a potentially useful marker for diagnosis
and follow-up in pancreatic cancer. Further evaluation is required on a large
number of patients to confirm these preliminary results and investigate a
possibile relationship with clinical features and survival.
P=0.0569P=0.0151P<0.0001P=0.0038P=0.0073
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PERIOPERATIVE MORBIDITY OF PANCREATIC HEAD RESEC-
TION MULTIVARIATE ANALYSIS COMPARING THE CLASSI-
CAL PANCREATO-/PANCREATICOJEJUNOSTOMY WITH THE
PANCREATIC ANASTOMOSIS DESCRIBED BY BLUMGART
Christiane J. Bruns1, Axel Kleespies, Matthias Roth, Christian Graeb,
Markus Guba, Martin K. Angele, Wolfgang Hartl, Markus M. Heiss2,
Karl-Walter Jauch
1Department of Surgery, University of Munich-Grosshadern; 2Department
of Visceral, Vascular, and Transplantation Surgery, University of Witten/
Herdecke
Introduction. Leakage from the pancreato-pancreaticojejunostomy is a
major cause of septic complications and mortality after classical partial
pancreatoduodenectomy (Kausch-Whipple procedure) as well as pylorus-
preserving partial pancreatoduodenectomy (Traverso-Longmire procedure).
The objective of this study was to evaluate the safety of a new technique of
pancreato-pancreaticojejunostomy, previously described by Blumgart which
should avoid shear forces at the pancreatic stump during tying of the sutures.
Methods. In two different patient?s cohorts with pancreatic head resections
for pancreatic cancer the classical pancreato-pancreaticojejunostomy (cppj)
was compared with the pancreatic anastomosis described by Blumgart (pjb).
From 01/1998 until 12/2002 (n90, m53, w37) the pancreatic
anastomosis following pancreatic head resection was exclusively performed
as a classical pancreato-pancreaticojejunostomy: after incision of the anti-
mesenterial wall of the bowel the back wall was sutured with single stitches
including the back wall of the pancreatic duct. After completion of the back
wall including the pancreatic duct the anterior wall of the anastomoses to the
bowel was sutured with single stitches, again including the front wall of the
pancreatic duct. From 01/2003 until 03/2005 (n92, m52, w40) a new
technique for the pancreatic anastomosis was applied. For the so-called
Blumgart technique transpancreatic U-stitches were placed straight through
the pancreatic remnant about 1 cm distal from the cut surface starting at the
ventral side of the pancreatic remnant through the remnant gland to the
dorsal side, then through the back wall of the jejunal loop and finally back
through the pancreatic remnant. In addition, after point incision of the anti-
mesenterical wall of the jejunal loop, a duct-to-mucosa anastomosis was
performed by single stitches. The pancreato-jejunostomy was finished by
placing the four transpancreatic U-stitches finally both through the front wall
of the jejunal loop and performing a knot on the jejunal wall. We
retrospectively collected the following information for each patient: age,
sex, preoperative co-morbidity, type of surgery, ASA-classification, intrao-
perative blood loss, duration of surgery, postoperative hospital length of stay,
postoperative length of ICU stay, local postoperative complications (insuffi-
ciency of the pancreatic or biliary anastomosis, postoperative hemorraghe)
and systemic postoperative complications (wound, central venous catheter,
and urinary tract infection, wound abscess). Comparisons between groups
were made by the unpaired t-test (continuous variables) and by Chi-square
statistics (categorical variables). A P value of .05 or less in a 2-tailed test was
considered statistically significant. Variables found to be associated with the
frequency of total systemic complications or of local complications in the
univariate analysis (PB.20) were entered into a stepwise logistic regression
model to estimate adjusted odds ratios (ORs) and 95% CIs.
Results. The age distribution and the incidence of any preoperative
interventions was comparable between the two groups, the perioperative
management was carried out following the same standard operating
procedures.
The univariate analysis of the data resulted in a significant higher hospital
mortality following classical pancreato-pancreaticojejunostomy as compared
to the pancreatic anastomosis described by Blumgart (cppj10% vs. cpb
4,3%, pB0.02) and the overall anastomotic insufficiency rate was signifi-
cantly higher (cppj17,7% vs. cpb9,7%, pB0.03). The duration of
surgery and the postoperative length of ICU stay were markedly longer
following classical pancreato-pancreaticojejunostomy as compared to the
pancreatic anastomosis described by Blumgart (37117 min vs. 32521
min, 7,71 vs. 3,82 days, n.s.). The multivariate analysis of the data
demonstrated that the technique of the pancreatic anastomosis was the only
variable that significantly influenced the postoperative frequency of total
systemic complications (p0,001, OR 7,11, 95% confidence interval 2,32
21,76) and local complications at the operation site (p0,038, OR 2,28,
95% confidence interval 1,04 4,98).
Summary. In our patient?s cohort the pancreatic anastomosis described by
Blumgart resulted in a significant reduction of perioperative morbidity as
compared to the classical pancreato-pancreaticojejunostomy. The multi-
variate analysis of the data demonstrated that neither ASA-classification, age,
or sex nor intraoperative blood loss or duration of surgery were significantly
associated to postoperative frequency of total systemic complications or local
complications at the operation site. The only factor of significant influence
was the technique of the pancreatic anastomosis. In our institution the
technical unproblematic, fast and reliably feasible pancreatic anastomosis
described by Blumgart became accepted as gold standard for the pancreato-
pancreaticojejunostomy following pancreatic head resection.
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REOPERATION FOR BLEEDING AFTER PANCREATODUODE-
NECTOMY: FROM ‘‘EARLY EASY’’ MANAGEMENT TO LATE
LIFE THREATENING CONDITIONS. RESULTS ON A CONSECU-
TIVE SERIES OF 658 PATIENTS
Giovanni Butturini1, Filippo Scopelliti, Alessandro Esposito, Marco Dal
Molin, Camilla Cena, Roberto Salvia, Nora Sartori, Massimo Falconi,
Claudio Bassi, Paolo Pederzoli
1Surgical and Gastroenterological Department University of Verona
Background. Whenever not promptly recognized and managed, bleeding
after pancreaticoduodenectomy (PD) is a potential lethal event. The aim of
this study is to report the relevance of bleeding on mortality rate after PD in a
high volume center.
Patients and Methods. Between November 1996 to November 2006, 658
consecutive Patients (365 Male, 293 Female, median age 62 years, range 7-
83) underwent PD for periampullary tumors. Peri-operative data and surgical
outcome were prospectively collected.
Results. 593 pilorus-preserving (PP) and 65 Whipple PD were performed.
Median operating time was 360 minutes (range 180960). Overall 8 (1.2%)
patients died for complications within 2 months from the operation. 21
(3.1%) patients were re-operated because of bleeding. 13 had the procedure
within 48 hours from PD and they all recovered well except one who had a
further re-operation consistent of total pancreatectomy for pancreatojeju-
nostomy dehiscence on day 7 and died later on day 37. Eight patients were re-
operated on between post-operative day 12 to p.o. day 46. Three of them
subsequently died for complications.
Discussion. Bleeding after PD has to be distinguished between early and
late. The former could be resolved with immediate re-laparotomy and
subsequent course relatively indolent. Late bleeding is more difficult to
manage and it is responsible of severe complications and high mortality rate.
Conclusions. The present prospective series of 658 PD demonstrated that
post-operative bleeding accounts for half of peri-operative deaths.
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LOW MORTALITY RATE IN SEVERE ACUTE PANCREATITIS
PATIENTS TREATED IN A TERTIARY REFERRAL CENTER
Alessandro Giardino1, Giuliano Barugola, Stefano Partelli, Giovanni Buttur-
ini, Marco Inama, Claudio Bassi, Paolo Pederzoli
1Surgical and Gastroenterological Department University of Verona
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Introduction. For almost a century the rate of complications in Severe
Acute Pancreatitis (SAP) paralleled the clinical severity of attack, recently it
has been proved that severity is more related to development and amount of
pancreatic necrosis. Nowadays surgical debridement and drainage remains
preferred approach for infected necrosis despite occasional reports of
successful conservative management. Mortality for acute necrotizing pan-
creatitis (NP) is ranging between 25% to 5% in specialized center.
Objectives. We report overall low mortality rate in the management of acute
necrotizing pancreatitis in a tertiary referral center particularly related to long
standing severe illness patients.
Methods. Data prospectively collected of all patients admitted at the
department of general and pancreatic Surgery of Verona with diagnosis of
acute pancreatitis between 1997 to 2004 were reviewed focusing on severe
ones. The continuous variables were described using the median value as a
measure and the interquartile range (IQR) as a dispersion measure.
Results. Among 784 consecutive patients suffering from acute pancreatitis,
there were 54 (6.9%) patients with CT proven necrotizing pancreatitis, 43
(79.6%) of these patients were transferred from other Institution after a
median time from diagnosis of 35 days (IQR 13.567.7). At the diagnosis all
NP patients received prophylactic antibiotics, 38 (70.3%) were treated with
imipenem.Overall 41 (75.9%) patients underwent surgery for sepsis due to
infected necrosis. Twenty of them had the first operation elsewhere, 18 (90%)
were subsequently re-operated in our Institution. The median length of stay
was 26 days (IQR 1946) with 4 deaths (7.4%).
Discussion and Conclusion. Patients suffering from acute necrotizing
pancreatitis should be transfer to tertiary referral center: repeated surgical
debridement of infected necrotizing pancreatitis must be considered the
standard that offers the best outcome as well demonstrated by our low death
rate ( 7.4%) even in long standing hospitalized patients.
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PREVENTION OF PANCREATIC FISTULA IN LEFT PANCREA-
TECTOMIES: STAPLER OR HANDSEWN CLOSURE?
R. Casadei1, N. Zanini, R. Pezzilli2, L. Calculli3, C. Ricci, T. Grottola, G.
Sciannamea, F. Minni
1Departments of Surgery, Policlinico S.Orsola-Malpighi, University of
Bologna, Italy; 2Departments of Medicine, Policlinico S.Orsola-Malpighi,
University of Bologna, Italy; 3Departments of Radiology, Policlinico S.Or-
sola-Malpighi, University of Bologna, Italy
Introduction. Morbidity after left pancreatectomies remains high even in
experienced centres ranging from 10 to 47 per cent. Pancreatic fistula and
leakage are the most common and dangerous complications. The appropriate
technique for closure of the pancreatic remnant is still debated: stapler or
handsewn closure?
Methods. We retrospectively reviewed our data regarding 101 consecutive
patients who underwent left pancreatectomies in our Institute since 1995.
Post-operative mortality, morbidity and incidence of pancreatic fistula were
evaluated according to some prognostic factors (age, ASA score, hyperten-
sion, congestive heart failure, coronary artery disease, cerebrovascular
disease, diabetes mellitus, COPD) and to pancreatic remnant treatment
after left or subtotal pancreatectomies, open or laparoscopic (handsewn
suture versus stapler suture). Data were evaluated using the Fisher’s exact
test.
Results. Overall post-operative morbidity and mortality were respectively
20.8% and 2.0% (2 patients died during postoperative course for acute
myocardial infarction). In 29 patients (28.7%) the pancreatic remnant was
treated using a stapler, in 72 patients (71.3%) the surgeon performed an
handsewn closure. Eleven patients (10.9%) developed a pancreatic fistula. All
of them were conservatively treated with medical and/or radiological
treatment. There was no significance statistical difference in mortality,
morbidity and incidence of pancreatic fistula for each prognostic factor
analyzed. A fistula developed in 5 patients of 29 treated with a stapler
(17.2%) and in 6 (8.3%) of the 72 patients in which an handsewn closure was
performed (p value0.287).
Conclusions. Age, co-morbidities, ASA score, surgical procedure, pancrea-
tic stump treatment and pancreatic disease are not linked to morbidity,
mortality and incidence of pancreatic fistula. Despite the recent results
published in worldwide literature which suggest the use of a stapler to treat
the pancreatic remnant, in our cases incidence of pancreatic fistula was
higher, even if not statistical significant, in patients in whom a stapler closure
was performed.
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ANTIBIOTIC PROPHYLAXIS IN SEVERE ACUTE PANCREATI-
TIS: EXPERIMENTAL EVALUATION OF ERTAPENEM EFFI-
CACY
Fausto Catena1, Luca Ansaloni, Gazzotti Filippo, Gagliardi Stefano,
Salomone Di Saverio, Luigi D’Alessandro, Principe Alfonso, Pinna Antonio
1Transplant, General and Emergency Surgery DPT, St Orsola-Malpighi
University Hospital, Bologna, Italy
Objective. Secondary infection of the inflamed pancreas is the principal
cause of death after severe acute pancreatitis (AP).
Prophylactic antibiotics that were used in AP were always initiated after hours
from induction of pancreatitis. The effectiveness of antibiotics initiated earlier
is unknown. The aim of this study was to evaluate the effectiveness of
ertapenem initiated when AP is induced in rats.
Method. 40 Sprague-Dawley rats were studied. AP was induced in rats by
intraductal injection of 3% taurocholate. Rats were divided randomly into
two groups: group 1 rats received normal saline as a placebo, group 2
received ertapenem 15 mg/kg after AP induction. At 24 h, 20 rats (10
group I and 10 group 2) were killed for quantitative bacteriologic study. A
point-scoring system of histological features was used to evaluate the
severity of pancreatitis. The remaining 20 rats (10 group I and 10 group 2)
were killed after 21 days for quantitative bacteriologic study and survival
analysis. Chi square, Student and Kaplan- Meier tests were used for
survival analysis. Results: All rats showed pathologic signs of acute
pancreatitis. Ertapenem administrated after induction of AP significantly
reduced the prevalence of pancreatic infection and 24 hours mortality as
compared to controls. 21 days survival was significantly better in group 2
compared to group 1.
Conclusion. Early antibiotic prophylaxis with ertapenem reduces pancreatic
infection rate after AP and it has a beneficial effect on survival.
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MULTIFOCAL BRANCH-DUCT IPMNS: A NEW DEAL TO BE
EXPLORED
Stefano Partelli1, alvise cavallini, roberto salvia, luca landoni, massimo
falconi, claudio bassi, paolo pederzoli
1Surgical and Gastroenterological Dept, GB Rossi Hospital , University of
Verona, Italy
Background. Branch duct IPMNs (BD-IPMNs) are supposed to have a less
aggressive biological behaviour, allowing a conservative management in
selected cases.
Method. All pts observed from 1990 to March 2006 with a diagnosis of BD-
IPMNs confirmed by the presence of more than one cystic lesion commu-
nicating with a non-dilated main duct at MRCP.
Results. 340 pts with IPMN were prospectively considered; 220 with
diagnosis of BD-IPMNs. 100 pts (45.5%) were multifocal. They were 37
male and 63 female with a median age of 67 years (range 4684). The
diagnosis was incidental in 98 pts (98%). Cases were classified according to
location and surgical resection required. Surgical procedures were: total
pancreatectomy (TP) in 1 case, atypical resection in 1 pt, PPPD in 5 and
distal pancreatectomy in 3. Final pathological examination was IPM
adenoma in 4 cases, IPM border line in 3, in situ carcinoma in 2 pts and
invasive carcinoma in the last 1 case. At a median follow-up of 30 months
(range 7127) all pts managed conservatively are alive without any significant
increase in diameter of the main lesion. 9 of 10 pts who underwent surgery
are alive and disease-free.
Conclusions. In our experience multifocality is present in 45.5% of the
suspected BD-IPMNs, and its observation is increasing. According to Sendai
Consensus Conference, BD-IPMNs could be conservatively managed also
when multifocality is present; follow up might be problematic because of the
number of lesions to be evaluated. Otherwise a surgical approach could oblige
to perform TP in over 30% of cases, exposing asymptomatic pts to a possible
overtreatment. In 30% of resected specimen a degeneration to carcinoma was
demonstrated: this rate is intermediate between the degeneration rate of main
and BD-IPMNs reported in literature. For these reasons in our opinion
multifocal IPMNs should be considered as a separate entity.
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QUALITY OF LIFE AFTER TOTAL PANCREATECTOMY: RE-
QUIEM FOR A SURGICAL DOGMA
Silvia Germenia1, roberto salvia, alvise cavallini, Leonardina Festa, claudio
bassi, massimo falconi, paolo pederzoli
1Surgical and Gastroenterological Dept, GB Rossi Hospital , University of
Verona, Italy
Background. Among pancreatic resections, total pancreatectomy (TP) has
the greatest biological "impact" and it is generally considered to lead to
significant impairments in the Quality of Life (QoL).
Patients and Methods. 41 patients submitted to TP from 1994 to 2005 in
our Surgical Department were studied; the 26 survivors (median follow up
42.5 months) were interviewed with the European Organization for Research
and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-
C30), in addition to other questions regarding pancreatic function.
Results. The QoL score after TP was rather good (median: 5; scale from 1 to
7). The preoperative QoL score, retrospectively assessed, was 6. Impairment
of QoL was statistically significant (pB0.05) only in patients with malignant
pathologies. The median insulin dose was 32 U/day and the median
glycosylated haemoglobin concentration was 8.5%. Hypoglycaemic ‘‘acci-
dents’’ occurred in 24 patients (92.3%); nevertheless, only in two cases
intensive cares were necessary. Exocrine failure was treated with a median of
85,000 units of lipase/day. Steatorrhoea was either not reported or only
occasional observed in 17 patients (65.4%). In general, patients show a
certain capacity to adapt to this symptom, which does not impair their QoL.
Weight loss was reported in 25 cases, but 20 patients (77%) still have normal
or high BMI.
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Conclusions. An impact of TP on patients’ QoL certainly exists, but in fact
it is not severe; so, in selected patients, PT is a viable therapeutic option.
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SYSTEMATIC REVIEW AND META-ANALYSIS OF STANDARD
AND EXTENDED LYMPHADENECTOMY IN PANCREATICO-
DUODENECTOMY FOR PANCREATIC CANCER
Michalski Christoph W.1, Kleeff Ja˜rg, Wente Moritz N., Diener Markus K.,
Bu¨chler Markus W., Friess Helmut
1Department of General Surgery, University of Heidelberg, Germany
Background. The extent of lymphadenectomy in pancreaticoduodenectomy
for pancreatic cancer is still controversially discussed. Some retrospective
studies have shown increased survival rates with extended surgery.
Methods. In this meta-analysis, rancdomized controlled clinical trials
(RCTs) were included which compared standard and extended lymphade-
nectomy within pancreaticoduodenectomy. Overall survival was analyzed
using hazard ratios (HRs) and corresponding standard errors (SE). Pooled
estimates of overall treatment effects were calculated using a random effects
model (odds ratio and 95% confidence interval, C.I.).
Results. A large number of retrospective analyses had to be excluded while in
total four RCTs were identified out of which only three were available as full
text. Thus, three RCTs were eligible for meta-analysis. The log hazard ratios
on survival of these RCTs were 0.36 (SE0.22), 0.15 (SE0.17) and
0.21 (SE0.15); the weighted mean log hazard ratio for survival, taken
across all three trials, was 0.93 (95% C.I. 0.77 to 1.13) revealing no
statistically significant differences for the standard or extended procedure
(P0.48). Morbidity and mortality rates were also comparable with a trend
towards higher rates of delayed gastric emptying for extended LA. The
number of resected lymph nodes was significantly higher in the extended LA
groups (PB0.00001).
Conclusions. Extended lymphadenectomy does not provide any survival
benefit but may be associated with a trend towards increased morbidity.
Thus, we believe that it should only be used within adequately powered
controlled clinical trials.
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MUCINOUS CYSTIC NEOPLASM OF THE PANCREAS DEFINED
BY OVARIAN STROMA: IS THIS REALLY AN AGGRESSIVE
ENTITY? LESSONS FROM 163 RESECTED PATIENTS
Stefano Crippa1, Roberto Salvia2, Andrew L Warshaw3, Ismael Dominguez
Rosado3, Claudio Bassi2, Silvia Germenia2, Mary Mino-Kenudson*, Giu-
seppe Zamboni$, Paolo Pederzoli2, Carlos Fernandez-del Castillo3
1Department of Surgery, University of Verona; 2Department of Surgery
University of Verona; 3Department of Surgery Massachusetts General
Hospital; *Department of Pathology Massachusetts General Hospital;
$Department of Pathology University of Verona
Objective. Mucinous cystic neoplasms (MCNs) of the pancreas have often
been confused with intraductal papillary mucinous neoplasms. We sought to
evaluate the clinico-pathological characteristics, prevalence of cancer, and
prognosis of a large series of MCNs in two tertiary centers.
Methods. Analysis of 163 patients with resected MCNs, defined by the
presence of ovarian stroma and lack of communication with the main duct.
Results. MCNs were seen mostly in women (95%) and in the distal pancreas
(97%); 25% were incidentally-discovered. Symptomatic patients typically
had mild abdominal pain, but 9% presented with acute pancreatitis. 118
patients (72%) had adenoma, 17 (10.5%) borderline tumors, 9 (5.5%) in-
situ carcinoma and 19 (12%) invasive carcinoma. Patients with invasive
carcinoma were significantly older than those with non-invasive neoplasms
(55 vs. 44 years, P0.01). Findings associated with malignancy were
presence of nodules (P0.0001) and diameter 50 mm (P0.0001). All
neoplasms with cancer were either 40 mm in size or had nodules. There was
no operative mortality, and morbidity was 46%. Median follow up was 57
months (range: 4233), and only patients with invasive carcinoma had
recurrence. The 5-year disease-specific survival for non-invasive MCNs was
100%, and for those with invasive cancer 63%.
Conclusions. This series, the largest with MCNs defined by ovarian stroma,
shows a prevalence of cancer of only 17.5%. Patients with invasive carcinoma
are older, suggesting progression from adenoma to carcinoma, therefore
warranting resection in all cases. In low risk MCNs (4 cm/no nodules), more
conservative resections can be considered.
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QUALITY-OF-LIFE IN PANCREATIC CANCER: ANALYSIS OF
STAGE AND TREATMENT
Ismael Dominguez Rosado1, Stefano Crippa2, Ruben Rodriguez, Oswaldo A
Razo, Mary Mino-Kenudson3, Sarah P Thayer, Andrew L Warshaw, Carlos
Fernandez-del Castillo
1Department of Surgery Massachusetts General Hospital; 2Department of
Surgery, University of Verona; 3Department of Pathology Massachusetts
General Hospital
Objective. Considering the limited treatment options in pancreatic cancer,
health-related quality of life (QOL) could play an important role in the
decision-making work-up. The gain in survival and palliation of symptoms
should be balanced against social and functional impairment. In pancreatic
cancer, most of QOL studies have been performed in resected patients.
The aim of this work was to compare QOL in patients with different stages of
pancreatic adenocarcinoma who underwent surgical and/or medical inter-
ventions. We also evaluated differing treatments, readmissions, need for
endoscopic palliation and survival as secondary endpoints.
Methods. A prospective single-center study comprising 94 patients (48
female, 46 male, mean age of 66 years, range: 4289) with pathologically
proven ductal adenocarcinoma of the pancreas was performed over a 2-year
period. Patients were evaluated with the Functional Assessment of Cancer
Therapy-Hepatobiliary (Fact-Hep) questionnaire at diagnosis, 3 and 6
months.
Results. At diagnosis, 31 patients (32.9%) had localized disease (Group 1);
34 (36.1%) were locally advanced (Group 2); and 29 (30.8%) had metastatic
disease (Group 3). There were no differences regarding age or gender
between groups. Psychiatric comorbidity (depression/anxiety) was present in
16% of patients before cancer diagnosis.
No significant difference in QOL was found between the three groups as a
whole. Within group 1 QOL was better among those who underwent
resection without adjuvant chemo/chemoradiation than in those treated
(p0.019). Additionally, higher QOL scores were found in the resected
group when compared to patients who did not undergo resection (p0.04).
No QOL differences were found regarding age, gender, and CA19-9 levels.
In Groups 2 and 3, endoscopic palliation of biliary obstruction was needed in
21 patients. Thirteen patients required one biliary stent, and eight required
two or more. There were no differences in QOL between these two groups.
Twenty-eight patients underwent resection with an average length of stay of
7.4 days. The number of admissions was similar in the resected vs non
resected patients (median 1.5 vs. 1) but hospitalization was greater in the
surgical group (median 12 vs 7; p0.001).
After a mean follow up of 8.3 months (range: 121), 64.5% of Group 1
patients, 23.5% of Group 2, and 7% of Group 3 were alive (p0.0001).
Conclusions. Unexpectedly, pancreatic cancer stage had no overall sig-
nificant impact on QOL. QOL was better in patients who underwent
resection, but chemoradiation diminished QOL, a fact that needs to be
balanced against its survival and palliation benefits.
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MIDDLE SEGMENT PANCREATECTOMY: PERIOPERATIVE
AND LONG-TERM RESULTS ON 62 CONSECUTIVE PATIENTS
TREATED AT A SINGLE INSTITUTION
Stefano Crippa1, Claudio Bassi2, Massimo Falconi2, Roberto Salvia2,
Giovanni Butturini2, Alessandro Esposito2, Rossella Bettini3, Paolo Peder-
zoli2
1Department of Surgery, University of Verona; 2Department of Surgery
University of Verona; 3Department od Surgery University of Verona
Objective. When small, benign or low-grade tumours of the pancreatic neck
cannot undergo enucleation, standard pancreatic resections are performed,
with a higher risk of exocrine/endocrine insufficiency. Middle segment
pancreatectomy is an alternative, parenchyma-sparing, technique that can
be performed in selected patients with pancreatic neck tumours. Aim of this
study is to evaluate perioperative and long-term results of this operation over
a 15-year period.
Method. Patients who underwent middle pancreatectomy at our Institution
were identified from prospectively collected database. Pre-, intra-, post-
operative and long-term FU data were analyzed.
Results. Sixty-two patients underwent middle segment pancreatectomy for
benign (n41), borderline/low grade (n17) and malignant neoplasms (n
4). Operative mortality was zero. Overall morbidity was 60%, even if the rate
of clinically significant pancreatic fistula was 21%. After a median follow-up
of 33 months, three patients (5%) developed new onset of diabetes and two
(3.2%) pancreatic exocrine insufficiency. Three patients with main duct
IPMN (5%) developed local recurrence.
Conclusions. Middle segment pancreatectomy is a safe and feasible
procedure for treating tumours of the pancreatic neck; it must be
performed in very well selected patients. In experienced hands it is
associated with no mortality but with high morbidity, even if the rate of
‘‘clinical’’ pancreatic fistula is 20%. It allows surgeon to preserve
pancreatic parenchyma with very low incidence of exocrine-endocrine
insufficiency.
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PANCREATIC ANASTOMOTIC LEAK AFTER PANCREATICO-
DUODENECTOMY IN 1507 PATIENTS. UPDATED REPORT
FROM AN INTERNATIONAL WEB-BASED CASE REGISTRY
Stefano Crippa1, Kaye Reid Lombardo2, Matthew Barnett3, Michael
Farnell2, Claudio Bassi*, L William Traverso$
1Department of Surgery, University of Verona; 2Department of Surgery
Mayo Clinic; 3Department of Biostatistics, Virginia Mason Clinic; *Depart-
ment of Surgery University of Verona; $Department of Surgery Virginia
Mason Clinic
Background. Several definitions for pancreatic leak (PL) exist and the
reported range of 2-50% underscores this variation. In an attempt to
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standardize the definition of PL’s, the International Study Group on
Pancreatic Fistula (ISGPF) defined a pancreatic fistula as ‘‘the output of
any volume of fluid on or after postoperative day 3 with amylase content
greater than three times the upper serum value.’’ The goal of this study is to
collect data that might further improve the ISGPF definition and reach the
goal of a universally accepted definition by including broad categories of
hospitals from around the world.
Methods. A web-based database was designed to collect patient demo-
graphic, preoperative evaluation, intraoperative and postoperative data on
patients that had a pancreatoduodenectomy (PD) for any cause. Each
participating surgeon was given a unique identifying code that allowed
them to enter de-identified patient data. Pancreatic anastomotic leak was
defined using either the ISGPF definition (3 days, amylase 3x normal) or
Sarr’s definition (5 days, amylase 5x normal). Missing data was excluded
from the descriptive analysis of each variable.
Results. There were 1,507 cases submitted to the database from 20
institutions and 40 surgeons. The median age reported was 64 (1591)
with 53.8% of patients being males. A history of pancreatitis was reported in
17.5% of all patients. The use of preoperative stents in the main pancreatic
duct was 6.7%. A PPPD was performed in 76.2% of patients. Median
operative time was 374 minutes (1891020 minutes) with a median
estimated blood loss of 350 cc’s (0-5000 cc’s). Surgeons reported the
consistency of the pancreas as very firm (12.9%), firm (54.7%) or soft
(32.4%). The median pancreatic duct size was 3 mm (050 mm). A duct-to-
mucosa anastomosis was performed in 66.4% of the cases with an internal
stent 49.9% of the time. Pancreaticojejunostomy was performed in 87.6% of
cases. The median LOS was 10 days (180 days) with a median ICU stay of
1 day (079 days). A diagnosis of ductal adenocarcinoma was reported in
n812 (77.4%) of patients on final pathology. Postoperative morbidity
included bile leak (3.5%), intraabdominal abscess, (6.5%), delayed gastric
emptying (12.5%), intraabdominal bleeding (3.6%), and reoperation (3.5%).
Thirty-day mortality was 1.3% (n18). Using the ISGPF definitions the
pancreatic leak rate was 21.2%. By comparison, using the Sarr definition of a
leak revealed a rate of 9.4%.
Conclusion. PD appears to be safe with a low post operative mortality. The
chemical leak rate from these data significantly differs when using 2 common
definitions. This highlights the need for a standardized definition making
continued participation in this study essential.
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DISTAL PANCREATECTOMY: A RETROSPECTIVE ANALYSIS
OF 248 OPERATIONS
Chiara Croce1, Marco Del Chiaro, Simone D’Imporzano, Nelide De Lio,
Vittorio Perrone, Emanuele Balzano, Ugo Boggi, Franco Mosca
1University of Pisa-Regional Referral Center for Pancreatic Disease
Introduction. Complications occurring after distal pancreatectomy (DP),
yet seldom fatal, occur frequently carrying significant morbidity and added
costs. We herein report our Institutional experience with a consecutive series
of 248 DPs and analyze their short and long term outcomes.
Methods. Between November 1987 and August 2006 248 DPs were
performed at a single Institution. Patients’ demographics, intraoperative
findings, pathology data and outcome were recorded prospectively into a
computer data-base and analyzed retrospectively for the purposes of this
study. There were 112 (45.2%) males and 136 (54.8%) females; the mean
age was 60.6 years (range 1586 ys); 216 patients (87.1%) underwent
splenopancreatectomy (SDP), while the remaining 32 (12.9%) received a
spleen preserving distal pancreatectomy (SPDP); in 22 cases the procedure
was carried out laparoscopically (0.9%).
Results. The median operative time was 357 minutes (range 140720
minutes); the median number of red blood cells units transfused was 0.4
(range 012). Perioperative morbidity and mortality rates were 24.6% (61/
248) and 3.6% (9/248), respectively. The most common surgical complica-
tions were: pancreatic fistula (n26; 10.5%); intraabdominal fluid collec-
tion/abscess (n7; 2.8%); and bleeding (n 6; 2.4%). A relaparotomy was
required in 12 patients (4.8%). Final pathologic diagnosis was pancreatic
adenocarcinoma in 88 patients (35.5%), neuroendocrine tumor in 42
patients (16.9%), cystic neoplasm in 44 patients (17.7%), other tumor
types in 49 patients (19.7%) and other benign disease in 25 cases (10.1%).
The median length of postoperative hospital stay was 15.9 days (range 4
101 days). Patients undergoing SDP and SPDP showed a similar post-
operative morbidity rates (59/216; 27.3% vs 5/32; 15.6%, respectively; p
ns). In particular no overwhelming post-splenectomy infection was recorded
following SDP, after a mean follow-up period of 51.4 months (range 5
222) despite our operative protocol did not include a systematic policy of
vaccination. In 22 patients (8.8%) the pancreatic body and tail were
resected en-bloc with at least one, non-splenic, large peripancreatic vessel.
In this sub-group of patients there was no increase in either morbidity
(24.7%) or mortality (1.3%) as compared to conventional DP. Likewise,
survival at 13, and 5 years was not worse after extended DP (60.9%,
27.1% and 6.5%, respectively) as compared to conventional DP (65.2%,
29.4% and 19.6%, respectively) (pNS). Survival of patients diagnosed
with ductal adenocarcinoma at the same time points was 60.1%, 27.8% and
22.3%, respectively.
Conclusions. Nowadays DP can be performed safely, even in case of
concurrent resection of large, non-splenic, retroperitoneal vasculature. The
spleen can be preserved safely. However, considering that spleen preservation
is technically more complex than splenectomy, and that the incidence of
overwhelming post-splenectomy infection is low (nihil in this study after the
reported follow-up period), candidates to SPDP should be selected carefully.
Pancreatic fistula, with its attendant risk of fluid collection/abscess formation,
remains the leading cause of morbidity after DP and, in this regard, few
improvements have been achieved over the years.
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ROLE OF MULTIDETECTOR COMPUTED TOMOGRAPHY
IN CHARACTERIZATION NEUROENDOCRINE PANCREATIC
LESIONS
Valentina Battaglia1, Salvatore Mazzeo, Carla Cappelli, Gabriele Caproni,
Annalisa Belcari, Sabrina Pallocci, Rosa Pasquariello, Elena Cavazza, Luca
Emanuele Pollina2, Niccola Funel2, Daniela Campani2, Marco Del Chiaro3,
Ugo Boggi3, Franco Mosca3, Carlo Bartolozzi
1University of Pisa-Department of Radiology; 2University of Pisa-Division of
Pathology; 3University of Pisa-Regional Referral Center for Pancreatic
Disease
Purpose. Role of multidetector CT in differentiating malignant and benign
lesions among neuroendocrine pancreatic neoplasms.
Materials and Methods. We evaluated 40 pancreatic lesions in 22 patients
(2 patients affected by MEN 1 syndrome with 15 and 5 lesions respectively).
CT scans were done before and after 120mL iodine contrast medium
administration (5 ml/min) in early arterial (20??), pancreatic (35??), venous
(70??) and delayed (180??) phases. Two different patterns of post-contrast
enhancement were identified: early enhancement (in arterial and pancreatic
phases) and delayed enhancement (in venous and delayed phases). For each
lesion also the greatest diameter was considered. CT results were compared
with pathological results after resection.
Results. 30/40 lesions showed an early enhancement with a mean diameter
of 12mm; at pathology 23/30 resulted to be benign, 2/30 borderline and 5/30
malignant lesions. Among the 10/40 lesions with delayed enhancement, 2
resulted to be borderline, while 8 neoplasms were malignant. At CT the mean
diameter of malignant lesions with early and delayed enhancement pattern
was 37mm and 42mm respectively.
The sensitivity and positive predictive value of CT in detecting the nature of
neuroendocrine lesions has been 91% and 83% respectively.
Conclusions. The multidetector study, performed by means of multi-
phasic approach allows to suggestof the nature of neuroendocrine
pancreatic neoplasms on the basis of their post-contrastographic enhance-
ment pattern.
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MULTIDETECTOR CT IN PANCREATIC NEOPLASMS: EVALUA-
TION OF RETROPORTAL PANCREATIC MARGIN INFILTRA-
TION AND CORRELATION WITH HISTOPATHOLOGICAL
FINDINGS
Salvatore Mazzeo1, Carla Cappelli, Valentina Battaglia, Gabriele Caproni,
Annalisa Belcari, Federica Forasassi, Sabrina Pallocci, Niccola Funel2, Luca
Emanuele Pollina2, Daniela Campani2, Marco Del Chiaro3, Ugo Boggi3,
Franco Mosca3, Carlo Bartolozzi
1University of Pisa  Department of Radiology; 2University of Pisa 
Division of Pathology; 3University of Pisa  Regional Referral Center for
Pancreatic Disease
Purpose. Role of multidetector CT in the assessment of the retroportal
pancreatic margin by correlating CT findings with histopathological results.
Materials and Methods. We evaluated 43 patients affected by ductal
adenocarcinomas of the pancreatic head or uncinate process, submitted to
surgical resection.
The suspicion of infiltration (microinfiltration or macroinfiltration) of the
retroportal margin arose at CT when the fatty layer localized between the
medial surface of the pancreatic head and uncinate process and the
mesenteric artery appeared obliterated, irregular or with abnormal density.
Results. CT suggested the infiltration of the retroportal lamina in 19 cases (8
microinfiltration, 11 macroinfiltration) and the absence of infiltration in 24
cases. At histopathology, the presence of infiltration was confirmed in 14/19
(74%) cases and the absence of infiltration was demonstrated in 21/24 (88%)
cases. In all CT cases of microinfiltration the retroperitoneal resection margin
was not infiltrated, while all cases (5) with infiltration of the retroperitoneal
margin were macroinfiltrated at CT. The sensitivity of CT was 82%,
specificity of 81% with an overall diagnostic accuracy of 81%.
Conclusions. Neoplastic infiltration of the retroportal fatty tissue represents
a critical factor in tumor staging and in surgical planning because it
frequently represents a site of persistence and recurrence of disease.
Multidetector CT is accurate in the assessment of the neoplastic infiltration
of the retroportal fatty tissue.
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PANCREATICOJEJUNOSTOMY VERSUS CLASSIC AND OPEN
PANCREATICOGASTROSTOMY FOLLOWING PANCREATICO-
DUODENECTOMY: A COMPARATIVE STUDY IN 261 PATIENTS
Alessandro Esposito1, Claudio Bassi, Giuseppe Malleo, Giovanni Butturini,
Roberto Salvia, Stefano Crippa, Francesco Bartolozzi, Paolo Pederzoli
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1Surgical and Gastroenterological Department, Hospital G. B. Rossi,
University of Verona
Hypothesis. Pancreaticogastrostomy (PG) and the ‘‘open’’, transgastric
variant are associated with a lower postoperative complication rate following
pancreaticoduodenectomy (PD) when compared to pancreaticojejunostomy
(PJ).
Design. Retrospective analysis of a prospectively collected database.
Setting. Academic tertiary care university hospital.
Patients. Between January 2002 to June 2006, 261 PDs for peri-ampullary
cancer in patients with soft residual parenchyma were carried out. Recon-
structions by PJ were 146. PG was performed in 115 patients; of these, 40
received ‘‘classic’’ and 75 ‘‘open’’ PG.
Main Outcome Measures. Indications for surgery, intraoperative and
postoperative variables, postoperative morbidity and mortality.
Results. The morbidity rate, as well as the incidence of multiple complica-
tions, were not significantly different between PJ, ‘‘classic’’ and ‘‘open’’ PG
group. On the contrary, the incidence of pancreatic fistula (PF) was
significantly lower in ‘‘open’’ PG group (p0.03). When analyzed according
to the ISGPF grading system, the distribution of PFs in the treatment groups
did not show significant differences, but a trend toward a lower rate of
‘‘severe’’ PFs (grades B and C) was found in ‘‘open’’ PG. Also, a significant
difference in the rate of biliary fistula was observed using gastric anastomosis
(either ‘‘classic and open’’ technique) instead of PJ (p0.03). With regard to
intra-abdominal collections and relaparotomy, we found significant differ-
ences in favor of ‘‘open’’ PG (pB0.001 and 0.04 respectively).
Conclusions. Retrospective analysis shows the PG, and in particular the
‘‘open’’ variant, is a safe alternative to PJ after PD, with a significantly lower
rate of PF, biliary fistula, intra-abdominal collections and relaparotomy.
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PROGNOSTIC FACTORS IN NON-FUNCTIONING PANCREATIC
ENDOCRINE TUMOUR: ANALYSIS ON 180 PATIENTS
Rossella Bettini1, Massimo Falconi, William Mantovani2, Letizia Bonin-
segna, Paola Capelli3, Aldo Scarpa3, Claudio Bassi, Paolo Pederzoli
1Department of Surgery; 2Department of Medicine and Public Health;
3Department of Pathology
Background. Endocrine pancreatic tumours are a rare and represent a
heterogeneous disease, whose natural history is not well known.
Aim. The study was aimed to asess in a single centre population of non-
functioning pancreatic endocrine tumor (NFPET) the prognostic role of
selected pathological and/or clinical parameters.
Methods. 180 patients suffering from sporadic NFPET entered in our
prospective database between 1990 and 2004 were analysed. Relevant
clinico-pathological data were collected and tested as predictors of prognosis
in univariate and multivariate models.
Results. After a median follow-up of 43.1 (range 0.4196) months, the
overall median disease-related survival was 116.4 months (95% CI: 65.2
164.7 months). At univariate analyses the following variables were negatively
associated with survival: non incidental diagnosis (p0.0003); pain (p
0.0157), jaundice (p0.001), anorexia (p0.0008), vomiting (p0.0009)
and weight loss (pB0.00001), size (p0,0017), poor differentiation (pB
0.0001), liver or nodal metastases (pB0.0001), Ki67 value5% (pB
0.0001). Upon multivariate analysis (Cox proportional hazard model) poor
differentiation (HR 7.3; 95% CI 3.1317; p0.0001), liver metastases (HR
3.29; 95% CI 1.57.2; p0.003), Ki675% (HR 2.5; 95% CI 1.22 5.09;
p0.012 ), weight loss (HR 3.06; 95% CI 1.585.9; p0.001) were
confirmed as unfavourable prognostic factors.
Conclusion. Our data confirm the prognostic role of Ki67, tumour
differentiation and liver metastasis and introduce weight loss at diagnosis as
clinical prognostic survival factors.
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SURVIVAL IN NON-FUNCTIONING PANCREATIC ENDOCRINE
TUMOR: ANALYSIS ON 180 PATIENTS
Rossella Bettini1, Massimo Falconi, William Mantovani2, Letizia Bonin-
segna, Paola Capelli3, Aldo Scarpa3, C Coppo2, Paolo Pederzoli
1Department of Surgery; 2Department of Medicine and Public Health;
3Department of Pathology
Background. Non-functioning pancreatic endocrine tumours (NFPET) are
a heterogeneous group of endocrine neoplasm. Few data are available in large
series according to different stage of the disease.
Aim. The study was targeted to a single centre population of NFPET in
order to assess the survival rate.
Methods. Between 1990 and 2004 all the patients suffering from sporadic
NFPET registered in a prospective database were analysed. Survival analysis
was performed by Kaplan-Meier survival function.
Results. One-hundred-eighty patients entered in the study (92 males; 88
female; median age 58 year). In 93 (51.6%) patients a radical resection was
achieved, whilst in 19 (10.5%) with unresectable liver metastases a debulking
procedure was performed. Twenty patients had a surgical by-pass. After a
median follow-up of 43.1 (range 0.4196) months, the overall median
disease-related survival was 116.4 months (95% CI: 65.2 164.7 months)
with 5 and 10-yr survival rate of 67 and 49.3%, respectively. No differences
were observed between unresected (5-yr: 37.3%; 10-yr: 17.4%) and palliative
resected patients (5-yr: 47%, 10-yr: not reached) (p0.81). Radically
resected patients had a 5-yr and 10-yr survival rate of 93 and 80.8%,
respectively. Patients with nodal involvement (N1) but no liver metastases
(M0) had a 5-yr survival of 49.4% (median 58.9 months, 95%CI: 29.5
88.3), whilst was 40% for those with M1(any N)(p0.01).
Conclusion. NFPET have a general good prognosis even in advanced stage
being the better for patients who can be radically resected.
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THE LAPAROSCOPIC APPROACH TO DRAINAGE OF PAN-
CREATIC PSEUDOCYSTS: IS IT SUITABLE FOR ALL COMERS
REQUIRING SURGERY?
N Hamza1, B Alkari, BJ Ammori
1Manchester Royal Infirmary
Introduction. Pancreatic pseudocysts (PP) are traditionally managed by
laparotomy. Our experience with the laparoscopic approach for all comers
with PP requiring surgical drainage is presented.
Methods. Between 2001 and 2007, 14 consecutive patients (8 male)
underwent 15 surgical drainage procedures for PP, all of which were
attempted laparoscopically.
Results. The median PP size was 13.5 (range, 6.523) cm. The procedures
included cyst-gastrostomy (n13), Roux-en-Y cyst-jejunostomy (n1), and
an unplanned external drainage due to extensive adhesions (n1). The
approach to cyst-gastrostomy was transgastric (n8), endogastric (n3)
and exogastric (n2). Two patients underwent a concomitant cholecystect-
omy. There were no conversions to open surgery. Pancreatic necrosis was
present in 12 patients of whom 9 required debridement. The median
operative time was 120 (interquartile range, 80145) minutes. There were
no postoperative complications and the median postoperative hospital stay
was 2 (range, 14) days. At a median follow up of 14.5 (range 141) months
one patient developed a recurrent PP (7.7%) that was drained laparoscopi-
cally.
Conclusions. Laparoscopic drainage of PP is a feasible, safe, an effective
alternative to laparotomy for all comers with PP that require internal
drainage, and is associated with rapid recovery, short hospital stay and a
recurrence rate comparable to open surgery.
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THE ROLE OF PANCREATICODUODENECTOMY IN THE
TREATMENT OF COMPLEX PANCREATIC TRAUMA
Aleksandar Karamarkovic1, Nenad Ivancevic2, Pavle Gregoric2, Ivan Blazic2,
Krstina Doklestic2
1University Center for Emergency Surgery, School of Medicine Belgrade;
2University Center for Emergency Surgery
Objectives/Background. This study evaluated the role of pancreaticoduo-
denectomy in the management of complex proximal pancreatic injuries.
Patients and Methods. Demographic data, mechanism and extent of
injury, Abdominal Trauma Index, operative procedure, postoperative course,
complications and outcome were analyzed in 64 patients who had pancreatic
injuries between January 2003 and December 2006.
Results. 8 patients (median age 27 years; 4 gunshot, 3 blunt trauma, 1
stab) had cephalic pancreaticoduodenectomy for complex duodeno-pan-
creatic injury. 2 had IVC and 1 portal vein injuries. Three patients had a
pylorus-preserving PD and five patients had a standard Kausch-Whipple
resection. The mean ATI was 47 (range 34 76). The median intraoperative
blood replacement was 1200ml (range 6006300 ml). The median
duration of surgery was 5h 25min (range 4h 10min to 6h 50min). One
patient died postoperatively of multi-organ failure. Complications included
anastomotic leaks due to pancreatic (1) and biliary (1) fistulae, delayed
gastric emptying (2). Factors complicating surgery were shock on admis-
sion, the number of associated injuries, coagulopathy, hypothermia and
gross bowel oedema.
Conclusions. Pancreaticoduodenectomy is a life-saving procedure applic-
able to a small cohort of patients with complex unreconstructable or
devitalized injuries to the pancreatic head. ATI score accurately predicted
severity and mortality.
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PANCREATIC CANCER  OCCURRENCE 913 YEARS EARLIER
IN ALLERGIC SMOKERS’’
Gerhard Leder1, Rainer Muche2, Cornelia Hasel3, Hans-Georg Beger*,
Doris Henne Bruns*, Bogdan Prokopczyk$
1Dept Surgery I, Univ Ulm; 2Dept of Biometry, UNiversity of Ulm; 3Dept.
Pathology, Univ. of Ulm; *Dept. Surgery I, Univ. of Ulm; $Dept. Pharma-
cology, Pennsylvania State University, Hersey, USA
Introduction. An increasing incidence of pancreatic cancer has been
observed during the last decades. This may be due to an increase of risk
factors such as smoking, that may accelerate onset of pancreatic cancer. An
additional risk factor for pancreatic cancer also may be allergies, that have
increased during the last decades, too. We provide epidemiological evidence
for such an association.
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Materials and Methods. Age of onset of patients with histo- or cytologically
proven adenocarcinoma of the pancreas was compared with linear regression
analysis depending on gender, smoking status and history of an allergy.
Additional variables included in the model were history of cancer in the
family and consumption of alcohol, which was analyzed in men only. Data
were obtained from our prospectively developed pancreatic tumor database.
Results. Multivariate analysis taking into account history of an allery,
smoking status, alcohol consumption and history of pancreatic cancer
revealed that an allergy was associated with a 3.11 years (SE 1.14, p
0.0068) earlier onset of pancreatic cancer in 349 male patients (intercept
65,69 years, SE 0.91). Smoking contributed to a 6.86 years earlier onset of
pancreatic cancer in this group of patients (SE 1.14, pB0.0000, rAˆ20.15).
The same analyis with the exception of alcohol consumption conducted in
202 female patients with pancreatic cancer showed a 3.68 years (SE 1.43, p
0.0107) earlier onset of pancreatic cancer when an allergy was present and a
9.48 years (SE 1.64, pB0.0000) earlier onset when patiens smoked (intecept
66.46 years, SE 1.15, rAˆ20.18).
Conclusions. Allergy and smoking may be associated with an approximate
mean loss of health life time in patients developing pancreatic cancer of
approximately 9-13 years, with smoking contributing by 6 9 and allergies by
34 years. This quantifieable epidemiological evidence further encourages
efforts to reduce both adverse factors.
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PREDICTING INFECTED PANCREATIC NECROSIS WITH THE
APPLICATION OF AN ARTIFICIAL NEURAL NETWORK
Andrey Litvin1, Oleg Jarikov, Shadi Mauda2, Abdulaziz Ali2, Gennadiy
Senchuk2
1Gomel Regional Clinical Hospital; 2Gomel State Medical University
Background. Infected pancreatic necrosis (IPN) is associated with high
morbidity and mortality and is mandatory for surgical or radiosurgical
intervention.
Aim. We evaluated the accuracy and discriminating power of an artificial
neural network (ANN) to predict infected pancreatic necrosis.
Patients and Methods. We analyzed data from 291 patients with severe acute
pancreatitis in 19962005. Predictors used for ANN training were selected by
computing the value of statistic and information gain with respect to infected
pancreatic necrosis. Presentation data on admission and at 48 hours were
collected. Acute Physiology and Chronic Health Evaluation (APACHE) II and
Glasgow severity (GS) score were calculated. The configuration of the ANN
was chosen by using a software tool. Then the training of the ANN was
performed based on data from a training set (n200). Testing validation was
performed with the remaining patients (n91) whose outcome regarding IPN
was unknown to the ANN. Area under the receiver operating characteristic
(ROC) curves were used to quantify predictive performance. ANN perfor-
mance was compared with those of the APACHE II and GS.
Results. ANN accuracy was 83.5%, sensitivity 78.1% and specificity 85.2%
in predicting IPN. The areas under the ROC curve follow: ANN, 0.816
(0.7760.852); APACHE II, 0.575 (0.5250.620); GS, 0.664 (0.618
0.709). ANN discriminatory power was superior to those of the other
predicting scoring systems (PB0.05).
Conclusions. An ANN was able to predict development of infected
necrotizing pancreatitis with considerable accuracy and outperformed other
clinical risk scoring systems. The ANN provided the best predictive
performance among all scoring systems.
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LOCALLY ADVANCED PANCREATIC HEAD ADENOCARCI-
NOMA: RESECTION OR PALLIATIVE SURGERY?
Mauro Frego1, Francesco Lupia, Davide F. D’Amico
1Clinica Chirurgica I-Universiti Padova
Background/Aims. The only definitive treatment for primitive pancreatic
adenocarcinoma is R0 resection, although with grim 5-year survival rate
results; surgical treatment of locally advanced tumors (defined by lymphatic
invasion and/or portal-mesenteric vascular involvement) is still a matter of
debate between aggressive and nihilistic surgeons. The aim of our study was
to determinate whether locally advanced pancreatic adenocarcinoma is better
treated by DCP or by derivative surgery, considering perioperative morbility,
mortality and long term survival.
Patients and Methods. It was performed a retrospective analysis of
pancreatic resections between 1996 and 2006 by revision of clinical-
radiological, intraoperative end postoperative (anatomopathologic) data;
patients or their relatives were contacted by phone call or through registries
office. Statistical analyses were performed by SPSS.
Results. 93 patients diagnosed with primitive pancreatic cancer underwent
surgical exploration: 24 patients were in stage I (resectable), 30 patients were
in stage II (locally advanced) and 39 presented with metastatic disease.
The Whipple resection was performed in 18 patients in stage II; the remaining
12 patients with locally advanced tumors underwent derivative surgery. No
statistically significative difference was observed between the two groups; the
following factors were analyzed: age (resected: 62912 ys, derivated 6698 ys,
p0.43), sex, ASA( p0.9), tumor site, tumor size (resected 3.291.3 cm,
derivated 3.291cm; p0.54), clinical presentation (pain, jaundice, weight
loss, anorexya, diarrhea, palpable mass, hyperglycemia).
One patient died postoperatevely after DCP; significative difference was
observed between the two groups in terms of morbility (resected 72%,
derivated 39%), intesive care unit stay (resected 3.2 days, derivated 0.7 days),
hemotransfusions (resected 5.2 U, derivated 1.3 U), relaparotomy (resected
22%, derivated 0%), postoperative hospital stay (resected 47.3 days,
derivated 22 days). Mean survival rate of patients who underwent derivation
was 8.2 months, while for resected patients was 39 months (p0.0001, three
5-year survivors); survival rate was similar between resected patients in stage I
and II. Invasion of peripancreatic nodes was associated with a mean survival
rate of 43 months after resection, while distal nodal involvement (hepato-
duodenal ligament and celiac trunk) was associated with a mean survival rate
of 16.3 months after the same treatment; patients with peripancreatic and
distant nodal metastasis who underwent palliative surgery achieved a mean
survival of 4.5 and 7.8. Mean survival was 39 months in resected patients
without vascular involvement, and 12.4 months in resected patients who
presented with portal mesenteric venous invasion.
Conclusions. patients with locally advanced disease who underwent surgical
resection presented more complications but better survival in comparison
with those patients in the same stage which have been surgically palliated.
Resection of locally advanced cancer leads to similar results in terms of
survival when compared with resection performed for cancer in earlier stage;
nevertheless, postoperative complications are more frequent in the former
group. A reasonable aggressive surgical approach extended to locally
advanced pancreatic head adenocarcinoma may lead to a considerable
increase in long-term survival.
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PROBIOTICS REDUCE OXIDATIVE STRESS IN THE EARLY
PHASE OF ACUTE PANCREATITIS
Femke Lutgendorff1, Lena M Trulsson, L Paul van Minnen2, Ger T Rijkers2,
Harro M Timmerman2, Hein G Gooszen2, Johan D So¨derholm, Louis MA
Akkermans2, Per A Sandstro¨m
1University Hospital Linko¨ping; 2University Medical Center Utrecht
Introduction. The underlying factors which determine the severity of acute
pancreatitis are poorly understood. Oxidative stress plays a major role in
acinar cell injury and may contribute to the severity of pancreatitis. In the
initial stage of acute pancreatitis, interstitial oedema and infiltration of
neutrophils contribute to oxidative stress in the pancreas. Prophylactic
administration of probiotics has been shown to reduce the severity of
experimental pancreatitis. However, little is known about the effects of
probiotics on pancreatic oxidative stress and the subsequent acinar cell injury.
Aim. The aim of this experiment was to study the effects of prophylactic
multispecies probiotics on oxidative stress and acinar cell injury during the
early phase of acute pancreatitis.
Methods. 48 Male Spraque-Dawley rats were allocated into 4 groups: 1)
controls (sham operated, no treatment), 2) pancreatitis, no treatment, 3)
pancreatitis and probiotics 4) pancreatitis and placebo. Pancreatitis was
induced by intraductal glycodeoxycholate infusion (15 mM) and intravenous
cerulein (5u g/kg/hr, for 6 hours). Daily probiotics or placebo were
administered intragastrically, starting five days prior to induction of
pancreatitis. Six hours after the induction of pancreatitis the animals were
sacrificed and pancreas samples were collected for analysis of lipid peroxida-
tion, pancreatic water content and histological grading of pancreatic injury.
In brief, normal was scored as 0, oedema as 13, fat inflammation as 13,
parenchymal inflammation as 13, peripheral necrosis as 12, fat necrosis as
37 and parenchymal necrosis as 37.
Results. Acute pancreatitis caused an increase in lipid peroxidation in
pancreas compared to controls (0.49 vs . 0.19 pM MDA/mg tissue; PB
0.001). Probiotics attenuated acute pancreatitis induced increase in lipid
peroxidation (0.27 vs . placebo 0.52 pM MDA/mg tissue; PB0.001). In the
pancreatitis group, histological scoring revealed extended areas of complete
structural damage by necrosis and a significant increase in pancreatic damage
compared to sham operated rats (4 (37.25) vs . 0 (00); P0.001). The
severity of pancreatic injury was abolished in animals pre-treated with
probiotics (1.5 (0.883.25) vs . placebo 5.5 (36.1); P0.014). The most
prominent effects of probiotics showed in the histopathological scores for
necrosis and oedema (0 (00) vs . placebo 1 (04.25); PB0.01 and 1 (0.5
1.1) vs. placebo 1.5 (1.32); PB0.05, respectively). Furthermore, water
content of the pancreas was significantly reduced in probiotic treated animals
(78.88 vs. 82.95% water; PB0.05).
Conclusion. Modulation of the intestinal microflora by multispecies
probiotics reduced the severity of experimental severe acute pancreatitis.
This was demonstrated by a reduction of acute pancreatitis induced oxidative
stress, acinar cell injury and interstitial oedema.
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EFFECTS OF THALIDOMIDE IN A MOUSE MODEL OF CER-
ULEIN-INDUCED ACUTE PANCREATITIS
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Carmelo Muia`, Concetta Crisafulli, Ajith K Siriwardena2, Salvatore Cuzzo-
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Introduction. Current knowledge shows that pathophysiology of acute
pancreatitis is characterized by intra-acinar enzyme activation and subsequent
dysregulation in immune response. Interactions between leukocytes, soluble
mediators and vascular endothelium contribute to the systemic progression of
the inflammatory response and, thus, to disease severity. Immunomodulatory
and anti-cytokine agents have been shown to significantly ameliorate the
course of experimental pancreatitis; but the effects of thalidomide, a TNF-
alpha inhibitor and anti-angiogenetic drug, have never been studied.
Objectives. The aim of the present study was to assess the effects of
thalidomide in a murine model of acute pancreatitis induced by the
secretagogue cerulein.
Methods. Acute pancreatitis was induced by injection of cerulein (hourly
5, 50 microg/kg) in mice (n20). Thalidomide was administered (200 mg/kg
orally) at 1 hour after first cerulein injection; control groups received vehicle
treatment. Mice were sacrificed by exsanguination at 24 hours after the
induction of pancreatitis. We analyzed histological and biochemical features
of pancreatitis, expression of proinflammatory cytokines, VEGF and adhe-
sion molecules, neutrophil infiltration (myeloperoxidase activity) and pan-
creas apoptosis.
Results. Treatment of the mice with thalidomide significantly reduced
histologic degree of pancreas injury, pancreas edema (pB0.01), amylase and
lipase plasma levels (pB0.01), intra-pancreatic and plasma levels of TNF-
alpha and IL-1 (pB0.01), immunostaining for p-selectin and ICAM-1 (pB
0.01), neutrophil accumulation (pB0.01), immunostaining for TGF-beta
and VEGF (pB0.01), the degree of pancreas apoptosis (assessed by
TUNEL) and immunostaining for FasL and Bax (pB0.01).
Conclusions. Our results provide the first evidence that thalidomide reduces
the development of cerulein-induced acute pancreatitis in mice. We propose
that this evidence may help to clarify the role of anti-TNF-alpha and
immunomodulatory agents in patients with acute pancreatitis.
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GLYCOGEN SYNTHASE KINASE 3-BETA INHIBITION ATTENU-
ATES THE DEVELOPMENT OF CERULEIN-INDUCED ACUTE
PANCREATITIS IN MICE
Giuseppe Malleo1, Tiziana Genovese, Emanuela Mazzon, Carmelo Muia`,
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Introduction. An area of current interest in pancreatitis research is on
identification of intracellular signal transduction pathways that regulate the
nature, magnitude and duration of the inflammatory response. Recent
findings showed that key pathologic responses of the injured pancreas are
regulated by protein-kinases. Glycogen synthase kinase-3beta has recently
been identified as an ubiquitous serine-threonine kinase that participates in a
multitude of cellular processes and signal transduction pathways. Also, it has
been shown to play an important role in the pathophysiology of a number of
diseases characterized by an enhanced or unregulated inflammatory response.
Objectives. To assess the effects of 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-
3,5-dione (TDZD-8), a potent and selective GSK-3beta inhibitor, in a
murine model of acute pancreatitis induced by the secretagogue cerulein.
Methods. Acute pancreatitis was induced by injection of cerulein (hourly
5, 50 microg/kg) in mice (n20 for each group). TDZD-8 was administered
(10 mg/kg intraperitoneally) at 1 and 6 hours after first cerulein injection;
control groups received vehicle treatment. Mice were sacrificed by exsangui-
nations at 24 hours after the induction of pancreatitis. We analyzed
histological and biochemical features of pancreatitis, expression of proin-
flammatory cytokines, VEGF and adhesion molecules, neutrophil infiltration
(myeloperoxidase activity), the formation of oxygen and nitrogen-derived
radicals and lipid peroxidation.
Results. Treatment of the mice with TDZD-8 significantly reduced histologic
degree of pancreas injury, pancreas edema (pB0.01), amylase and lipase
plasma levels (pB0.01), intra-pancreatic and plasma levels of TNF-alpha and
IL-1 (pB0.01), immunostaining for ICAM-1 (pB0.01), neutrophil accu-
mulation (pB0.01) and immunostaining for TGF-beta and VEGF (pB0.01).
Similarly, immunostaining for iNOS and plasma nitrite/nitrate levels as well as
immunostaining for nitrotirosine and tissue malondialdheide levels were
significantly reduced (pB0.01) after treatment with TDZD-8.
Conclusions. Our results provide the first evidence that glycogen synthase
kinase-3beta inhibition reduces the development of cerulein-induced acute
pancreatitis in mice. We propose that blocking protein-kinases activity may
be a novel approach for the therapy of this inflammatory condition.
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DEVELOPMENT OF PANCREATIC CANCER RELATED CA-
CHEXIA AND THE SYSTEMIC EFFECTS OF MONONUCLEAR
CELLS FROM THE LIVER
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Background. The development of cachexia in patients with pancreatic
cancer is a severe complication and has a poor prognostic impact. Up to now,
there is still a lack of a definition of cachexia in the recent literature, but an
unintended weight loss of more than 10% of body weight in the past 6 months
is widely accepted as cachexia. Despite of the clinical impact of cachexia, our
knowledge about the molecular pathomechanisms which finally lead to the
cachexia syndrome is limited. Furthermore, the frequency of the clinical
development of cachexia in patients operated for pancreatic cancer has not
been evaluated yet. Recent publications denote an important role of the liver
in the development and regulation of tumor associated cachexia. Up to now no
effort has been put on the examination and characterization of histopatholo-
gical sections of normal liver in patients with tumor associated cachexia.
Aim. The aim of this study was first, to characterize the patients operated
with pancreatic cancer regarding cachexia and second, to correlate the
reported molecular changes in the liver with clinical or histopathological
findings in normal liver sections of patients with and without cancer cachexia.
Methods. In the clinical evaluation 244 pancreatic cancer patients were
included. Additionally, 50 sections of normal liver from these patients have
been stained for CD45 and CD68. Subsequently, the whole tissue sections
were semi-automatically analysed, by counting the stained area of the
complete section as a marker for invasion of mononuclear cells. The result
of the analysis was then correlated with the clinical findings of the patients.
Results. We could demonstrate that about 40% of the patients operated for
pancreatic cancer already have cachexia. Furthermore, cachexia seems not to
be dependent on tumor size or tumor load. CA19-9 levels and tumor size
were not different between patients with and without cachexia. On the other
hand systemic effects like development of distant metastasis and diabetes
mellitus was higher in the cachexia group. In patients with cachexia there was
an elevated infiltration of CD68 positive cells in the liver, which correlated
negatively with the nutritional status (albumin) of the patients and positively
with the inflammatory status (CrP) of the patients.
Conclusion. Our results suggest that the clinical development of cachexia is
not primarily dependent on the tumor size/load, but rather dependent on the
systemic effects of the tumor. This is underlined by the finding that already
normal liver tissue of patients with tumor-associated cachexia is infiltrated by
immunmodulatory cells, which directly affects the clinical condition of the
patient.
101
REFINING THE ROLE OF LAPAROSCOPIC ULTRASOUND FOR
THE STAGING OF PANCREATIC MALIGNANCIES
Santambrogio Roberto1, Opocher Enrico2, Pisani Ceretti Andrea, Barabino
Matteo3, Costa Mara, Leone Sara, Montorsi Marco*
1Hepatobiliary surgical Unit San Paolo Hospital; 2Chief hepatobiliary
surgical Unit San Paolo Hospital; 3Hepatobiliary surgical Unit San Paolo
Hospital; *Cattedra ed UO Chirurgia Generale. Istituto Clinico Humanitas
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Introduction. Given the poor outlook of patients with pancreatic cancer,
there is a need for early and accurate staging of the disease: laparoscopic
ultrasound (LUS) was employed in this prospective study to evaluate the
resectability of tumors of the duodeno-pancreatic area.
Methods. Two consecutive studies were performed: in the first, all
consecutive patients with pancreatic cancer were submitted to LUS. In the
second study, only the patients with high probability to be not resectable were
submitted to LUS (primary tumors greater than 4 cm, tumors in the body or
tail of the pancreas, patients with equivocal findings of metastasis on CT,
ascites, or clinical or laboratory findings suggesting advanced disease such as
marked weight loss, hypoalbuminemia, and elevated CA 199). In the first
study, 40 patients were enrolled. On the basis of preoperative findings, 22
patients were considered to have resectable tumors (group A), while 18
patients had unclear resectable tumors (group B). In the second study, 49
patients were enrolled: 33 patients were considered to have resectable tumors,
7 not resectable and 9 unclear resectable tumors (group submitted to LUS).
Results. LUS was satisfactory performed in all cases (40 in the first study
and 9 in the second). Time required for a complete laparoscopic and LUS
examination ranged from 25 to 60 minutes. In the first study, all cases were
validated by laparotomy. LUS changed the planned surgical strategy in 30% of
cases (12/40 patients). These changes were due to simple laparoscopic
exploration in 4 cases, who had peritoneal and/or visible liver metastases and
to LUS in the remaining 8 cases. In the group A, LUS predicted a potentially
resectable tumor in 12 out of 22 patients considered resectable preoperatively.
The other 10 cases were judged unresectable for vascular encasement in 4 cases,
for peritoneal metastases in 2 cases and in the other 4 cases for both. In the
group B, in 3 out of the 18 patients preoperatively considered with unresectable
pancreatic tumors, LUS did not find any signs of vascular encasement or occult
metastasis. However, in 7 patients with dubious vascular encasement by LUS,
laparotomic exploration found 4 vascular encasement preventing radical
surgery: in this group of patients, surgical exploration for assessing resectability
is mandatory. In the second study, in 2 out of 33 patients potentially resectable
laparotomic exploration found vascular encasement in 1 case and peritoneal
metastases in the other. The 7 patients preoperatively irresectable were found
all irresectable. In the last 9 patients, LUS found 7 patients with irresectable
disease, while 2 patients were submitted to pancreatic resection.
Conclusions. LUS seems to represent a useful examination for staging
pancreatic malignancies prior to surgical resection only in selected patients
with high probability to have a irresectable disease.
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POSTOPERATIVE PANCREATIC FISTULAS: RESULTS OF A
RETROSPECTIVE STUDY WITH FISTULOGRAPHY AND CLIN-
ICAL CORRELATION
Enrico Molinari1, Niccolo` Faccioli, Alessio Comai, Farah Moore, Roberto
Pozzi Mucelli, Claudio Bassi
1Hospital GB Rossi, University of Verona, Italy
Aim. To describe the radiological features of post-operative pancreatic fistula
(PF) after pancreaticoduodenectomy (PD) and their correlation with the
clinical impact.
Materials and Methods. A retrospective study was performed on the
fistulogram carried out for clinical suspicion to PF after PD. Out of a total of
380 PDs performed from 2001 to 2005, 56 fistulogram were found.
PF was clinically defined according to the international study group (ISGPF)
as Grade A, B and C.
Fistulograms were performed only on patients with important clinical impact
of PF (Grade B and C) or with suspect of drain migration into an intestinal
loop.
We correlated the results of fistulography (incidence and site of PF,
occurrence of fluid collection, communication with main pancreatic duct,
biliary tree and jejunal loop and presence of drain into the jejunal loop or
stomach) with the clinical suspicion of PF.
Results. Forty-two out of 56 Patients (75%) had PF confirmed by
fistulogram.
We visualized 29 communications with the jejunal loop, 8 with the jejunal
loop and the biliary tree, 12 with the main pancreatic duct and 9 with the
stomach.
In 14 Patients (25%) the drain was abnormally placed inside the jejunal loop
or stomach: in all these cases, once the drain was mobilized, the complication
resolved within 72 hours.
Conclusions. Fistulogram help in the confirmation of clinical suspected of
PF decreasing post-operative morbidity and re-operation rate. Fistulogram is
determinant in distinguishing cases of gastro-intestinal fistula due to the
migration of the drain into an intestinal loop.
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POSITIVE NODES NUMBER AND ECHELON ARE BETTER
PREDICTORS OF OUTCOME FOR PANCRETIC DUCTAL CAN-
CER THAN NODE STATUS
Paolo Massucco1, Enrico Sgotto2, Roberto Lotesoriere2, Alfredo Mellano,
Lorenzo Capussotti
1Istituto Per La Ricerca e La Cura Del Cancro; 2Ospedale Mauriziano
‘‘Umberto I’’
Aim. To evaluate the impact of positive nodes number and their distribution
on survival of pancreatic head ductal cancers after resection with extended
lymphadenectomy.
Patients and Methods. From 1/1995 to 12/2004, 80 patients were
consecutively resected for ductal pancreatic head cancer. They underwent a
lymph node dissection extended to hepatic pedicle, celiac trunk, SMA
(anterior and right lateral aspect) and para-aortic nodes from celiac trunk to
IMA. Positive nodes were classified as first echelon if peripancreatic or
second echelon if beyond peripancreatic node groups. After exclusion of
operative mortality (5) and deaths for other causes (2), we analysed by
univariate and mutivariate analysis the impact on overall survival of the
following prognostic factors: sex, age 65 years, Ca199 200, operation
type (DCP vs total pancreatectomy), vein resection, postoperative morbidity,
blood transfusion, G (12 vs 3), tumor diameter 2 cm, T (12 vs 3), N
status, N echelon (0 vs first vs second echelon), positive N number (0 vs 13
vs 3), R status, perineural invasion, neoplastic emboli, adjuvant che-
motherapy.
Results. Overall median survival was 16 months. Ten patients are alive and
disease-free with a median follow-up of 43 months. N status was 0 in 17
cases. Among 56 N cases, nodes echelon was peripancreatic in 25 and
beyond peripancreatic in 31. Ca199 200, diameter 2 cm, N echelon,
positive N number, R status and adjuvant chemiotherapy were significant
outcome predictors to univariate analysis. All the variables but Ca199
retained their significance to multivariate analysis. The survival of patients
with first echelon positive nodes was not inferior to N0 cases. Median
survivals for patients with first and second echelon positive nodes were 22
and 14 months, respectively (pB0.03).
Conclusions. Along with tumor diameter, R status and adjuvant chemother-
apy, type of nodal involvement was a significant prognostic factor to
multivariate analysis. Both nodes echelon and positive nodes number were
better predictors of outcome than node status.
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CHEMORADIATION AND CURATIVE RESECTION FOR PAN-
CREATIC ADENOCARCINOMA REFERRED AFTER PRIOR PAL-
LIATIVE SURGERY
Paolo Massucco1, Enrico Sgotto2, Roberto Lotesoriere2, Alfredo Mellano,
Lorenzo Capussotti
1Istituto Per La Ricerca e La Cura Del Cancro; 2Ospedale Mauriziano
‘‘Umberto I’’
Background. Resectability criteria of locally advanced pancreatic head
cancer varies widely among surgical departments. In clinical practice, the
final decision is often determined at laparotomy on the bases of clinical
judgment by the surgeon. In such cases, the enrolment for chemoradiation
after radiological reassessment of local disease spread, could permit a chance
of curative resection to patients deemed unresectable during a previous
operation.
Patients and Methods. Since 1999 all the patients consecutively observed
with diagnosis of locally advanced pancreatic cancer were enrolled in
institutional protocols of primary chemoradiation. All patients had biopsy
proven disease, were staged by CT and classified on the basis of precise
determination of the pattern of vascular involvement. Among them, three
patients were referred after a prior palliative operation during which
the tumor had been deemed unresectable.
Results. Previous palliative surgery consisted in a double biliary and gastric
bypass in 2 cases and a gastric bypass in the remaining. Tumors were classified
as borderline resectable locally advanced head cancers, because of vein stenosis
in 2 and SMA impingement in the last one. Maximum tumor diameter was
superior to 4 cm and CA199 was superior to 500 in all. One patient had back
pain and low PS. They underwent chemoradiation consisting in 50Gy EBRT
and gemcitabine preceded by induction chemotherapy with gemcitabine and
oxaliplatin in 2 cases. All showed absence of disease progression at restaging
and were scheduled for surgery. A duodenopancreatectomy was performed in
all. Previously constructed Roux limbs were reused in 2 cases. There were 2
complications: a case of DGE and an hemoperitoneum requiring reoperation.
Final pathology revealed a single positive peripancreatic node in 2 cases; in one
case retroperitoneal margin was closer than 1 mm. All the patients are alive and
disease-free at 68, 19 and 14 months from surgery.
Conclusions. Intraoperative assessment of resectability is unreliable. Patient
with locally advanced cancer should be properly staged and included in a
multidisciplinary treatment protocol. Prior palliative surgery does not
preclude the feasibility of chemoradiotherapy and the chance of long term
survival after a curative resection.
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MANAGEMENT OF DELAYED ARTERIAL HAEMORRHAGE
AFTER PANCREATICODUODENECTOMY
Madhava Pai1, Paolo Limongelli2, James Jackson3, John Tierris2, Robin
Williamson2, Long Jiao2
1Dept. of HPB Surgery, Hammersmith Hospital, London, UK; 2Dept. of
HPB Surgery, Hammersmith Hospital, London, UK.; 3Dept. of Radiology,
Hammersmith Hospital, London, UK.
Background. Controversy exists regarding the best management of delayed
haemorrhage after pancreaticoduodenectomy. The current manuscript ana-
lysed the published literature describing this complication to examine the role
of diagnostic and interventional radiology and laparotomy in the manage-
ment of this serious condition.
Methods. A literature search of all reported cases of delayed haemorrhage
after pancreaticoduodenectomy was performed. For meta-analysis, the end
points evaluated were of operative and functional outcomes and adverse
events. A random-effect model for analysis and sensitivity analysis was used
to examine the bias in patient selection.
Results. One hundred cases of delayed arterial haemorrhage have been
described in the literature following 2503 pancreaticoduodenectomies
(3.9%). The incidence of recurrent bleeding and mortality were 42.2% and
28.8% respectively in those managed initially by laparotomy as compared
with 23.6% and 14.6% in those managed by arterial embolisation.
Conclusions. Delayed arterial haemorrhage after pancreaticoduodenectomy
carries significant mortality. Radiological management with transarterial
embolisation would seem to be a better treatment option than laparotomy.
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LIMITED PANCREATIC RESECTION FOR BENIGN OR BOR-
DER-LINE LESIONS OF THE PANCREAS
Cosimo Sperti1, Claudio Pasquali, Laura Frison, Mattia Berselli, Tania
Saibene, Sergio Pedrazzoli
1Clinica Chirurgica 4  University of Padua
Pancreatic lesions located in the head or the body of the gland are usually
removed by pancreaticoduodenectomy or distal pancreatectomy; however,
these procedures can be associated with impaired pancreatic function or post-
splenectomy infections. To avoid an extensive pancreatic resection, more
limited pancreatectomy, such as central pancreatectomy (CP) and duode-
num-preserving pancreatic head resection (DPPHR) have been proposed as
organ-sparing procedures to decrease postoperative functional problems. We
report our further experience with these techniques, with particular attention
to perioperative outcome.
Methods. From November 1985 to December 2005, 54 patients underwent
segmental pancreatectomy: 30 patients had CP and 24 had DPPHR. There
were 19 males and 35 females, with mean age of 50.2 years (range 1374
years). The Final pathologic diagnosis were: 13 serous cystadenomas, 9
insulinomas, 9 non-functioning endocrine tumors, 7 intraductal papillary
mucinous neoplasms, 7 chronic pancreatitis, 4 mucinous cystadenomas, 2
metastatic renal cell carcinomas, 1 papillary-cystic tumor, 1 biliary cyst and 1
solitary true cyst.
28 Abstracts
Results. There were no operative death. Postoperatice course was compli-
cated in 27 patients (50%): 16 patients showed a pancreatic fistula (30%), 5
biliary fistula (1 reoperation), 2 abdominal abscess (1 reoperation), 2
peritoneal bleeding (1 reoperation), 1 digestive bleeding, and 1 pneumonia.
Morbidity accounted for 15/30 (50%) patients who underwent CP: pancrea-
tic leak was the most frequent complication (n13; 43%). Complications
occurred also in 12/24 (50%) patients who had DPPHR: biliary leakage was
present in 5 patients (21%). At a median follow-up of 48 months (range 14-
168) only one patient showed recurrence of the tumor (renal cell metastases);
6 patients (11%) had impaired glucose metabolism and 10 patients (18%)
required pancreatic enzyme supplementation.
Conclusions. Segmental pancreatic resection may preserve endocrine and
exocrine function in a significant proportion of patients. While operative
mortality is absent, this type of surgery is associated with a high complication
rate, even in experienced hands. So, caution is necessary when using these
procedures, accurate selection of the patients being essential.
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THE MANAGEMENT OF RECURRENT PANCREATIC AND PERI-
AMPULLARY CANCER
Cosimo Sperti1, Claudio Pasquali, Laura Frison, Mattia Berselli, Tania
Saibene, Sergio Pedrazzoli
1Clinica Chirurgica 4  University of Padua
Complete resection of primary tumor is the treatment of choice for patients
with pancreatic or periampullary malignancies. Unfortunately, most of the
patients develop tumor’s recurrence within 2 years of surgery, and recurrent
cancer remains a significant therapeutic challenge. Little is known about the
effect of treatment of patients with recurrent carcinoma in the periampullary
region.
The purpose of this study was to evaluate the effect of treatment on patients
with recurrent pancreatic or periampullary cancer who had previously been
treated with curative intent.
Methods. From January 1998 to December 2005, 82 patients who under-
went resection for pancreatic (n65) or periampullary cancer (n17) were
prospectively investigated with intensive follow-up including tumor markers
(CEA and CA 199), abdominal ultrasound and/or helical computer
tomography, chest X-ray, every 3 months for the first 2 years, and then
every six months. Whole-body PET scan was performed also in 74 patients.
Median follow-up time was 24 months (range 1496 months). Validation of
diagnosis was made by surgery, percutaneous biopsy, or follow-up.
Results. A total of 66 patients showed tumor’s recurrence: 56 with
pancreatic cancer and 10 with periampullary cancer. Eighteen patients
underwent surgery. 8 had radical resection of tumor’s recurrence, 3 palliative
resection, and 7 had bypass operation. The median survival time after
recurrence in this group was 11.5 months: 16.5 months after resection and 4
months after palliative surgery. Thirty-four patients underwent chemiother-
apy and/or radiotherapy with a median survival time of 9.0 months, while 14
patients had only supportive therapy with a median survival time of 2.5
months.
Conclusions. Radical resection of recurrent tumor may be achievable in
selected patients who had undergone pancreatectomy for pancreatic or
periampullary carcinoma. Prolonged survival is possible in this subset of
patients comparing to those receiving chemotherapy or supportive care alone.
Intensive and accurate follow-up is warranted for these patients in order to
improve the management of recurrent disease.
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JAUNDICE IS RELATED TO DECREASED CIRCULATING IM-
MUNE CELLS AMOUNT IN PANCREATIC ADENOCARCINOMA
PATIENTS
Cinzia Nobili1, Luca Degrate, Roberto Caprotti, Claudio Franciosi, Fabrizio
Romano, Fabio Uggeri, Franco Uggeri
1Department of Surgery, San Gerardo Hospital
Introduction. Literature reports that, in cancer patients, jaundice is related
to an impaired immune function, consisting in lowered levels of circulating
lymphocytic cytokines. Our study was aimed to evaluate the relationship
between elevated bilirubin levels and immune system circulating cells in
pancreatic cancer patients.
Methods. Between September 2002 and September 2006, 49 pancreatic
adenocarcinoma patients were classed in group A with bilirubinemia 5mg/
dL and group B with bilirubinemia B5mg/dL. For each group the amount of
total lymphocytes, T (CD3), CD4 and CD8 lymphocytes and Natural
Killer (NK) cells was determined. Immune deficiency consisted in total
lymphocytes B1500/mmc, CD3 B900/mmc, CD4 B500/mmc, CD8
B400/mmc, NK B200/mmc.
Results. In group A all the considered parameters were lower than in group
B, although statistical significance was achieved only for total lymphocytes
(1,3769602 vs 1,8439585/mmc; p 0.0096) and T lymphocytes (1,0109
508 vs 1,3269531/mmc; p 0.0567). Our data show a strong relationship
between hyperbilirubinemia and decreased count of total lymphocytes (OR
4.43; IC 95% 2.91 5.95; p 0.0145), CD3 (OR 6.35; IC 95% 4.118.59; p
0.0169), CD4 (OR 13.41; IC 95% 6.6520.17; p 0.0046) and NK (OR
3.69; IC 95% 2.345.04; p 0.0359).
Conclusion. Our data showed that jaundice is strongly related to decreased
levels of immune cells within the bloodstream in pancreatic adenocarcinoma
patients. This may justify a preoperative immunotherapy in order to improve
the immune function.
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LIMITED PANCREATIC RESECTIONS FOR NON-INVASIVE IN-
TRADUCTAL PAPILLARY AND MUCINOUS NEOPLAMS (IPMN)
OF THE PANCREAS
Sauvanet Alain1, Blanc Benjamin, Couvelard Anne2, Vullierme Marie-
Pierre3, Pessaux Patrick, Cazals-Hatem Dominique2, Ruszniewski Philippe*,
Belghiti Jacques
1APHP, Department of HPB Surgery, Hospital Beaujon, University Paris
VII; 2APHP, Department of Pathology, Hospital Beaujon, University
Paris VII; 3APHP, Department of Radiology, Hospital Beaujon, University
Paris VII; *APHP, Department of Gastroenterology, Hospital Beaujon,
University Paris VII
Aims of the Study. In case of non-invasive IPMN limited to a branch-duct
(BD) or to the mid-pancreas, a pancreaticoduodenectomy (PD) or a distal
pancreatectomy (DP) can be considered as excessive due to its functional
disorders. An enucleation (E) or a medial pancreatectomy (MP), preserving
more parenchyma, could be an alternative. The aim of this study was to study
the results of E and MP in non-invasive IPMN.
Patients and Methods. Of 179 patients operated on for IPMN from 1997
to 2006, 34 (19%) had an attempt to E (n20) or MP (n14), indicated for
pain/pancreatitis (n21), suspicion of IPMN involving the main duct (MD)
(n9) or involving BD with mural nodules (n2), or suspicion of mucinous
cystadenoma (n2). Lesions treated by E were localized in the uncinate
process (n10), head (n3), neck (n2), and distal pancreas (n5).
Peroperative frozen section (FS) was routinely performed.
Results. Of 20 attempts to E, 3 were immediately converted into to PD due
to marked inflammation (n2) or result of FS (n1). During the 17 E, the
communicating duct (CD) could be analyzed by FS in 13 cases. At definitive
pathological examination (accuracy of FS 100%), the BD was involved by
low-grade (mild or moderate) dysplasia (LGD) (n16) or high-grade
dysplasia (HGD) (n1); the CD was normal (n6) or involved by LGD.
Of 14 attempts to PM, 7 (50%) were followed by 1 to 2 additional segmental
resection due to result of FS (involvement of MD, and/or involvement of BD
 borderline IPMN); results of the second FS was normal in 3 cases and
‘‘abnormal’’ in 4 (leading to immediate conversion to 2 PD and 1 DP,
whereas one patient had 1 contra-indication for PD). Overall, of the 35
pancreatic cut surfaces analyzed by FS, definitive pathological examination
confirmed results of FS in 34(97%). Specimens of the 11 MP included LGD
in 9 and HGD in 2.
There was no postoperative death. Mean length of stay was 21 days after E
and 38 days after MP. Pancreatic fistula occurred after 53% of E and 82% of
MP, and healed under medical treatment associated with percutaneous
drainage (n3), pancreatic endoprosthesis (n2), transarterial emboliza-
tion (n1), and reoperation (n1). During follow-up (median length for E
and PM  20 and 37 months, respectively), all patients are alive without
symptoms recurrence; de novo diabetes and de novo exocrine insufficiency
needing enzyme therapy occurred in one patient each (both after MP).
Postoperative imaging (MRI9CT9endoscopic ultrasound; n23 patients)
demonstrated that only 2 patients developed another BD localization after E.
Conclusions. This study demonstrates that limited pancreatic resections can
be performed for non invasive IPMN limited to a BD or to the mid-portion of
the pancreas. Their immediate morbidity seems counterbalanced by infre-
quent postoperative functional disorders and low rate of medium-term
recurrence. If these results are confirmed by a longer follow-up, this approach
will increase acceptance of surgery in patients with non-invasive IPMN.
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PATTERNS OF FAILURE FOLLOWING CURATIVE RESECTION
OF PANCREATIC ADENOCARCINOMA
Baki Topal1, Raymond Aerts, Steffen Fieuws2, Freddy Penninckx
1UZ.Leuven, Abdominal Surgery; 2KU.Leuven, Department of Biostatistics
Introduction. Surgical resection is the only potentially curative treatment of
pancreatic cancer. Diffuse metastatic disease is responsible for death from
pancreatic cancer. However, data are lacking with regard to patterns of failure
indicating where and when recurrences arise after curative (pR0) resection.
Methods. From January 1998 until December 2005, 152 consecutive
patients (M/F: 79/73; median age 66 years (3285 y.)) with ductal
adenocarcinoma of the pancreas underwent surgical resection with curative
intent. Patient data were analysed retrospectively. Patients (n12) with
positive margins of the resected specimen (pR1) were excluded from the
study. Combination chemo-radiotherapy was conducted in 3 patients in a
neo-adjuvant setting and as adjuvant therapy in 37 patients. In 29 patients
only chemotherapy was given as adjuvant treatment. Adjuvant therapy was
more frequently given in patients with an unfavourable pathological TNM
classification (UICC 2002; p0.0003).
Results. Postoperative mortality rate was 2.1%. Follow-up (median 16 (0
98) months) was complete, except in 1 patient. Kaplan-Meier disease-free
(DFS) and overall survival (OS) rates at 1, 3, 5-y were 48%, 20%, 12% and
68%, 25%, 17%, respectively. Cancer recurrence was observed in 103
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patients. The site of primary recurrence was intra-abdominal (liver, locor-
egional and peritoneal) in 80.6%, extra-abdominal (mainly pulmonary) in
15.5%, and synchronously intra- and extra-abdominal in 3.9%. Survival rates
(DFS & OS) were comparable between patients with and without adjuvant
therapy (log-rank0.065).
Conclusions. The majority of patients with pancreatic adenocarcinoma
develop cancer recurrence even after curative resection. Recurrences are
located predominantly in the abdominal compartment. Systemic adjuvant
therapy seems to have limited benefit on survival, indicating the need for
efficient novel anti-cancer agents and new therapeutic approaches.
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MILD ACUTE BILIARY PANCREATITIS: VALIDITY OF THE
MAGNETIC RESONANCE CHOLANGIO-PANCREATOGRAPHY
(MRCP) BEFORE THE VIDEOLAPAROCHOLECYSTECTOMY
(VLC)
Tiziano Pio Valentino1, Caterina Santacroce, Alberto Fersini, Nicola
Tartaglia, Antonio Ambrosi, Vincenzo Neri
1University of Foggia  Dept. of Surgical Sciences  Div. of General Surgery
Introduction. The therapeutic ERCP before the VLC in the patients with
moderate-severe acute biliary pancreatitis (ABP) is a well recognized practice;
the necessity of ERCP in the patients with mild acute biliary pancreatitis is
not well defined.
Objectives. Aim of the study: to evaluate the usefulness of the MRCP before
the VLC in patients with mild ABP.
Methods. In the period 2003 2006, twenty-five patients were submitted to a
MRCP (15 females, 10 males, mean age 62 years, range 3275) with mild
ABP (Glasgow’s criteria) without increase of the cholestasis tests (direct
bilirubin, alkaline phosphatase, gamma-GT) and absence of choledocho-
lithiasis at ultrasonography. During a follow-up period of 1560 days after
the VLC, the presence of jaundice or relapse of ABP were evaluated in all
patients by means of clinical/laboratory/instrumental examinations.
Results. Six patients had choledocholithiasis (stones/sand/sludge) at the
MRCP and they were submitted to an ERCP, stones removal and after to the
VLC; 19 patients with a negative MRCP were submitted to the VLC. All the
25 patients did not have jaundice or relapse of the ABP during the follow-up
period.
Conclusions. The MRCP was an accurate investigation for the preoperatory
diagnosis of choledocholithiasis; so, it is an important procedure for patients
with mild ABP, avoiding the ERCP.
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EARLY RESULTS OF A RANDOMISED TRIAL OF A SHORT
COURSE OF POSTOPERATIVE ANTIBIOTIC THERAPY IN
LOW-RISK ACUTE CHOLECYSTITIS
Josep M Badia1, Aurora Aldeano, Jordi Navines, Jaime Jimeno2, Lluis Oms3,
Miquel Casal, Xavier Guirao, Guzman Franch, Antonio Sitges-Serra2
1Hospital General de Granollers; 2Hospital del Mar; 3Hospital de Terrassa
Short courses of antibiotics have been suggested for resectable surgical
infections. Early surgical operation is the treatment of choice for acute
cholecystitis. Adjuvant antibiotic treatment is always given, but the optimal
choice, timing and duration of antibiotics in operated cholecystitis remain
unclear.
Aim. To compare the early postoperative results in terms of surgical site
infection (SSI), other morbidity and hospital stay between two groups of
patients operated for acute cholecystitis with different lenght of antibiotic
therapy.
Methods. Multicenter prospective randomised clinical trial comparing a
short course of antibiotic treatment (SC: preoperative treatment with
Piperacillin-tazobactam until 24 hours of operation) with a long course
(LC: same treatment prolonged for 5 days after surgery) for acute
cholecystitis treated by early cholecystectomy. Inclusion criteria were:
acute cholecystitis confirmed by ultrasonography, admitted B2 days after
the onset of symptoms, and operated B4 days of admission. Exclusion
criteria were: subhepatic abscess, biliary peritonitis, suspicion of cholangitis,
and confirmed bacteremia. Patients were followed for 30 days after
operation. An intention-to-treat analisis was used. The chi-square and
Student-Fischer tests were used for statistical analysis. Level of significance
was stated at pB0.05.
Results. One-hundred forty-five patients entered the study. Six were
excluded, 66 were allocated to SC group and 73 to LC group. Both groups
were comparable in sex, age, weight, level of inflammation encountered at
surgery, surgical technique (open or laparoscopic), and duration of operation.
ASA level were higher in SC group (ASA I-II: 54 SC vs 49 LC, p0.01). No
statistical differences were found in non-infectious postoperative complica-
tions (4.5% SC vs 6.8% LC, p0,7) or SSI: overall (SC 13.5% vs LC 8.2%,
p0.4), superficial wound infection (SC 10.6% vs LC 8.2%, p0.8), and
organ-space infection (SC 3% vs LC 1.4%, p0,6).
Conclusions. In a preliminary analysis of results, no significant differences
were found between a short course of antibiotic treatment -covering the
preoperative period and the day of operation- and a long course after early
cholecystectomy in uncomplicated cases of acute cholecystitis.
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EMERGENCY LAPAROSCOPIC CHOLECYSTECTOMY FOR
ACUTE CHOLECYSTITIS: THE DELAY BEYOND 72 HOURS
DOES NOT INCREASE OPERATIVE DIFFICULTY OR RISK
Ammar Darwish1, Suleiman Al-Hourani, Basil Ammori
1Manchester Royal Infirmary
Background. There is reluctance to perform emergency laparoscopic
cholecystectomy (LC) in patients with acute cholecystitis (AC) if surgery is
delayed beyond 72 hours in fear of increased operative difficulty, morbidity
and conversion to open surgery.
Methods. We adopted a policy of offering an emergency LC to patients with
AC regardless of the delay incurred while awaiting access to the CEPOD
theatre. The outcomes of surgery in patients operated on within 72 hours of
admission (Group I) were compared with those who underwent delayed
emergency LC (Group II).
Results. Between 2001 and 2006, 75 patients underwent emergency LC for
AC (Group I, n22; Group II, n53). There was no difference between the
groups with regard to age, sex distribution, ASA score and frequency of
previous abdominal surgery. The interval between admission and surgery was
significantly shorter in Group I (median, 2 vs. 7 days, pB0.001). There were
no conversions to open surgery. No differences were observed between the
groups in the frequency of gangrene of gallbladder (9% vs. 6%, p0.627),
operating time (median, 80 vs. 80 minutes, p0.456), postoperative
morbidity (4.5% vs. 7.5%, p0.664) and mortality (4.5% vs. 1.9%, p
0.503), or postoperative hospital stay (median, 2 vs. 2 days, p0.403). There
were no bile duct injuries.
Conclusions. The delay in performing emergency LC for AC beyond 72
hours does not increase operative difficulty or risk of operative morbidity.
Patients with AC should not be denied an emergency LC if access to theatre
was delayed.
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DAY-CASE LAPAROSCOPIC CHOLECYSTECTOMY-RESULTS
OF A NEW SERVICE IN A LARGE UK TEACHING HOSPITAL
Chris Briggs1, Iain Cameron, Andrew Cresswell, Maureen Monda, Glen
Irving, Mark Peterson
1Sheffield Teaching Hospitals NHS Trust
Introduction and Aim. Our aim was to set up a laparoscopic cholecys-
tectomy service in a large teaching hospital. The day case unit had never
undertaken a laparoscopic procedure up to commencing this project.
Between May 2004 and April 2005 inpatient cases were performed in the
day case unit to enable theatre staff to develop the skills needed for
laparoscopic cholecystectomy. True day case procedures began in May
2005.
Methods. From May 2005 a prospective audit has been undertaken for all
cases. Patients who have had an inpatient episode of gallstone pancreatitis or
acute cholecystitis were not deemed suitable for a day case operation.
Following discharge all patients are contacted by telephone on day two, five
and fourteen to monitor their recovery. Data collected is entered into a
database.
Results. 54 patients to date have attended with the intention of having a day
case laparoscopic cholecystectomy. All operations have been completed
laparoscopically, with 91% of patients successfully discharged on the day of
surgery. Telephone phonebacks indicated that 91% of patients were
‘‘extremely satisfied’’ with the experience, and 82% had returned to work
and/or normal activities by day 14. The hospital readmission rate after
discharge was 2%.
Conclusion. Our results compare favourably with the literature to date and
demonstrate this is a safe, acceptable and effective procedure even in a day
surgery unit which is inexperienced in laparoscopic surgery.
*We would happily present this as a poster if not acceptable for oral
presentation.
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QUALITY OF LIFE IN BILE DUCT INJURY PATIENTS IS NOT
EXPLAINED BY FACTORS RELATED TO THE BILIARY INJURY
BUT BY SOCIO DEMOGRAPHIC AND PSYCHOSOCIAL CHAR-
ACTERISTICS OF THE PATIENT
de Reuver Philip1, Rauws Erik, Lameris Johan, Oort Frans, Sprangers
Mirjam, Gouma Dirk
1Amsterdam Medical Center
The socio-economic impact of bile duct injury (BDI) is illustrated by
increased costs, high rates of litigation claims and long-term impaired quality
of life (QoL) in BDI patients. Previous research on QoL in BDI patients
showed the detrimental effect of BDI on QOL outcome. However, the
outcome was not influenced by injury related factors as the type of injury or
the duration of treatment. Because of this remarkable finding, the aim of the
present study is to determine the extent to which injury related factors, socio
demographic and psychosocial factors explain QoL in BDI patients.
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Between 1990 and March 2005 462 patients were referred to Amsterdam
Medical Centre for the treatment of BDI. Four-hundred-and-three BDI were
considered as eligible participants in this study of whom 65% (n261)
returned a completed questionnaire. Medical charts from responding patients
were analyzed for clinical data and socio demographic variables. QoL was
surveyed by the SF-36 and Gastrointestinal Quality of Life index. Surveyed
psychosocial variables were legal activity, neuroticism, health locus of control
and illness perception.
A multivariate analysis confirmed that QoL in BDI patients is not explained
by severity of the injury or the duration of treatment. QoL in BDI patients is
explained by age, self reported symptomatology, co morbidity, neuroticism,
locus of control, and illness perception.
These findings show that QoL in BDI patients is not explained by injury
related factors but by factors related to the patient’s socio demographic
characteristics and psychosocial profile. These findings might explain the
discrepancy between good functional outcome after treatment for BDI and
the reported poor QoL outcome in these patients.
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ENDOSCOPIC TREATMENT OF BILE DUCT INJURY: LONG
TERM OUTCOME AND PREDICTORS FOR SUCCESS
de Reuver Philip1, Rauws Erik, Vermeulen Mattijs, Gouma Dirk, Bruno
Marco
1Amsterdam Medical Center
Background. Endoscopic stent therapy is widely accepted as the initial
treatment modality for bile leakage and/or bile duct strictures resulting from
bile duct injury (BDI) during laparoscopic cholecystectomy. Although,
reliable factors for predicting success would be extremely useful, they are
unreported.
Aim. To analyze the short and long term outcome of endoscopic stent
therapy after BDI, to identify factors predicting successful outcome of stent
therapy for bile duct strictures, and to determine the effect of sequential
insertion of multiple stents for strictures.
Methods. Between January 1990 and January 2006, 203 patients underwent
endoscopic stent therapy for BDI. From a prospective database two groups of
patients were composed: patients with bile duct leakage (n93) and patients
with a bile duct stricture (n110).
Results. Minor stent related complications occurred in 12 patients (13%)
with bile duct leakage. Median duration of stenting was 1.5 months (range 1-
11). One patient was referred for surgery, 3 patients (3%) developed a
stenosis after stricture free interval, and one patient died due to a BDI related
cause. The overall success rate was 96% (n89). In patients with a bile duct
stricture minor stent related complications occurred in 33% (n36)). The
median duration of stenting was 11 months (range 169) with a median
number of stents of 2 (17). Subsequent surgery was indicated in 22 patients
(20%), 6 patients (6%) developed a stenosis after stent removal, and two
patients (2%) died due to a BDI related cause. After a mean duration of
follow-up of 4.5 years liver function tests did not show signs of occult bile
duct strictures. The overall success rate was 74% (n81). In patients treated
for a stricture the independent predictor for success was the number of stents
inserted during the first procedure (Odds ratio [OR]2.9 per stent, 95%
confidence interval [CI]1.1-8.2, p0.04). Independent predictors for
failure were injuries classified as Bismuth III (OR0.12, CI0.020.91,
p0.04) and IV (OR0.04 CI0.0030.55, p0.02), and endoscopic
stenting before referral (OR0.23, CI0.060.87, p0.03). After the
introduction of multiple stent therapy at the end of 2001, the overall success
did not improve (before 77% vs. after 66%, p0.25), while more patients
reported stent related pain (before 11% vs. after 28%, p0.02).
Conclusions. Endoscopic stent therapy is associated with an excellent
outcome in patients treated for postoperative bile duct leakage and good
outcome after strictures. The benefit of sequential insertion of multiple stents
is not readily apparent from this cohort and further study is needed to
elucidate this discrepancy.
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SURGICAL TREATMENT OF MID AND DISTAL BILE DUCT
CANCER
Antonio Frena1, Giuseppe La Guardia, Federico Martin
1Surgical Department  General Surgery 2  Central Hospital of Bolzano
Introduction. carcinoma of the mid or distal third of the common bile duct
is a fairly rare nosological entity in the Western world, accounting for 13
23% of tumours of the extrahepatic bile ducts. The surgical treatment varies
in relation to the site: in the case of carcinomas of the distal common bile duct
the operation of choice is duodeno-pancreatectomy, whereas for tumours of
the mid common bile duct there is still no unanimous consensus of opinion
regarding the type of surgery.
Aim. The prognosis of these tumours is, on the whole, better than that of
carcinomas of the proximal choledochus.
Methods. we retrospectively assessed 37 patients with non-hilar extra-
hepatic bile duct tumours observed in our surgery department from 1985 to
2005. The patient series comprised 21 men and 16 women, with a mean age
of 71 years. The presenting symptom was jaundice in 95% of cases. In 23
cases the carcinoma affected the distal common bile duct and in 14 cases the
mid common bile duct.
Results. 15 patients were treated with a radial intent by either duodeno-
pancreatectomy (13 cases) or by resection of the common bile duct (2 cases).
Ten patients with local inoperability or liver metastases were treated with a
palliative biliodigestive anastomosis. Twelve patients were excluded from
surgery and treated endoscopically. Postoperative staging identified 1 patient
as stage Ia, 2 patients as stage Ib, 8 patients as stage IIa, 3 patients as stage
IIb, and 1 patient as stage III according to the new TNM classification. There
was no operative mortality. Survival at 1, 2 and 5 years was 51%, 27% and
14%, respectively.
Conclusions. carcinoma of the mid or distal portion of the common bile
duct is a tumour that offers fairly good prospects of survival. Surgical
radicality is achieved essentially by obtaining ductal and radial margins
which are free of microscopic infiltration and by means of a thorough
lymphadenectomy. These conditions can be achieved more easily in
carcinomas of the distal portion of the duct owing to the extent of the
duodeno-pancreatectomy they require. In carcinomas of the mid common
bile duct the anatomical contiguity with the portal vein is responsible for a
lower resectability rate.
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COMPARISON OF THE RESULTS OF SURGICAL TREATMENTS
FOR PERIAMPULARY MALIGNANCIES
Igor Ignjatovic1, Djordje Knezevic, Slavenko Ostojic, Zoran Djordjevic,
Srbislav Knezevic, Slavko Matic
1Institute for digestive diseases, Clinical Centre of Srebia
Background. Proximal pancreatectomy is a first choice procedure in a
treatment of periampullary malignancies. It can be performed as a duode-
nopancreatectomy (DP) which could be done as a standard (D1), radical
(D2) and radical extended (D3) Whipple’s procedure, pilorys preserving
duopdenopancreatectomy (PPDP), and duodenum preserving pancreatic
head resection (DPRCP).
Methodology. On our department in the period from 20002005 we have
operated on 206 patients with various periampullary malignancies. Standard
Whipple’s procedure was done in 72 (35%), radical Whipple’s procedure in
80 (39%) and PPDP in 54 (26%) patients. No DPRCP was done in this
series.
Results. R0 resection was achieved in all patients. Definite histological
findings revealed: pancreatic head adenocarcinoma 60%, adenocarcinoma of
Vater’s papilla in 34%, distal common bile duct cholangiocarcinoma 4%,
duodenal adenocarcinoma 1% and leiomyosarcoma 1%. Most frequent
analyzed and involved limphnodes were in groups 13, 17, 12, 8, 14, 16.
Conclusion. There were no significant difference in long term survival
between three groups of patients (D1, D2, PPDP). Resection can be
considered as a palliative or even unnecessary in following terms: involvement
of limphnode groups 12h and 9, and involvement of paraortic and
mesenterial limhnodes.
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BILIRUBIN AND/OR C-REACTIVE PROTEIN AS CORRECTION
FACTOR OF CARBOHYDRATE ANTIGEN 19/9 IN DIAGNOSTIC
WORKUP OF CHOLOSTATIC JAUNDICE - A PRELIMINARY
STUDY
Gaetano La Greca1, Rosario Lombardo, Maria Sofia, Francesco Barbagallo,
Giorgio Castello, Salvina Gagliardo, Saverio Latteri, Rosanna T. Portale2,
Stefano Puleo2, Domenico Russello
1Department of Surgical Sciences, Organ Transplantation, and Advanced
Technologies, University of Catania, Cannizzaro Hospital, Catania, Italy;
2Department of General Surgery, Vittorio Emanuele Hospital, Catania, Italy
Background. CA 19/9 is often abnormal in many patients with cholostatic
jaundice. This marker is unfortunately increased not only in patients with
pancreatic or biliary cancers but also in benigne biliary diseases with jaundice
beeing therefore often missleading. Some reports suggested empirically to
correct the abnormal increase of this markers divide it by the value of
bilirubin. These problems of interpretation of pathologic CA 19/9 levels
occurs more frequently in diseases associated with relevant inflammation due
to jaundice. The AA tried to find and analyze a possibile relation between
inflammation and CA 19/9 to find a ratio or a better corrective factor to
increase predictivity and reduce the percentage of missleading false positive
values.
Method. This preliminary observational study included 60 patients with
cholostatic jaundice that were recorded concerning all routine laboratory
tests including PCR, bilirubin, CA 19/9. These parameters were anlyzed,
calculated and combined differently and related to the diagnosis.
Results. All the patients had abnormal bilirubin levels, 58,3% had
pathologic CA 19/9 levels, 45% of the patiens were affected by malignancy
of the pancreas or biliary tract and all the other 55% were affected by benigne
biliary disease. 88,8% of the patient with malignancy had pathologic CA 19/9
with extreme variable range (3836182, nv B35). 31,4% of the patient with
pathologic Ca 19/9 levels had false positive being affected benigne diseases.
After correction dividing CA19/9 levels by bilirubin level 41,6% of the
patients with malignancy turned in the empiric normal range becoming false
negative, on the contrary 90% of the false positive Ca 19/9 levels in benigne
disease turned in a normal and true positive range. If the correction factor
used was the division of the Ca 19/9 levels by CRP values 79,1% of patients
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with malignancy remained true positive and 70% of false positive Ca19/9
levels turned in a true positive level.
Conclusion. Bilirubin level as simple correction factor of pathologic Ca 19/
9 is effective for benign disease not for maligne disease as true positive
becomes false negative in 41,6%. CRP as correction factor of jaundiced
patient with pathologic Ca 19/9 levels could be perhaps useful as a
correction factor to improve the diagnostic value in the diagnosti workup
of jaundiced patients due to uncertain benigne or maligne disease
convincing us to continue to deepen this aspect of oncologic research
concerning tumor markers.
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THE SIMULTANEOUS LAPARO-ENDOSCOPIC RENDEZ VOUS
FOR PATIENTS WITH CHOLECYSTO-CHOLEDOCOLITHIASIS
IN 80 CONSECUTIVE CASES: AN EFFECTIVE AND SAFE OP-
TION
Gaetano La Greca1, Francesco Barbagallo, Maria Sofia, Saverio Latteri,
Salvina Gagliardo, Emanuele Grasso, Manuela Di Stefano, Rosario Lom-
bardo, Michele Di Blasi2, Domenico Russello
1Department of Surgical Sciences, Organ Transplantation, and Advanced
Technologies, University of Catania, Cannizzaro Hospital, Catania, Italy;
2Department of Surgical Sciences, Organ Transplantation, and Advanced
Technologies, University of Catania, Cannizzaro Hospital, Catania
Background and Aims. The management of patients affected by gallstones
and common bile duct stones is still a challenge as there are different
successful available options. An alternative to both sequential approach or
totally laparoscopic treatments consists of the simultaneous laparo-endo-
scopic ‘‘Rendez-Vous’’ (RV) procedure which combines laparoscopic chole-
cystectomy, intra-operative cholangiography and endoscopic common bile
duct clearance.
Method. The authors report their experience with the ‘‘Rendez-vous’’ in a
group of 80 consecutive patients.We point out that in fact in our definition
the ‘‘Rendez-vous’’ consist of combined laparo-endoscopic simultaneous
approach involving the endoscopist and surgeon in the operating room during
the unique anesthesia to clear common bile duct stones or solve associated
problems related to sludge or other problems at the papilla of Vater. Our
definition of RV is somewhat different as other consider a RV only when the
surgeon pass the guide wire through the cystic duct to help the endoscopist
All the records of the treated patients were analyzed concerning main clinical
data the relevant technical features and the results concerning the overall
effectiveness and safety.
Results. The diagnosis of common bile duct stones was certain preopera-
tively in 47 patients (58,7 %), in 33 patients (41,2%) the diagnosis of stones
in the common bile duct was not given preoperatively. The RV procedure was
feasible in 78 patients 97,5%. The effectiveness of the procedure was 100%
concerning the clearance of CBD stones, sludge, and/or resolution of
problems at the papilla. Minor morbidity affected 3,3% of the patients.
The whole operating time was prolonged by a mean of 14 minutes. The mean
hospital stay was 3.8 days. Only one patient (1,2%) referred a recurrence of a
stone.
Conclusions. This experience shows that this simultaneous laparo-endo-
scopic approach for the treatment of cholecysto- choledocolitiasis is related to
a very high effectiveness that seems to be better than those reported in the
literature for the other available treatment’s options. This high effectiveness
and the related low morbidity and the data form the literature suggests that
the procedure is also extremely safe and therefore, if the mandatory
collaboration between surgeons and endoscopists is guaranted, it can be an
usefull option for the patient, the surgeon, the endoscopist and the hospital.
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REAPPRAISAL OF DIAGNOSTIC LAPAROSCOPY FOR PERIAM-
PULLARY TUMOURS
van der Gaag Niels A1, van Berge Henegouwen Mark I, Harmsen Kennard,
Busch Olivier RC, van Gulik Thomas M, Gouma Dirk J
1Academic Medical Center, department of surgery
Background. A significant number of patients, scheduled for explorative
laparotomy (EL) for a suspected periampullary malignancy, undergo a
palliative bypass procedure due to distant metastases (liver, peritoneal)
and/or locoregional ingrowth. Controversy still exits on the additional value
of a diagnostic laparoscopy (DL) as an upstaging modality to preclude a
noncurative EL. Routine DL was eliminated in 1998 from the diagnostic
protocol in our institution since a prospective study revealed a yield of only
13% for distant metastases. Moreover, a better outcome of patients after
surgical palliation was observed, compared with endoscopic palliative
treatment.
Objective. To evaluate the rationale of a strategy without routine use of DL,
for patients undergoing an EL for a suspected periampullary malignancy, in
terms of resection vs. bypass ratio and to analyze the indications for
performing a bypass procedure.
Methods. In the period 19932006 987 patients underwent an EL for the
suspicion of periampullary malignancy, potentially resectable on radiological
imaging. Between 19931998 (period I) 288 patients had a DL performed
as a routine diagnostic procedure, whereas between 19992006 (period II)
583 patients had no routine DL performed. Patient characteristics and
pathological findings in each period were analyzed, as well as rates of
resection and bypass procedures and the indications to perform a bypass
procedure.
Results. Patient characteristics did not significantly differ between periods.
Pathological findings after resection were (period I/II): solid neoplasm 89%/
78%, cystic neoplasm 1%/11%, benign 10%/11%. Resection rate was 67%
(n193/288) in period I and 66% (n383/583) in period II, whereas the
bypass rate was 33% (95/288) in period I and 34% (200/583) in period II.
Locoregional ingrowth as indication for a bypass procedure decreased from
76% (n72/95) in period I to 53% (n105/200) in period II. Distant
metastases as indication for a bypass procedure increased from 24% (n23/
95) in period I to 48% (n95/200) in period II (pB0.05).
Conclusion. The overall resectability rate for periampullary malignancies
has remained unchanged. Irresectability due to locoregional ingrowth
declined during the study period, probably as a result of the introduction
of advanced radiological techniques and the application of well-defined
criteria for resection. However, a proportional increase in distant metastasis
was found, which might have been due to the implementation of a
diagnostic protocol without routine use of DL. Further studies might
identify a subgroup of patients in which a DL can prevent an unnecessary
exploration.
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THE OUTCOME OF SURGICAL MANAGEMENT OF PERIAM-
PULLARY TUMOURS
Madhava Pai1, Paolo Limongelli2, Gordon Stamp3, Nagy Habib, Robin
Williamson2, Long Jiao2
1Dept. of HPB Surgery, Hammersmith Hospital, London, UK; 2Dept. of
HPB Surgery, Hammersmith Hospital, London, UK.; 3Dept. of Histopathol-
ogy, Hammersmith Hospital, London, UK
Background and Aims. Surgery remains the curative option for treatment
of periampullary tumours. The result of surgery in this group of patients was
examined to assess the outcome and survival in our unit.
Methods. A retrospective review of patients with periampullary tumours
undergoing either resection or palliative bypass.
Results. A total of 140 patients were identified between January 1995 and
September 2004 who had surgery for preoperative diagnosis of periampullary
tumours consisting of curative resection (n112) and palliative bypass (n
28). The overall median survival was 6 and 20 months either after by pass or
resection respectively. The overall 5-year actuarial and disease-free survivals
after resection were 9.8 and 14.2% for palliative procedure and curative
resection respectively. In patients with pancreatic adenocarcinoma, an
advanced Union International Contra la Cancrum (UICC) status was
identified as a significant predictor for shorter disease-free survival (p
.01). In patients with periampullary tumours of non- pancreatic origin,
postoperative sepsis (p.008) and the presence of four or more lymph nodes
were found to be associated with worse survival (p.009), whereas a poor
tumour differentiation was found to be significantly related to shorter disease-
free survival (p.03).
Conclusions. Patients who had non pancreatic periampullary tumours had a
better prognosis and survival than those with pancreatic periampullary
tumour. Factors influencing survival and recurrence included stage of
disease, number of lymph nodes, postoperative sepsis, and tumour grading.
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LAPAROSCOPIC CHOLECYSTECTOMY (LC) AND COMMON
BILE DUCT EXPLORATION (CBDE) IN PATIENTS WITH A
PREVIOUS GASTRIC RESECTION
Alessandro Maria Paganini1, Mario Guerrieri2, Jlenia Sarnari2, Angelo De
Sanctis3, Giancarlo D’Ambrosio*, Adriana Rotundo$, Luciana Barchetti§,
Emanuele Lezoche*
1II Clinica Chirurgica, Universita’ AˆœLa Sapienza, Rome, Italy; 2Depart-
ment of General Surgery, Universita˜ di Ancona, AN, Italy; 3Department of
General Surgery, Universita˜ di Ancona, AN,Italy; *II Clinica Chirurgica,
Universita’ AˆœLa SapienzaA˜,AˆI, Rome, Italy.; $II Clinica Chirurgica,
Universita’ AˆœLa Sapienza, Rome, Italy.; §II Clinica Chirurgica, Universita’
AˆœLa SapienzaAˆI, Rome, Italy.
Background. An increased incidence of cholelithiasis is reported after
truncal vagotomy and gastric resection. Adhesions from previous gastric
surgery are often considered a contraindication to laparoscopic surgery. Aim
was to evaluate the feasibility and long-term results after LC and CBDE in
patients with a previous gastric resection.
Methods. From April 1991 to February 2007, CBD stones were present in
363 out of 3455 patients (10.5%) (139 males, 224 females, mean age 57.6
years, range 1296 years) who underwent LC. Among these, 19 patients (13
males, 6 females, mean age 66.3 years, range 3079 years) had a previous
gastric resection (18) or gastrectomy (1).
Results Group 1 Group2 p.
Patients 344 19
Preoperative failed ES 44 (13.5%) 1 (5.3%) B0.05
Conversions 14 (4.3%) 1 (5.3%) n.s
Completed laparosc. 330 (95.9%) 18 (94.1%) n.s.
Transcystic/Chol.tomy 199/131 5/13 B0.05
Morbidity 9 (2.7%) 3 (16.7%) B0.001
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Mortality 1 (0.3%) 0 n.s.
Retained CBD Stones 13 (3.9%) 4 (22.2%) B0.001
Recurrent CBD Stones 5 (1.5%) 0 n.s.
Overall Success Rate 95.3 76.7 B0.001
Retained CBD stones were safely treated through the biliary drainage sinus
tract. At a mean follow up time of 130.8/26.4 months (range 70.6178.7
months) no biliary stricture at the site of the choledochotomy has been
observed.
Conclusions. Laparoscopic CBDE during LC for stones in patients with a
previous gastric resection is feasible and it does not increase the conversion
rate. The presence of complex ductal stone disease is associated with a higher
retained stones rate but this may be safely solved postoperatively through the
biliary drainage sinus tract avoiding endoscopic sphincterotomy which is
usually unsuccessful in this complex situation.
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LAPAROSCOPIC COMMON BILE DUCT STONE CLEARANCE
USING FLEXIBLE CHOLEDOCHOSCOPY
Baki Topal1, Raymond Aerts, Freddy Penninckx
1UZ.Leuven, Abdominal Surgery
Introduction. Laparoscopic common bile duct exploration (LCBDE) is as
safe and efficient as endoscopic retrograde cholangiopancreatography
(ERCP) in achieving bile duct clearance from stones. No clear guidelines
are available on LCBDE with respect to indications for trans-cystic approach
vs. choledochotomy and whether to use flexible choledochoscopy (FCD) or
intra-operative cholangiography (IOC) guidance.
Methods. From January 2001 until November 2006, 113 consecutive patients
with common bile duct stones (CBDS) and gallbladder in situ were enrolled in
a prospective non-randomized study to undergo LCBDE on an intention to
treat basis. Pre-operative ERCP with attempt to stone clearance was
performed in 24 patients. Twenty-three patients were aged 80 years or older
with severe co-morbidity. Laparoscopic CBDE was attempted for CBDS in
the presence of acute cholecystitis in 24 patients. LCBDE was performed via
trans-cystic approach in 83 and via choledochotomy in 30 patients. Flexible
choledochoscopy was used in 79 and IOC-guidance in 34 patients.
Results. No mortality occurred. Postoperative complications were encoun-
tered in 9 patients. Laparoscopic stone clearance of the bile duct was
successful in 91.8% of the patients. Median (range) length of hospital stay
(LOS) was 2 (024) days after trans-cystic LCBDE and 6 (234) days after
stone clearance via choledochotomy (pB0.0001). Choledochotomy was
performed for CBDS measuring 11.5 (530) mm in diameter while trans-
cystic LCBDE was successful for stones measuring 5 (214) mm (pB
0.0001). Duration of surgery was 75 (30180) minutes when FCD was
used, and 107 (45240) minutes in patients undergoing LCBDE under
IOC-guidance (pB0.0001).
Conclusion. Laparoscopic CBDE with stone extraction can be performed
with high efficiency, minimal morbidity and without mortality. Trans-cystic
approach is feasible in most patients, while choledochotomy should be
restricted for large bile duct stones that cannot be extracted through the cystic
duct. The use of a flexible choledochoscope is preferable above IOC-
guidance.
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CLINICAL MODEL TO PREDICT COMMON BILE DUCT
STONES IN PATIENTS WITH GALLSTONE DISEASE
Baki Topal1, Steffen Fieuws2, Raymond Aerts, Freddy Penninckx
1UZ.Leuven, Abdominal Surgery; 2KU.Leuven, Department of Biostatistics
Introduction. About 15% of individuals with gallstones will develop
common bile duct stones (CBDS) that can cause severe complications and
death. The probability that a patient has CBDS is a key factor in determining
diagnostic and treatment strategies. The aim of the present prospective study
was to validate and redefine a predictive model containing measurable
indicators for CBDS in patients with cholelithiasis planned for cholecystect-
omy.
Methods. From October 2005 until September 2006, 335 consecutive
patients with symptoms of gallstone disease were considered for cholecys-
tectomy (M/F: 127/208; median age 59 years (19-91 y.)). Statistical analysis
was performed on prospective patient data obtained at the time of first
presentation to the hospital. Demonstrable CBDS at the time of ERCP or
intra-operative cholangiography was considered as the gold standard for the
presence of CBDS.
Results. CBDS were demonstrated in 53 patients. The predictive model for
CBDS contained serum levels of alkaline phosphatase, total bilirubin,
aspartate transaminase (AST), ultrasonography showing duct stones or
dilatation, and age. Various combinations of these indicators resulted in
predicted probabilities ranging from 2.9% to 99.3%. External validation of
the existing predictive model resulted in a c-index equal to 0.706. An
increased accuracy was obtained with the new model, as suggested by the c-
index of 0.782 derived from the internal validation.
Conclusions. The current model is easily applicable in daily practice and
able to calculate the predicted probability of CBDS in patients with gallstone
disease. Its variability confirms that predictions in clinical practice are
suboptimal at best. The model can be used as guidance in further diagnostic
and therapeutic strategies.
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ARGON PLASMA COAGULATION FOR AMPULLARY CARCI-
NOMA
C Ross Carter1, Sameer Mihrshahi, A Peter Wysocki2
1NHS Scotland; 2Queensland Health
Background. Pancreaticoduodencetomy is the mainstay for managing most
patients with ampullary adenocarcinoma with actuarial 5 year survival at least
50% in most modern series. Literature regarding the management of non-
operable patients is sparse with most reporting median survival of less than 10
months with stenting alone.
Methods. 17 patients with ampullary adenocarcinoma diagnosed with a
combination of side-viewing duodenoscopy, computed tomography and
histology who have been routinely managed with endoscopic stenting and
argon plasma coagulation over a period of 5 years.
Results. The mean number of endoscopy sessions was 4.3 per patient. The
mean and median survival was 17 months and 12 months respectively.
Conclusions. There is insufficient published data regarding non-operative
outcome of patients with ampullary carcinoma to determine whether Argon
Plasma Coagulation extends survival but these results are encouraging.
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PROCEDURE OF MIDDLE AND LOWER COMMON BILE DUCT
CARCINOMA
Yukihiro ISO1, Tokihiko Sawada, Junji Kita, Mitsugi Shimoda, Kyu
Rokkaku, Masato Kato, Keiichi Kubota
1Dokkyo University Hospital, HPB Surgery
Objective. The only treatment which promise better prognosis for carci-
noma of middle and lower bile duct (CaMLB), is pancreatico-duodenectomy
(PD). In this study, we retrospectively evaluated the safety and prognosis of
PD for CaMLB.
Methods. Between April 2000 to December 2006, 34 PDs were performed
for CaMLB at our department. Mean age was 64.2 years old, and there were
20 males (58.8%) and 14 females (41.2%). Preoperative biliary drainage was
performed in 32 cases (94.1%). Extended lymph adenectomy including
lymph nodes aliving the common hepatic artery and celiac axis was
performed in all patients.
Results. In 34 PDs, 4 cases underwent PD with extended right hepatectomy
because of hilar invasion. And 2 cases underwent PD with portal reconstruc-
tion due to portal invasion. Mean operation time was 600.0 min and mean
operative blood loss was 573.5 ml. There were no operation-related deaths.
Pathological examination revealed that there were 6 cases of stage, 14 cases of
stage, 7 cases of stage, 6 cases of stage a, and 1 case of stage b. The survival
rates at 1 and 3 years were 88.2% and 62.7%, respectively.
Conclusions. PD with extended lymph adenectomy for CaMLB is a safe
method and promise a better clinical outcome.
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EFFECT OF GRAFT STEATOSIS ON ORGAN BLOOD FLOWAND
OUTCOME AFTER LIVER TRANSPLANTATION
Martin K. Angele1, Markus Rentsch2, Wolfgang Hartl2, Christian Graeb2,
Karl-Walter Jauch2, Florian Lo¨he2
1Department of Surgery, Klinikum Grosshadern, Ludwig-Maximilians Uni-
versity; 2Department of Surgery, Klinikum Grosshadern, Ludwig-Maximi-
lians-University of Munich
Objective. To determine the effect of graft steatosis on intraoperative organ
blood flow, postoperative liver function and long-term organ survival.
Background. To overcome the increasing discrepancy between liver organ
availability and requirement livers with poor organ quality are increasingly
accepted for transplantation. In the past steatosis has been thought to be a
major risk factor for graft dysfunction.
Methods. 225 consecutive liver transplants (age 48 years911,5) were
reviewed. Organ blood flow (perfusion of portal vein and hepatic artery),
hepatic function (AST, ALT, bilirubin, prothrombin time on 1st, 2nd and 7th
postoperative day) and organ survival were determined. Donor liver grafts
were categorized into two subgroups according to the degree of macro-
vesicular steatosis: mild (less than 30 %) (N175), or moderate to severe
(30 %) (N50) steatosis.
Results. The results indicate that moderate to severe steatosis was associated
with significantly increased AST and ALT levels after operation and with a
significantly diminished prothrombin time on the 1st and 2nd postoperative
day. By day 7 differences in liver function were no longer evident. Portal and
hepatic blood flow were not affected by the degree of liver steatosis. After
adjustment for potential confounders, organ survival did not depend on the
degree of donor steatosis (5-year-survival rates: 68% and 58% with steatosis
B30%, or 30%, respectively) (hazard ratio 0.754, confidence interval
0.458 1.242, p0.268).
Conclusion. Differences in organ blood flow are not responsible for
temporally diminished organ function in moderately or severely steatotic
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livers following transplantation. Steatotic livers can be transplanted safely
with good results for long-term organ survival if other contraindications are
absent.
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USE OF ELDERLY GRAFTS FOR LIVER TRANSPLANTATION:
THE PARADOXICAL PARADIGM OF OCTOGENARIAN DONORS
Matteo Cescon1, Gian Luca Grazi, Alessandro Cucchetti, Matteo Ravaioli,
Giorgio Ercolani, Marco Vivarelli, Massimo Del Gaudio, Antonietta D’Er-
rico2, Antonio Daniele Pinna
1Liver and Multiorgan Transplant Unit, Department of Surgery and
Transplantation, University of Bologna, Bologna, Italy; 2Department of
Oncology and Hematology, Pathology Division of the ‘‘Felice Addarii’’
Institute, University of Bologna, Bologna, Italy
Objective. To analyze the outcome of liver transplantation (LT) according to
different categories of donor age, with particular reference to octogenarian
donors.
Background. Older donor age is considered a risk factor for poor outcome
in liver transplantation, but a stratification of results according to classes of
old donor age has rarely been reported.
Methods. 553 LTs performed between 1998 and 2006 were divided
according to donor age categories (group 1 [n173]: B50 years; group 2
[n96]: 50-59 years; group 3 [n132]: 6069 years; group 4 [n111]:
7079 years; group 5 [n41]:or 80 years). Clinical parameters were
comparable between groups. Group 5 donors had the lowest mean ICU stay
and ischemia time, with only one graft showing macrovescicular steatosis
30%. Recipient and donor parameters were similar between groups in 221
HCV-positive patients.
Results. 5-year graft survival was significantly higher in group 1 (75%) vs.
group 3 (60%) and 4 (62%) (P0.01 and P0.001, respectively), and in
group 5 (81%) vs. group 3 and 4 (P0.04 and P0.01, respectively). Group
5 had the shortest time to HCV recurrence, but also the highest rate of patients
receiving antiviral treatment and showing sustained virological response. Graft
losses due to HCV recurrence were significantly lower in group 1 (7%)
compared to group 3 (21%) and 4 (25%) (PB0.05), but not to group 2 (15%)
and 5 (12%). At multivariate analysis, donor age 60 79 years, recipient HCV-
positive status, MELD scoreor 25, and urgent LTwere predictors of poor
survival, whereas donor age 60-79 years and post-transplant corticosteroid
boluses were predictors of graft loss due to HCV recurrence.
Conclusions. The careful management of very old donors, even without a
selection based on recipient clinical conditions, definitely supports their use
for non-HCV-related diseases. The contribution of an extensive use of
antiviral drugs, made possible by a good graft functional recovery, can lead to
acceptable results also in HCV-infected patients.
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LIVER TRANSPLANTATION FOR RECURRENT HEPATOCELLU-
LAR CARCINOMA ON CIRRHOSIS AFTER LIVER RESECTION
Massimo Del Gaudio1, Giorgio Ercolani2, Matteo Ravaioli3, Matteo Ces-
con*, Augusto Lauro2, Marco Vivarelli2, Matteo Zanello2, Francesco Tuci2,
Alessandro Cucchetti2, Giuliano La Barba2, Gaetano Vetrone2, Gian Luca
Grazi2, Antonio Daniele Pinna2
1Liver and Multiorgan transplantation Unit-S.Orsola Hospital- University of
Bologna; 2Liver and Multiorgan Transplantation Unit-S.Orsola Hospital-
University of Bologna; 3Liver and Muliorgan Transplantation Unit-S.Orsola
Hospital-University of Bologna; *Liver and Multiorgan transplantation Unit-
S.Orsola Hospital-University of Bologna
Introduction. Liver transplantation (LT) is the best treatment for HCC
arising on a background of cirrhosis, but organ shortage limits this option.
Liver resection (LR) provides a broader application for patients with small
HCC with preserved liver function, employing LT as a salvage procedure in
the event of HCC recurrence.
Objectives. The aim of this study is to establish the safety and efficacy of the
strategy of LT in case of HCC reucurrence after LR.
Methods. From 1996 to 2005, we treated 309 cirrhotic patients with HCC:
165 LRs and 144 LTs. Salvage LT (n16) was compared with primary LT
for HCC (n128) documented by histology, to assess the safety of this
procedure. Among these 16 cases, the outcome of LT for HCC recurrence
after LR (n10) was compared with the outcome of primary LT with HCC
(n128); another 6 salvage LTs were performed for end-stage liver disease.
To analyze the outcome of each surgical strategy, LR in transplantable
patients (n81), according to local selection criteria of LT, was compared
with primary LT (n128).
Results. There was no operative mortality in the salvage LT group vs. 6% in
the primary LT group (pNS); in addition, there was no difference
regarding HCC recurrence (10% vs 9%) and post-operative morbidity.
Five-year overall survival was 100% vs 69% (pNS) and disease-free
survival was 83% vs 86% for salvage and primary LT, respectively (pNS).
Compared with primary LT, transplantable resected patients had a similar 5-
year overall survival: 70% vs 69%, but a lower disease-free survival 48% vs
86%, pB 0.0001.
Conclusion. LR is a valid treatment for small HCC in selected patients and
in the event of recurrence, salvage transplantation is a safe and effective
procedure.
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LIVER TRANSPLANTATION USING SEPTUAGENARIAN AND
OCTAGENARIAN DONORS: COMPARISON BETWEEN THREE
DIFFERENT PERFUSION SOLUTIONS
Enrico Gringeri1, Francesco D’Amico, Michele Valmasoni, Alessandro
Vitale, Francesco Ciarleglio, Amedeo Carraro, Alberto Brolese, Giacomo
Zanus, Patrizia Boccagni, Daniele Neri, Nela Srsen, Umberto Cillo, Davide
D’Amico
1Hepatobiliary Surgery and Liver Transplant Unit  University of Padova
Introduction. The chronic shortage of organ donation and the increasing
number of patients listed for liver transplantation has questioned an arduous
debate about acceptance criteria for donor organs. In the last years several
strategies have been afforded to expand organ procurement and livers from
older donors still represent a consistent organ-pool for transplant. However,
their use is associated to a high risk of primary graft dysfunction (PDF). In
this contest, we retrospectively examined the efficacy of three different
perfusion solutions commonly used for liver-graft preservation.
Patients and Methods. From May 2000 to January 2005, 292 ortothopic
liver transplants were performed using 28 (9,6%) septuagenarian and
octagenarian liver donors (mean age 73,3 years, range 70 to 82). They
were perfused using Celsior (CSImtix; Sangstat, Lyon, France) solution
in ten cases, University of Wisconsin solution (UWViaspan; Dupont
Pharma, Dordrecht, The Netherlands,) in eight cases and Custodiol
(HTKKoeler Chemie, Custodiol) in eight cases. Liver allografts were
perfused via the aorta according to manufacturing and donor weight. The
main donor and recipient variables were evaluated among the three groups.
Liver biopsies were performed in all cases. All patients received Cyclospor-
ine (CyA) or Tacrolimus (FK 506) as immunosuppressant therapy.
Statistical analysis was made using Student’s t test (P B 0.05 statistically
significant).
Results. No differences were observed related to age, gender, cause of
death, lenght of ICU-stay, haemodinamic instability, drug infusion and liver
enzymes among the three groups. Liver biopsy revealed steatosis B30% in
CS group (2 cases), UW group (1 case) and HTK group (2 cases).
Recipient characteristics (age, gender, etiology of liver desease, Child-Pugh
class and UNOS status) were comparable in all 3 groups. No differences
among them were identified in relation to the main intra-operative and
peri-operative data (cold ischemia time, warm ischemia time, surgical
procedure, transfusion of homologous packed red blood cell and fresh
frozen plasma or immunosuppression therapy). PDF was observed in 1
case in both CS and HTK groups and in 2 cases in UW group. No
primary-non-function (PNF) event was observed. One-year actuarial
patient (CS 87%, UW 85%, HTK 86%) and graft survival (CS 81%,
UW 83%, HTK 83%) rates were similar.
Conclusions. The three different preserving solutions used were efficient to
preserve old liver grafts for clinical liver transplantation. A larger randomized
clinical trial is needed to confirm these results.
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ROLE OF SPLENIC ARTERY EMBOLIZATION IN THE TREAT-
MENT OF SMALL FOR SIZE SYNDROME IN ADULT TO ADULT
LIVING RELATED LIVER TRANSPLANTATION
Salvatore Gruttadauria1, Lucio Mandala`, Joannis Petridis, Emerico Luna,
Roberto Miraglia, Settimo Caruso, Giovanni Vizzini, Riccardo Volpes, Wallis
Marsh, Angelo Luca, Amadeo Marcos, Bruno Gridelli
1ISMETT-UPMC Italy
Background and Aim. The portal hyperperfusion or small for size
syndrome (SFSS) is a well recognized clinical complication that may occur
after segmental liver transplantation. Here we present our strategy to perform
early splenic artery embolization (SAE) for the treatment of SFSS after living
related liver transplantation (LRLT).
Methods. Five patients developed small-for-size syndrome defined as: onset
within the 1st week after LRLT of progressive hyperbilirubinemia without
mechanical cause, cholestasis at liver biopsy, and refractory ascites in absence
of vascular complications.
Results. All five patients (Table 1) underewent SAE improved rapidly their
clinical condition, with an evident decrease in the value of bilirubin in the
serum, in production of ascites and improvement of the pancytopenia.
Coagulopathy expressed by the INR value was not a reliable marker of SFSS
in this series; in fact a slight improvement of this test was present already
immediately after LRLT before SAE.
Conclusion. There is clear a contribution of splenic flow to portal
hyperperfsion, early SAE can relief the partial graft from the deleterious
effect of portal overflow.
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LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCI-
NOMA UNDER THE MILAN CRITERIA
Andres Valdivieso1, Mikel Gastaca, Javier Bustamante, Jose Ramon Fernan-
dez, Maria Jesus Hernandez, Javier Gonzalez Uriarte, Milagros Testillano,
Maria Jesus Suarez, Patricia Ruiz, Jorge Ortiz De Urbina
1Liver Transplant Unit. Hospital Cruces
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Aim. Limits of hepatocellular carcinoma(HCC) for liver transplanta-
tion(LT) are being discussing nowadays. We report our experience with LT
for HCC under Milan criteria with five year follow-up.
From February 1996 to October 2005 we performed 566 LTon 536 patients.
HCC with cirrhosis was the main reason of LT in 133 cases (25%).
Patients were predominantly males(81%). Average age was 5897 years.
Hepatitis C virus cirrhosis (HCV) was the underlying disease in 52.5%,
alcoholic cirrhosis in 36%, and hepatitis B virus cirrhosis in 6%. Only 5
patients had alpha-phetoprotein higher than 200 ng/ml. These patients had
no preferences in the waiting list, and their average stay was 114 days. A doble
therapy based on tacrolimus and steroids was used in the majority of the
patients. Median ICU and hospital stay was 3 and 15 days, respectively.
In the explanted liver, only 70% still fulfilled the Milan criteria, while 16%
fulfilled the San Francisco criteria and 14% were out of the former criteria.
Microvascular invasion was seen in 21 livers.
Tumour recurrence appeared in 12 patients (9%). The average time of
recurrence after transplantation was 18 months (r 244.5m), and the average
survival after recurrence was 20 months (r 5.553m). Recurrence was
surgically removed in 5 patients: one patient with lymph node retroperitoneal
recurrence is alive 41 months after surgery; the other 4 patients with
recurrence at adrenal gland(2) and liver(2), died due to the tumour at 6,
33, 36 and 53 months, respectively. Average survival of resected patients was
31.5 months.
The follow-up was 18649947 days(r 4373925d). Hospital mortality was
2.25% and overal one was 25%. Ten patients died of tumoral recurrence: 5
fulfilled the Milan criteria in the explanted liver (5.3% mortality); 1 fulfilled
San Francisco criteria (4.7% mortality) and 4 did not fulfilled either criteria
(21% mortality).
Actuarial survival at 1, 5 and 10 years was 95%, 81% and 77.5%,
respectively. Patients with alcoholic cirrhosis had better survival than HCV
cirrhotic patients at 1, 5, and 10 years (91.5%,87.5%,85.5% versus 81.5%,
77% and 70%, respectively).
Conclusion. Liver transplantation is an excellent treatment for hepatocel-
lular carcinoma under the Milan criteria, even if these criteria are exceeded
after surgery. However, when the explanted liver shows tumour out of either
Milan or San Francisco criteria, the mortality was considerably increased.
Consecuently, exceeding the Milan criteria preoperatively was probably
associated with worse outcome.HCC on HCV cirrhotic patients has less
survival than alcoholic cirrhotic patients due to the poor survival of HCV
cirrhosis.When recurrence is resected an increase in survival can be expected.
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LONG TERM RESULTS OF LIVER TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA: AN UPDATE OF THE UNI-
VERSITY OF PADOVA EXPERIENCE
Alessandro Vitale1, Enrico Gringeri2, Michele Valmasoni2, Francesco
D’Amico2, Amedeo Carraro2, Alberto Pauletto2, Francesco Junior
D’Amico2, Marina Polacco2, Davide Francesco D’Amico2, Umberto Cillo2
1Uniti Chirurgia Oncologica, Istituto Oncologico Veneto (IOV), IRCCS 
Padova; 2Uniti Chirurgia Epatobiliare e Trapianto Epatico, Universiti Padova
Background. Hepatocellular carcinoma (HCC) competes with benign liver
disease as indication for liver transplantation (LT). Aim of this study is to
determine long term results of LT for HCC at Padua University.
Methods. We retrospectively analysed the prognostic role of HCC diagnosis
at pathologic exam in adult LT. In the HCC group we evaluated the
prognostic role of the time of diagnosis (incidental versus non incidental) and
of pathologic tumor TNM staging. The primary end point was 1, 3, and 10-
years patient survival.
Results. From 1991 to 2006, 550 adults underwent to first LT at Padua
University. HCC was found in 120 patients at pathologic exam. In 26 cases
(22%) the diagnosis of HCC was incidental. There were 59 cases (49%) of
pathologic T1-T2 tumor (1 nodule B5 cm, or 23 nodules B3cm,
without metastases and/or vascular invasion), and 61 cases (51%) of
pathologic T3  T4a tumor. HCC diagnosis did not show a significant
prognostic impact at Cox survival analysis. After a median follow up of 31
months, 1, 5, and 10 years survival was 91%, 81% e 73% in the HCC
group, and 84%, 76%, e 67% in the non HCC group. Time of HCC
diagnosis (incidental versus non incidental) and the pathologic TNM
staging (T1-T2 versus T3 T4a) did not result significant survival pre-
dictors at Cox analysis.
Conclusion. In our experience, the long term results of LT for HCC
overlapped with that of LT for benign disease, although 51% of tumors were
T3-T4a at pathologic exam.
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THE PROGNOSTIC IMPACT OF MELD SCORE IN PATIENTS
UNDERGOING LIVER TRANSPLANTATION WITH SUB OPTI-
MAL LIVERS
Alessandro Vitale1, Francesco D’Amico2, Alberto Brolese2, Giacomo Za-
nus2, Patrizia Boccagni2, Daniele Neri2, Marina Polacco2, Francesco Junior
D’Amico2, Davide Francesco D’Amico2, Umberto Cillo2
1Uniti Chirurgia Oncologica, Istituto Oncologico Veneto (IOV), IRCCS 
Padova; 2Uniti Chirurgia Epatobiliare e Trapianto Epatico, Universiti Padova
Background/Aims. The aim of this retrospective study is to analyze the
prognostic impact of MELD score in patients undergoing LT with sub-
optimal livers.
Methods. Between January 2002 and January 2006, 160 adult patients with
liver cirrhosis received a whole liver for primary LT at our Institution: 81 had
a sub-optimal liver (SOL group), 79 had an optimal liver (group OL).
Definition of sub-optimal liver was: one major criteria (age60 years,
steatosis 20%) or at least two minor criteria (sodium 155 mEq/l, ICU
stay 7 days, dopamine 10 microg/kg/min, abnormal liver testes, and
relevant hemodinamic instability).
Results. Baseline recipients characteristics were comparable in the two study
groups. The SOL group had a significant higher number of early graft deaths
Table 1. Demographics, operative data and outcome related to the five recipients of LRLT with SFSS
Name Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Demographics
AGE 48 61 37 47 60
Sex M M F M M
Blood Type 0 0 AB 0 B
AGE 47 60 37 47 60
Diagnosis HCCHCV HCVautoimmune criptogenic HBV HCV
MELD 18 26 23 18 15
CP B8 C11 C12 B9 C11
Status 2B 2B 2B 2B 2B
GRBW 1.02 1.26 1.55 1.14 1.44
Operative data
Bilirubin (mg/dL) Peak Before SAE 14 17 15 17.1 22
Ascites Volume Peak Before SAE (ml/day) 2100 1800 1800 2000 2200
INR Before SAE 1.1 1.4 1.0 1.4 1.3
Platelets Before SAE 53 24 76 25 29
Graft type RL RL RL RL RL
Bil. Rec. Duct To Duct Duct To Duct Duct To Duct Duct To Duct Duct To Duct
Outcome
Bilirubin (mg/dL) After SAE 5 ReOltx 0.6 3.8 1.8
Ascites Volume After SAE (ml/day) B100 ReOltx B100 B100 B100
INR after SAE 1.1 ReOltx 1.0 1.9 0.9
Platelets After SAE 209 ReOltx 104 99 158
ICU  LOS 3 6 3 2 2
T-LOS 43 75 17 54 27
Graft failure none 31-May-06 none none none
Retransplant POD none POD 28 none none none
Survival (days) 362 28 135 92 92
CP indicates Child-Pugh, GRBW, graft weight to recipient body weight ratio, Bil.Rec, biliary reconstruction, ICU, intensive care unit, LOS, length of stay,
T-LOS, total length of stay.
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(B30 days) than the OL group, while the 3 year Kaplan Meier patient survival
was similar. Using logistic regression, MELD score was significantly related to
patient death only in the SOL group (P.01), and ROC curve method identified
17 as best MELD cut off. Three-year survival was 93% and 85% in the OL
group in patients with a MELD 17 and 17 respectively (P.05), while it
was 94% and 72% in the SOL group (PB.05). Similarly, MELD  17 was
significantly associated with early graft death rates only in the SOL group.
Conclusion. This study advised not to use sub optimal livers in patients
with advanced MELD score, thus supporting a donor-recipient matching
policy.
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ARE WE PUSHING PATIENTS TO WRITE US?
Gian Luca Grazi1
1University of Bologna
Internet has led to widespread web consulting, whose proportions are not yet
known and on whose management there is no agreement as yet.
We verified the typology and needs of people and patients of a single language
population inquiring about a homogeneous group of diseases treated in
tertiary reference centers and their reason for writing. Data were extracted
and coded from e-mail messages received over 27 months by a non
institutional web site (www.chirurgiadelfegato.it) devoted to surgically
treatable hepato-biliary-pancreatic diseases. Consultation activity was ver-
ified by the number of answers and subsequent messages.
1247 users sent 1788 messages to one of the website address. 1179 (94.6%)
of them inquired about clinical problems. Data were collected on the
demographics of senders, of patients, on the nature of the clinical problem
and on the reasons for the messages.
A mean of 2.1 messages/day were received. Queries were sent by patients in
260 (22.1%) instances and by others in 750 (63.6%). Two hundred thirty
seven (20.1%) had medical enclosures. The presence of a malignant disease
was reported in 705 (59.8%) messages. Description of previously undertaken
therapy was present in 613 (52.0%) cases. An answer was given to 1177
(94.4%) first messages and a further message was received from 401 (34.1%)
users. Second messages were characterized by a shorter time to receive an
answer (2.593.6 vs. 3.595.3). Each user sent a mean number of 1.490.7
messages (from 1 to 8).
Web consulting is a powerful tool for patients and health professionals
emerging from physician communication problems. Nevertheless, the Inter-
net is still pushing doctors toward a reconsideration of the principles of
medical ethics and a revaluation of rules and regulations to deal with these
new communication methods.
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THE EFFECT OF SIGNALLING LIMPHOCYTE ACTIVATING
MOLECULE (SLAM) AND SLAM-ASSOCIATED PROTEIN ON
CYTOTOXIC T-CELLS
Mehrle Stefan C.1, Schmidt Jan, Buechler Markus W., Maerten Angela2
1Department of Surgery, University of Heidelberg, Germany; 2National
Centre for Tumor Diseases, University of Heidelberg, Germany
Signalling Lymphocyte Activating Molecule (SLAM; CD150) is a costimu-
latory receptor involved in lymphocyte activation.. SLAM Associated Protein
(SAP; SH2D1A) has a strong affinity to activated SLAM. SLAM bound SAP
can activate FYN or can recruit already activated FYN, which enhances
lymphocyte activation.
Upon stimulation of the TCR an increase of cytotoxic activity can be
observed that peaks at day seven of cultivation. Our research shows a strong
correlation between the cytotoxic maximum of effector cells at day seven and
the expression maximum of Signalling Lymphocyte Activating Molecule
(SLAM) and SLAM Associated Protein (SAP) at day six of cultivation. This
correlation can be shown both on surface expression of SLAM as well as on
mRNA and protein levels for both SLAM and SAP.Over expression of SLAM
at difference days of cultivation increased cytotoxic activity at day seven, but
also induced cytotoxicity earlier during cultivation.
To prove that SLAM caused the increased cytotoxicity we silenced both
SLAM as well as SAP using small interfering RNAs (SiRNAs). Silencing
of SLAM results in the reduction of SLAM surface expression as well
as SLAM mRNA expression. In addition the absence of SLAM in effector
cells leads to reduced cytotoxic activity when compared to untreated effector
cells. Silencing of SAP does not affect the expression of SLAM; however
silencing SAP has the same negative effect on effector cell cytotoxicity as the
silencing of SLAM. This supports the thesis that SAP is bound to SLAM
upon activation and triggers lymphocyte activation. In addition we could
show that SLAM is primarily localized in Lipid Rafts on activated CD8
T-cells by generating HLA-A2 specific T-cell clones and activating them
with HLA-A2 specific peptides presented by T2 cells or HLA matched
dendritic cells.
By establishing an animal model using immunodeficient mice and a
subcutaneous tumour model using COLO205, a colo-rectal carcinoma cell
line, we further investigated the effect of SLAM and SAP on acti-
vated T-cells. The mice received the tumour cells and subsequently were
treated with effector cells. We can show that the survival of the mice is
increased when treated with effector cells expressing SLAM in comparison to
mice that received SLAM silenced effector cells. Furthermore we can show
that mice receiving SLAM overexpressing T-cells show the best survival rates.
In conclusion; SLAM and SAP are important for T-cell cytotoxicity, cells
lacking either SLAM or SAP show a reduced cytotoxicity, cells with increased
SLAM levels show an increased cytotoxic activity.
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ABSENCE OF RECRUITMENT OF NK CELLS TO COLORECTAL
LIVER METASTASES (CLM)
Sian Pugh1, Moh’d Abu Hilal, Neil Pearce, John Primrose, Salim Khakoo
1Southampton University Hospital
Introduction. Colorectal cancer is a common cause of cancer related death
in the UK. Approximately half of all patients have advanced disease at
presentation or subsequently develop liver metastases. Tumour cells have
been demonstrated to down-regulate MHC Class I and thus evade the
cytotoxic T lymphocyte response. As NK cells lyse MHC class I low targets,
tumour cells are more susceptible to attack by NK cells.
Objectives. To determine the role of NK cells in the immune response to
CLM.
Methods. We have determined the frequency of specific lymphocyte subsets
within macroscopically normal liver and tumour tissue by flow cytometry in
10 patients having a liver resection performed for CLM.
Results. We found a significantly lower number of NK cells in the tumour in
comparison to the healthy liver (358 cells/mg and 1062 cells/mg respectively,
pB0.01). However in contrast to NK cells, T cells were capable of infiltrating
the tumours (liver 921 cells/mg and tumour 1452 cells/mg). The NK:T cell
ratio was 1.15:1 in the normal liver compared to 0.25:1 in the tumour (pB
0.001).
Discussion and Conclusions. These data indicate an absence of NK cells
in the tumourous tissue. Thus an inadequate innate immune response to
colorectal liver cancer may be one mechanism that permits disease recurrence
within the liver.
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UK PRACTICE OF USING PRINGLE MANOEUVRE DURING
LIVER RESECTIONS
Irfan Ahmed1, J Hammond, Dileep N Lobo, Ian J Beckingham
1Nottingham University Hospitals
Background. Hepatic inflow occlusion (Pringle manoeuvre) is often
employed for the reduction of blood loss during resectional liver surgery.
There is much variation in the usage and duration of this manoeuvre. This
study was undertaken to determine the current practice of UK liver surgeons.
Methods. All the practicing liver surgeons (n67) identified from UK
liver surgeons group (UKLSG) were contacted via email, telephone or in
person. Surgeons not responding in 4 weeks were sent a reminder email.
Questions were asked about frequency of use of Pringle manoeuvre,
maximum clamp time, liver recovery time and average number of cycles of
vascular occlusion.
Results. Of the 47/67 (70%) surgeons who responded to the questionnaire,
33/47 surgeons performed more than 20 liver resections a year. 40/47 (85%)
used the Pringle manoeuvre for a variable period of time. 12/47 (25%)
surgeons used continuous occlusion for the duration of hepatic resection.
Clamp times for the 28 surgeons practicing intermittent occlusion were B10
minutes for 8 surgeons, 1020 minutes for 14 and 30 minutes for 6
surgeons. 20/28 (71%) surgeons using intermittent occlusion allowed a 5-10
minutes recovery period between two periods of occlusion. The remaining 8
surgeons used a 1020 minutes recovery period.
Conclusion. There is no consensus among UK surgeons regarding use of
Pringle manoeuvre during liver resections and practice remains variable.
More research is needed to facilitate the standardization of the practice of
Pringle manoeuvre on the basis of evidence.
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EARLY EXPERIENCE WITH LAPAROSCOPIC LIVER RESEC-
TION FOR MALIGNANT AND BENIGN LIVER TUMOURS
Bassam Alkari1, Anas Owera, Basil J Ammori
1Manchester Royal Infirmary
Background and Aims. Advancements in surgical technique and technol-
ogy have facilitated laparoscopic liver resection in selected patients. The aim
of this study is to evaluate the feasibility and outcome of laparoscopic liver
resection.
Methods. Patients with lesions situated in the anterior and left lateral
segments were selected for laparoscopic resection. Data were collected
prospectively.
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Results. Between 2003 and 2006, 17 patients (8 males) with a median
(range) age of 63 (3283) years underwent 17 laparoscopic hepatic resec-
tions for colorectal metastases (n14) and other indications (n3). The
resections included left hepatic lobectomy (n9), bi-segmental (n4),
uni-segmental (n2) resections, and metastatectomy (n2). All procedures
were completed laparoscopically and there was one intra-operative complica-
tion of port-site small bowel injury that was managed laparoscopically with
no adverse effect. Estimated median (range) blood loss was 100 (25 500) and
one patient received a total of two units blood transfusion. One 83-year-old
female patient developed a transient left bundle branch block in recovery but
recovered with no complications. The median (range) post-operative hospital
stay was 3 (114) days. The resection margins were clear in 12 of 14 patients
with malignant disease; and at a median (range) follow up of 13.5 (536)
months, 4 patients (29%) had disease recurrence and 12 patients (86%)
are alive.
Conclusions. In selected patients with lesions in the anterior and left lateral
segments, laparoscopic liver resection is feasible, achieves adequate cancer
resection, and is associated with smooth and rapid recovery. Long-term
follow up data are required for oncological results.
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MULTIFOCAL MANIFESTATION DOES NOT AFFECT VAS-
CULAR INVASION OF HEPATOCELLULAR CARCINOMA:
IMPLICATIONS FOR PATIENT SELECTION IN LIVER TRANS-
PLANTATION
Florian Lo¨he1, Ulrich Beuers2, Markus Rentsch, Christian Graeb, Alexander
Gerbes2, Karl-Walter Jauch, Martin K. Angele3
1Department of Surgery, Klinikum Grosshadern, Ludwig-Maximilians-Uni-
versity of Munich; 2Internal Medicine II, Klinikum Grosshadern, Ludwig-
Maximilians-University of Munich; 3Department of Surgery, Klinikum
Grosshadern, Ludwig-Maximilians University
Background and Aims. Liver transplantation (OLT) for hepatocellular
carcinoma (HCC) improves patient survival when tumour size and number
are limited according to the Milan criteria. However, the impact of tumour
size vs. the number of lesions for tumour recurrence after OLT is unclear.
Microvascular invasion appears to be a significant risk factor for tumour
recurrence. Therefore, it was the aim of this study to investigate tumour
differentiation and microvascular invasion in relation to tumour number and
size and their impact on survival after transplantation.
Patients and Methods. In 97 adult HCC patients who underwent OLT
between June 1985 and December 2005 the incidence of microvascular
invasion, tumour differentiation and the number and size of tumour lesions
were analyzed retrospectively. Their impact on survival was studied by
multivariate analysis.
Results. Microvascular invasion was the only independent negative predictor
of survival after OLT for HCC (p0.025). Tumour size 5 cm was
predictive for microvascular invasion (p0.007). In contrast, tumour number
did not affect the incidence of microvascular invasion or cumulative survival.
Conclusion. The size of the largest HCC lesion, but not the number of
tumours determined microvascular invasion, a predictor of the outcome
following OLT for HCC. Thus, the number of HCC lesions should not be
applied for patient selection prior to OLT. These data support the extension
of Milan criteria for selection of HCC patients for OLT with regard to
tumour number, but not tumour size.
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THE EFFECT OF DIPYRIDAMOLE ON LIVER REGENERATION
IN EXPERIMENTALLY HEPATECTOMIZED RATS
Tarik Artis1, Huseyin Esin2, Hizir Akyildiz2, Fatih Mutlu2, Seda Artis2, Zeki
Yilmaz2
1Erciyes University Medical School Department of General Surgery; 2Erciyes
Universty Medical School Department of General Surgery
Background and Aim. The phosphodiesterase inhibitors (PDEIs) have
been proposed to improve hepatic reperfusion injury and hepatosplanchnic
circulation, but the effects of these agents on liver regeneration have not been
investigated thoroughly. To assess the effect of dipyridamole, a type 5 PDEI,
on liver regeneration in experimentally hepatectomized rats.
Materials and Methods. This experimental study has been performed in
Hakan C¸etinsaya Experimental and Clinical Research Center (DEKAM) at
Erciyes University Medical Faculty between April and June 2006. Sixty
Wistar-Albino rats weighting between 250 and 350 g were used in the study.
Rats were divided into two as the control and dipyridamole groups. Each
group has been divided into three subgroups containing 10 rats each. First,
jugular venous catheters were placed before hepatic resection. After 70% liver
resection has been performed to the rats, upon resection dipyridamole
infusion to the study group and 0.9% NaCl infusion to the control group has
been done. After 70% liver resection the study and control groups received
dipyridamole and 0.9% NaCl infusion, respectively. Then the resected wet
liver tissues were weighted. Rats were allowed to survive for 24th, 48th and
72nd hours and then they were sacrificed. Blood samples were collected from
vena cava inferior and remaining liver tissues were resected and weighted.
Serum AST, ALT, ALP, albumin and PT were measured. Relative liver
weight was used as a morphological parameter for liver regeneration.
Histopathologic assessment has been performed to determine mitotic index
and Proliferating Cellular Nuclear Antigen (PCNA).
Results. There were statistically significant differences between dipyrida-
mole and control groups in ALP and relative liver weights at 24th, 48th and
72nd hours (pB0.05).
There were also statistically significant differences between the groups in PT
and albumin levels at all times but 48th hours for PT and 24th and 72th hour
for albumin levels (pB0.05). Mitotic index and PCNA labelling index were
significantly higher in dipyridamole group for each time period (pB0.05).
Conclusion. Dipyridamole increases liver regeneration both morphologi-
cally and functionally in experimental liver resection model in rats. With
further studies, clinical implementation should be considered.
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EXTRACORPOREAL PORCINE LIVER PERFUSION SYSTEM AS
A LIVER SUPPORT DEVICE
Jai Bikhchandani1, Syed Naqvi, Matthew Metcalfe, Bubby Thava, M
Nicholson, DP Berry, AR Dennison
1Leicester General Hospital, University Hospitals of Leicester
Analysis of the dipyridamole and control groups at the 24th, 48th,and 72th hours
Groups 24th Hour 48th Hour 72th Hour
Relative Weight (%) Control 11,4693,20 24,7795,41 24,4995,05
Dipyridamole 21,4795,03 34,3197,94 48,3393,63
p pB0.001 P0,006 pB0.001
AST Control 1482,7091099,40 561,109390,72 210,90974,48
Dipyridamole 564,609187,61 309,609136,38 133,60917,51
p P0.027 P0,071 P0.01
ALT Control 622,309510,69 245,309155,33 91,30945,15
Dipyridamole 322,229136,70 134,10940,56 46,30920,36
p P0,01 P0,053 P0,01
ALP Control 300,10953,12 397,80969,71 553,309172,43
Dipyridamole 218,80943,53 311,30968,81 398,10993,77
p P0,001 P0,012 P0,022
Albumin Control 2,7390,24 2,6790,247 2,6390,14
Dipyridamole 3,1190,37 2,7090,14 2,8090,18
p P0,015 P0,741 P0,035
PT Control 19,5690,66 17,5390,83 16,4290,86
Dipyridamole 19,3890,62 18,4190,61 16,7590,64
p P0,542 P0,015 P0,347
Ml(%) Control 3,2090,91 6,7091,70 3,8090,78
Dipyridamole 7,9091,91 11,2091,68 9,3091,94
p pB0.001 pB0.001 pB0.001
PCNA(%) Control 5,9092,13 8,4091,07 6,0091,63
Dipyridamole 13,9092,02 20,9094,05 14,7091,05
p pB0.001 pB0.001 pB0.001
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Background and aims. A large number of acute liver failure patients die
while waiting for a liver transplant. An effective liver support device can
keep these patients alive till a donor becomes available or the native liver
regenerates. An isolated perfused porcine liver can provide such support. In
the past, this has been achieved by perfusing porcine liver with patients’
blood. The theoretical risk of transmission of xenogeneic viruses into
humans can be avoided by separating the patient circulation from the
extracorporeal porcine liver circulation using an optimum filter that would
prevent transfer of unwanted large molecules or pathogens. The current
study was designed to develop a new model of extracorporeal porcine liver
perfusion incorporated with a filter capable of providing liver functions
across a membrane.
Materials and methods. The experimental set up included two circuits-
one for the normothermic perfusion of porcine liver comprising of two
reservoirs, centrifugal pump, paediatric oxygenator and a heat exchanger.
The other circuit consisted of a reservoir and a roller pump circulating fluid
having high levels of ammonia and bilirubin, mimicking a patient in acute
liver failure. A hollow fibre filter unit, Evaclio EC2A, separated the two
circulations. Organ was retrieved from slaughterhouse animals and perfused
using autologous blood through the hepatic artery and portal vein at
physiological pressures. Viability and function of the liver was assessed by
bile production and the elimination kinetics of test substances indocyanine
green and galactose. Clearance of ammonia and bilirubin was recorded.
Results. A total of 20 isolated porcine livers were perfused using the
extracorporeal circuit for a mean duration of 5.81.5 (2.59.5) hours. The
bile output recorded was 6.095.3 (1.223.0) ml/hour. About 73% of added
indocyanine green was cleared from the perfusate within 15 minutes. The
mean galactose elimination rate was 128.051.9 (66.6222.3) mg/min/Kg
of hepatic tissue. The model was shown to lower the ammonia and bilirubin
levels.
Conclusion. Preliminary data suggests that this model for extracorporeal
porcine liver perfusion can provide liver function(s) across a semi-permeable
membrane. The logical progression is to support an animal model of acute
liver failure using this perfusion system in further studies.
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THE EFFECT OF MELATONIN ON SERUM AND LIVER LIPID
PEROXIDATION AND NF-KAPPA B EXPRESSIONS IN LPS
INDUCED HEPATIC ISCHEMIA REPERFUSION INJURY
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2Mersin University, Medical Faculty, Department of General Surgery;
3Mersin University, Medical Faculty, Department of Pathology; *Mersin
University, Medical Faculty, Department of biochemistry; $Mersin Univer-
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Hepatic ischemia-reperfusion injury (HIR) is a severe condition which is seen
after hepatic arterial injury and in hepatic graft in living donor transplanta-
tion. Increased Nitric Oxide (NO) production and inducible Nitric Oxide
Synthtase (iNOS) expression is observed. Interactions between NO and free
radicals causes production of hazardous peroxynitride (ONOO-) anions, and
cellular injury and apoptosis as a result. IR is reported to induce tolerance to
subsequent endotoxin stimulation if the lipopolysaccharide (LPS) challenge
is delayed until the late, neutrophil-mediated phase of reperfusion.
NF-Kappa B is a transcription factor implicated in the transcriptional
upregulation of these inflammatory genes in response to changes in cellular
oxidation-reduction status. The target genes of NF-kappa B in various cell
types encode proteins involved in immune, inflammatory and acute-phase
responses and cytokine activations.
Melatonin (M), a specific inhibitor of iNOS, directly decreases the expression
iNOS, and the release of cytokines, and adhesion molecules. Melatonin also
functions as a potent antioxidant because it scavenges hydroxyl freeradicals
and peroxynitrite (a reactive oxidant produced from the reaction of NO and
superoxide, and inhibits the NF-kappa B activation.
The aim of this study is to invastigate the effect of M, given before or after
lipopolysaccaharide(LPS), in HIR. Six groups were designed for the study. 8
Wistar Albino rat (150200 g) were used for each group. Group A: Sham,
Group B: HIR, Group C: HIRM, Group D: HIRLPS, Group E: HIR
LPSM, Group F: HIRMLPS. No substance was given to the rats in
group A and B. Ischemia was induced with vascular clampage for 45 minutes.
With declampage reperfusion injury induced for 45 min. 10 min before
reperfusion, Melatonin 10mgr/kg in group C and LPS 10 mg/kg in group D
was given intraperitoneally. In group E first LPS than M were given 10 min
before reperfusion, while in group F first M than LPS were given. After
reperfusion for 45 min rats were sacrified and blood and liver tissue samples
were taken. Serum and tissue myeloperoxidase (MPO), malondialdehyde
(MDA), and SGOT, SGPT levels were measured. Histopathological ex-
minations for liver tissue and immunohistochemical analysis for tissue NF-
KB levels were also performed. In Group B, D, and E, serum and tissue
MPO and MDA levels were higher relatively to other groups. Immunohis-
tochemical staining for liver tissue NF-kappa B expression, is increased in the
same groups. Differences between the groups were statistically significant.
Results of our study indicates decreased liver tissue and serum lipid
peroxidation with Melatonin given before LPS. However, when the sepsis
is established, melatonin did not decrease lipid peroxidation.
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THE EFFECTS OF CHOLESTASIS ON LIPID PEROXIDATION
AND ULTRASRUCTURAL CHANGES IN RAT LIVER TISSUE
AFTER BILE DUCT LIGATION
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Duygu Dusmez Apa, MD**, Faik Yaylak, MD*, Ebru Balli, MD***, Lulufer
Tamer, MD****, Arzu Kanik, PhD*****, Suha Aydin, MD*
(*) Mersin University Medical School, Department of General Surgery; (**)
Mersin University Medical School, Department of Pathology; (***) Mersin
University Medical School, Department of Histology; (****) Mersin Uni-
versity Medical School, Department of Biochemistry; (*****) Mersin
University Medical School, Department of Biostatistics.
The mechanisms and mediators responsible for the pathogenesis of liver
damage caused by acute biliary obstruction remain largely unknown,
although intrahepatic accumulation of toxic bile salts, increased production
of proinflammatory cytokines (TNF and IL-6), bacterial endotoxins and
oxidative stress are thought to be the important causes. Lipid peroxidation
(LP) is an important problem in obstructive jaundice (OJ). Nitric oxide (NO)
production and inducible nitric oxide synthase (iNOS) activity are increased
and antioxidative activity is decreased. The antioxidant defense system is
impaired by decrease in reduced glutathione (GSH) and the activity of
glutathione peroxidase in OJ. In this study, we planned a model in which we
could examine changes in LP assays, iNOS expression and histopathological
and ultrastructural changes in the liver tissue of cholestatic rats in the first
eight days after the bile duct ligation (BDL) as the duration and intensity of
hyperbilirubinemia increase.
We randomized 30 rats into 5 groups. Group A: Sham group; Groups B, C,
D and E represented OJ groups, and were first, third, fifth and eighth days
after BDL respectively. Bilirubin, nitrite, nitrate and malondialdehyde
(MDA) levels of serum, and MDA, GSH and Na/K ATPase activity
levels of tissue were detected in biochemical methods. The tissue iNOS
expression was illustrated immunohistopathologically. Liver tissue samples
were examined with light and electron microscopy to evaluate the histo-
pathological and ultrastructural changes.
Serum bilirubin levels increased progressively as the duration of BDL
increased. Serum and tissue MDA levels started to increase significantly at
the first day of BDL and reached to peak level at the third day of BDL. Tissue
ATPase levels decreased progressively. Serum nitrite and nitrate levels started
to increase just after the BDL and reached to peak value at the third day.
Tissue GSH levels decreased progressively. Histopathologically ductal pro-
liferation in group A and group B were significantly lower than group D and
group E. INOS expression started just after cholestasis and reached to peak
value at the third day of BDL and than decreased slightly even though
bilirubin levels continued to increase. Electron microscopic changes were
detected since day 1 and the changes became more evident after day 3.
The most intensive LP, NO formation and iNOS expression in OJ are at the
third day of BDL; apart from the duration of clolestasis and level of bilirubin.
The continuous reduction in GSH levels lead to downregulation of iNOS
protein and NO synthesis. While cholestatic changes and apoptosis seem to
correlate each other in accordance with the values of LP, hyperbilirubinemia
and tissue GSH levels; iNOS expression follows a different pathway.
146
HCC OCCURRING AFTER LIVER RESECTION FOR HEPATO-
BLASTOMA IN A GIRL AFFECTED BY FAMILIAL ADENOMA-
TOUS POLYPOSIS (FAP)
Francesco Cetta1, Armando Dhamo, Giuliana Malagnino, Antonio Acqua-
viva2, Andrea Cariati3
1Department of Surgery, University of Siena, Italy; 2Department of
Pediatrics, Obstetric and Gynecology, University of Siena, Italy; 3Policlinico
di Genova
A 2-year-old girl, after initial chemotherapy according to the SIOPEL
protocol, underwent right liver lobectomy for a huge hepatoblastoma (HB)
(foetal HB, mixed type, with clear cell). Twelve years later, after a long
asymptomatic interval, a new huge nodule (10x9 cm in diameter) was
detected in segment 4 by both CT and MNR. She underwent segment 4
segmentectomy. Histologic examination showed mature HCC with pseudo-
glandular pattern. The patients finally died, at age 15.
This girl belongs to an extended kindred with familial adenomatous polyposis
(FAP) (23 siblings in 4 generations) with APC germ-line mutation at codon
1061 in 7 affected siblings.
Interestingly, extensive screening for colonic polyps in the patient relatives
could have anticipated of about 7 years the current diagnosis of FAP in this
kindred.
HB, a rare childhood tumor, is extremely frequent in FAP (relative risk
1000). Less than 100 FAP associated HBs have been reported up to now.
However, this is the first report of a FAP patient, who developed HCC, i.e. a
completely different tumor, after initial liver resection for HB.
HCC and HB are primary tumors of the liver, which not only show
morphologic and ultrastructural diversity, but also greatly differ in terms of
genetic alterations, suggesting different carcinogenetic pathways. A detailed
ultrastructural and genetic analysis of the present patient who, in different
periods of life, developed both HB and HCC, could give a better insight into
mechanisms of liver carcinogenesis.
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EPIDEMIOLOGY OF PRIMARY LIVER CANCER  A 31 YEAR
ANALYSIS
Anthony Chan1, Ajith Siriwardena
1HPB Research Group, Manchester Royal Infirmary
Introduction. The majority of tumours that present in the liver are usually a
result of metastatic disease. Primary cancer of the liver is a relatively rare
occurrence.
Methods. The Surveillance, Epidemiology, and End Results (SEER)
Program, compiled by the National Cancer Institute (NCI), is a cancer
registry collecting data in 9 regions (‘registries’) of the United States. We used
SEER*Stat software to obtain the data for our analysis.
Results. Between the period of 1973 and 2003, there were 23,048 cases of
primary liver cancer recorded by the SEER program, accounting for just
0.71% of all cancers of the body. The most common histology of liver cancer
(75.3%) is hepatocellular carcinoma (HCC); other types including adeno-
carcinoma, cholangiocarcinoma and carcinoid tumours make up just 5.2%,
3.9% and 0.4% respectively. The (age-adjusted) incidence of HCC is 2.66
per 100,000, peaking in the 7579 year age group (incidence13.98) before
decreasing slightly thereafter. Over the past 31 years, the incidence has risen
on average 4.03% per year (APC, PB0.05) to reflect a percentage change of
189.69% (from 1.508 in 1973 to 4.369 per 100,000 in 2003). HCC is now 3
times more common in males (adjusted Male:Female ratio in 20033.05),
and slightly more common in the white population (adjusted white:black
ratio in 20030.80).
The majority (70.91%) of HCC are of unknown histological grading. Of
those successfully graded, most are well differentiated (11.41%), moderately
differentiated (8.88%) or poorly differentiated (7.46%) and only 1.34% are
anaplasic. Most HCC are diagnosed with localised spread (30.17%).
Regional and distant spread make up 25.20% and 22.19% respectively,
and 22.43% remain unstaged. Only a minority (0.01%) of HCC are
diagnosed in situ. The observed 5-year survival rate for primary cancer of
the liver is generally very poor (6.10%). As expected, survival rates decrease
with greater spread of the tumour; HCC diagnosed with regional and distant
metastases yield survival rates of just 4.30% and 1.40% respectively. Better
differentiated tumours also fair better, with well and moderately differen-
tiated tumours having survival rates of 13.10% and 12.50% respectively;
anaplastic tumours have poor survival at 4.80%. Survival rates have slightly
improved over the period analysed, from 2.90% in 1973 to 7.30% in 1998.
Discussion. Primary cancer of the liver is rare and associated with poor
survival. The past 31 years has seen its incidence increase slowly and the
prognosis remaining poor.
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PERITONEAL IMPLANTATION OF CRYOPRESERVED ENCAP-
SULATED PORCINE HEPATOCYTES IN RATS WITHOUT IM-
MUNOSUPPRESSION: VIABILITY AND FUNCTION
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Honiger3, Marie-Christine Saint-Paul*, Pascal Bayer, Vincent Raimondi,
Roger Rahmani2, Jean Mouiel, Jean Gugenheim
1Lab. de Recherches Chirurgicales, Universite´ de Nice Sophia Antipolis,
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Introduction and Aim. Encapsulated hepatocyte transplantation is a
promising approach to cell transplantation without immunosuppression as
an alternative to whole organ liver transplantation. The aim of this study was
to assess viability and function of encapsulated cryopreserved porcine
hepatocytes implanted intraperitoneally in rats without immunosuppression.
Materials and Methods. Porcine hepatocytes were isolated by collagenase
digestion method, encapsulated in AN69 polymer and cryopreserved at -196
degrees Celsius for 1 month. Four groups were created: Group 1 (n10),
cryopreserved encapsulated porcine hepatocytes cultured in albumin-free
medium for 10 days; Group 2 (n10), cryopreserved encapsulated porcine
hepatocytes implanted in rat peritoneum without immunosuppression for 1
month, and cultured for 10 days after explantation; Group 3 (n10), freshly
encapsulated porcine hepatocytes cultured for 10 days; Group 4 (n10),
freshly encapsulated porcine hepatocytes implanted in rat peritoneum with-
out immunosuppression for 1 month, and cultured for 10 days after
explantation. Hepatocyte viability, liver enzymes release, urea and albumin
production were measured. Hepatocyte function was assessed by measuring
EROD enzyme activity in presence of specific cytochrome P450 inducers.
Results. There was no significant difference in urea synthesis between the 4
groups. Albumin synthesis was significantly decreased in group 2 compared
to other 3 groups (pB0.01). There was no significant difference in AST,
ALT and LDH concentrations in culture medium (p0.05). Encapsulated
cryopreserved porcine hepatocytes explanted from rat peritoneum after 1
month appeared morphologically viable and their ultrastructure was pre-
served. Hepatocyte function was maintained.
Conclusion. Long-term cryopreservation of porcine hepatocytes results in
retention of their biological activity and in significant viability when
transplanted into rat peritoneum without immunosuppression. Cryopre-
served hepatocytes were as efficient as fresh hepatocytes.
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TWO PHOTON MICROSCOPY FOR THE STUDY OF EARLY
TUMOR/STROMAL INTERACTIONS IN METASTATIC LIVER
DISEASE
D. Lee Gorden1, Weili Fu2, Jaehong Im3, Lynn M. Matrisian, Ruth J.
Muschel3
1Vanderbilt University Medical Center, Nashville, TN USA; 2University of
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Introduction. Colorectal cancer remains one of the leading causes of cancer
related deaths in Europe and the United States. Most patients will succumb
to their disease with metastases in the liver. Many of the cellular processes
and mechanisms that govern the earliest steps in metastasis of this tumor
remain elusive. In these studies we examine the utility of multiphoton
microscopy to study metastatic disease in the liver in an orthotopic, intact
whole organ, murine model of colorectal cancer metastasis.
Experimental Procedure. C57BL/6 mice undergo splenic injection of
syngeneic murine colon carcinoma cells. Mice are sacrificed at prescribed
time points and the livers are prepared for imaging of the intact organs on a
glass plate by use of a Leica microsystems DM LFS A microscope and Leica
Confocal System TCS SP2 (True Confocal Scanner), fitted with a Mai Tai
Wideband, Mode-Locked Ti:Sapphire laser (Spectra-Physics). Tumor cells
are labeled by the stable transfection of a GFP reporter gene. The vasculature
of the liver is separately labeled by perfusion using rhodamine dextran. The
whole organ preparations remain stable for several hours.
Results. Whole murine livers are examined by multiphoton microscopy at 2
hour, 6 hour, 12 hour, 24 hour, 48 hour, 72 hour, and 7 day time points.
Histology, including the complex vasculature of the liver, is visualized in clear
detail. Focal planes at up to 100 ?m depth from the surface of the liver are
visualized and digital stacks of images can be reconstructed in 3 dimensions
to clearly demonstrate tumor cells, intravascular, and extravascular spaces.
Early time points (2,6,12, 24 hours) after splenic injection demonstrate single
GFP positive cells and occasional clusters of cells within the hepatic
vasculature. Over time, cells demonstrate intravascular clustering (48, 72
hours) that is most pronounced at the 7 day time point. At these time points,
we observed a marked contribution of host cells (cells lacking GFP
expression) in microscopic lesions. The identity of these cells, which make
up a substantial proportion of the tumor, is currently under investigation.
Conclusions: Multiphoton microscopy provides a unique capability to image
metastatic tumor cells within the orthotopic microenvironment of the liver.
Relationships of tumor cells to their microenvironment and patterns of tumor
cell growth, can be uniquely observed and quantitated using this model
system. Multiphoton imaging allows for direct observation of the earliest
interactions of colorectal cancer cells with the microenvironment of the
metastatic site in the liver.
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ENUCLEATION AND RESECTION FOR SURGICAL TREATMENT
OF GIANT LIVER HEMANGIOMA
Giulio Belli1, Alberto D’ Agostino, Corrado Fantini, Luigi Cioffi, Andrea
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Hemangioma is the most frequent focal liver lesion. It affects mainly women
and may cause symptoms such as abdominal pain, mass, and early satiety, or
complications such as heart failure or coagulopathy (Kasabach-Merrit
syndrome). Indication to surgery are untreatable symptoms and inability to
exclude malignancy. Between January 2000 and April 2006 we evaluated 180
patients in an out-patients setting; of them 12 patients affected by giant
symptomatic hemangiomas (range 813cm) were operated. When super-
ficially located in the liver (4 cases) hemangiomas were treated by enuclea-
tion. Detailed pathologic examination has demonstrated an interface between
hemangiomas and the normal liver tissue that allowed the procedure. In the
resected patients (8 cases) enucleation was not feasible for biliary or vascular
envolvment or deep location in the liver. In this group 3 right hepatectomy, 3
left lateral sectionectomy and 2 bisegmentectomy were carried out. Median
operative blood loss was 90 ml (range, 50190 ml) in the enucleated patients
and 270 (150500 ml) in the resected patients. No transfusions were used in
both groups. We had no mortality and 2 minor postoperative complications.
Surgical treatment of liver hemangiomas is limited to giant and strongly
symptomatic lesions or to cases of uncertain diagnosis. No mortality and a
low complications rate are mandatory. When feasible enucleation is the
procedure of choice.
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LAPAROSCOPIC LIVER RESECTION FOR HEPATOCELLULAR
CARCINOMA ON HISTOLOGICALLY PROVED CIRRHOSIS:
SHORT AND MIDDLE TERM RESULTS. A COMPARATIVE
STUDY
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Background. To date there are no prospective randomized studies that have
clearly shown benefits of laparoscopic hepatic surgery over traditional open
technique. Our objective was to compare the short and middle term results (2
years) between open and laparoscopic hepatectomy for HCC in cirrhotic
patients.
Methods. 23 patients with HCC on histologically proved cirrhosis who
underwent a laparoscopic hepatectomy (LH) in a five years period (May
2000  December 2004) were compared with an historical group formed of
23 patients who underwent a conventional open resection (OH). Inclusion
criteria were Child-Pugh A cirrhosis, small sized (?B5 cm) exophitic or
subcapsular tumor located in anterolateral segments of liver (segment II-VI
according to Couinaud’s classification). In LH group we performed 15
subsegmentectomies, 3 segmentectomies and 5 left lateral sectionectomies
while in OH group were performed 12 subsegmentectomies, 5 segmentec-
tomies and 6 left lateral sectionectomies.
Results. One patient (4.3%) of LH group was converted to laparotomy for
inadequate exposition. Mean operative time was statistically longer in LH
group (148 min vs 125) while blood transfusions (4 patients (17.3%) vs 0 ),
Pringle maneuver (5 patients (21.7%) vs 0 ), mean hospital stay (12 days vs
8.3) and postoperative complications (11 patients (47.8%) vs 3 (13%) were
significantly higher in OH group. There was no difference with statistical
relevance in blood loss, surgical margins, mortality and 2-years survival rate
between the two groups.
Conclusion. This study confirms that laparoscopic liver resection, in
properly selected patients, could improve patients’ QOL avoiding the
disadvantages of open hepatectomy. It should be increasingly used in liver
surgery, especially for cirrhotic patients, but only by surgeons expert in both
liver and advanced laparoscopic surgery.
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SAFETY OF LIVER RESECTIONS OUT OF A HIGH CASE-LOAD
SPECIALIZED CENTER
Raffaele Dalla Valle1, Nicola Busi, Marco Bertolani, Paolo Buniva, Francesco
Fontanazza, Stefano Sassi, Samantha Scarpelli
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Aim. The relationship between volume and outcome has been established in
the literature for several complex surgical procedures. Hepatic resection is
one such high-risk surgical procedure. Operative mortality is still greater than
2% even in most large high volume hepatobiliary units. In this study we
report the first 93 liver resections undertaken at a single institution of general
surgery. The aim of the report is to demonstrate that hepatic resection can be
approached safely and routinely performed in a tertiary referral surgical
center without a specific program of hepato-pancreato-biliary surgery.
Method. Demographic, clinical, pathological, treatment and follow-up data
were recorded prospectively on all the liver resection performed by the author
between 01/01/2002 and 31/12/2006. The main outcome measures of the
study were operative mortality and morbidity rates.
Results. Malignant tumours were the most common indication for hepatic
resection (82 cases) with 42 resections being undertaken for metastatic
colorectal cancer. Thirty-six patients underwent a lobectomy (right lobect-
omy 22, left lobectomy 16) while a further 8 patients underwent extended
resection, and 47 patients underwent segmental or bi-segmental hepatic
resection. Major and minor liver resections were equally distributed over the
four years of the study period. More than 50% of patients were submitted to a
major liver resection. In 6 cases a right portal vein embolization and in 1 case
a right portal vein ligation were necessary to reach an adequate volume of the
remnant liver. There were 9 ri-resections. Additional surgical procedures
were performed in 12 cases. Major complications occurred in 6 patients
(6,4%) while 19 patients (20,4%) experienced a minor complication. The 30-
day mortality rate was 2,1%. The first patient died from a liver failure
following an extended right resection for an HCC involving the right lobe
with right portal vein thrombus. The second patient, submitted to a right
hepatectomy for an HCC, died on day 20 from pulmonary complications.
Both these two patients were operated during the last period of the study. The
rate of postoperative liver failure was 3,2%. The risk of complications was
directly related to the magnitude of resection. All the six major complications
were observed in patients undergoing resection of more than two liver
segments.
Conclusions. Our experience suggests that liver resection can be undertaken
safely with low mortality and morbidity rates also at a relatively low-volume
referral center, provided an experienced surgical team prove to be skilled with
advanced surgical techniques in hepatic resection.
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TRANS-ARTERIAL CHEMOEMBOLIZATION FOR HEPATOCEL-
LULAR CARCINOMA-INSTITUTIONAL EXPERIENCE
Osama Damrah1, Madhav Pai2, Paul Tait2, Nagy Habib, Ruben Canelo2,
Long Jiao
1Hammersmith Hospital-Imperial College London; 2Hammersmith Hospital
Introduction. Lipiodol chemoembolization is a widely used method of
treatment for patients with unresectable hepatocellular carcinoma (HCC),
but its efficacy remains debated. The aim of this study was to assess the
outcome of trans-arterial chemoembolisation (TACE) in the management of
unresectable hepatocellular carcinoma.
Methods. Between January 2002 and May 2006, patients with unresectable
hepatocellular carcinoma who had lipidol chemoembolization( lipido plus
doxorubicin) were reviewed. Both patient, and tumour characteristics, results
of chemoembolization including complications and survival were collected
for analysis.
Results. A total of 28 patients received 61 TACE procedures with a mean
number of treatment of 2 per patient . Tumours were large and multifocal,
Okuda score was II and III in 50% of patients . Twenty patients had a repeat
TACE (71%), 4 three times (14%) and one five times respectively (4%). All
patients tolerated the procedure well. Post TACE, one patient developed liver
abscess which was treated with percutaneous drainage and one patient
developed acute renal failure treated with dialysis. . Mild abdominal pain and
fever were common and occurred in 40% of the patients. The mean follow-up
time was 17 months (range, 156 months). Seven patients die of tumour
progression (25%), one of of acute gastrointestinal haemorrhage from
varices. (3.6%) Partial Response achieved in 50 % of the patients . The 3-
year survival was 68%.
Conclusion. TACE is an effective therapeutic option for cirrhotic patients
with unresectable HCC.
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MULTIMODAL TREATMENT OF LIVER METASTASIS FROM
GASTROINTESTINAL STROMAL TUMOURS
Osama Damrah1, Peter Sipos2, Andrea Lauretta3, Madhav Pai2, Hapreet
Wasan2, Nagy Habib, Long Jiao, Ruben Canelo2
1Hammersmith Hospital-Imperial College London; 2Hammersmith Hospi-
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Introduction. Gastrointestinal Stromal Tumours (GIST) clinical behaviour
is unpredictable and surgery alone does not cure recurrent GIST. Metastatic
liver disease is a major determinant of patient’s survival.
Methods. Database and records of patients with liver metastasis from GIST
(n13) treated at our unit between January 2002 and June 2006 were
reviewed.Treatment modalities included surgical resection , radio frequency
ablation , hepatic artery chemoembilisation , imatinib mesylate, and selective
internal radiation therapy using Yttrium microsphres (SIRTEX) .Patient
demographics, clinicopathological characteristics of the primary tumour
and the extent of intrahepatic and extrahepatic metastatic disease were
recorded.
Results. There were 6 (46%) males and 7 (54%) females. The mean age at
time of diagnosis of the primary tumour was 65.59.7 years (range 4580).
Five patients (38%) had synchronous metastasis at presentation.The primary
tumour site was the stomach in six patients (46%), terminal ileum three
patients (23%), duodenum two patients (15%) and the pelvis in two patients
(15%). The mean size of the metastatic liver lesions was 8.03cm4.33(SD).
In 7 patients liver resections were performed (in 3 patients repeatedly). RFAs
were performed in 4 patients, in two patients repeatedly. In two patients
trans-arterial chemoembolisation (TACE) was performed and one patients
was treated with SIRTEX treatment. 5 patients were treated with imatinib,
two patient received repeated series.
One patient received 8 therapeutic modalities, 2 patients 7 modalities and
another patient received 4 treatment modalities. The more modalities were
given the longer survival time was observed.
Resection and imatinib treatment significantly improved the survival time in
comparison with imatinib treatment alone (p0.031). Of all patients who
underwent hepatectomy , three patients survived more than 5 years (23 %)
after the initial hepatectomy.
The average survival was 35.14 month.
Conclusion. Multimodal approach for patients having liver metastasis from
GIST provides better survival rates.Well-conducted prospective studies are
needed to further evaluate the different treatment options
155
TUMOUR PROLIFERATION EVIDENT BY NEOVASCULARISA-
TION FOLLOWING PORTAL VEIN EMBOLIZATION
Osama Damrah1, Nagy Habib, Long Jiao
1Hammersmith Hospital-Imperial College London
Introduction. Although Portal Vein Embolization (PVE) proved to be
effective in extending the indications for liver resection in patients previously
considered with non-resectable liver tumours, the effects of this procedure on
tumor growth remain controversial.
Methods. Histological specimens were obtained from 21 patients with liver
tumours of mean age 63 year and male to female ratio 4:3 who underwent
major liver resection between 2001 and 2006. Patients were divided into two
groups, PVE group (n12), and non-PVE group (n9). Patients in PVE
group underwent preoperative PVE prior to liver resection. Of those patients
8 had Colorectal Liver Metastasis (CLM) , 1 had Hepatocellular Carcino-
ma(HCC), 1 had Neuroendocrine Tumour, 1 had metastatic GIST, and 1
had Gall bladder carcinoma. Patients who underwent major hepatic resection
without PVE served as control group; 4 of which had CLM, 1 had HCC, 1
had Cholangiocarcinoma, 1 had Neuroendocrine Tumour, 1 had metastatic
GIST, and 1 had metastatic Pancreatic cancer.
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The resected livers were examined using immunhistochemical staining of
tumour cells. Cell proliferation was determined by over or under-expression
of Vascular Endothelial Growth Factor (VEGF), Hypoxia Induced Factor
(HIF) and CD34.
Results. VEGF was overexpressed in the PVE group (75%) compared to
non-PVE group (56%) (P0.03), where in PVE group 5 livers showed
strong positivity, 4 were positive and 3 were negative, while in non-PVE
group we had 2 strong positive results, 3 positive and 4 negative results.
Overexpression of HIF and CD34 was also evident in PVE group, HIF was
positive in 67%; strongly positive in 2 patients, positive in 6 patients and
negative in 4 patients, where as in the non-PVE group HIF was positive in 3
patients (33%) and negative in 6 patients, (P0.02). As for CD34 marker, in
PVE group, it was positive in 10 patients (83%) and negative in 2 patients.
Where as in the non-PVE group, CD34 was positive in 4 patients ( 44%) and
negative in 5 patients, (P0.04). Correlation with clinical findings and
radiological progression was made.
Conclusion. We conclude that PVE increases tumor proliferation and
overgrowth partly through increasing factors responsible for promoting
neovascularisation. Although PVE is effective in extending indications for
surgery, this potential effect on tumour growth should be taken into
consideration.
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THE EFFECT OF ISCHEMIA INDUCED BY PORTAL VEIN
EMBOLIZATION ON TUMOUR PROLIFERATION: IMMUNOHIS-
TOCHEMICAL STUDY
Osama Damrah1, Nagy Habib, Long Jiao
1Hammersmith Hospital-Imperial College London
Introduction. Although Portal Vein Embolization(PVE) proved to be
effective in extending the indications for liver resection in patients previously
considered with non-resectable liver tumours, the effects of this procedure on
tumor growth remain controversial.
Methods. Histological specimens were obtained from 21 patients with liver
tumours of mean age 63 year and male to female ratio 4:3 who underwent
major liver resection between 2001 and 2006. Patients were divided into two
groups, PVE group (n12), and non-PVE group (n9). Patients in PVE
group underwent preoperative PVE prior to liver resection. Of those patients
8 had Colorectal Liver Metastasis (CLM), 1 had Hepatocellular Carcinoma
(HCC), 1 had Neuroendocrine Tumour, 1 had metastatic GIST, and 1 had
Gall bladder carcinoma. Patients who underwent major hepatic resection
without PVE served as control group; 4 of which had CLM, 1 had HCC, 1
had Cholangiocarcinoma, 1 had Neuroendocrine Tumour, 1 had metastatic
GIST, and 1 had metastatic Pancreatic cancer.
The resected livers were examined using immunhistochemical staining of
tumour cells. Cell proliferation was determined by over or under-expression
of Ki-67, a protein related to cell proliferation.
Results. Ki67 was overexpressed in 58% of patients who underwent PVE; 3
livers showed strong positive result, 4 were positive and 5 were negative.
While only 4 patients (44%) had Ki67 positive in the non-PVE group, (P
0.04).
Conclusion. We conclude that PVE increases tumor proliferation and
overgrowth. Although PVE is effective in extending indications for surgery,
this potential effect on tumour growth should be taken into consideration.
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PROLIFERATIVE ACTIVITY OF LIVER TUMOURS FOLLOWING
EMBOLIZATION OF THE PORTAL VEIN
Osama Damrah1, Nagy Habib, Long Jiao
1Hammersmith Hospital-Imperial College London
Introduction. Although Portal Vein Embolization (PVE) proved to be
effective in extending the indications for liver resection in patients previously
considered with non-resectable liver tumours, the effects of this procedure on
tumor growth remain controversial.
Methods. 12 patients with liver tumours of mean age 63 year and male to
female ratio 4:3, underwent preoperative PVE between 2001 and 2006 (PVE
group). Of these patients 8 had Colorectal Liver Metastasis, 1 had
Neuroendocrine Tumour, 1 had metastatic GIST, and 1 had GB carcinoma.
9 patients who underwent major hepatic resection without PVE served as
control (non-PVE group) 4 of which had Colorectal metastasis, 1 had
Hepatocellular Carcinoma, and, 1 had Cholangiocarcinoma, 1 had Neu-
roendocrine Tumour, 1 had metastatic GIST, and 1 had Pancreatic cancer.
The resected livers were examined using immunhistochemical staining of
tumour cells. Cell proliferation was determined by over or under-expression
of Ki-67, Vascular Endothelial Growth Factor (VEGF), Hepatocyte Growth
Factor (HGF), Hypoxia Induced Factor (HIF), CAIX and CD34.
Results. Ki67 was overexpressed in 50% of patients who underwent PVE
and in 42.9% of patients who did not have PVE (pB0.05). Again VEGF was
overexpressed in the PVE group(63.6%) (pB0.05) No significant over-
expression difference was noted in the other markers (HIF,CAIX and
CD34).Correlation with clinical findings and radiological progression was
made.
Conclusion. We conclude that PVE increases tumor proliferation and
overgrowth. Although PVE is effective in extending indications for surgery,
this potential effect on tumour growth should be taken into consideration.
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ACCURACY OF 3 DIMENSIONAL LIVER IMAGES RECON-
STRUCTED FROM CT SCANS USING COMPUTER SOFTWARE:
PROSPECTIVE NON-RANDOMISED STUDY
Osama Damrah1, Ruben Canelo2, Paul Tait2, Long Jiao, Nagy Habib
1Hammersmith Hospital-Imperial College London; 2Hammersmith Hospital
Introduction. The ability to construct a 3D model of the liver and its
structures before hepatic resection could be useful in determining the extent
and nature of resection. Accurate assessment of Liver and tumour volume
dictates functional liver volume and predicts postoperative liver failure in
patients undergoing resection.
Methods. A prospective non-randomized study was conducted on patients
scheduled for liver resection following discussion at multi-disciplinary meet-
ing. 3D models were constructed from CT images using computer software.
From these 3D models, total LV , functional LV, and tumor volume were
calculated.The resected Liver volume was also calculated and was compared
to the resected liver weight.
Results. A total of 37 patients of mean age 63 (3178), and male to female
ratio 2:1 were scheduled for liver resection, mean height was (162.49
9.08cm) and mean weight was (73.87912.39). Of these patients; 28 had
Colorectal Metastasis, 5 had Hepatocellular Carcinoma, 3 had cholangio-
carcinoma, and 1 presented with metastatic leiomyosarcoma of the round
ligament. Pre-operatively; 9 patients went for volume enhancing emboliza-
tion, 2 had a non-resectional approach, and 1 patient was subjected to further
imaging due to proximity of the tumour to the vessels. 8 patients underwent
right hemihepatectomy, 5 underwent extended right hemihepatectomy, 3 had
extended left hemihepatectomy, 5 were operated using Habib resection, 4
had right trisectionectomy, and 1 had left medial sectionectomy, 1 had
trisegmenectomy, 4 patients were managed by local resection, 1 by central
resection, 2 by wedge resection, and atypical resection was used in 3 patients.
Postoperative blood tests showed mean bilirubin level (17.3923.9), Albumin
(35.194.32), PT (11.0691.18), and serum creatinine level (86.4915.22).
Incidence of postoperative liver failure was 0%. The mean total liver volume
calculated based on 3D-CT model was (15659404 ml), mean functional
liver volume was (14049358 ml), and mean tumour volume was (1049 142
ml). computer prediction of resected LV using 3D reconstructed CT images
correlated well with resected liver weight, mean of resected liver volumes
predicted was (578.469307 ml) and the mean specimens weights was
(415.69200.68 g) (P0.05).
Conclusion. 3D-CT reconstructed images can accurately predict resected
liver volume and future liver remnant volume during liver resection surgeries.
It aids the decision on the need for pre-operative portal vein embolization to
induce liver hypertrophy.
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SURVIVAL RESULTS OF NON-SURGICAL TREATMENT MOD-
ALITIES FOR MALIGNANT LIVER TUMOURS
Osama Damrah1, Hassan Garba2, Paul Tait2, Hapreet Wasan2, Long Jiao,
Nagy Habib, Ruben Canelo2
1Hammersmith Hospital-Imperial College London; 2Hammersmith Hospital
Introduction. Surgical resection provides the best survival for patients with
primary and secondary liver cancer. It is only possible in 15% 20% of
patients. Non-surgical treatment modalities remain the only option.
Methods. From November 2004, patients whose liver tumours were not
amenable for surgery were considered for chemotherapy, radiofrequency
ablation, trans-arterial chemoembolization and yttrium-90 microspheres
treatment after discussion at our multidisciplinary meeting. None of the
patients had extra hepatic disease.
Results. A total of 123 patients were considered for chemotherapy (n27),
radiofrequency ablation (RFA) (n41) trans-arterial chemoembolization
(TACE) (n20) and yttrium-90 microspheres treatment (n14). They
were 71 men and 52 women with a mean age of 57. Among them 58 had
colorectal liver metastases (CLM), 27 had Hepatocellular carcinoma (HCC)
and the remaining 38 were grouped as others. The mean survival time for
each treatment group was 18.8 months, 18.1 months, 18.7 months and 15.1
months for RFA, yttrium-90 microspheres treatment, chemotherapy and
TACE respectively. As for type of diseases, patients with colorectal liver
metastases had 75%, 56% and 24% survival rates at 1-, 2-, and 3 years
respectively, compared with 60%, 43% and 13% for the noncolorectal group.
The HCC group had 43%, 18% and 10% survival rates over the same period.
Conclusion. Patient’s survival is more correlated to the tumour histopato-
logical type than the non-surgical treatment modality used. Younger patients
survived longer and this we attribute to co- morbidities in the elderly.
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LAPAROSCOPIC LIVER RESECTION FOR HEPATOCELLULAR
CARCINOMA
Tayar Claude1, Laurent Alexis, Cherqui Daniel
1Dept of Surgery, Hopital Henri Mondor, Creteil  France
Laparoscopic liver resection was developed by a limited number of teams over
the past 10 years. We report our experience with this approach in patients
with HCC and chronic liver disease as part of a prospective evaluation.
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Patients. From November 1998 to August 2006, 48 underwent laparoscopic
resection (study group). Tumors were 10 cm or less in size and all but one
were located in peripheral segments. Liver disease was due to hepatitis B or C
in 28 patients, alcohol in 15 and others causes 5. Five-port CO2 laparoscopy
was used and the specimen was extracted in a bag through a separate lower
abdominal incision.
Results. One segment or less was resected in 31 patients including non
anatomical resection in 18. Fourteen patients underwent left lateral
sectionectomy and one underwent right hepatectomy. Thirty-seven (77%)
had intermittent pedicular clamping for a mean of 38 minutes (range 14
117). Seven (15%) conversions to laparotomy occurred for moderate
hemorrhage in 4 cases and insufficient exposure 3. Mean operative
duration was 203978 minutes (range 60360). One patient received 2
units of red cells intraoperatively and two other patients were transfused
postoperatively. Mortality and morbidity rates were 0% and 25% respec-
tively. Transient liver failure and ascites occurred in 3 (6%) patients and
there were no bile leaks. One patient required laparotomy the same day for
operative site bleeding. No source of bleeding was found. Mean hospital
stay was 12.2913.8 (range 176). Mean tumor size and surgical margin
were 38 mm (range 10100) and 13 mm (range 158) respectively. After a
mean follow-up of 28 months (range 0.587), 26 patients (54%) developed
intrahepatic tumor recurrence of which one died. Eight patients underwent
orthotopic liver transplantation. Overall 5-year survival rate was 68%
(43%93%).
Conclusion. Our study shows that, in selected patients, laparoscopic liver
resection for HCC can be associated with no mortality, minimal morbidity
and good survival. In addition, it allows complete histological study and does
not compromise potential subsequent transplantation. We believe that it has a
place in the therapeutic armamentarium of HCC, either with curative intent
or as a bridge to liver transplantation.
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POSTOPERATIVE OUTCOME AFTER MAJOR HEPATECTOMY
FOR COLORECTAL LIVER METASTASES IN PATIENTS WITH
SINUSOIDAL INJURY REQUIRING PREOPERATIVE RIGHT
PORTAL VEIN EMBOLIZATION
Giraudo Giorgio1, Oussoultzoglou Elie, Rosso Edoardo, Nakano Hiroshi,
Casnedi Selenia, Bachellier Philippe, Jaeck Daniel
1Hopital de Hautepierre
Summary background data. Sinusoidal injury is significantly associated
with high morbidity after major hepatectomy in patients receiving neoadju-
vant chemotherapy. However, it is still unclear whether sinusoidal injury is a
risk factor for right hepatectomy in patients with initially unresectable
colorectal liver metastases.
Objective. To evaluate whether preoperative right portal vein embolization
influences the postoperative outcome after major liver resection for colorectal
liver metastases in patients with sinusoidal injury.
Patients and Methods. Between March 1997 and April 2006, 99 patients
underwent right (n65) or extended right (n34) hepatectomy for color-
ectal liver metastases in our institution. Among them, 65 patients considered
as initially unresectable due to insufficient future remnant liver volume,
underwent a right preoperative portal vein embolization (PVE). Sinusoidal
injury and postoperative outcome were analyzed.
Results. Two patients without preoperative PVE died during the post-
operative period. One of them had sinusoidal injury. In 55 patients a
sinusoidal injury was observed. Clinicopathologic findings and preoperative
PVE were similarly distributed in patients with and without sinusoidal injury.
Bilobar distribution and the number of liver metastases were higher in
patients who underwent preoperative PVE. Postoperative grade 3 and 4
morbidity and liver failure occurred in 43 and 18 patients respectively. Grade
3 and 4 morbidity rate was significantly higher in patients with sinusoidal
injury (56.3 % versus 27.2% respectively, P0.003). Moreover, sinusoidal
injury is an independent factor associated with an increased grade 3 and 4
morbidity. In patients with sinusoidal injury, similar morbidity was observed
in patients requiring or not requiring preoperative PVE.
Conclusion. The present study suggests that morbidity was similar in
patients with sinusoidal injury requiring or not requiring PVE, although
bilobar disease and number of liver metastaes were significantly higher in
patients undergoing preoperative PVE.
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LONGER WAITING TIME SUCCEEDS IN COMPENSATING IN-
SUFFICIENT HYPERTROPHY AFTER PORTAL VEIN EMBOLI-
ZATION IN INJURED LIVER PARENCHYMA
Rosso Edoardo1, Oussoultzoglou Elie, Giraudo Giorgio, Bachellier Philippe,
Jaeck Daniel
1Hopital de Hautepierre
Summary and Background. Preoperative portal vein embolization (PVE)
is indicated in patients presenting too small future remnant liver (FRL). A
prospective study (Ann Surg 2003;237:20817) showed no benefit of PVE
for patients with normal liver parenchyma undergoing right hepatectomy.
However, data are lacking about period of time required for adequate liver
hypertrophy in patients with injured liver.
Objective. To evaluate whether time for liver regeneration after PVE is
longer in injured liver parenchyma.
Patients and Methods. Between January 1997 and March 2006, 146
patients requiring a right or extended right hepatectomy for primary and
secondary liver tumors underwent contralateral PVE in our institution. Liver
volumes and time required for gain of adequate hypertrophy for safe liver
surgery were evaluated.
Results. Controlateral PVE was performed successfully in 145 patients. In
one patient the procedure was abandoned because of failure to catheterise
the left portal branch. One-hundred-fourteen patients (78.6%) underwent
the planned hepatectomy and 27 did not because of insufficient FRL
hypertrophy (n12) and/or disease progression (n19). The mean
increase of the FRL volume after PVE was 10.890.7 %. Pathological
type of the liver cancer, existence of cirrhosis, of diabetes mellitus and
administration of chemotherapy did not affect the amount of liver
regeneration. The mean delay between PVE and adequate FRL hypertro-
phy was 2.290.1 months. The mean time for gain of adequate volume in
cirrhotic, diabetic and chemotherapy treated patients were respectively
2.990.4 months, 2.190.2 months and 2.390.1 months. The mean time of
adequate liver volume gain was significantly longer in patients presenting
injured liver (cirrhosis, chemotherapy and diabetes mellitus) compared to
patients with a normal liver parenchyma (2.491.1 versus 1.890.6 months,
P0.009).
Conclusion. These results show that contralateral PVE is a safe and efficient
procedure inducing hypertrophy of the FRL either normal or injured.
Moreover, time mitigates insufficient hypertrophy after PVE in injured liver
parenchyma.
163
LIVER RESECTION USING HEAT COAGULATIVE NECROSIS.
INDICATIONS AND LIMITS OF A NEW METHOD. A SINGLE
CENTRE EXPERIENCE WITH 20 CASES
Gregor A. Stavrou1, Nagy Habib2, Karl J. Oldhafer
1Department of General and Visceral Surgery, HPB Section, Celle General
Hospital; 2Liver Surgery Section, Department of Surgical Oncology and
Technology, Imperial Faculty of Medicine, Hammersmith Hospital Campus
Introduction. Intraoperative blood loss has long been identified as one of
the major morbidity and mortality predictors for liver surgery-a new
approach towards achieving a bloodless resection is the use of heat
coagulative necrosis in healthy liver tissue creating a zone of necrosis in
which resection can be performed with a scalpel.
The latest stage of this technique uses a 4-probe array device (Habib Sealer)
to induce necrosis-unfortunately there is little but promising data for this new
method up to now. We used it for a variety of liver resections ranging from
wedge resection to trisegmentectomy to find the best indications and limits of
the method in a collective of 20 patients.
Materials and Methods. Between March 2005 and June 2006 we
performed 28 liver resections on 20 consecutive patients (m:f ratio 9:11,
mean age 65,8 years) with the device.
The most common indication was metastatic colorectal cancer (75%). We
treated a heterogeneous patient collective in terms of tumour localisation and
extent of resection-resectability was enhanced through downsizing che-
motherapy (2 cases) and portal hypertrophy induction (1 case).
12 patients with metastatic colorectal cancer had received adjuvant che-
motherapy after the primary operation according to histological staging-
metastatic liver disease was synchronous in 6 cases and metachronous in 8
cases (mean time to metastasis 25,75 months).
Resection was performed after creating a necrotic zone at the intended
resection plane using a scalpel. The device achieved an area of coagulation of
1cm width in which even larger vessels and bile ducts were safely sealed.
Resection with the scalpel left 4mm of the coagulated area behind on the
remnant.
Results. Operative spectrum covered parenchyma-saving atypical resections
(8), one- or bisegmentectomies at different locations (15), hemihepatec-
tomies (1left, 3right) and an extended right hepatectomy.
With one exception intraoperative blood loss was lower than 100mls.
Perioperative transfusion was required in 2 cases, mean pre- and post-
operative haemoglobin were 13 mg/dl and 10,6 mg/dl respectively.
Mean hospital stay was 12,2 days (7 to 26 days). 4 patients (20%)
developed an operation related complication comprised of abscess forma-
tion at the resection site (2 patients had simultaneous bowel resection). In
3 cases CT-guided drainage was sufficient, one case needed operative
revision.
Follow up shows tumour free survival for the first 13 patients with a follow up
of nine months, long-term results are pending.
Discussion. Liver resection using the sealer device seems a safe and time-
efficient method though it requires extensive knowledge of intrahepatic vessel
anatomy. A time saving advantage is that liver mobilisation can be forgone in
most of the cases. Resection itself is achieved rather quickly. In terms of
indications in our view the method is good for atypical (deep) resections-
especially in Segment IV. Resections in proximity of hilar structure or large
vessels are not favourable for the fear of thermal damage. Extended resections
are possible if performed in a hybrid technique with conventional hilar
preparation.
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PERCUTANEOUS SCLEROTHERAPY OR SURGICAL TREAT-
MENT OF SIMPLE LIVER CYSTS AND POLYCYSTIC LIVER
DISEASE
D. Erdogan1, O.M. van Delden2, E.A.J. Rauws3, O.R.C. Busch, J.S.
Lameris2, D.J. Gouma, T.M. van Gulik
1Academic Medical Center, Department of Surgery, Amsterdam, The
Netherlands; 2Academic Medical Center, Department of Radiology, Am-
sterdam, The Netherlands; 3Academic Medical Center, Department of
Gastroenterology, Amsterdam, The Netherlands
Cystic liver lesions comprise a heterogeneous group including the most
common, simple liver cysts (solitary and multiple) followed by polycystic liver
disease (PLD). Nowadays, management of symptomatic liver cysts encom-
passes percutaneous aspiration and instillation of a sclerosant (i.e. percuta-
neous sclerotherapy) or surgical deroofing. The aim of this study was to
assess the treatment of simple liver cysts and PLD using percutaneous
sclerotherapy and/or surgical procedures. A total of 54 patients referred for
treatment of simple liver cysts (solitary and multiple) and PLD between
January 1997 and July 2006 were retrospectively analyzed. The criterion for
diagnosis of multiple, simple liver cysts was the presence of more than 1 but
fewer than 4 cysts, and for PLD, the presence of four or more cysts in the
liver.
Simple liver cysts were treated in 41 pts (76%) with a mean size of 12.6 cm.
The most common reason for referral was abdominal pain or discomfort
(85%). Percutaneous sclerotherapy was performed as initial treatment in 30
pts, showing recurrence in 6 pts (20%). The mean aspirated volume of the
cyst was 2223 ml (range 505000). Complications were encountered in 2 pts
(6.7%), including an intracystic bleed without requiring further treatment
and an infected cyst which needed admittance for antibiotic treatment. Only
1 patient (1/30; 3.3%) showed concomitant recurrence of symptoms and
percutaneous sclerotherapy was carried out. Surgical treatment was initially
performed in 11 pts with recurrence in 3 pts (27%). Additional percutaneous
sclerotherapy was carried out in 2 patients because of concomitant
progressive abdominal complaints (2/11; 18.2%). In patients with simple
liver cysts, no significant differences were seen in recurrence rate after
surgical treatment compared to recurrence after percutaneous sclerotherapy
[27.3% (3/11) vs. 20% (6/30), respectively; P0.680].
PLD was diagnosed in 13 pts (24%) and all experienced progressive
abdominal complaints. The mean cyst size was 13 cm. Percutaneous
sclerotherapy was performed in 9 pts. However, only 4 of the 7 pts
(77.8%) with cyst recurrence required repeat percutaneous sclerotherapy
because of progressive abdominal pain. Surgical treatment was undertaken in
4 pts (30.8%) with recurrence in all. Eventually, liver transplantation was
required in 2 patients.
Conclusions. The majority of patients with simple liver cysts and PLD are
referred for progressive abdominal pain. As initial treatment, percutaneous
sclerotherapy is appropriate for predominantly superficially located cysts.
Surgical treatment is indicated in cyst recurrence after percutaneous
sclerotherapy.
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CLOSURE OF BILIARY DUCTS AND ADHESIVE STRENGTH OF
FIBRINOGEN-COATED COLLAGEN PATCH OR LIQUID FIBRIN
SEALANT IN AN EXPERIMENTAL LIVER RESECTION MODEL
IN PIGS
D. Erdogan1, W. de Graaf2, T.M. van Gulik
1Academic Medical Center, Department of Surgery, Amsterdam, The
Netherlands; 2Academic Medical Center, Surgical Laboratory, Amsterdam,
The Netherlands
Background. Surgical management of the cut surface after liver resection
consists of hemostasis and closure of bile leaks. Several fibrin sealants may be
used to attain this goal. No studies have assessed the efficacy of these sealants
for prevention of biliary leaks, nor the adhesive strength of these sealants to
the resection surface of the liver. The aim of this study was to assess the
efficacy of sealing of biliary ducts and the adhesive strength of two types of
commercially available sealing agents, i.e. a fibrinogen-coated collagen patch
(TachoSil†) and a liquid fibrin sealant (Tissucol†) in a partial liver resection
model in pigs.
Materials and Methods. Fibrin sealant is a hemostatic agent composed of
fibrinogen and thrombin. The fibrinogen-coated collagen patch Tachosil†
(Nycomed GmbH, Breda, Netherlands) was compared with the liquid fibrin
sealant Tissucol† (Duo 500, 2 ml, Baxter Hyland Immuno, Uden, Nether-
lands). Eight pigs (Vendrig, Amsterdam, The Netherlands) weighing 3545
kg were randomized in 2 groups. Each pig underwent laparotomy and
resection of the left medial lobe of the liver. Larger blood vessels in the
resection surface were suture closed, whereas small bile ducts were left
unclosed. Thereafter, the tip of a 16 Ch silicon catheter was introduced into
the common bile duct through a distal incision until the confluence of the
hepatic ducts. Pigs were assigned to two groups: application of Tachosil†
(n4) or Tissucol† (n4) on the resection surface of the remnant liver.
After 2 hours, pressure in the intrabiliary system was increased gradually by
infusing sodium chloride through the catheter. Intrabiliary pressure was
continuously monitored using an intraluminal pressure sensor. Results are
expressed as mean9 standard error of the mean (SEM). Student’s t-test was
used for differences between groups. PB0.05 was considered significant.
Results. No difference was seen in the number of blood vessels closed in the
resection surface of the group with Tachosil† compared to the group with
Tissucol† (4.090.4 vs. 5.590.5; P0.0677). No difference was observed in
the number of bile ducts in the resection surface of the group with Tachosil†
compared to Tissucol† (2.590.3 vs. 2.390.3; P0.5416). No bleeding or
bile leakage was observed in both groups after application of the sealants on
the resection surface of the liver remnant. No significant difference in
haemostasis time after Tachosil† or Tissucol† was observed (210.0912.9
sec vs. 208.8914.2; P0.9506). The pressure that could be resisted with
Tissucol† was significantly lower compared to that after application of
TachoSil† (77.098.6 mmHg vs. 131.8916.3 mmHg; P0.0405).
Conclusions. Application of TachoSil† on the resection surface is equally
effective in obtaining haemostasis and in sealing of biliary ducts compared
with Tissucol†. The adhesive strength of Tachosil† on the resection surface,
however, is superior to Tissucol†.
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IMPACT OF THE HEMORRHAGIC FORMS ON THE MANAGE-
MENT OF HEPATOCELLULAR ADENOMA
Dib Mohammad1, Savier Eric, Breton sylvie2, Vaillant Jean-Christophe,
Siksik Jean-Michel, Hannoun Laurent3
1Service de Chirurgie He´pato-bilio-pancre´atique. Transplantation He´patique
(Pr Hannoun). Groupe Hospitalier Pitie´-Salpe´trie`re. APHP; 2Service de
Chirurgie He´pato-bilio-pancre´atique. Transplantation He´patique (Pr Han-
noun); 3Service de Chirurgie He´pato-bilio-pancre´atique. Transplantation
He´patique. Groupe Hospitalier Pitie´-Salpe´trie`re. APHP
Introduction. Haemorrhages or malignant transformation are the main
complications of hepatocellular adenomas (HCA). The first objective of the
surgical treatment is to prevent them. For small HCA, risk of malignancy is
low, and interruption of hormonal treatment is some times considered as
sufficient. In such cases, the hemorrhagic risk is considered low as well.
However, our own experience does not favour such conservative attitude.
The aim of this study was to appreciate the impact of the hemorrhagic forms
on the surgical management of HCA.
Method. The study was retrospective and monocentric. Liver adenomatosis
was excluded. Patients were divided into three groups according to the pre-
operative data. Group 1: hemoperitoneum revealing HCA (n3). Group 2:
non complicated HCA (n9). Group 3: radiological signs and/or macro-
scopic pathological evidence of tumour haemorrhage (n11). Statistical
comparisons were performed between groups 2 and 3 only. Data are mean9
S.E.M.
Results. From 1990 to 2005, among 917 hepatectomies, 23 (2,6%) were
performed for one (n19) or for 2 to 3 HCA (n5). Group 1: two women
and a man were operated on for hemoperitoneum. The maximal preoperative
diameter of the tumour was of 7,791,9 cm, the weight of the specimen was of
7529305 g, the stay in ICU was of 9,093,5 days and two patients were
transfused. Group 2: there were 7 women and 2 men, mean age 4594 years
old. Abdominal pain was present in 5/9, initial haemoglobin level at
presentation was 13,790,5 g/dl. The tumours measured 6,590,9 cm. The
specimen weighted 441983 g, ICU stay was 1,790,3 days. None was
transfused and morbidity was null. Group 3: women only, mean age 3693
years old (p0,11), had pain in 9/11 (p0,18), haemoglobin level was
11,190,6 g/dl (p0,003), tumour diameter was 10,491,4 cm (p0,02)
and specimens weighted 8009192 g (p0,08). ICU stay was 7,193,4 days
(p0,17). Morbidity was not specific (n3).
Discussion. In this short series, haemorrhage complicating an HCA
occurred in 61% of the cases (14/23). In this group, surgical resections
were larger and morbidity was not absent any more. A slight low haemoglobin
level could be regarded as a sign of alarm.
Conclusion. In the absence of predictive factor of haemorrhage, we consider
asymptomatic HCA for resection, irrespective of the size of the tumour,
especially in young patients.
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TEMPORARY LIVER BLOOD-OUTFLOW OCCLUSION IN-
CREASES EFFECTIVENESS OF RADIOFREQUENCY ABLA-
TION: AN EXPERIMENTAL STUDY
Zdenek Subrt1, Alexander Ferko2, Bohumil Jon2, Petr Hoffmann3, Vera
Tycova*, Miroslav Ryska$, Petr Dvorak3, Vendelı´n Chovanec3, Jan Raupach3
1Dept. of Field Surgery, Military Health Science Faculty, Hradec Kra´love´,
Defense University Brno, Czech Republic; 2Dept. of Surgery, Charles
University Medical School and Teaching Hospital, Hradec Kra´love´, Czech
Republic; 3Dept. of Radiology, Charles University Medical School and
Teaching Hospital, Hradec Kra´love´, Czech Republic; *Dept. of Pathology,
Charles University Medical School and Teaching Hospital, Hradec Kra´love´,
Czech Republic; $Dept. of Surgery, Central Military Hospital and 2nd
Medical Faculty, Charles University, Prague, Czech Republic
Aim. To evaluate the feasibility of liver blood outflow (LBOF) occlusion and
its impact on the effectiveness of radiofrequency ablation (RFA).
Methods. The experiment was performed on 10 pigs. The animals were
divided into groups A and B according to RFA protocol. In group A (n5)
the RFA time was that taken to reach the target temperature of 1058C,
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whereas group B (n5) had a constant RFA temperature of 1058C and
constant time of 8 min. The liver blood flow (LBF) was quantified using
Doppler ultrasonography before LBOF occlusion and after that. RFA were
performed using an expandable 3 cm RF needle. Two liver ablations created
in different liver lobes were compared; the first ablation was created before
balloon inflation and the second one was created under LBOF occlusion. The
time required for RFA procedure, liver ablation volumes, shape and
microscopic changes of the thermoablated zones were recorded.
Results. The LBF dropped significantly in all liver vessels after balloon
inflation. The volume of the ablated area was 8.292.2 cm3 and increased
significantly after LBOF occlusion to 17.493.8 cm3 (pB0.001), in group A.
A significant enlargement of the ablated area with occluded LBF was
registered in group B, it was 6.792.8 cm3 versus 19.491.8 cm3 respectively
(pB0.01).
Conclusions. Temporary LBOF occlusion led to a significant reduction in
liver blood flow, enlargement of the thermoablated area volume and
homogeneity of the coagulated zones.
Supported by Research Project MZO 00179906 Ministry of Health Care,
Czech Republic and Research Project 0FVZ0000503 of the Ministry of
Defense, Czech Republic.
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RADIOFREQUENCY-ASSISTED LIVER RESECTION. ANALYSIS
OF A GROUP OF CONSECUTIVE PATIENTS TREATED AT A
SINGLE CENTER
Alexander Ferko1, Zdenek Subrt2, Eduard Havel, Bohumil Jon
1Dept. of Surgery, University Hospital Hradec Kra´love´; 2Dept. of Field
Surgery, Military Health Sciences Faculty
Aim. To evaluate clinical experience with radiofrequency (RF)-assisted liver
resection in patients with metastatic liver disease.
Methods. A group of consecutive patients who underwent liver resection
using the RF-assisted technique were prospectively followed.
Results. Between July 2005 and July 2006, 65 liver resections were
performed, among these, 40 procedures were performed using the RF
technique for metastatic liver disease. The mean operative time was 141
(range 64233) minutes, and the mean duration of RF parenchyma
coagulation of the resected surface was 17.5 (range 232.5) minutes; mean
10, (range 912) minutes in the case of right hemihepatectomy. Blood
transfusions associated with the operation were administered in 3 patients
(7.5%). The mean number of transfusion units of red blood cells adminis-
tered was 0.2 (range 03). Liver resection was complicated by biliary fistula
in 1 patient (2.5%) after mesohepatectomy, hepatic abscess was observed in 1
patient (2.5%) and subdiaphragmatic abscess was observed in 2 patients
(5%).
Conclusion. This study indicates that RF-assisted resection may have a
benefit in decreasing perioperative blood loss and the volume of transfused
blood, without a higher incidence of wound or infectious complications.
An increased incidence of pleural effusions that required evacuation was
noted.
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NONOPERATIVE AND OPERATIVE MANAGEMENT OF BLUNT
HEPATIC TRAUMA
Antonio Frena1, Giuseppe La Guardia, Federico Martin
1Surgical Department  General Surgery 2  Central Hospital of Bolzano
Background. liver injuries are the most frequent cause of death in the field
of abdominal traumas. The increase in road accidents and sports injuries
makes discussion of the treatment modalities increasingly relevant in this
area.
Aim. In recent years we have witnessed an evolution in the therapeutic
management of such injuries with the increasingly frequent use of non-
operative procedures for the management of non-complex lesions.
Methods. a retrospective study was conducted in 111 cases of liver injuries
observed in our department over a 20-year period (19852005). The mean
age of the patients was 31 years. The most frequent causes were road
accidents (48%), followed by sports injuries (23%) and occupational
accidents (11%).
Results. 82 patients (74%) were treated surgically and 29 conservatively. In
58 cases (35 of which treated surgically), the liver injury was isolated, while in
the other 53 cases lesions were also present in other abdominal organs. The
liver injuries, classified according to the AAST, were grade I in 47 cases,
grade II in 30 cases, grade III in 19 cases, grade IV in 5 cases, and grade V in
10 cases. Thirty-five percent of grade I-II lesions were treated conservatively,
while 94% of grade III-IV-V lesions received surgical treatment. The overall
operative mortality was 12.5%.
Conclusions. The evolution of the management of liver injuries has
witnessed an increase in conservative treatment, particularly for grade I
and II lesions. There is no alternative to surgical treatment when the injury
involves the major hepatic vessels or substantial amounts of parenchyma. The
mortality rate is high compared to that of elective liver surgery, but this is due
to the frequent associated lesions in other organs and apparatuses.
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LIVE CELL CAPTURING (LCC) AND PANCREATIC CANCER
CELL CULTURES:A NEW METHODOLOGICAL APPROACH
Niccola Funel1, Daniela Campani, Marco Del Chiaro2, Luca Pollina, Mauro
Baron3, Ugo Boggi2, Izabela Noll3, Franco Mosca2, Generoso Bevilacqua
1Division of Surgical, Molecular and Ultrastructural Pathology, University
and Hospital of Pisa; 2Division of General Surgery and Transplantation,
University and Hospital of Pisa and Regional Referral Center for Pancreatic
Diseases Treatment; 3Leica Microsystems SPA
Introduction. Setting up of primary cultures from pancreatic adenocarci-
noma is a delicate and complex procedure with very low chances of succeeding.
One of the major issues is represented by the difficulty to separate epithelial
cells from fibroblasts, which are very abundant due to the marked desmoplastic
reaction associated to pancreatic adenocarcinoma. Aim of the present study
was to expand the epithelial cell population by using laser microdissection on
primary cultures derived from pancreatic adenocarcinoma.
Materials and methods. 90 samples from primary pancreatic adenocarci-
noma were selected to set up primary cultures. Cells were grown in RPMI
1640 (10% FCS, 1% L-Glu, 1% Antibiotics) at 378C in 5% CO2 humidified
atmosphere. Seven primary cultures ( PP78, PP109, PP117, PP147, PP161,
PP244 and PP391) were obtained. Primary cell cultures PP244 an PP391
were sown (passage 428 and 38, respectively) on a new support of poly-
ethylene tereftalate (PET) (IBIDI system, Figure 1), specifically designed for
the laser microdissection instrument (Leica LMD6000). Very few cells,
where microdessected using differential contrast microscopy from both
cultures and directly transferred into the under IBIDI support by Live Cell
Capturing (LCC) (Figures 12).
Results. Microdissected primary cells from PP244 and PP391 cultures grow
to form a single layer in the IBIDI support (Figure 3).
Conclusions. Cell growth and migration on the new IBIDI membranes,
were comparable to those obtained using standard supports (Figure 3).
Furthermore, LCC allowed successful isolation and expansion of cell
cultures. This new method could offer several advantages: 1) reduced
primary culture time setting, by isolating a target cell type from the original
mixed cell population; 2) isolation of different cell populations within a single
primary culture; 3) the study of molecular interactions between tumor and
stromal cells into a model near to in vivo conditions.
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THERMAL AND MORPHOPHYSIOLOGIC CHARACTERISTICS
OF RADIO-FREQUENCY ABLATION ZONES IN VIVO PORCINE
LIVER
Antanas Gulbinas1, Tomas Vanagas2, Zilvinas Dambrauskas, Mindaugas
Rakauskas3, Leonid Ivanov, Juozas Pundzius2, Giedrius Barauskas2
1Institute for Biomedical Research, Kaunas University of Medicine; 2Depart-
ment of Surgery, Kaunas University of Medicine; 3Lithuanian Veterinary
Academy
Aim of study. To evaluate morphologic characteristics, thermal conditions
and activation of apoptosis within different radio-frequency ablation (RFA)
zones in porcine liver.
Methods. Approval of the study protocol was obtained from the Ethics
Committee at the State Food and Veterinary Service of Lithuania. Internally
cooled monopolar electrodes (exposed tip length  2 cm) and power output
Assemblage of tray for Live Cell Capturing on primary cell cultures.
The IBIDI system consists in an upper support where cells grow
and in an under support where cells are harvested after laser
microdissection.
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of 25 W were used to produce 30 ablated zones in vivo porcine liver. Tissue
temperatures were acquired by type K thermocouple during the procedure at
5 and 10 mm distance from the active electrode. Animals were sacrificed
upon completion of the ablation procedure. Macroscopic measurements and
histological assessment of HE stained slides of each ablated zone was
performed to characterize the tissue damage. Western blot analyses of
caspase-3 expression in lysates from tissue samples were performed to
evaluate activation of apoptosis in different RFA zones.
Results. Morphologic analysis revealed following zones of tissue destruction:
the inner zone of tissue necrosis (central zone) and transition zone. The
structureless necrotic masses with damaged structure of hepatic cells were
observed in central zone. The transition zone contained apparently unda-
maged hepatic tissue with signs of subacute hemorrhage  the infiltration of
blood cells. The tissue adjacent to the transition zone was morphologically
normal.
The mean measurements of central zone was 2191 mm longitudinally and
1191 mm transversally. Mean measurements of overall ablated area were
3693 and 2392 mm respectively. Temperatures at 5 mm from active probe
(within central zone) gradually increased for 5 minutes to reach average
temperature of 708C and stabilized thereafter. At 10 mm point (within
transition zone) temperature was gradually increasing for 10 minutes to reach
the average temperature of 508C.
The median concentration of protein in central zone tissue lysates was 38,14
mg of protein per gram of tissue. It was significantly lower when compared to
protein concentration in transition zone and normal tissue lysates (60,29 mg/
g and 82,23 mg/g respectively) suggesting thermal protein destruction.
Western blot analysis detected inactive 32-kDa caspase-3 unit and did not
detect the active 17-kDa subunit of caspase-3 either in ablated tissue or in
normal liver tissue, suggesting that apoptosis was not induced immediately
after RFA.
LCC (Living Cell Capturing). a: Primary Cell Culture grow on the upper IBIDI support (magnification 6,3X). b: cut of interesting areas. c:
samples harvested into the under IBIDI support (magnification 10X).
Primary Cell Culture grow on IBIDI system after Live Cell Capturing  LCC. a and b: Primary cell culture PP244 are growing on PET
membrane (Red Line). c and d: Tumoral cells grow on and near PET membrane (Yellow and Green Lines).
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Conclusion. Our results suggest that non-viable tissue is obtained in central
zone of tissue destruction only, whereas there is no evidence of either necrosis
or apoptosis in transition zone immediately following radio-frequency
ablation procedure.
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STAGED LIVER RESECTION AND PORTAL VEIN EMBOLISA-
TION: EXPERIENCE AT A SINGLE CENTRE
Andrew J Healey1, Adel Abulkhir, Osama Damrah, Madhava Pai, Paolo
Limongelli, Paul Tait2, James Jackson2, Nagy Habib, Long Jiao
1Hammersmith Hospital, Imperial College; 2Hammersmith Hospital, De-
partment of Radiology
Aim. To assess outcome after a 2-stage liver resection combined with portal
vein embolization (PVE) in the treatment of patients with unresectable
multiple and bilobar metastatic liver disease (BMLD) at a single centre.
Patients and Methods. Between November 2001 and December 2006, 21
patients with unresectable BMLD were selected for a TSLR. A right or an
extended right hepatectomy was planned after treatment of left FLR
metastases to achieve a curative resection. The first-stage hepatectomy
consisted in a clearance of the left hemiliver by resection or radiofrequency
destruction of metastases of the left FLR. Subsequently, a right PVE was
performed to induce atrophy of the right hemiliver and hypertrophy of the left
hemiliver. Finally, a second-stage hepatectomy was planned to resect the
right liver metastases.
Results. There was no operative mortality. Post-PVE morbidity was 9.3%;
postoperative morbidity was 19.1% and 5.0% after first and second-stage
hepatectomy, respectively. TSHP could be achieved in 13 of 21 patients
(61.9%). The 2-year overall and disease-free survival rates were 85.0%
and 63.4%, respectively, in the 13 patients in whom the TSLR was
completed.
Conclusions. In selected patients with initially unresectable BMLD, a
TSLR combined with PVE can be achieved safely with long-term sur-
vival similar to that observed in patients with initially resectable liver
metastases.
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LAPAROSCOPIC LEFT LATERAL SEGMENTECTOMY FOR
COLORECTAL CANCER METASTASES
Eric Herrero Fonollosa1, Esteve Cugat Andorra`, Santi Sanchez Cabus,
Noelia Perez Romero, Constancio Marco Molina
1Hospital Mutua de Terrassa
Introduction. Laparoscopic treatment should be considered for selected
patients with benign and malignant lesions in the left lobe or frontal segments
of the right liver. The immediate benefits seem to be those of any miniinvasive
surgery: reduced trauma to the abdominal wall, early mobilization, shorter
hospital stay, and better cosmetic results.
Case Report. We present a 76-year-old male who underwent colorrectal
resection for carcinoma 2 years before (pT3N0M0). In subsequent controls
CEA elevation was detected. An abdominal CT scan was performed showing
2 liver metastases in segments II and III. No extra hepatic disease was
reported after complete study with thoracic CT scan and PET. The patient
underwent surgery on May 2006. A left lateral segmentectomy (segments II
and III) was performed by laparoscopic approach. Pathological findings were
consistent with metastasic colorrectal adenocarcinoma in the 2 resected
nodules with safe resection margin.
Discussion. The recent rapid developments of innovative laparoscopic
instruments and improvements in surgical skill have made laparoscopic-
assisted liver resection possible. Obviously, extensive experience in laparo-
scopic and hepatobiliary surgery is mandatory in carrying out liver resection
through the minimal access approach.
In appropriately selected patients, laparoscopic liver resection is feasible and
safe, and achieves acceptable survival among individuals with hepatic
malignancy. The evolution of laparoscopic hepatectomies probably will
depend on the development of new techniques and instrumentations. The
use of the haemostatic and sealant materials, widely used in open surgery,
presents technical variations in its use in laparoscopic surgery, just as is we
show in this video.
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BILIARY DRAINAGE MORBIDITY AND PORTAL EMBOLIZA-
TION MORBIDITYBEFORE CURATIVE SURGERY OF CHOLAN-
GIOCARCINOMA
Cheron Nathalie1, Yzet Thierry2, Dewaele Francois, Chatelain Denis3,
Mauvais Francois*, Mulieri Giacco$, Bartoli Eric, Regimbeau Jean-Marc$,
Dupas Jean-Louis§
1Department of Gastroenterology CHU Amiens France; 2Department of
Radiology CHU Amiens France; 3Department of Pathology CHU Amiens
France; *Department of Surgery CH Beauvais France; $Department of
Surgery CHU Amiens France; §Department of Gastroenterolgy CHU
Amiens France
Cholangiocarcinoma (CC) is a rare cancer with poor prognosis. Agressive
surgical treatment is the only means of enabling patient survival. The type of
resection depends on wether the CC is located in intrahepatic (IHCC), in the
hilus or in the distal bile duct (DBDCC). It has been suggested that pre-
operative biliairy drainage (wich remains controversial) and portal vein
embolization reduce the risk of post operative complications. The goal of the
present work was to evaluate i) the morbidity of the pre-operative therapeutic
acts and ii)the results of medical and surgical management for CC patients.
Patients and methods. In this prospective study, we recorded the
demographic, clinical, biological, morphological, histological, therapeutic
and follow-up characteristics of 58 CC patients treated between November
1st 2002 and June 30 st 2005. In all cases, treatment decisions were taken by
a multidisciplinary cancer care team. According to the clinical and
morphological parameters, patients for whom surgical resection was though
to be most appropriate underwent primary resection either alone or with a
pre-operative, therapeutic act: endoscopic or percutaneous biliary drainage
and/or portal embolization. The results of the medical and surgical manage-
ment were evaluated in terms of morbidity and mortality associated with the
pre-operative and surgical acts and in term of survival.
Results. surgical treatment was recommanded to 25 of the 58 CC patients
(5IHCCs, 11 HCCs, and 9 DBDCCs). Percutaneous and endoscopic biliary
drainage was performed in 9 and 3 patients respectively, i.e, 12 in all (11
HCCs and 1 DBDCCs). Complications were observed in 4 of these cases (33
%; 1 subcapsular haematomas, 1 biloma, 2 cases of acute pancreatitis). Portal
embolization was performed pre-operatively in 6 patients and was compli-
cated by portal thrombosis in one case. The mortality of these pre-operative
acts was zero. Nine patients were excluded from surgery: 1 refusal, 4 cases of
peritoneal carcinosis (3 of wich were revealed by pre-operative coelioscopy), 1
locally advanced CC, 2 cases of complications associated with drainage and 1
with portal embolization. Hence, curative resection was performed in 16
cases: 3 IHCCs (hepatectomy in the absence of prior act), 4 HCCs
(hepatectomy and primary bile duct resection, drainage n4) and 9
DBDCCs ( duodenopancreatectomy, drainage n1). Postoperative infec-
tious comlications were observed in 2 patients (HCCs) having undergone
pre-operative biliary drainage. No post-surgery deaths occured. Seven
patients received adjuvant treatment ( radiochemotherapy or chemotherapy
alone). Cumulative survival at 30 months was 40%.
Conclusions. The present results emphazise that pre-operative biliary
drainage of CCs for which curative resection is envisaged has a high
morbidity rate and is associated with complications that can subsequently
rule out surgery. The act’s risk/benefit ratio in CC therapy needs to be
evaluated in terms of both its modalities and its indications.
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RUPTURED HEPATIC ABSCESS CAUSED BY FISH BONE PE-
NETRATION OF THE DUODENAL WALL.: REPORT OF A CASE
Yoshihiko Kadowaki1, Ryuji Tamura, Takahiro Okamoto, Takashi Mori
1Kobe Red Cross Hospital, Japan
Accidental ingestion of foreign bodies into the gastrointestinal tract is not
uncommon. However, the development of hepatic abscess secondary to
foreign body perforation is extremely rare. We describe herein the case of a
ruptured hepatic abscess due to fish bone penetration of the duodenal bulb,
resulting in the generalized peritonitis. A 73-year-old man was admitted to
our hospital complaining of whole abdominal pain and high grade fever.
Computed tomography (CT) of the abdomen revealed ascites and hetero-
geneously enhanced mass with a less-dense center and a linear dense object.
We made a diagnosis of ruptured hepatic abscess caused by a calcified foreign
body. Peritoneal lavage, drainage of the hepatic abscess with the removal of
the fish bone and simple closure of hepatoduodenal fistula were performed.
The patient recovered eventually.
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INTRAHEPATIC SEGMENTAL BILE DUCT B3 CHOLANGIOEN-
TERIC BYPASSIN THE MANAGEMENT OF UNRESECTABLE
MALIGNANT HILAR OBSTRUCTION
Aleksandar Karamarkovic1, Pavle Gregoric2, Ivan Blazic2
1University Center for Emergency Surgery, School of Medicine Belgrade;
2University Center for Emergency Surgery
Introduction/Aim. Palliating the effects of biliary obstruction is a major
goal of therapy in patients with unresectable cancer at the hepatic duct
confluence. This study was undertaken to evaluate the effectiveness of
intrahepatic holangioenteric bypass to the segmental bile duct B3 in patients
with unresectable hilar cholangiocarcinoma or gallbladder carcinoma.
Methodology. The confluence pattern and surgical anatomy of the bile duct
branch B3 of segment S3 of the liver was studied in 33 liver casts. It is
important to understand the detailed anatomy of B3, its confluence patterns
and its relation to the segmental portal venous branch P3. We did not register
any anatomical variations of segmental biliary ducts B2 and B3.
Results. Since March 2001, we have performed intrahepatic segmental bile
duct B3 cholangiojejunostomy by Roux-en-Y fashion utilizing a round
ligament approach in 23 patients with malignant obstructive jaundice due
to unresectable hilar cholangiocarcinoma (13 cases) and gallbladder cancer
(10 cases). There was no postoperative surgical complications (postoperative
bleeding, bile leakage, abscess formation) in our series. Operative mortality
rate after B3 cholangiojejunostomy was 4.3% (one patient). The palliation of
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symptoms was effective in postoperative period. Median survival after
cholangioenteric bypass was 9 months (range, 122 months).
Conclusions. Intrahepatic B3 cholangiojejunostomy can provide useful
palliation from jaundice, pruritus and cholangitis with acceptable mortality
and morbidity rates. Among the surgical and non-surgical palliative
treatments of malignancies of the hilus, the intrahepatic cholangio-anasto-
mosis is the procedure which gives the best comfort and less iatrogenic
complications.
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MANAGEMENT OF METASTATIC LIVER DISEASE BY REGIO-
NAL HEPATIC ARTERY INFUSION (HAI) CHEMOTHERAPY
Aleksandar Karamarkovic1, Vojin Mihailovic2, Ivan Blazic3, Pavle Gregoric3
1University Center for Emergency Surgery, School of Medicine Belgrade;
2Univerity Center for Emergency Surgery; 3University Center for Emergency
Surgery
Introduction. Liver resection is the best option in the treatment of the
metastatic disease. Surgical resection if feasible is the treatment of choice
since it produces a 5 year survival rate of about 30%. In order to achieve
better results repeated surgical resection, hepatic artery chemoembolisation,
cryo and thermo surgery, ethanol injection of the tumor and RFA are being
investigated as potential treatment option for such patients. Locoregional
HAI chemotherapy is of the mayor interest.
Methodology/Results. retrospectively was evaluated the effects of HAI for
liver metastases. 20 patients were treated with implantable catheter-port
system(Implantofix?) for non-resectable metastic lesions: colorectal 12,
pancreatic 3, breast 4 and gynecol. 1. Angiography was performed to identify
variations in arterial anatomy. Administered dose was 750 mg/b of 5 FU, 6
cycles of 5 days per month. Assessment of response to treatment was based
on CT and tumor markers CA 199, CEA. We had no patient with complete
response, partial response-50% of tumor volume CT control had 2 (10%)
partial 25% of tumor size 5 (25%), 4 (20%) patients had very limited
response. Unfortunately 9 (45%) patients had rapid tumor progression.
Intraoperative mortality, was 0%. Total morbidity was: port side infection in
2 (10%), perforation and thrombosis of the catheter in 1(5%). The median
survival was 12 months. The maximum of 34 months survived lady operated
for colorectal adenocarcinoma with synchronous liver secondary tumor.
Sucessfuly resection, after down-staging of tumor was performed in 4 cases.
Conclusion. Results of our study are disappointing. Patients with hepatic
replacement by tumor 30% and concomitant extrahepatic metastatic
disease are throught to be inappropriate candidates for hepatic artery
chemotherapy.
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HEPATOBILIARY CYSTADENOCARCINOMA: A CASE REPORT
Aleksandar Karamarkovic1, Vojin Mihailovic2, Pavle Gregoric3, Ivan Blazic3
1University Center for Emergency Surgery, School of Medicine Belgrade;
2Univerity Center for Emergency Surgery; 3University Center for Emergency
Surgery
Introduction. Hepatobiliary cystadenoma is a rare neoplasm occuring in
middle-aged women. The clinical feature is not marked but abdominal
fullness and abdominal mass are the most common symptoms.
Case report. A 49-year old woman was admitted to our clinic with right
upper quadrant abdominal discomfort and 6cm-sized unilocular hepatic
cystic mass. The medical history was not unusual; laboratory tests were
normal. Serum CEA, CA 199, and alpha-fetoprotein levels were normal.
CT demonstrated a unilocular cyst in Couinaud’s segment S4. The mass
wass localized on the undersurface of the liver between the round ligament
and gallbladder, above the the hilar structures, without communication with
biliary tract. Anatomical segmentectomy S4 was performed with currative
intention (R0 resection). A unilocular cyst surrounded by a thin fibrous wall
was filled with mucinous and gelatinous fluid. Histologically, the inner
surface was lined with mucin-producing cuboidal epithelia accompanied by
focal papillary growth, which is consistent with cystadenoma. The stromal
mass was in situ papillary adenocarcinoma. The postoperative course was
uneventful. The patient is doing well 14 months after surgery, without signs
of tumor recurrence.
Conclusion. Cystadenocarcinomas usually arise from pre-existing cystade-
nomas. The treatment of choice is complete surgical resection.
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ADJUVANT CHEMOTHERAPY USING UFT FOR HEPATOCEL-
LULAR CARCINOMA: FINAL REPORT OF PROSPECTIVE, RAN-
DOMIZED STUDY
Keiichi Kubota1, Takehiko Nemoto, Junji Kita, Mitsugi Shimoda2, Tokihiko
Sawada3
1Department of Gastroenterological Surgery, Dokkyo University Hospital;
2Department of Gastroenterological Surgery; 3Department of Gastroenter-
ological Surgery, Dokkyo Unversity Hospital
Background/Aims. This study aims to prospectively evaluate the efficacy of
adjuvant chemotherapy using UFT (5-FUuracil) for preventing early
recurrence of hepatocellular carcinoma (HCC).
Methods. 81 patients who had undergone curative resection for HCC
(Stages IIII) were assigned to either UFT per-oral administration (400mg)
(Group 1) or non-administration (Group 2) group according to age (B60 or
6075 years), ICGR15 (B20 or 2040 %) and vp (absent or present) by
prospective, randomized method. Dihydropyrimidine dehydrogenase (DPD)
and thymidylate synthase (TS) gene expression were quantified by TaqMan
reverse transcription-PCR assay.
Results. The disease free rates at 12 months were 68% and 63.5% in groups
1 (n34) and 2 (n40), respectively (p0.31). In group 1(n21), the TS
and DPD mRNA were measurable with respective mean values of 2.43 and
9.63. The recurrence rate within 6 months tended to be lower in 12 patients
(group 1A) with low TS (B2.43) and low DPD mRNA (B9.63) values than
that in 8 patients (group 1B) with high TS (?2.43) and high DPD mRNA
(?9.63) values (25% vs 50%) (p0.25). The disease free period tended to be
longer in group 1A than in group 1B (15.4M vs 7.6M). In group 2, there
were no differences in the recurrence rate within 6 months according to the
TS and DPD mRNA values.
Conclusions. Adjuvant UFT administration was considered effective for
preventing early recurrence in patients with low TS and low DPD mRNA
values after resection of HCCs. Selective administration of 5-FU is
recommended.
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SYSTEMATIC SUBSEGMENTECTOMY IS AN ADEQUATE PRO-
CEDURE FOR PREVENTING RECURRENCE OF HEPATOCEL-
LULAR CARCINOMA
Keiichi Kubota1, Junji Kita, Mitsugi Shimoda2, Tokihiko Sawada3
1Department of Gastroenterological Surgery, Dokkyo University Hospital;
2Department of Gastroenterological Surgery; 3Department of Gastroenter-
ological Surgery, Dokkyo Unversity Hospital
Background/Aims. Hepatocellular carcinoma (HCC) is characteristic of
causing intrahepatic metastasis (im). Systematic (anatomic) subsegmentect-
omy (SS) was developed to extirpate the total portal area containing a
hepatocellular carcinoma (HCC) and im. This study aims to clarify the
efficacy of SS by comparing recurrence pattern (RP) of HCC after SS and
limited resection (LR).
Methods. 52 SS and 69 LR cases for one HCC were enrolled in this study.
Their clinicopathological data and disease-free survival time (DFST) were
evaluated retrospectively.
Results. Group characterisitics (SS vs LR): Age; 65y vs 69y, ICG15; 14.8%
vs 22.4% (pB0.01), Alb (g/dl); 3.8 vs 3.4 (pB0.01), Tumor size (cm); 2.7 vs
2.5, LC; 32/52 vs 55/69. Pathological data: portal invasion (vp); 11 vs 9, im;
10 vs 7. RP: (SS) 20 of 52 patients (38%) developed recurrence (Liver; 18,
Lung; 1, Bone; 1). 3 of 11 patients with vp and 3 of 10 with im developed
recurrence in the liver. 8 of the 18 patients (44%) underwent re-resection,
while the remaining 10 received TAE. (LR) 44 of 69 patients (64%)
developed recurrence (Liver; 43, Lung; 2). 8 of 9 patients with vp and all 7
patients with im developed recurrence in the liver. 6 of 43 patients underwent
re-resection, while the remaining 37 received TAE. Cumulative survival rate
at 5 years: 89.8% vs 84% (p0.453). DFSTat 3 years: 44.5% vs 29.7% (p
0.042).
Conclusion. In terms of DFST, SS is considered adequate for extirpating
single HCC.
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LIVER TRAUMA
Daniel Langer1, Frantisek Belina, Robin Strnad, Petr Chmatal, Pavel Kupka,
Jiri Lacman2, Radek Dolezel, Miroslav Ryska
1Surgery Department, 2nd Faculty of Medicine, Charles University and
Central Military Hospital Prague, Czech Republic; 2Radiology Department,
Central Military Hospital Prague, Czech Republic
Objective. A contemporary possibilities of diagnostic and therapeutic
process in hepatic trauma patients is presented.
Methods. A retrospective analysis was used in our group of 108 patients (78
men, 30 women), who were treated in our surgery department since the 7/
1996 till 12/2006. There were blunt injuries in 93.5%, associated extra-
hepatic injuries occurred in the most of our patients; the mean ISS rate was
30.7. Operative treatment indication was in more then half of patients
(63.8%). The motor vehicle accidents occupied the foremost position in
frequency of traumatic causes.
Results. Mortality rate of our group was 29.6 per cent. We did not note
any death of penetrating trauma of liver. There were 5 deaths out of 39
patients with conservative approach treatment (12.8%) for extrahepatic
cause. 27 (43.5%) of blunt hepatic trauma patients died after surgical
treatment (17 patients for traumatic shock, 10 for MOF). There were 5
(4.6%) of biliary complications in our group. The mean hospital stay in
ICU was 21 days.
Conclusion. There was increasing occurrence of hepatic trauma revealed at
one side whereas descending mortality rate was recorded on the other over
the last decade. Still more sophisticated diagnostic methods (bed-side
ultrasound, spiral CT, MRI) and development of miniinvasive procedures
all provide treatment for the most of hepatic trauma patients without surgical
intervention. If there is a patient status available for operative treatment we
vote for considerate and no-time-consuming operative care. We prefer staged
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operative strategy in very severe cases (damage control surgery). The high
level of injury severity score, the characteristic of hepatic injury or multiple
trauma of abdominal organs were reasons for more then a half number of
surgically treated patients in our group.
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URGENT RESECTION OF SPONTANEOUSLY RUPTURED LI-
VER TUMOURS: REPORT OF THREE CASES
La˜¡szla˜ Sasi Szaba˜1, Zsolt Szentkereszty, Bala˜izs Kutassy2, Istva˜in Csa˜zy2,
Pa˜#ter Sa˜ipy
1Inst. of Surgery, Auguszta Surgical Center, Medical Health Science
Center,University of Debrecen, Hungary; 2Department of Pediatric Surgery,
Paediatric Institute, Medical Health Science Center,University of Debrecen,
Hungary
Introduction. The rupture of the tumour is a potentially fatal complication
of liver neoplasms. The authors present three cases of urgently operated
ruptured liver tumours with different origins.
Methods.
Case 1. A 7 years old girl with a positive familiar anamnesis of hepato-
blastoma was admitted with signs of severe abdominal bleeding. During the
operation a ruptured tumour was removed from the 4th segment of the liver.
Histology proved hepatoblastoma.
Case 2. A 51 years old female was admitted with DIC. The origin was an
enormous ruptured hemangioma occupying the right hepatic lobe. After an
unsuccessful chemoembolisation an urgent right lobectomy was performed.
Case 3. An 65 years old male was planned to undergo staging laparoscopy
due undetermined neoplasm of the liver suspected to be HCC. During
laparoscopy we detected the rupture of the tumour of the left lobe. After
conversion a left lobectomy was performed.
Results. The 7 years old girl received chemotherapy. After 27 months she is
free of recurrency.
The 51 old year old female died after 8 months due to the rupture of lung
hemangiomas.
The 65 years old male died 13 months after the resection because of
recurrence of the HCC.
Discussion/Conclusion. In certain cases when the chemoembolisation is
not successful and delayed operation is not affordable urgent liver resection is
the treatment of choice. It can result a good survival rate comparable to those
undergoing elective surgery although the complication rate is higher and the
recurrence of the disease is more common.
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THE ROLE OF ULTRASOUND TO DETECT RESECTABLE RE-
CURRENCE AFTER HEPATECTOMY FOR COLORECTAL LIVER
METASTASES
Chris Mann1, Christopher P Neal, Matthew Metcalfe, Clare Pattenden,
Yvonne Rees, Ashley Dennison, David Berry
1Department of Hepatobiliary and Pancreatic Surgery, University Hospitals
of Leicester
Background. Recurrence occurs in the majority of patients following
hepatectomy for colorectal liver metastases. Repeat resection offers a
feasible treatment for some of these patients. The aim of this study was
to evaluate an ultrasound-based follow-up in the detection of resectable
recurrent disease.
Methods. All patients undergoing hepatectomy for colorectal liver metas-
tases at a single hepatobiliary referral centre in the UK from January 1999 to
January 2005 were identified. Parameters reviewed included rates of
recurrence, modality and timing of detection, rates of repeat hepatectomy,
and survival.
Results. During the study period 191 patients underwent initial resection of
colorectal liver metastases, and of these, 109 patients developed recurrent
disease. In total, 21 patients underwent potentially curative intervention (16
hepatic resections, 4 pulmonary resections and 1 staged pulmonary/hepatic
resection). Ten patients (13.9%) presenting with recurrent disease prior to 12
months after initial resection were amenable to curative resection compared
to 11 patients (29.7%) presenting after 12 months. Sonographic surveillance
identified all of the potentially resectable recurrent hepatic disease in this
series.
Conclusions. Ultrasonography is effective in the detection of potentially
resectable hepatic recurrence after hepatectomy for colorectal liver metas-
tases; however routine chest imaging is needed.
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MAJOR RESECTION OF HEPATIC COLORECTAL LIVER ME-
TASTASES IN ELDERLY PATIENTS ? AN AGGRESSIVE AP-
PROACH IS JUSTIFIED
Chris Mann1, Christopher P Neal, Sarah Thomasset, Clare Pattenden,
Matthew Metcalfe, Ashley Dennison, David Berry
1Department of Hepatobiliary and Pancreatic Surgery, University Hospitals
of Leicester
Introduction. With a progressively ageing population, increasing numbers
of elderly patients will present with colorectal metastases and be referred for
surgical resection. The aim of this study was to assess the safety of hepatic
resection in patients over seventy years of age by comparing outcomes with
those of a younger cohort of patients.
Patients and Methods. 49 patients over 70 years old who underwent
hepatic resection of colorectal liver metastases were compared to 142 patients
less than 70 years of age in terms of pre-, peri-, and post-operative results, as
well as long-term survival.
Results. Major resections were performed in 61.2% of the elderly group and
67.6% of the younger group. The two groups were comparable in terms of
operative duration, transfusion rate, length of HDU stay and post-operative
hospital stay. The elderly group had a non-significant increase in post-
operative morbidity. The 30-day and 60-day/inpatient mortality rates were
similar between the two groups (elderly 0% and 4.1%; younger 2.1% and
2.8%). Long-term disease-free survival was similar between elderly and
younger patients.
Conclusion. This study confirms that an aggressive surgical policy towards
colorectal metastases in elderly patients is associated with low peri-operative
morbidity and mortality, as well as good long-term outcomes.
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REPEAT RESECTION FOR HEPATIC COLORECTAL METAS-
TASES CAN EFFECTIVELY CURE RECURRENT HEPATIC DIS-
EASE
Chris Mann1, Christopher P Neal, Matthew Metcalfe, Clare Pattenden,
Sarah Thomasset, Ashley Dennison, David Berry
1Department of Hepatobiliary and Pancreatic Surgery, University Hospitals
of Leicester
Introduction. Disease recurs in up to three quarters of patients following
hepatectomy for colorectal liver metastases, and is confined to the remnant
liver in approximately half of cases. It is therefore potentially amenable to
further hepatic resection. The aim of this study was to analyse the results of
repeat hepatic resection at a single tertiary hepatobiliary referral centre in the
United Kingdom.
Patients and Methods. All patients undergoing repeat hepatectomy for
colorectal liver metastases at a single hepatobiliary referral centre in the UK
from January 1999 to January 2005 were identified. The outcome of these
patients was analysed and compared with those patients not developing
recurrent disease.
Results. 17 patients underwent repeat hepatectomy during the study period,
one as part of a staged pulmonary/hepatic procedure, with a mortality rate of
0%. The overall survival was significantly improved in those patients
undergoing repeat resection than those with recurrent disease treated by
palliative measures only (p0.008); 3-year survival rates 66% vs. 25%. The
survival of patients undergoing repeat hepatic resection was similar to those
patients not developing recurrent disease (p0.976); 3-year survival rates
66% vs. 69%.
Conclusion. Repeat hepatectomy for recurrent colorectal liver metastases
can be performed with low mortality rates, and can effectively cure patients of
recurrent hepatic disease.
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HEPATIC ADENOMATOSIS : A CASE REPORT
Stefano Cappato1, Claudio Bagarolo2, Diego Dedola3, Marco Filauro3
1General and Hepatobiliopancreatic surgery Unit Galliera Hospital Genoa
Italy; 2General and Hepatobiliopancreatic surgery unit Galliera Hospital
Genoa Italy; 3General and Hepatobiliopancreatic Surgery Unit Galliera
Hospital Genoa Italy
Hepatic adenomatosis (HA) is a rare disease defined by the presence of
multiple hepatic adenomas. The natural history and treatment of HA are not
yet well defined , because the potential for intraperitoneal hemorrhage or
malignant transformation is difficult to estimate.
Furthermore the technical difficulties of complete resection of all adenomas
may present unique operative challanges.
In contrast to solitary adenomas , HA shows no association with the use of
oral contraceptives and increase in size and propensity to rupture during
pregnancy is also not known.
We report an atypical case of hepatic adenomatosis associated with a
significant increase in size and number of lesions during pregnancy.
A 32-year-old woman was found to have two hepatic hypervascular tumors
located in the right liver. The patient had history of oral contraceptives.
Nodule biopsy suggested focal nodular hyperplasia.
After pregnancy she was reevaluated ad it was noticed a marked increasing in
size and number of lesions. A new biopsy suggested hepatic adenomas.
Segmental hepatectomy was performed along with radiofrequency ablation.
Histopatological examination of the surgical specimen confirmed estrogen
positive hepatic adenomatosis.
Although lack of estrogen receptors in many lesions described in literature
may suggest that estrogen does not play a dominant role , our case shows that
analysis of estrogen receptor status may help in the treatment strategy.
187
COMPLICATIONS OF THE HYDATID LIVER CYSTS. HOW DO
WE MANAGE THEM
48 Abstracts
Radoje Colovic1, Slavko Matic, Miodrag Jovanovic, Nikica Grubor, Mihajlo
Jagodic, Vladimir Radak
1Institute for Digestive diseases, Clinical Centre of Serbia
The hydatid cyst of the liver is benign, usually uncomplicated disease, but
which occasionally may complicate in one of four ways: perforate, become
infected, give complications on bile ducts or blood vessels.
1. The perforation of the cyst is rare today, giving an anaphylactic reaction of
various intensity and give dissemination from mild to incurable. 2. The
infection of the cyst is almost always caused by communication with bile
ducts. The infected hydatide cyst presents as a low grade liver abscess but
which may rarely perforate into the pleural cavity, right lung giving
biliobronchial fistula, through the abdominal wall in previously operated
patients or into the surrounding organs. All are very rare today. 3.
Complications on blood vessels are rare and may express as a compression
on the inferior vena cava, on portal vein, or cause thrombosis of the portal
vein or perforate into the hepatic veins. 4. Complications on bile ducts are the
most frequent appearing in up 30% of cases. Cyst over 10 cm, cyst localized
in the left lobe and centrally localized cyst are more likely to damage the bile
ducts. This complication may stay clinically silent, but may cause obstructive
jaundice, cholangitis or even pancreatitis. Those cysts are usually infected.
The communication may be suspected preoperatively but must be established
during the operation. Operative cholangiography is of grate importance. It
may be performed either through the cystic duct or trough the defect to show
distal and/or peripheral part of the biliary tree. The biliary tree must be
cleaned up and the defect repaired. The method of repair depends on the
rank of the involved bile duct, on the size and the shape of the defect and on
the approachability for repairmen. It may be simple suture, direct repair,
repair over a T tube or anastomosis with Roux en Y jejunal limb.
Omentoplasty is recommended and the drainage is mandatory. The drain
should not be removed early as the bile leak may appear even after several
days postoperatively. In some cases of bile duct damage a liver resection may
be a good solution, but in the author’s experience major liver resections are
not indicated. Choledochoduodenostomy, in author’s view, is not indicated
and it may cause more problems then good.
The author presents a number of different complications, most of which on a
biliary tree in a manner ‘‘How I do it’’.
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MUCINOUS CYSTADENOMA OF THE LIVER IN A PATIENT
WITH MALIGNANT HISTIOCYTOSIS
Natasa Colovic1, V Jurisic, Slavko Matic2, Milica Colovic
1Institute for Hematology, Clinical Centre of Serbia; 2Institute for Digestive
diseases, Clinical Centre of Serbia
Introduction. Hepatic cystadenoma is a very rare cystic tumor of the liver
and association with malignant histiocytosis has not been reported so far.
Case outline. In a 64-year-old female on physical examination hepatome-
galy (2 cm) was found. After ultrasound and CT scan analyses liver cyst
was diagnosed and surgically treated. The whole cyst was removed. The
histology of the cyst showed a mucinous cystadenoma. Four months the
patient noticed cutaneous changes and systemic lymphadenopathy. Histology
and immunohistochemistry of the lymph node and bone marrow specimens
showed extensive infiltration with atypical cells, resembling malignant
histiocytes [CD45, CD45RO, CD11c, CD68, lysozyme, antitrypsin and
?1-antichimotrypsin positive, CD1, CD35, B-cell and T-cells markers
negative]. She was treated with vinblastine, methotrexate and dexametasone
(3 cycles) without response. The therapy was switched to the CHOP
(cyclophosphamide, vincristine, doxorubicin, and prednisone) protocol
with a good response but without achieving a complete remission. Two
months after completion of 6 cycles of protocol CHOP she had headache,
vomiting finally lost consciences and become paraparetic. CT scan was
normal but in sediment of cerebrospinal fluid histocytes were found. The
patient was treated with intratechal application of methotrexate, pednisolone
and cytosine arabinoside and systemic therapy with vepesid and cyclopho-
sphamide. Her condition improved but she hasn’t achieved remission.
Conclusion. An association of mucinous cystadenoma of the liver and
malignant histiocytosis is unusual. There are some literature data of
associations of other malignant tumors and malignant histiocytosis.
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THE IMMEDIATE REGENERATIVE RESPONSE AFTER PAR-
TIAL HEPATECTOMY VARIES WITH PORTAL PRESSURE AND
FLOW IN THE LIVER REMNANT. A STUDY OF GENE EXPRES-
SION PROFILES IN THE PIG
Kim Erlend Mortensen1, Lene Conley2, Jakob Hedegaard2, Peter Soeren-
sen2, Christian Bendixen2, Arthur Revhaug3
1Department of Gastrointestinal Surgery, University Hospital of Northern
Norway and Laboratory of Experimental Surgery, University of Tromsa˜aˆa˜,aˆ,
Norway; 2Department of Genetics and Biotechnology, Research Centre
Foulum, Faculty of Agricultural Sciences, University of Aarhus; 3Laboratory
of Surgical Research, Institute of Clinical Medicine, University of Tromsa˜aˆa˜,aˆ
Introduction. The majority of studies on liver regeneration to date have
been conducted after 2/3 hepatectomy (PHx) in rodents and most studies on
cell cycle and apoptosis in cell cultures and yeast two-hybrid systems.
Prevailing theories on triggering events leading to regeneration include
humoral, metabolic and flow-mediated mechanisms, the latter emphasizing
the importance of shear stress mediated nitric oxide (NO) regulation. Recent
microarray studies reveal that a multitude of cellular systems are simulta-
neously activated and repressed following PHx, notably, genes regulating
protein, nucleic acid, cytoskeleton and extra cellular matrix synthesis and
genes controlling cell cycle entry and apoptosis.
Aims. To investigate whether the grade of resection and hence the portal
venous pressure, would be reflected in the gene expression profiles in the
regenerating liver.
Methods. We employed a global porcine cDNA microarray chip with
approximately 23.000 genes represented to explore gene expression profiles
in consecutive biopsies from liver remnants after two different grades of
resections (Low Poprtal venous Pressure Resection (LPPR) and High Portal
venous Pressure Resection (HPPR)) in the pig. Analysis of gene function was
performed using Gene Ontology and OMIM.
Results. Six pig livers were resected with 62% and 75% resulting in a portal
venous pressure increase from a baseline of 6,1 mmHg to 8,2 and 12 mmHg
respectively. A total of 1095 genes were differentially expressed post PHx in the
LPPR group and 1010 genes in the HPPR group. Differentially expressed genes
in the HPPR group have functions related primarily to apoptosis, nitric oxide
metabolism and oxidative stress, whereas differentially expressed genes in the
LPPR group potentially regulate the cell cycle. Common to both groups was
the upregulation of genes regulating inflammation, transport, cell proliferation
and development and protein metabolism. Also common to both groups was
both up- and downregulation of genes regulating cell-cell signaling, signal
transduction, cell adhesion and translation. Genes regulating the metabolism of
lipids, hormones, amines, and alcohol were downregulated in both groups.
Conclusions. A higher degree of liver resection results in the differential
expression of genes controlling apoptosis, NO metabolism and oxidoreduc-
tase activity, whereas a lower degree of resection results primarily in the
differential expression of genes controling cell cycle progression. Multiple
other cellular systems are simultaneously activated in both resection groups
tentatively redirecting resources to cell proliferation, extra cellular matrix
synthesis and angiogenesis after PHx.
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THE P95 SUBUNIT OF HER2 IS HIGHLY EXPRESSED IN COL-
ORECTAL LIVER METASTASES AND CORRELATES WITH MA-
TRIX METALLOPROTEINASE-2 EXPRESSION
Christopher P Neal1, Elena P Moiseeva2, Sarah Dillon2, Margaret M
Manson2, Ashley R Dennison, David P Berry
1Department of Hepatobiliary and Pancreatic Surgery, Leicester General
Hospital; 2Cancer Biomarkers and Prevention Group, University of Leicester
Introduction. The HER2/ErbB2 oncoprotein, combined with Erb4, is
prognostic in the context of primary colorectal cancer and is overexpressed
in 80% of colorectal liver metastases (CLM). Cleavage of the HER2p185
receptor, possibly due to matrix metalloproteinase (MMP) activity, results in
a soluble extracellular domain and an intracellular activated HER2p95 kinase
domain. The importance of this latter form has not been investigated. The
aim of this study was to examine expression of these two forms of HER2 in
colorectal liver metastases and to determine their association with clinico-
pathological characteristics and with matrix metalloproteinase activity.
Methods. Quantitative analysis of protein expression using Western blotting
was performed on metastatic samples from sixteen patients undergoing
resection of CLM. MMP-2 and -9 expression was measured by zymography.
Correlations between biomarker expression levels and clinicopathological
characteristics were determined.
Results. HER2p185 and/or HER2p95 fragment were expressed in 14 (88%)
samples of liver metastases. In 12 cases, the levels of HER2p95 were
significantly greater than the levels of HER2p185. Active MMP2, proform
MMP2 and MMP9 were expressed in 81%, 100% and 88% of cases
respectively. Increased Her2p185 levels were negatively correlated with
Memorial Sloane-Kettering Clinical Risk Score (P0.004). A clear trend
was noted between increased active MMP2 expression and increased expres-
sion of HER2p95 (P0.055). A significant association was also noted between
expression of MMP9 and active or proform MMP2 (P0.0009 and 0.029
respectively).
Discussion. These results confirm that HER-2 is commonly expressed
within CLM, and demonstrate that the dominant form of the protein is the
truncated intracellular fragment HER2p95. These findings suggest that, in
the context of CLM, agents targeting the tyrosine kinase domain of HER2
may have more clinical utility than monoclonal antibodies directed solely
against the extracellular domain.
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THE RELATIONSHIP BETWEEN SYSTEMIC INFLAMMATION,
SOCIOECONOMIC DEPRIVATION AND CANCER-SPECIFIC
SURVIVAL IN PATIENTS WITH RESECTABLE COLORECTAL
LIVER METASTASES
Christopher P Neal1, Christopher D Mann, Claire J Pattenden, Giuseppe
Garcea, Ashley R Dennison, David P Berry
1Department of Hepatobiliary and Pancreatic Surgery, Leicester General
Hospital
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Introduction. Socioeconomic deprivation has previously been demonstrated
to be independently associated with decreased cancer-specific survival in
patients undergoing resection of primary colorectal cancer. This association
was proposed to be due, in part, to increased systemic inflammation in
deprived patients. The aim of this study was to determine the prognostic
potential of socioeconomic deprivation and systemic inflammation (mea-
sured by peripheral neutrophil count and serum albumin) in the context of
resectable colorectal liver metastases (CLM).
Methods. Data on patients undergoing resection of CLM between January
1999 and December 2004 were reviewed. Pre-operative clinicopathological
variables, including the Memorial Sloane-Kettering Clinical Risk Score
(CRS), neutrophil count and serum albumin were recorded. Deprivation
was measured using the Carstairs deprivation index, which has been
extensively used in cancer patients. Variables were compared to cancer-
specific survival by entry into a Kaplan-Meier model and application of the
log rank test. Significant variables were entered into a Cox regression analysis
in order to determine independent prognostic significance.
Results. 174 patients underwent hepatic resection for CLM over the study
period and were eligible for inclusion. Median pre-procedure neutrophil
count was 6.5109/L (range 3.012.8) and median Carstairs score was
1.35 (range 4.31 to 12.22). By univariate analysis, significant variables for
decreased cancer-specific survival included increasing CRS (P0.008),
increasing neutrophil count (PB0.001) and decreasing serum albumin
(P0.009). Deprivation showed a non-significant trend towards poorer
survival (P0.1) and no significant association with systemic inflammation.
On multivariate analysis, significant variables for decreased cancer-specific
survival were increasing neutrophil count (PB0.001), decreasing serum
albumin (P0.004) and increasing CRS (P0.007). When combined with
the CRS, neutrophil count identified five patient groups with progressively
poorer cancer-specific survival (PB0.001).
Conclusion. Systemic inflammation, but not socioeconomic deprivation, is
associated with decreased cancer-specific survival following resection of CLM.
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EXPRESSION OF CYCLO-OXYGENASE-2 (COX-2) CORRE-
LATES WITH EPIDERMAL GROWTH FACTOR RECEPTOR
(EGFR) IN RESECTED COLORECTAL LIVER METASTASES
(CLM) AND PREDICTS SHORTENED DISEASE-FREE SURVI-
VAL
Christopher P Neal1, Elena P Moiseeva2, Sarah Dillon2, Margaret M
Manson2, Ashley R Dennison, David P Berry
1Department of Hepatobiliary and Pancreatic Surgery, Leicester General
Hospital; 2Cancer Biomarkers and Prevention Group, University of Leicester
Introduction. Epidermal growth factor receptor (EGFR) and the prosta-
glandin endoperoxidase COX-2 are implicated in the pathogenesis of
colorectal cancer (CRC) and are key targets for novel molecular therapies.
Cooperation between the EGFR and COX-2 pathways in carcinogenesis has
been demonstrated in other malignancies, suggesting that combining targeted
therapies against EGFR and COX-2 may further improve anti-cancer
efficacy. The aim of this study was to examine expression of EGFR, COX-
2 and the prostaglandin metabolising enzyme prostaglandin dehydrogenase
(PGDH) in resected CLM, determining their correlations with each other
and with clinicopathological characteristics.
Methods. Quantitative analysis of protein expression using Western blotting
was performed on metastatic samples obtained from sixteen patients under-
going resection of CLM. Correlations between biomarker expression levels
and clinicopathological characteristics were determined.
Results. EGFR, COX-2 and PGDH expression was detected in 44%, 63%
and 100% of CLM respectively. Increasing EGFR expression was signifi-
cantly associated with increasing COX-2 expression (P0.004), whilst
PGDH expression was associated with neither EGFR nor COX-2 expression.
No association between COX-2 or EGFR expression and tumour number,
tumour size or Memorial Sloane-Kettering Clinical Risk Score was demon-
strated. Increasing COX-2 expression was, however, significantly associated
with both decreased disease-free survival (P0.03) and decreased hepatic
disease-free survival (P0.027) following metastasectomy, whilst increasing
EGFR showed a non-significant trend towards decreased disease-free survival
(P0.18).
Discussion. These findings support a biological link between EGFR and
COX-2 in metastastic colorectal cancer akin to that demonstrated in other
maligancies, and suggest a role for COX-2 in the development of an
aggressive tumour phenotype. These findings confirm the potential for
COX-2 inhibition with or without concomitant EGFR inhibition in the
treatment of metastatic colorectal cancer.
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INTEGRATED CT-PET DETECTS EXTRAHEPATIC DISEASE
WITH GREATER SENSITIVITY THAN CT/MRI IN PATIENTS
WITH POTENTIALLY RESECTABLE COLORECTAL LIVER ME-
TASTASES
Christopher P Neal1, Giuseppe Garcea, Daniel C Jones, Christopher D
Mann, Christina Pollard, Ashley R Dennison, David P Berry
1Department of Hepatobiliary and Pancreatic Surgery, Leicester General
Hospital
Introduction. Integrated computed-tomography/positron emission tomo-
graphy (CT-PET) is increasingly being advocated for the evaluation of intra-
and extra-hepatic disease in patients with colorectal liver metastases (CLM).
To date, however, few studies have evaluated the accuracy of CT-PET in the
context of CLM. In this paper we evaluate the sensitivity and specificity of
CT-PET in the context of potentially resectable CLM, and report the first
comparison of this technique with a CT and magnetic resonance imaging
(MRI)-based imaging protocol (CT/MRI).
Methods. All patients who, due to diagnostic uncertainty following standard
imaging, required CT-PET between June 2004 and June 2006 were eligible
for inclusion. Results of CT-PET and our standard imaging protocol
(contrast-enhanced CT scanning of the abdomen/pelvis/thorax and MRI of
the liver) were compared with actual disease distribution (determined by
laparotomy/intra-operative ultrasound (IOUS), laparoscopy/IOUS and/or
serial CT scanning).
Results. Over the study period 37 patients underwent CT-PET and were
eligible for inclusion. CT/MRI and CT-PET showed comparable sensitivity in
detection of the number/distribution of intrahepatic metastases (53 unilobar
vs. ]4 unilobar vs. bilobar), with sensitivities of 89% and 92% respectively
(PNS). CT/MRI and CT-PETalso demonstrated equal sensitivity (89%) in
the detection of pulmonary metastases. CT-PET was, however, significantly
more sensitive in the detection of non-pulmonary extrahepatic disease than
CT/MRI. Non-pulmonary extrahepatic disease was missed by CT/MRI in
64% of cases, whereas CT-PET failed to detect such disease in only 14% of
cases (p0.02). Both CT/MRI and CT-PET demonstrated high specificity in
the detection of non-pulmonary extra-hepatic disease, with false-positive rates
of 9% and 4% respectively (PNS).
Discussion. This is the first study to compare integrated CT-PET with a
CT/MRI-based imaging protocol in the context of potentially operable CLM.
CT-PET was found to provide similar information to CT/MRI regarding the
intra-hepatic distribution of CLM, but demonstrated significantly superior
sensitivity in the detection of non-pulmonary extra-hepatic disease, without
any corresponding loss of specificity.
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LONG-TERM RESULTS OF LIVER RESECTION FOR NON-COL-
ORECTAL NON-NEUROENDOCRINE METASTASES
Thomas O’Rourke1, Shinn Yeung2, Russell Strong2, Fenella Welsh, Tim
John, Paris Tekkis3, Myrddin Rees
1The North Hampshire Hospital; 2Princess Alexandra Hospital; 3Imperial
College, St Mary’s Hospital
Introduction. The safety and efficacy of liver resection for colorectal and
neuroendocrine liver metastases is now well established. However, there
remains a paucity of data regarding the long-term effectiveness and a lack of
consensus for the treatment of non-colorectal, non-neuroendocrine (NCNN)
liver metastases.
Methods. A retrospective review of the prospective database and medical
records of patients undergoing resection for NCNN liver metastases at the
North Hampshire and Princess Alexandra Hospitals between 1986 and 2006
was undertaken. Clinical, demographic and operative data was collated and
patient survival was analysed using the Kaplan-Meier method.
Results. 114 cases in 101 patients were identified from the database. Overall
survival at 3, 5 and 10 years was 55, 38 and 23% respectively. There was
improved outcome when the size of the largest metastasis is less than 5cm.
The presence of hepatoduodenal ligament lymphadenopathy, positive resec-
tion margins or extrahepatic tumour were predictors of diminished survival.
The type of tumour, tumour-free interval and number of metastases did not
significantly impact upon long-term survival.
Conclusion. In selected cases, liver resection for NCNN metastases is an
effective management option for patients with disease isolated to the liver.
The long-term survival is comparable to that achieved in liver resections for
colorectal liver metastases. Our data supports the cautious application of liver
resection in this diverse group of patients.
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RADIOFREQUENCY ENERGY ASSISTED HEPATECTOMY IN
COLORECTAL LIVER METASTASES
K. N. Nikas , K. E. Tsimogiannis , E. Sioziou , G. Gogos-Pappas , N.
Benetatos , E. C. Tsimoyiannis
Department of Surgery, ? G.Hatzikosta ? General Hospital, Ioannina ,
Greece
Background. Liver surgery remains the gold standard for the treatment of
liver tumors . Radiofrequency energy seems to be the most sucessful and
versatile technique from all the others that were being applied to liver surgery.
Aim. Retrospective study of the results in patients with colorectal liver
metastases, than radiofrequency energy assisted hepatectomy (RFaHE) was
performed.
Material-Methods. Since March 2002, 21 RFaHE for colorectal liver
metastases were performed . 11 pts. were male and 10 female with mean age
60.2911.3 (range 3580). Synchronous colorectal liver metastases were
occured in 13 pts. (in 3 of them a laparoscopic approach (LA) was
performed) and metachronous metastases in 8(1by LA). Laparoscopically
were treared pts. with hepatic tumors less than 5 cm in diameter, located in
segments II to VI without previous liver surgery.
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Results. Number of metastases who were treated was 65. Wedge resection
was performed in 27 cases (LA:2), segmentomy in 16 (LA:1), right
hepatectomy in 2 and RF ablation in 20 cases (LA :12) . Hepatic resection
only was performed in 15(71.5%) pts. and 6(28.5%) underwent resection
and radiofrequency ablation. In all cases the mean blood loss was 1259
65ml.Post-operative bleeding was occured in 1 case, bile leakage in 1 and
pleural effusion in 2 cases . Patients were followed during a mean period of
25930 months and the cases of reccurence were 3(14.3%) . Died are 8(38%)
pts., 13(62%) still alive with 11 of them free-disease sympthoms. Mortality
rate during first 30 post-operative days was 0%.
Conclusions. Hepatic resection is the treatment of choice for colorectal liver
metastases. The use of RF in the management of liver metastases, especially
in hepatectomies, seems to offer advantages but require a greater number of
studies to be confirmed in order to improve the survival and quality of life in
patients with colorectal liver metastases.
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REPEATED LIVER RESECTIONS FOR MALIGNANT TUMOURS
Yury Patyutko1, Igor Sagaidak, Anton Ivanov, Danil Podluzhny
1State institution N.N. Blokhin Cancer Research Center
Key words. repeated liver resection
Aim. Demonstration of the liver surgery capabilities in the treatment of the
recurrent hepatic malignancies
Seven hundreds sixteen hepatic resection have been performed in the
Department of hepatopacreatobiliary surgical oncology, Cancer Research
Clinic, State institution N.N. Blokhin Cancer Research Center for primary
and secondary liver malignancies since 1990. One hundred eight (14.6%)
patients developing intra- and extrahepatic recurrences underwent the
varying repeated procedures: hemihepatectomies  19, segmentectomies
and wedge liver resections  37 (including 9 third liver resections), radio-
frequency ablation  47, cryoablation -8 and hepatic lymph node dissection -
3. The metastatic lesions originated from the following primary malignancies:
the colorectal carcinoma  in 35, the hepatocellular carcinoma  in 16, the
gall-bladder carcinoma  in 4, the pancreatic head carcinoid tumour  in 4,
the adrenal gland carcinoma  in 4, the ovarian carcinoma  in 1, the cervix
carcinoma  in 1, the sex cord tumour  in 1 and the embryonal sarcoma in 1
patient. Twenty three patients developed the recurrences within six months
after the first liver resection, 25 patients  in a term of six to twelve months
and the rest ones later than one year. Three patients with isolated hilar lymph
node metastases had undergone the liver resections for hepatocellular
carcinoma 3 to 10 years prior to the second procedure. The repeated liver
resections appeared much more challenging comparing with the primary ones
due to the prominent abdominal adhesions and the altered anatomy. They
also demonstrated the higher morbidity rate  45% versus 29% for the first
liver resections. The mortality rate after re-resections was 2.9%. The
actuarial 5-year survival rates were 36.5, 49.5 and 52.2% in patients
undergoing repeated liver resections for colorectal metastases, non-colorectal
metastases and intrahepatic recurrences of primary hepatic tumors, respec-
tively. The repeated liver resections can pronouncedly improve survival in the
accurately selected patients.
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REGIONAL CHEMOTHERAPHY IN THE TREATMENT OF GAS-
TRIC CARCINOMA METASTATIC TO THE LIVER (GCML):
LONG-TERM RESULTS
A.A. Polikarpov1, P.G. Tarazov, I.Sh. Gasanov, D.A. Granov
1Dept. of Angio/Interventional Radiology, St. Petersburg Research Institute
of Roentgenology
Purpose. To evaluate survival of pts with GCML after hepatic artery
infusion (HAI) and transcatheter artery chemoembolization (TACE).
Materials and Methods. Between 1992 and 2002, 28 pts with advanced
unresectable GCLM received transcatheter treatment. Of them, 19 pts
underwent 52 courses HAI with 5-FU, Doxorubicin and Cisplatin. In the
remaining 9 cases, 18 courses TACEs with 6080 mg Doxorubicin in 1020
ml Lipiodol plus Gelfoam were performed.
Results. At present all pts died.In group of HAI, one complete and four
partial tumor responses are seen. Stabilization was noticed in 6 pts, while 8
pts showed tumor progression. The mean survival for HAI was 12.41.9
mo, with 1-, 2- and 3-yr survival 47%, 11% and 5%, respectively.After
TACE, stabilization developed in 4 and progression in 5 pts. The mean
survival was 8.42.2 mo (pB0.05 if compared with HAI), and 1-, 2-and 3-
yr survival 22%, 11% and 0%, respectively.
Conclusion. For the pts with unresectable GCLM HAI is more effective
palliation than TACE.
198
COMPLICATIONS AFTER PERCUTANEOUS TRANSFEMO-
RALLY IMPLANTATION OF A CATHETER-PORT SYSTEM FOR
INTRAARTERIAL CHEMOTHERAPY OF COLORECTAL LIVER
METASTASES
M.I. Generalov1, P.V. Balakhnin, P.G. Tarazov, A.A. Polikarpov, A.V. Kozlov,
V.A. Tsurkan
1Dept. of Angio/Interventional Radiology, St. Petersburg Research Institute
of Roentgenology
Purpose. To evaluate the complications in patients who underwent
percutaneous transfemorally implantation of a permanent catheter-port
system for intraarterial hepatic chemotherapy and to determine their clinical
relevance and specific management.
Methods. Catheter-port systems were placed in 18 patients with colorectal
liver metastases. Under fluoroscopic guidance, infusion catheter was posi-
tioned so that the tip was placed in the distal part of the right gastroepiploic
artery and a side hole in the common hepatic artery. Intraarterial oxaliplatin
plus 5-fluorouracil and systemic leucovorin were administered.
Results. No complications occurred during the implantation procedures.
The mean number of intrahepatic chemotherapy cycles was 8 (118).
During the follow-up period (27550, mean 234 days), complications
occurred in 9 patients (50%) and included: hepatic artery thrombosis (n
4), exposure of the port due to skin defect (n3), gastropancreatoduodenal
misperfusion (n2), catheter dislocation, broken catheter, and broken port
reservoir (each one). Surgical (plastic of skin defect, remove and change
reservoir) or interventional radiological (local thrombolysis, coil embolization
artery supply, replacement catheter) corrections were performed successfully,
and no discontinuation of intrahepatic therapy was needed.
Conclusions. Percutaneous implantation of implantable catheter-port
system for intrahepatic chemotherapy is relatively safe procedure. Technical
and pharmacologic complications are common, but can be effectively treated
by minimally invasive approaches.
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INTRAARTERIAL CHEMOTHERAPY USING IMPLANTABLE
CATHETER-PORT SYSTEM IN THE TREATMENT OF PATIENTS
WITH COLORECTAL LIVER METASTASES: FURTHER EXPERI-
ENCE
M.I. Generalov1, P.V. Balakhnin, A.A. Polikarpov, I.O. Rutkin, V.N.
Polysalov, P.G. Tarazov
1Dept. of Angio/Interventional Radiology, St. Petersburg Research Institute
of Roentgenology
Purpose. To evaluate initial clinical results of catheter-port based contin-
uous hepatic artery infusion chemotherapy (HAI) in the treatment of
colorectal liver metastases.
Methods. Since December 2001 to December 2006, thirty five patients with
colorectal liver metastases were treated with HAI, using implantable catheter-
port system. Laparotomic approach was used in 17 and percutaneous
transfemoral implantation in 18 patients.
Results. No complications occurred during the implantation procedures.
The mean number of chemotherapy cycles per patient was 6 (1 to 18). The
mean follow-up period was 241 (27730) days. At present, 24 patients are
alive within 3 and 29 months and continue to receive HAI, while 11 patients
died in 4 to 22 months due to tumor progression. The common 1-year
survival is 77%.
Conclusion. Initial results showed that HAI using catheter-port system is
feasible and potentially effective for the treatment of unresectable colorectal
liver metastases.
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CYTOREDUCTIVE OPERATIONS COMBINED WITH HEPATIC
ARTERY INFUSION PUMP PLACEMENT FOR TREATMENT OF
UNRESECTABLE LIVER TUMORS
I.O. Rutkin1, V.N. Polysalov, V.V. Borovik2, M.I. Generalov, P.G. Tarazov
1Dept. of Angio/Interventional Radiology, St. Petersburg Research Institute
of Roentgenology; 2Dept. of Operative surgery, Research Institute of
Roentgenology and Radiation Therapy, St.Petersburg, Russia
Purpose. To evaluate the initial results of treatment protocol for unresect-
able liver tumors with combination of cytoreductive surgery: resection and/or
radiofrequency ablation (RFA) of tumor nodules with hepatic artery infusion
pump placement (HAIP) followed by chemotherapy.
Methods. Since April 2003 to April 2006 this protocol was used to treat 14
pts with unresectable liver tumors. 12 pts were operated for colorectal
metastases, one for hepatocellular carcinoma and one for metastatic
carcinoid. The mean number of tumor nodules was 2 (15) and mean
tumor size was 66 (34186) mm. Of 14 pts, seven received RFAHAIP,
four resectionRFAHAIP and three resectionHAIP. All patients get
chemotherapy via implanted HAIP postoperatively.
Results. No serious complication was observed. The mean follow-up
period was 428 (1261012) days with mean number of chemotherapy
cycles 6 (2 to 11) per patient. At present, 8 pts are alive within 6 to 37 mo
and continue to receive chemotherapy, while 6 patients died 421 mo due
to tumor progression. The common 1- and 2-year survival was 85% and
57%.
Conclusion. The combination of cytoreductive surgery with HAIP seems to
be a perspective protocol for the treatment of unresectable liver tumors.
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DOES MULTISLICE COMPUTED CHEST TOMOGRAPHY (CCT)
IMPROVE DETECTION OF PULMONARY METASTASES (PMS)
Abstracts 51
OVER CHEST X-RAY (CXR) IN PATIENTS WITH POTENTIALLY
RESECTABLE COLORECTAL LIVER METASTASES
Himaz Marzook1, Andrea Griffin, Clare Byrne, Paula Ghaneh, Andrew Wu,
Graeme Poston
1University Hospital Aintree
Introduction. The 2006 UK guidelines for PRCLM recommend CCT to
exclude PMs1, but positive CCT yield following normal CXR is B5%2.
PRCLM patients are increasingly referred for pneumonectomy. It is unclear
whether this strategy influences PRCLM referral. We reviewed outcomes
with regard to detection methods of co-existing PMs, subsequent develop-
ment of PMs, and long-term outcome among PRCLM patients undergoing
hepatectomy.
Methods. Retrospective analysis of a prospectively collected consecutive
cohort of 268 PRCLM patients, referred between 01/01/2004 and 31/12/
2005, all with 12 month post-hepatectomy follow up. 52 were deemed
unresectable; 9 of 28 given chemotherapy became resectable with curative
intent. The 188 deemed resectable at time of referral are the subject of this
study. All patients had CXR and CT lung bases (included in CT abdomen).
CCT was only performed following suspicious CXR or CT lung bases. Post-
hepatectomy, CCT was performed at six monthly intervals for a minimum of
12 months.
Results. 13/188 (6.9%) CXRs were suspicious for PMs, confirmed in 12/188
(6.4%), 12/13 were among 18/188 (9.6%) abdominal CTs suspicious for
PMs, 14/188 (7.4%) confirmed; 4/188 (2.1%) lesions radiologically benign.
Of 170 with both negative CXR and abdominal CT, 23/188 (13.5%)
developed PMs within 12 months of hepatectomy. Overall 37/188 (19.7%)
presented with, or developed PMs: 28/37 (77%) had unresectable chest
disease; 9 (23% of all PMs, 4.8% overall of patients undergoing hepatect-
omy) underwent pneumonectomy.
Conclusions. The purpose of chest investigations of PRCLMs is to exclude
hepatectomy because on the basis of unresectable PMs, or detect potentially
resectable PMs. Despite advances in CT technology over the last decade, our
CCT yield [14/188 (7.5%)] over CXR [12/188 (6.4%)] was B1% overall,
and detection of resectable PMs B5%, no better than a decade ago2. Our
data suggest that the yield of CCT over CXR to detect potentially curable
PMs may not be clinically significant.
References
[1] Garden et al. Gut 2006;55(S111):iii1 iii8.
[2] Povoski et al. Ann. Surg. Oncol. 1998;5:915.
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SIMULTANEOUS LAPAROSCOPIC RECTAL AND LIVER RESEC-
TION
Luca Aldrighetti1, Saverio Di Palo2, Carlo Pulitano’, Elena Orsenigo2, Marco
Catena, Andrea Vignali2, Gianfranco Ferla, Carlo Staudacher2
1Department of Surgery, Liver Unit, Scientific Institute San Raffaele, Vita-
Salute San Raffaele University; 2Department of Surgery, Scientific Institute
San Raffaele, Vita-Salute San Raffaele University
Background. The optimal surgical strategy for the treatment of resectable
synchronous liver metastasis from rectal cancer remains controversial. The
optimal surgical strategy for the treatment of synchronous resectable color-
ectal liver metastasis has not been defined. Simultaneous rectal and liver
resection has been associated with increased postoperative morbidity.
Methods. A 59 years old man was admitted to our Department for
adenocarcinoma of the distal rectum and a resectable solitary synchronous
liver metastasis located on the left lobe. First of all, the patient has been
submitted to laparoscopic low anterior resection. Then a left lateral
sectionectomy was performed. Laparoscopic liver resection was performed
combining the ultrasonic dissector and the ultrasonic coagulating cutter.
Results. Postoperative courses were uneventful. Intraoperative blood losses
were 350 ml and length of operation was 450 minutes. The patient was
discharged on post operative day 8 and he is disease free at 6 months after
surgery.
Conclusions. Laparoscopic liver resection performed simultaneously to the
laparoscopic low anterior resection is feasible and safe.
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USE OF RECOMBINANT ACTIVATED FACTOR VII AS ADJUNC-
TIVE THERAPY TO CONSERVATIVE MANAGEMENT IN SEVERE
BLUNT LIVER TRAUMA
Alejandro Serrablo1, Jose Manuel Gavin, Jaime Ruiz-Montoya, Sofia Borlan,
Raquel Valero, Jesus Esarte, Jose Maria Artigas
1Miguel Servet University Hospital
Introduction. Hepatic trauma occurs in approximately 5% of all admissions
in emergency rooms. The anatomic location and the size of the liver make the
organ even more susceptible to trauma. Major liver injuries continue, despite
technical advances, a challenge to surgeons and the last decade there has been
a increasing interest in the conservative management even in the severe liver
injury.
Because of the excellent results in patients with haemophilia, it has been
suggested that rFVIIa (recombinant activated factor VII) might have a place
in other acquired clinical conditions characterized by incoercible bleeding
despite appropriate blood component therapy.
Aim. Two case severe blunt liver trauma report (grade V) in which was used
rFVIIa to avoid continous bleeding and to get a conservative management.
Results. The first case was a a 27 years old male, 90 kilogrames with traffic
trauma. He was admitted in Trauma ICU with liver injury grade V (giant
central haematoma) and spleen haematoma.
The second case was a 43 years old male , 67 kilogrames with traffic trauma.
He was admitted in Trauma-ICU with multiple fractures and liver injury
grade V (intrahepatic middle and right hepatic vein injury and haematoma
what affected VI,VII,VIII liver segments (16cm)). The haemoglobin level in
ICU was 10.0 and 5.2 g/dL, arterial tension 100/67 and 110/70 mmHg,
Glasgow score 15 and 15, respectively. We decided conservative management
with appropriate blood component therapy and alone dosis rFVIIa(60microg/
kg and 50 microgr/kg, respectively).
In the outcome of the first case, suffered hepatic insufficiency and two
haemobilia episody.
Both of them were discharged without abdominal surgery.
Conclusion. All reports to date, including our own experience, suggest that
rFVIIa is a safe drug for use in trauma without adverse effects. However,
further research, preferably as a large randomised clinical trial, is needed to
ascertain whether rFVIIa therapy might improved clinical outcomes and
conservative management in these patients.
Off label administration of rFVIIa might keep in mind as adjunctive therapy
in severe liver injury.
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ERITROPOETIN AND FACTOR YIIA DURING HPB- SERGERY
Alexey Severtsev1, Dimitry Tchudaev2, Vladimir Ovtchinnikov2, Vera Se-
vertseva2, Eduard Nikolaenko2
1Central Clinical Hospital #1 of the LLC ‘‘Russian Railways’’; 2Central
Clinical Hospital #1 of the LLC ‘‘Russian Railways’’
Introduction. Erythropoietin is a drug that stimulates the product of
erythrocytes. Activated drug of recombinant factor YIIa is connected with
tissue factor in the place of tissue damage. The ‘‘recombinant factor YIIa-
tissue factor’’ complex activates factor X and leads to thrombin formation.
The use of recombinant factor YIIa comes into the process of coagulation
only in the place of the damage and doesn’t cause system activation of
coagulation. Its application in some clinical investigations showed encoura-
ging results. Unfortunately by now there are no works evaluating the use of
these two active substances in general surgery and especially in HPB surgery,
where significant hemorrhage takes place. The aim of this study is to estimate
the initial results of application of erythropoietin and recombinant factor YIIa
with patients with extended operations on liver and pancreas accompanied
with significant hemorrhage.
Materials and methods. In the work under the ‘‘planning’’ of perioperative
hemorrhage, which we have been carrying out in our clinic since 1998 and
that is drawn up in the form of clinical trial since 2005, we used
erythropoietin (Epocrin, Russia) and recombinant factor YIIa beginning
from August, 2005. Epocrin was taken into investigations because it most
economical.
Results and preliminary conclusions. By now there are estimated results
on 12 patients only. But now it is clear enough that with extensive
hepatectomy (right-side and left-side lobectomy and trisectorectomy as well
as total pericystectomy (echinococcus) without cross-clamping of hepato-
duodenal ligament) and pancreatectomy (or difficult Wipple procedure) with
blood loss up to 2 liters the use of these medicines together decrease for sure
the perioperative blood loss of 500 ml, there’s no need in hemotransfusion of
allogenic blood during the operation and postoperative transfusion of
allogenic blood is decreased from 3 to 1 units.
The expediency of the use of these two medicines is dictated by the fact that
the use of erythropoietin in perioperative period is accompanied with the
marked intraoperative bleeding sickness of tissues. And input of recombinant
factor YIIa into the treatment regimen lessens this negative feature of
erithropoesis stimulator.
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CARCINOID LIVER METASTASIS WITH THE USE OF OCTREO-
TIDE BEFORE AND AFTER SURGERY
Alexey Severtsev1, Dimitry Tchudaev2, Vladimir Ovtchinnikov2, Vera Se-
vertseva2, Lali Kogonia2, Irina Grishina2
1Central Clinical Hospital #1 of the LLC ‘‘Russian Railways’’; 2Central
Clinical Hospital #1 of the LLC ‘‘Russian Railways’’
Background. The carcinoid tumor is the rare tumor. The diagnosis before
surgery is difficult before surgery, especially when the main tumor is localized
in small intestine and there are multiple liver metastases. Usually the
diagnosis confirmation is very controversial (even to use such new modalities
as PETand Octreoscan). Sometimes the clinic data are much more important
that other investigations. According to basic data octreotide is very effective
for such kind of tumors.
Aim. The purpose of this study was to present the opportunity using of
octreotide as diagnostic and treatment test in the course of carcinoid disease.
Methods. During 2 years period (20052006) we treated 5 patients with
carcinoid tumors located at the upper part of jejunum and in the last part
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of ileum with the development of carcinoid syndrome with multiple liver
metastases. All conventional tests before surgery confirmed the presence of
malignant tumors without primary origin. Because of suspicion of
carcinoid syndrome we used high doses of octreotide for prophylactic
treatment.
Results. We had got the decline of symptoms before surgery for all patients.
These results confirmed the diagnosis of carcinoid. The surgery confirmed
our preoperative diagnosis and the praesens of tumors in above mentioned
part of bowl. After intestine resection (in all cases) we made citoreductive
surgery of liver tumor nodules and the implantation of catheter into hepatic
artery. During postoperative patients received high doses of octreotide and
Sandostatin LAR. Carcinoid syndrome resolved completely and the lost
metastases in liver were reduced dramatically.
Conclusions. Our results confirmed that the use of octreotide is an effective
treatment of carcinoid tumors and carcinoid syndrome before and after
surgery and could be use as diagnostic modalities for these patients.
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COMBINED OPERATIONS ON THE ADVANCED CANCER OF
STOMACH WITH LIVER RESECTION
Alexey Severtsev1, Eugeny Brekhov2, Dimitry Tchudaev2, Mikhail Bjakhov2,
Lali Kogonia2, Vladimir Ovtchinnikov2, Vera Severtseva2, Irina Grishina2
1Central Clinical Hospital #1 of the LLC ‘‘Russian Railways’’; 2Central
Clinical Hospital #1 of the LLC ‘‘Russian Railways’’
Introduction. According to our data the advances of stomach cancer into
liver is 5% of all of operated patients. 10% of them have solitary or isolated
dissimination by one lobe of liver metastatic affection.
The Aim of the Study. The aim of our study is to estimate of the nearest
and follow up results of treatment of patients with stomach cancer with
resectable tumor process in liver.
Materials and Methods. During the period from 1984 till 2007 181
patients with cancer of stomach and dissemination of the process into liver
have been operated in our clinic. There were 73 patients with direct growth
into liver, the other ones with isolated by one lobe of liver metastatic
affection. The volume of gastric resection and lymphatic system dissection
were standard. The volume of resections of liver: 32 patients with left-side or
right-side anatomic lobectomy of liver, 67 patients with anatomic sector- and
segmentectomy, the other patients were with non-anatomic resections. In the
postoperative period 80 patients got different regimens of chemotherapy.
Results. Every year it is marked demographically the decrease of the number
of such operations. It is caused by the improvement of preoperative
diagnostic. The lethality during the postoperative period is 11 patients
(6.08%). The number of complications is 62 patients (34.25%). There is no
dependence on the volume resection of liver. The follow up results: 1 year 
42 patients (23.2%), 3 years  11 patients (6.08%), 5 years  2 patients
(1.1%). All the patients observed during 1 year and more received
chemotherapy.
Conclusion. It is necessary to perform operations on stomach cancer with
involving of liver. The lethality and the number of complications after such
operations are relatively small. All the patients should receive chemotherapy.
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REPEATED LIVER RESECTION FOR RECURRENT HEPATO-
CELLULAR CARCINOMA
Mitsugi Shimoda1, Masato Katoh, Junji Kita, Tokihiko Sawada, Keiichi
Kubota
1Second Department of Surgery, Dokkyo University School of Medicine
Aim. We evaluated the role of repeat liver resection for recurrent hepato-
cellular carcinoma (HCC).
Material and Methods. We performed 244 cases of liver resection for HCC
from April 2000 to March 2006. One hundred and 9 of 244 cases had
recurrent HCC, and 34 of 109 cases underwnet repeat liver resection. We
divided into 3 groups as follows: repeat resection group (A), no-repeat
resection group (B) and none recurrent group (C). We analyzed the over all
survival rate in those groups. According to Makuuchi criteria, surgical
resection and procedure were determined.
Result. There were 29 males and 5 females in the Group A, 25 cases had
hepatitis C, 5 cases had hepatitis B 2 cases had hepatitis B and C, and two
had unknown cirrhosis. Six cases need to 2 times or more repeat resection
(twice times: 5 cases, 3 times; one case). Surgical procedures were as follows:
partial resection: 26 cases, subsegementecytomy: 5, anterior resection: 1,
lateralsegemntectomy: 1 and right lobectomy: 1. The averages of blood loss,
Pringle?s time and operative times were 626 g, 41 min. and 5 hr 34 min.,
respectively. Two cases died of HCC after repeat resection. The mean
survival time was 18.9 months and the mean disease- free survival time was
11.6 months after first operation. Five year overall patient survival rate for
each group were, 92% for A group, 42% for B group and 78% for C group. A
group showed significantly better survival than B group (PB0.001). There
was no significantly difference between A and C group in patients surveival
(p0.277).
Conclusion. Repeat liver resection for recurrent HCC had favorable survival
rate in this study. This survival rate was almost similar number for none
recurrent of HCC cases. The aggressive repeat liver resection is suggested to
be a most effective treatment for recurrent HCC.
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SHORT-TERM AND LONG-TERM RESULTS OF LAPAROSCOPIC
OPERATIONS ON THE LIVER AT NON-PARASITIC CYSTS
Yury Starkov1, Kirill Shishin
1A.V.Vishnevsky Institute of Surgery
Ninety nine patients with 169 non-parasitic liver cysts were operated in
A.V.Vishnevsky Institute of Surgery from February, 1992 till December,
2006. Ninety one were females and 8  males; their age varied from 32 till 78
years (middle age was 63 years). Fifty seven patients had chronic calculous
cholecystitis with liver cysts, 39 patients had only liver cysts, 2  cysts
gastroesophageal reflux disease, and 1 patient  cysts, gastroesophageal
reflux disease and chronic calculous cholecystitis. Plural cysts were found at
32 patients and solitary  at 67. The cyst sizes exceeded 5 cm at 45 patients,
that at presence of clinical semiology was the sufficient indication for the
surgical treatment, independently from any accompanying surgical pathol-
ogy. The size of liver cysts at this group of patients varied from 5 up to 18 cm
(average size  10.692 cm (9SE). Complications occurred at 6 patients: 5
had cyst infection and 1- intracystic bleeding. There were no cases of
cystobiliary fistulas in our supervision.
Cyst fenestration with wide excision of its walls was performed for
subcapsular and superficial intraparenchymal cyst. The intraparenchymal
part of a cyst was deepitelised by various methods. Deep intraparenhimal
cysts depending on their size were underwent punctional or punctional-
drainage sclerotization. Atypical liver resections with wide excision of cystic
walls with doubtful blood supply was done for large superficial intrapar-
enchymal cysts in one or several segments.
The long liquid leakage on drainages within 57 days was marked in the
postoperative period at 11 patients. The bile leakage from 300 up to 100 cc
per day occurred in one case after atypical liver resection for the big cyst of 2,
3 and 4th segments and resolved spontaneously within 1 month. Average
duration of the postoperative period was 9 days (from 4 days till 1 month).
Liquid congestions in a residual cavity were observed at 4 patients and were
successfully treated by a unitary puncture under the ultrasonic control.
Long-term results from 1 to 10 years were observed at 45 patients, at whom
cyst sizes exceeded 5 cm. Residual cysts at the operation cite were found in
two cases 1.5 and 2 years after the operation in dorsal segments of the right
lobe of a liver, but their sizes were essentially less in comparison with
preoperative. Considering the absence of clinical signs the repeated inter-
vention was not performed.
Long-term experience shows, that laparoscopic treatment of non-parasitic
liver cysts liver is accompanied by good results with small quantity post-
operative complications and low rate of recurrences. Wide excision of
protruding cystic walls with deepitelization of a residual cavity is the most
widespread and effective operation. Laparoscopic atypical liver resections
with excision of thin, partially sclerotic functionally defective sites areas of
parenchyma is indicated at big and giant liver cysts. Laparoscopic punction
and punction-drainage methods of treatment are auxiliary in addition to
cystic excision. They provide radicalism of intervention at patients with plural
liver cysts with intraparenchymal or dorsal location.
209
METHODS OF PARENHIMAL DISSECTION AND THE HEMOS-
TASIS AT LAPAROSCOPIC OPERATIONS ON THE LIVER
Yury Starkov1, Kirill Shishin
1A.V.Vishnevsky Institute of Surgery
Today laparoscopic technologies are one of actively developing directions of
surgical hepatology, reflecting general tendencies of development of Surgery.
World experience shows, that similar operations for small size local lesions are
radical enough, possess all advantages of miniinvasive interventions and
usually are accompanied by non-complicated postoperative period. The basic
real approach to increase the safety of operations is prevention of the possible
bleeding which is realized by precise manipulations with application of
consecutive or simultaneous various methods of dissection of hepatic tissue
and hemostasis on the incision line. The variety of techniques of dissection of
hepatic tissue described in the literature (usage of ultrasonic scissors,
destructor-aspirator, clips, vascular endostapler, equipment as LigaSure,
TissueLink, supplemented by mono-, bipolar, or argonoplasmal coagulation
etc.) does not allow to choose a unique optimal way of a resection, and once
again specifies a necessity of their effective combination.
Superficial liver areas (23 cm from a capsule) usually do not contain large
vessels. Optimal tools to incise the parenchyma are ultrasonic scissors which
provide reliable hemostasis. The additional hemostasis is achieved using
various kinds of electrocoagulation. Methods of contactless coagulation
(argonoplasmal, hydrothermal, spray) have obvious advantages.
Safe dissection of deep liver areas means topical diagnostics and marking of
large vessels by dynamic laparoscopic ultrasound for their pre´cised allocation
and their crossing after their clipping or sewing. The sufficient for crossing
dissection of vessels from parenchyma is performed by destructor-aspirator,
water-jet dissector, instruments or devices as Tissue-Link. The hemostasis is
made using various variants of contactless electrocoagulation.
Large veins are crossed with vascular staplers. Veins of moderate diameter
(up to 34mm ) can be crossed after processing by the device as LigaSure or
clipping.
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Vascular isolation of a liver is not an obligatory stage of laparoscopic
operations. Pringle method can be applied if uncontrolled bleeding occurs
at segmentary resections for a period of maintenance of the reliable
hemostasis. The experience of laparoscopic liver resections on 29 patients
shows, that the combination of various techniques of parenchymal dissection
and hemostasis allow to perform safe laparoscopic resections even at patients
with a cirrhosis.
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LAPAROSCOPIC VERSUS OPEN HEPATIC RESECTIONS FOR
BENIGN AND MALIGNANT NEOPLASMS  A META-ANALYSIS
Constantinos Simillis1, Vasilis A Constantinides, Paris P Tekkis, Ara Darzi,
Richard Lovegrove, Long Jiao2, Anthony Antoniou
1Imperial College London, Department of Surgical Oncology and Technol-
ogy, St Mary’s Hospital, London; 2Imperial College London, Department of
General and Hepatopancreatobiliary Surgery, Hammersmith Hospital
Background. Laparoscopic surgery for hepatic neoplasms aims to provide
curative resection while minimizing complications. The present study
compared laparoscopic versus open surgery for patients with hepatic
neoplasms with regard to short-term outcomes.
Methods. Comparative studies published between 1998 and 2005 were
included. Evaluated endpoints were operative, functional, and adverse events.
A random-effects model was used and sensitivity analysis performed to
account for bias in patient selection.
Results. Eight nonrandomized studies were included, reporting on 409
resections of hepatic neoplasms, of which 165 (40.3%) were laparoscopic and
244 (59.7%) were open. Operative blood loss (weighted mean difference
123 mL; confidence interval179, 67 mL) and duration of hospital
stay (weighted mean difference2.6 days; confidence interval3.8,
1.4 days) were significantly reduced after laparoscopic surgery. These
findings remained consistent when considering studies matched for the
presence of malignancy and segment resection. There was no difference in
postoperative adverse events and extent of oncologic clearance.
Conclusions. Laparoscopic resection results in reduced operative blood loss
and earlier recovery with oncologic clearance comparable with open surgery.
When performed by experienced surgeons in selected patients it may be a safe
and feasible option. Because of the potential of significant bias arising from
the included studies, further randomized controlled trials should be under-
taken to confirm these findings and assess long-term survival rates.
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EARLY ENTERAL NUTRITION AFTER LIVER RESECTION
Viktoria Makarova1, Vladimir Nikoda, Lilia Polishchuk, Oleg Skipenko
1Russian Research Center of Surgery
Type of nutritional support in patient after liver resection is still controversial.
Early enteral nutrition most probably should decrease incidence of post-
operative complications. The aim of our study is investigate the impact of
early postoperative enteral nutrition on convalescence after liver resection.
Materials and Methods. Between January 2000 and April 2005, 63
patients who underwent hepatic resection for colorectal metastases at the
Department of hepatobiliary sugery, National Research Center of Surgery
were identified. Factors associated with morbidity and mortality, demo-
graphics, operative and clinical data were collected and analyzed. Recorded
biochemical values included serum glutamic oxaloacetic transaminase
(AST), serum glutamic pyruvic transaminase (ALT), alkaline phosphatase,
serum urea nitrogen, gamma-glutamyltransferase, serum albumin, white
blood cells and total lymphocyte counts. The patients were divided into two
groups: 29 patients (EN group) received oral enteral nutrition. It was started
on postoperative day 1 by giving 200 kKal/d with increase to 600 800 kKal/d
from day 2 or 3. The second (control) group (34 pts) received parenteral
nutrition.
Result. The two groups of patients were similar in sex, age, type and volume
of hepatic lesion and other preoperative indices. The proportion undergoing
major hepatectomy and other important intraoperative factors were similar
between groups. No significant difference in postoperative hospital stay
occurred between groups. However, a significant beneficial effect of EN on
length of intensive care unit stay was observed in group 1. The difference was
mainly due to a significant reduction in infectious and non- infectious
(cardiac and respiratory failure) complications (EN 7% vs control 21%; p
0.0428 and EN 7% vs control 27%; p0/0492, respectively), and period of
the recovery of intestinal motility (EN 1594.3 vs control 1896.1 ; p0/03).
There were no differences between groups in serum albumin, urea nitrogen,
lymphocyte counts and liver-specific biochemical parameters.
Conclusion. We conclude that early enteral nutrition after hepatectomy is
helpful for recovery of intestinal motility, decreasing consequences of
hypercatabolism, preventing septic complications, induced by surgical stress.
Early orally enteral nutrition should be used whenever possible.
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LAPAROSCOPIC LIVER SURGERY: A NINE-YEAR CASE SERIES
Laura Spencer1, Matthew Metcalfe, Andrew Strickland, Elizabeth Elsey,
Gavin Robertson, David Lloyd
1Leicester Royal Infirmary
Objective. This case series aims to describe a developing experience in
laparoscopic liver surgery and presents results from 40 procedures including
right hemihepatectomy, left lateral lobectomy and microwave ablation
therapy.
Methods. Forty patients undergoing laparoscopic liver surgery between
September 1997 and November 2006 were included. The data set was
collected from medical records and included: operative procedure and
duration, intraoperative blood loss, conversion to open operation rates,
length of hospital stay, complications, mortality, histology of lesions/
resection margins, and disease recurrence.
Results. The mean age of patient was 59 years, 17/40 were male, 23/40
female, 23/40 of lesions treated were benign and 17/40 malignant. Operations
included: laparoscopic anatomical resections n15, non-anatomical resec-
tions n11, microwave ablations n8 and deroofing of cysts n7. Median
anaesthetic time was 120 minutes (range 40240 minutes), mean blood loss
78 ml and 1/40 operations were converted to open (due to equipment
failure). Median resection margins were 10 mm (range 114mm) and
median length of stay 3 days (range 110). Operative and 30-day mortality
were zero and there has been no local disease recurrence.
Conclusion. Laparoscopic liver surgery appears safe, effective and is
associated with reduced hospital stay. Larger studies are required to confirm
it is oncologically sound.
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CHANGES OF SERUM REDOX STATE DURING EXTENDED
LIVER RESECTIONS WITH ISCHEMIC PRECONDITIONING
Hahn Oszkar1, Kupcsulik Peter K
11st Dept of Surgery Semmelweis University
Background. The purpose of this study was to determine the changes of
oxygen-derived free radicals (ODFR) levels, and to compare the I-R damage
of the liver with, or without ischemic preconditioning (IP) prior to portal
clamping of the liver during major hepatectomies.
Materials and Methods. Hundred patients were randomly divided into
three groups: with (n45; preconditioning group), or without (n45;
without preconditioning group) IP (5 minutes of portal triad clamping and
10 minutes of reperfusion in 2 cycles) before major hepatectomy under
vascular exclusion of the liver preserving the caval flow. In the third group
(n10; control group) only explorative laparotomy was performed. Serum
free radicals and antioxidants concentrations such as aspartate transferase,
alanine transferase, alcalic phospatase, gamma-glutamil transferase, bilirubin
and prothrombin levels were measured. Morbidity and mortality were
determined in both groups.
Results. The amount of serum ODFR and antioxydants were correlated with
the tumor size and the length of the ischemia. The levels of serum ODFR,
AST, ALT, on the first postoperative day were significantly lower in
preconditioned than in not preconditioned patients (pB0.05). IP signifi-
cantly increased the level of serum antioxydants. Beside the previous, serum
ALP, GGTand bilirubin levels, morbidity, mortality rates and lengths of ICU
and hospitalization stays were significantly lower only in steatotic, fibrotic and
cirrhotic patients. Changes in ODFR and antioxydants levels describes the
characteristic of I-R injury of the liver.
Conclusions. Ischemic preconditioning is a suitable method to decrease I-R
injury of the liver in humans. The strategy is particularly effective in patients
with liver steatosis, fibrosis or cirrhosis and especially in patients with longer
duration of ischemia (25 minutes).
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NEW AND INNOVATIVE USE OF THE GYRUS PLASMAKINETIC
BIPOLAR COAGULATION DEVICE FOR LIVER RESECTION IN
CIRRHOTIC AND NON-CIRRHOTIC LIVERS
Jeremy Tan1, Andrew Hunt, Luc Delriviere, Andrew Mitchell
1Sir Charles Gairdner Hospital
Introduction. Performing liver resection for a cirrhotic liver can be a
challenging undertaking. We report the use of a novel pulsed bipolar
coagulation device which has proved to be useful in performing parenchymal
transection through both cirrhotic and non-cirrhotic livers.
Methods. A retrospective study of 30 consecutive liver resections from July
20, 2005 to November 1, 2006 was undertaken. The surgical technique did
not differ for cirrhotic versus non-cirrhotic livers other than the fact that a
Pringle manoeuvre was avoided for the cirrhotic livers. The Gyrus Plasma-
Kinetic pulsed bipolar coagulation device was used for liver parenchymal
transection. Argon beam coagulation as well as clips and sutures were used as
necessary.
Results. There were 18 males and 12 females. Six patients had histopatho-
logical confirmation of cirrhosis in the adjacent liver. 16 patients (53.3%) did
not require any blood transfusion. There was no difference in the proportion of
patients receiving a blood transfusion between the cirrhotic and non-cirrhotic
groups (p0.46).The average age was 54.8913.8 yrs, with a range of 29 to 87
yrs. There were 27 open procedures and 3 laparoscopic procedures. Of these,
there were 13 major resections (?3 segments) and 17 minor resections (B3
segments). Average operation time was 263.19117.2 min. Length of stay had
a median of 9 days. There were no post-operative deaths. 6 patients (20%) had
significant post-operative complications. These included two bile leaks early in
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the study which appeared to be remedied by alteration of the power setting on
the generator.
Conclusion. The novel techinique of using the Gyrus PlasmaKinetic pulsed
bipolar coagulation device coupled with Argon beam coagulation and other
traditional haemostatic and biliostatic modalities for liver resection is safe and
reliable. In particular, cirrhotic livers could be resected without the risk of
greater blood loss or complications.
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BREAST CANCER LIVER METASTASES-IS SURGICAL TREAT-
MENT INDICATED?
Vladislav Treska1, Tomas Skalicky2
1Dept. of Surgery, Univ.Hospital; 2Univ. Hospital, Dept. of Surgery
Aim. Metastasizing of the breast carcinoma to the liver has been considered
the sign of the disease process generalization with a poor therapeutic
prognosis. Therefore, the aim of this study was to assess the results of liver
resections and /or radiofrequency ablations (RFA) in patients with breast
cancer liver metastases (BCLM).
Patients and method. 358 patients with liver tumours were operated on at
our Department between January 2000 and December 2006.17 patients with
primary breast carcinoma were operated on for liver tumours. BCLM were
diagnosed in 15 patients (4.2%), in two patients benign tumours were found
(focal nodular hyperplasia, chronic liver abscess). The average age of patients
with BCLM was 48.5 years (3371). The average period of time from the
date of the primary surgery for the breast carcinoma till the BCLM appeared,
was 4.7 years (3 months to 9 years). BCLMs were solitary in 12 cases and in
three cases the metastases were multiple. Four right hepatectomies, two
segmentectomies, three left lobectomies, five RFA, one combined procedure-
liver resection and RFA were performed. In 10 cases, the histological
examination proved a ductal carcinoma and in six cases a lobular carcinoma.
Following surgery, all female patients underwent curative chemotherapy.
Results. There was 0% postoperative (30 days) mortality. The morbidity was
6.3% (iatrogenic injury of biliary tree during complicated hepatectomy in one
patient). The data were statistically evaluated according to the Kaplan-Meier
analysis (patients survival, disease free interval). 12 months and 30 months
survival rate were 100%, and 66.7%, respectively. A disease free interval was
0% and 71.5%, respectively for the same periods of time following the liver
surgery and/or RFA for BCLM.
Conclusion. Based on our own results and in conjunction with the current
literature data, it is clearly evident that liver resections and/or RFA followed
by chemotherapy is the therapeutic method of choice in patients suffering
from BCLM.
The Study was sponsored by Grant IGA MZ NG 8301 3 .
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REPEATED LIVER PROCEDURES FOR COLORECTAL LIVER
METASTASES RECURRENCE
Vladislav Treska1, Tomas Skalicky2, Stanislav Kormunda3
1Dept. of Surgery, Univ.Hospital; 2Univ. Hospital, Dept. of Surgery; 3Dept.
of Social Medicine, University Hospital
Background. Recurrence of colorectal liver metastases (CRLM) after
primary liver surgery developes in 6080%. Of those 30% of recurrences
are localised to the liver.The aim of this study was to evaluate the long-term
results of repeated liver procedures for recurrent CRLM.
Method. Total of 205 patients with CRLM were operated on from January 1,
2000 to December 31, 2006.Repeated procedures (liver resection, and/or
radiofrequency ablation) were performed on 29 patients (14.1%) in the
interval of 638 months after primary liver surgery. A total of 57 procedures
were performed (16 liver resections, 34 radiofrequency ablations and 7
combined procedures). Two patients had staged liver and lung resections for
CRLM. The average age of patients was 62.399.6 years. The statistical
analysis was performed using S.A.S. software 8.02.
Results. 30 days post-operative mortality was zero. Four patients (13.8%)
suffered from wound infection or bile leakage in the postoperative period.
82.3; 65.1; 36.5% of patients survived 1, 2 and 3 years after the repeated
procedures. Disease free interval (DFI) was 33.1%; 6.3% and 0.6% for 1, 2
and 3 years.
Conclusion. Repeated liver procedures are fully indicated in patients with
good life expectancy. These procedures don?t increase postoperative morbid-
ity and mortality of patients and significantly prolong patients life.
The study was supported by Grant NR 8301-3 and Research project MSM
0021620819 .
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99MTC-GSA SCINTIGRAPHY WITH SPECT FOR THE ASSESS-
MENT OF HEPATIC FUNCTION AND FUNCTIONAL VOLUME
DURING LIVER REGENERATION IN A RAT MODEL
W. de Graaf1, R. L. Vetelainen, A. K. van Vliet, R. J. Bennink2, T. M. van
Gulik
1Department of Surgery/Surgical Laboratory, Academic Medical Center,
University of Amsterdam, The Netherlands; 2Department of Nuclear
Medicine, Academic Medical Center, University of Amsterdam, The
Netherlands
Small animal models are crucial in order to gain insights in the complex
recovery mechanisms of liver function during liver regeneration. Many
quantitative liver function tests require repetitive blood samples, and are
therefore difficult to use in small animals. 99mTc-mebrofenin hepatobiliairy
scintigraphy (HBS) has been introduced for non-invasive assessment of liver
function in the clinical setting as well as in experimental research. However,
HBS is restricted to planar modalities in small animals since hepatic kinetics
are generally too fast for SPECT acquisition. 99mTc-GSA scintigraphy is an
alternative, receptor mediated, non-invasive liver function test. After hepatic
uptake, 99mTc-GSA remains trapped in the liver enabling additional
SPECT for the assessment of both liver function and liver functional volume
within one test.
In this study, we evaluated the use of 99mTc-GSA scintigraphy combined
with SPECT for the assessment of liver function and liver functional volume
in normal and regenerating rat liver. Reproducibility of 99mTc-GSA
scintigraphy and SPECT was investigated by repeated measurements within
the same rat. For the assement in a regenerating liver, liver function (99mTc-
GSA uptake),liver functional volume by 99mTc-GSA SPECT and conven-
tional liver volume was assessed on 1, 3, 5 and 7 days (n6 per time point)
after 70% partial hepatectomy (PH).
The correlation between repeated 99mTc-GSA measurements was signifi-
cant and strong (r0.754, p0.019). In normal rat livers, there was a strong
and significant correlation between functional volume assessed by 99mTc-
GSA SPECT and conventional liver volume (r0.93, pB0.0001). Correla-
tion between 99mTc-GSA uptake and conventional liver volume was
moderate (r0.62, p0.043). The mean liver functional volume and
conventional liver volume was significantly (pB0.05) decreased 1 day after
70% PH (8.0790.27 ml and 6.7790.12 ml, respectively) compared to
baseline (12.1490.20 ml and 12.3890.32, respectively), after which it
regenerated to normal liver volume at day 5 (11.8290.39 ml and 12.159
0.45 ml) and day 7 (11.8090.37 ml and 11.7690.50 ml). There was a
strong correlation between the functional volume and conventional volume in
the regenerating liver (r0.86, pB0.0001). One day after 70% PH, the
99mTc-GSA uptake (8.0190.62 %/min) significantly decreased compared
to baseline (27.0891.82 %/min), after which it slowly increased to baseline
level at day 7 (21.7191.94 %/min). During the regeneration process 99mTc-
GSA uptake was significantly lower compared to both conventional volume
(pB0.001), and functional volume (pB0.001), when expressed as a
percentage of baseline levels (fig. 1).
99mTc-GSA scintigraphy combined with SPECT is a feasible, non-invasive
method for the assessment of hepatic functional volume in normal, as well as
in regenerating rat livers. However, the hepatic 99mTc-GSA uptake as a liver
function test seems to underestimate the hepatic regeneration.
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RADIOFREQUENCY THERMAL ABLATION OF 195 PATIENTS
WITH COLORECTAL CANCER LIVER METASTASES
Dariusz Zadrozny1, Zbigniew Sledzinski, Walenty Adamonis, Tomasz Gor-
ycki, Michal Studniarek, Kamil Bury
1Medical University of Gdansk, Poland
The aim of this study is to report our results of 195 patients treated with
percutaneous radio-frequency thermal ablation (P-RFTA) due to colorectal
liver metastases. Between 2001 and 2006 three hundred thirty-four treat-
ments were performed in 195 patients (112 M, 83 F) with a mean age of 63
years (2085). The mean number of metastases was 5.8 (39) per patient
and the mean maximum diameter was 4.9 cm (1,512). In all patients the
ablation was performed using ‘‘Cool-Tip’’ equipment (Tyco Healthcare) in
total intravenous anaesthesia (TIVA). All patients had been rejected for
surgical resection. In 146 patients chemotherapy with 5-FU and Leucovorin
as the only adiuvant regimen was given, 20 patients received no chemother-
apy. The mean follow-up time was 18 months (066.7 mo). During this time
126 patients developed new metastases in the liver and/or extrahepatic
spread. in 3 patients liver foci were succesfully resected due to tumor
downsizing and no signs of extrahepatic disease, in 3 patients  without
recurrence in the liver  resection of solitary lung metastases were performed.
The median survival time is 17.6 months, which is better as expected in such
During the regeneration process, there was a significant difference
between 99mTc-GSA uptake and both conventional liver volume
(PB0.001), and liver functional volume (PB0.001), when data
was expressed as a percentage of baseline levels.
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chemotherapy regimen. In this group of patients 9 major and 13 minor
complications occured (2,69% and 3.89% of all treatment sessions). P-RFTA
is a promissing method in the reatment of colorectal liver metastases.
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RADIOFREQUENCY ABLATION IN THE TREATMENT OF HE-
PATOCELLULAR CARCINOMA
Dariusz Zadrozny1, Zbigniew Sledzinski, Tomasz Gorycki, Michal Stud-
niarek, Walenty Adamonis, Kamil Bury
1Medical University of Gdansk, Poland
One hundred and fife patients (57M, 48F) aged 2086 years (mean 63) were
treated in our institution due to hepatocellular carcinoma (HCC) using
radiofrequency thermal ablation between 2001 and 2006. In all patients,
except one, the cause of HCC liver cirrhosis, in one-intoxication with
undefined toxin. 209 thermal ablation sessions were done, 205 of them
percutaneously (mean 2 sessions / patient  1 to 11) . This treatment was
combined with transarterial chemoembolization (TACE) in 6 patients. 196
percutaneous ablations were performed using US guidance. In 9 patients
lesions were indetectable in US, so combined approach US/CT was used.
Total number of RFTA treated lesions was 209 (mean 2.0/patient), mean
maximum diameter was 6,8 cm (212 cm), in three patients treated
additionally with TACE intrahepatic spread with maximum 22 lesions was
found. There was one death related to RFTA  sepsis due to liver abscess
after fourth ablation for 12 cm HCC  patient was treated outside of our
center. 5 major local complications occured (twice a subcapsular hematoma,
three liver abscesses), treated conservatively.
Mean follow-up time is 16 month (052), mean survival time since the first
ablation is 13 month (152,2). Three patients with borderline match to
Milano criteria were transplanted after 13, 16 and 48 month after RFTA,
they are still alive.
Conclusion. RFTA is a promissing method in the reatment of HCC and
gives the patient a chance for prolonged survival.
220
FEASIBILITY, SAFETY AND EFFICIENCY OF LAPAROSCOPIC
LIVER SURGERY: THE SOUTHAMPTON EXPERIENCE
Mohammed Abu-Hilal1, Bashar Zeidan, Mark McPhail, Tom Roe, MJ
Hallam2, Shadi Zeidan, John Primrose, Neil Pearce
1Southampton University Hospital; 2Southampton General Hospital
Hepatobiliary-Pancreatic Surgical Unit, Department of General Surgery,
Southampton University Hospital, Southampton, UK
Background. Experience in laparoscopic liver surgery (LLS) is increasing
but still limited to a few centres. More reports are needed to confirm
feasibility, safety, efficacy and to encourage the expansion of the laparoscopic
approach in liver surgery. We report our 3 year experience in this field.
Methods. Between August 2003 and January 2007, 45 patients (20 male, 25
female; median age 66 (range 2188) years) were put forward for LLR. Two
surgeons were involved (NWP and MAH). The indication was malignancy in
28 cases, suspicious lesions in 14, hydatid lesion in 2 and mass effects in 1.
Results. In 8 patients LLS was not performed; 5 were converted and 3 were
abandoned due to peritoneal disease diagnosed at laparoscopy. Thirty seven
patients had LLS; left lateral sectionectomy (17) wedge resection involving 2
segments or more (10) and simple wedge resection (6). Anatomical major
resections were performed in four patients; 2 right and 2 left hepatectomies.
Median operative time was 205 (100320) minutes, median blood loss 150
(25800) ml, and median hospital stay 3 (18) days. Negative resection
margins were obtained in 36 patients (97%) with a median resection margin
of 12 (230) mm. Performing analysis of variance (ANOVA) across different
resection types showed blood loss and resection margin achieved were not
significantly different. As expected single wedge resections were associated
with a shorter operation (p0.040) and hospital stay (p0.037) compared
with resections involving two or three or more wedges. Only five (11%)
complications were encountered with only one (bile leak) being major. Three
patients (7%) experienced new recurrence one of which died at 8 months
post op. Median follow up is 10 (241) months.
Conclusion. Technical expertise in LLS is growing, such that high standards
of operative care may be achieved. Larger prospective studies are required to
assess the equivalence to the open technique in short and long term results.
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INTRATUMORAL INJECTION OF MACROPHAGE-ACTIVATING
LIPOPEPTIDE IN PATIENTS WITH PANCREATIC CARCINOMA:
A PHASE I/II TRIAL
Objective. This phase I/II trial examined safety and efficacy of the toll-like
receptor 2/6 agonist MALP-2 in combination with gemcitabine in patients
with incompletely resectable pancreas carcinomas.
Summary Background Data. MALP-2 acts an immunological adjuvant
and has been described recently to prolong survival in a mouse model of an
orthotopic, syngeneic pancreas tumor.
Methods. Men and women with incompletely resectable pancreas carcino-
mas were eligible while patients with R0 or R1 resections or with peritoneal
carcinosis were excluded. Ten patients were injected intratumorally during
surgery with 20-30A˜,Aˆmg MALP-2 followed by postoperative chemotherapy.
Samples were taken from peripheral blood and wound secretion, and assayed
for cell content, cytokine and CRP levels, and NK activity.
Results. A MALP-2 dose of 20 A˜,Aˆmg given to 5 patients was well tolerated.
In two out of three patients treated with 25A˜,Aˆmg MALP-2 and in one out of
two patients treated with 30A˜,Aˆmg serious adverse events occurred (asystole,
myocardial infarction and endotoxin-like shock). They recovered completely.
Clear signs of local MALP-2 effects were: influx of lymphocytes and
monocytes in wound secretions, and abolishment of inhibition of NK activity.
The actual mean survival is 16.3 A˜,Aˆ93.8 months; the median survival being
9.3 months. Three patients are still alive after 26 months.
Conclusions. Up to 20A˜,Aˆmg MALP-2 were well tolerated, and no systemic
effects were noted. The mean survival of 16.3 months is remarkably high.
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FEASIBILITY AND SAFETY OF LAPAROSCOPIC DISTAL PAN-
CREATECTOMY AND LAPAROSCOPIC PANCREATICODUODE-
NECTOMY
Suleiman Al-Hourani1, Basil Ammori
1Deparment of Surgery, Manchester Royal Infirmary, Manchester, UK
Background. Advances in operative techniques and technology have
facilitated laparoscopic distal pancreatectomy (LDP) and laparoscopic
pancreaticoduodenectomy (LPD).
Methods. All distal pancreatectomies were attempted laparoscopically, while
selected patients underwent LPD.
Results. Eleven patients with a median (range) age of 64 (3279) years
underwent LDP with (n3) and without (n4) splenic preservation and
LPD (n4). All procedures were completed laparoscopically. The median
operating times for LDP and LPD were 315 and 675 minutes respectively
with a median blood loss of 300 and 400 ml respectively. The morbidity,
pancreatic fistula, re-admission, re-operation, and mortality rates were 30%,
20%, 20%, 0% and 0% respectively. The median (range) postoperative
hospital stay after LDP and LPD was 8 (414) and 13 (923) days
respectively. Tumours were 1.0 10.5 cm in diameter and included endocrine
(n5), adenocarcinoma (n4), cystadenoma (n1) and pseudopapillary
tumour (n1). At a median (range) follow up of 5 (250) months, one
patient has died of brain metastases, while the remainder remain disease-free.
Conclusions. The laparoscopic approach to distal pancreatectomy and
pancreaticoduodenectomy is feasible and safe. The pancreatic fistula rate is
equivalent to that observed with open surgery. Growth of experience,
technique refinements and long-term follow up data are needed.
Introduction.
Material and Methods.
Patients.
Ethics.
Methods.
Statistical analysis.
Data was analysed using the software package SPSS 10 (Chicago, Illinois,
USA). Results were expressed as medians and interquartile ranges (IQR).
Comparison between groups was performed using the Mann-Whitney U test
and the ?2 test as appropriate. Significance was accepted at the 5% level.
Univariate analysis was performed utilising the ?2 test for categorical variables
and the Mann Whitney U test for continuous variables. Results
were expressed as number (per cent) and as mean (SD) respectively. Stepwise
logistic regression analysis was used to identify independent predictive
factors. Statistical analyses were performed using SPSS for Windows version
11.0. Statistical significance was accepted at p ?0.05. The positive and
negative predictive values for independent predictive factor were calculated.
The sensitivity, specificity, positive (PPV) and negative (NPV) predictive
values, positive (PLR) and negative (NLR) likelihood ratios for APS and
APACHE II scores at 24 hours, peak serum CRP and the intestinal
permeability index for the prediction of severe attacks were calculated using
MedCalc 6.12 for Windows 98 software (MedCalc Software, Mariakerke,
Belgium), and the best cut-off levels were identified. Receiver operator
characteristic (ROC) curves were constructed and areas under the curve and
their 95% confidence intervals (95% CI) were calculated. An area under the
curve of 1 indicates 100% sensitivity and specificity while an area of 0.5
indicates no discriminatory power (Zweig 1993). The areas under the curve
were statistically compared using MedCalc software.
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MANAGEMENT OF PANCREATIC PSEUDOCYSTS IN A DIS-
TRICT GENERAL HOSPITAL: TEN YEARS EXPERIENCE
Background. Pancreatic psedocysts can cause prolonged morbidity and
mortality. No management protocol was found in literature. This study aims
towards suggesting a guideline for their management in hospitals other than
centres of excellence.
Methods used. This is a retrospective study based upon computer database
of 42 patients (median age 58 yrs) with pancreatic pseudocyst treated over 10
yrs in our DGH. In the absence of a protocol, treatment was empirical.
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Results. 12 pseudocysts resolved spontaneously on conservative manage-
ment (mean cyst size 4 cm, range 315 cm ). Endoscopic Internal drainage
(EID) and Percutaneous drainage (PD) were tried in 3 and 13 cases
respectively. Including 1 case of failed EID and 7 cases of failed PD , 21
patients underwent laparotomy of which 11 patients had complications(
mean cyst size 10 cm, range 420 cm)
Discussion. All treatment options had certain advantages and limitations.
The best possible plan of management is summarised below:
1. Pseudocyst size B6 cms following acute pancreatitis  wait and watch.
2. Pseudocyst size 6 cms, perform ERCP to see pancreatic duct. If duct-
pseudocyst communicates, observe.
3. Pseudocyst 610 cms following acute pancreatitis, no complication-image
guided PD.
4. Pseudocyst 610 cms, no complications, following acute pancreatitis, if
fails to resolve after one attempt at aspiration , plan surgical or endoscopic
internal drainage after cyst maturation. ERCP findings will guide treatment
option in chronic pancreatitis.
5. All else, uncomplicated  endoscopic or surgical dependent internal
drainage.
6. Immature cyst with abscess formation  surgical external drainage.
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BIOMARKERS OF PROGNOSIS AND RESPONSE TO OPERA-
TIVE RESECTION FOR PANCREATIC CANCER
Andrew V. Biankin1, James G Kench2, Davendra Segara3, David A.
Skalicky3, Sandra A. Biankin3, Samuel C. L. Kuo3, Emily K. Colvin3,
Johana M. Susanto3, Peter H. Cosman3, Neil D. Merrett*, Elizabeth A.
Musgrove3, Susan M. Henshall3, Robert L. Sutherland3
1Cancer Research Program, Garvan Institute of Medical Research, 384
Victoria St. Darlinghurst, and Division of Surgery, Bankstown Hospital,
Eldridge Road, Bankstown; 2Cancer Research Program, Garvan Institute of
Medical Research, 384 Victoria St. Darlinghurst, and Institute of Clinical
Pathology and Medical Research, Westmead Hospital; 3Cancer Research
Program, Garvan Institute of Medical Research, 384 Victoria St. Darlin-
ghurst; *Division of Surgery, Bankstown Hospital, Eldridge Road, Bankstown
A current challenge in the treatment of cancer is identifying biomarkers of
response to therapies in order to tailor optimum treatment to individual
patients. Pancreatic Cancer (PC) is the fourth leading cause of cancer death
in Western societies with a 5-year survival rate of less than 10%. Pancrea-
tectomy is the only therapeutic intervention that offers the chance of long
term survival, however, only 10 to 20% of patients who undergo pancrea-
tectomy survive 3 years with prognostic factors only determined after
pathological examination of the resected specimen. Identification of a
biomarker of response to surgical resection that can be determined
preoperatively offers the potential to significantly improve survival and
quality of life for patients with PC by improving patient selection for
pancreatectomy.
We examined the aberrant expression of over 20 genes identified using
transcript profiling or known to be important in carcinogenesis using
immunohistochemistry and in-situ hybridisation in a cohort of 124 patients
with pancreatic cancer to identify potential biomarkers of prognosis and
response to operative resection.
Aberrant expression of p53, p21WAF1/CIP1, p27KIP1, p16INK4A, cyclin
D1, cyclin E, DPC4/Smad4, EGFR, beta-catenin, sfrp4, HER2, LMO4,
HOXB2, c-myc, LRAT, S100P, S100A6, S100A2, RAI3 and CRBP1 were
identified in a significant proportion of PC.
Multivariate analysis of clinicopathological variables (tumor size, differentia-
tion, subtype, lymph node metastases, perineural invasion and vascular space
invasion), treatment parameters (margin involvement, adjuvant therapy,
resection type), and aberrant expression of the above candidate biomarkers
identified that HOXB2 expression, S100A2 expression, and resection margin
involvement by tumor were the only independent prognostic factors. Patients
who had absent HOXB2 expression, low/absent S100A2 expression and had
clear margins after pancreaticoduodenectomy (39%) had median survival of
34 months, a survival of 48% at 3 years, 30% at 5 years, and 21% at 10 years,
compared to those with HOXB2 expression, lhigh S100A2 expression and/or
positive surgical margins who had all died by 28 months.
HOXB2 and S100A2 expression may represent surrogate markers of
advanced disease, can potentially be assessed preoperatively using FNAB,
and is currently the best predictor of outcome and response to operative
resection to be reported. Preoperative assessment of HOXB2 expression has
potential clinical utility in predicting response to operative resection for PC to
allow better selection of patients for operative intervention.
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SURGICAL TREATMENT OF THE PANCREATIC CANCER
Dragoljub Bilanovic1, Tomislav Randjelovic, Darko Zdravkovic, Borislav
Toskovic, Srdjan Dikic, Natasa Ristic, Natasa Stanisavljevic
1Medical Center ‘‘Bezanijska kosa’’
Background. Pancreatic cancer is a highly lethal disease and the most
frequent histology is adenocarcinoma. The advances in therapy do not
improve the prognosis significantly. The new methods of exploration have not
improved its detection at an earlier stage of the disease.
Method. The authors analyzed the resectability rate, treatment, morbidity,
mortality and follow up of 196 pts (118 male and 78 female) with pancreatic
cancer treated and prospectively monitored at the Medical Centre ‘‘Beza-
nijska kosa’’ from January 2000 to December 2005.
Results. Tumor localization: head (128 pts or 65.3%), head and body (20 or
10.2%), body (23 or 11.7%), body and tail (17 or 8.7%), tail (4 or 2.05%)
and multicentric (4 or 2.05%). Histology was: ductal adenocarcinoma (186
pts. or 94,9%), mucinous cystadenocarcinoma (3), malignant neuroendo-
crine tumor (5) and Frantz tumor (2). Radical (potentially curative)
procedure was performed in 63 cases (32.1%) and 133 palliative procedures
(67.9%). In the group of patients that underwent potential curative resection
there were 39 cephalic duodenopancreatectomies, 8 total duodenopancrea-
tectomies, 13 distal, 2 central, 1 near total pancreatectomies. Portal vein (PV)
resection was performed in 2 pts and lateral PV excision in 3 pts. The
operative treatment of pancreatic head cancer in the group of patients that
underwent palliative procedures in most cases (97 pts) involved biliary enteric
bypassing (hepaticojejunostomy) and prophylactic or therapeutic GEA as a
standard procedure. Operative mortality in radically treated was 5 pts (7.9%)
and the most serious complication in this group was pancreatic fistula. In the
group of patients that were subjected to palliative procedures mortality was 8
pts (6%) largely due to very poor condition of patients. The average survival
in the group that underwent palliative treatment was 13.5 months (followed
up 68 pts who were operated from january 2000 to december 2004). In the
Major complications in patients and relation to other factors
Sex Age Cause RS CS A/C Procedure Complications Outcome
M 74 GS 5 11 A ED RD, CA, ARF Lost to FU
F 57 GS 2 9 A P/C ED *
F 67 GS 5 8 A CON Bilateral pleural effusion Discharge
M 32 AA 4 20 C CG, DPSPL Recurrence, chronic pain On review
M 75 GS 5 10 A ED ED done for psoas abscess *
M 73 GS 4 10 A Endo CG, ED CI after Endo CG, Septic Sh Died
F 68 GS 1 10 A CG Cyst infection, Septic Shock Died
M 41 ? 2 20 C P/C ED, CJ RD, Septicaemia On review
F 53 AA 3 10 A P/C ED,CG Cyst infection Discharge
F 68 GS 1 10 A CG ExpCBD Biliary peritonitis On review
M 40 BOTH 0 5 A ED RD, Recurrence Discharge
M 55 GS 2 13 A CG Adhesive obstruction On review
F 32 TRAUMA 4 15 A P/CED, CG Recurrence On review
M 43 AA 1 4 A CON Pancreatic insufficiency Died
M 53 AA 4 8 A CON RD Discharge
RD: Respiratory distress; CG: Cysto-gastrostomy; CJ: Cysto-jejunostomy
CI: Cyst infection; Endo CG: Endoscopic Cysto-gastrostomy; CON: Conservative;
P/C: Per cutaneous; GS: Gall stone disease; AA: Alcohol abuse; RS: Ransom score
DPSPL: Distal pancreatectomy plus splenectomy; Exp CBD: Exploration of common bile duct; CS: Cyst size; A/C: Acute or chronic;
ARF: Acute renal failure.
 :Patient died due to some other cause. (One died six monts after ED from Myocardial ischaemia; The other died from septic shock
following cholecystectomy, a few months after the P/C drainage).
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group of radically treated pts 23 have died to date and their average survival
time was 26 months.
Conclusion. Although surgical resection is not efficient in the long-term, it is
currently the only procedure for extending the lifetime and provide with the
hope of total cure. The quality of life can be significantly improved within
the group of patients with non-resectable tumors with adequate palliative
procedures (biliodigestive bypass and GEA).
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CARCINOMAS OF THE PANCREATIC HEAD INFILTRATING
MAJOR BLOOD VESSELS: IS IT WORTY TO OPERATE?
Dean Bogoevski1, Emre Yekebas2, Guell Cataldegirmen2, Cristina Kunze3,
Jussuf Kaifi3, Jogesh Vashist3, Paulus Schurr3, Karim Gawad3, Jakob Izbicki3
1University clinic Eppendorf  Hamburg; 2University Clinic Eppendorf 
Hamburg; 3University Clinic Eppendrof  Hambrug
Background. Evidence is growing that carcinomas of the pancreatic head
infiltrating major blood vessels (portal vein, superior mesenteric vein, hepatic
or mesenteric artery) can be safely treated by pancreatoduodenectomy with
en-bloc resection of the infiltrated vessels. Prognosis of these patients is a
matter of debate.
Methods. Morbidity, mortality, and long-term survival in patients under-
going pancreatoduodenectomy with or without vascular resections (VR) were
investigated. Between 1994 and 2005, 524 pancreato-duodenectomies were
performed for malignancies. One-hundred patients (19.1%) had additional
VR. 58 patients underwent venous resection with tangential excision with
direct suture, 8 patients tangential excision with patch, 14 segmental
resection with end-to-end anastomosis, 14 segmental resection with graft
interposition and 6 patients different arterial resections. Additionally, 20
patients had vascular resections for benign and borderline dignities.
Results. Long-term survival was analyzed in 77 patients with pancreatic, in
12 patients with ampullary and in 11 patients with distal bile duct cancers
using univariate (log-rank) and multivariate (Cox regression) methods. In 68
among 100 patients with VR, histopathology showed true tumor involve-
ment. In the complete study group, negative resection margins (R0) were
obtained in 85 of patients with VR and in 86% of patients without VR. No
statistical difference was detected between both groups when comparing
median operative time (350 VR versus 360 minutes w/o VR), and median
volume of intraoperatively transfused blood units (3 units in both groups).
Postoperative surgical complications/mortality occurred in 26%/7% (VR)
versus 31%/5% (no VR, n.s.). Analysis of long-term survival in all 424
patients without VR revealed five-year survival probability of 16% compared
to 4% in patients with VR (median overall survival 14 vs. 13 months; p
0.27). In multivariate modelling, resection margin and histological grading
significantly influenced survival.
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DIFFERENTIAL GENE EXPRESSION IN HUMAN PANCREATIC
CELL LINES L3.6PL (METASTATIC) AND FG (NON-META-
STATIC)
Christiane J. Bruns1, Peter Camaj2, Martin Luckner2, Michael Bru¨ckel2,
Helmut Blum3, Karl-Walter Jauch
1Department of Surgery, University of Munich-Grosshadern; 2Department
of Surgery, University of Munich-Grosshadern, Munich; 3Gene Center,
University of Munich-Grosshadern, Munich
Background. Our model consists of two pancreas carcinoma cell lines:
parental FG cell line and L3.6pl generated from FG via three cycles of in vivo
selection in nude mice.
Methods. Nude mice were injected orthotopically with 1106 human
pancreatic tumor cells L3.6pl or FG, respectively. Body weight and tumor
parameters were continuously monitored.
In vitro production of VEGF was determined by ELISA and cell proliferation
by MTT-Assay. RNA from 3 biological replicates of the both cell lines was
hybridized with human gene chips (Affymetrix).
The results were validated by RT-PCR and by western blotting. Expression of
the chosen genes was investigated in pancreatic cancer tissues isolated from
patients and compared with healthy tissue from the same pancreas using RT-
PCR and immunohistochemistry. Protein-protein interactions were investi-
gated by immunoprecipitation and Western blotting.
Results. The volume of L3.6pl-tumors at day 37 after injection was 15-fold
larger than the volume of FG-tumors. The body weight of L3.6pl-injected
mice was 71% of the body weight of FG-injected mice. Primary L3.6pl-
tumors were very well vascularized and liver metastases were detectable at the
time of sacrifice. In vitro, we measured 9-fold more VEGF protein content in
conditioned media of L3.6pl cells as compared to conditioned media of FG
cells. Proliferation rate of L3.6pl cells was 1,5-fold higher as compared to FG
cells.
The analysis of differential gene expression has revealed 38 genes transcrip-
tional upregulated in L3.6pl cells. One part of the genes belongs to the
interferon signalling cascade such as the receptor (IFNAR), signal transdu-
cers (STAT1, NFkB) or targets of the interferon regulation (IFIT3, G1P2).
Affymetrix analysis demonstrated a very strong upregulation of uPA
transcripts important for metastasis development.
We have chosen for further investigations the 6,4-fold upregulated EFEMP1
gene (EGF-containing fibulin-like extracellular matrix protein 1). By RT-
PCR we confirmed the upregulation of the following transcripts in L3.6pl
cells: IFNAR1, NFkB, IFIT3, EFEMP1 and PLAU. Interestingly, L3.6pl
cells did not only express a higher amount of total NF?B, but also a higher
amount of the phosphorylated protein.
We have immunoprecipitated EFEMP1 protein using anti-EGFR antibody.
The yield of this immunoprecipitation was inversely proportional to
concentration of EGF in cell culture.
Conclusion. So far we can conclude that the upregulation of IFNAR1,
NF?B, IFIT3, EFEMP1 and PLAU in L3.6pl is associated to metastasis and
angiogenesis in pancreatic cancer. We have demonstrated that the EGF-
homologous protein EFEMP1 binds to EGF-receptor and therefore might
activate EGF-signalling and influence proliferation and metastasis of the
cancer cells. (Supported by KFO128/1-1, TP3, Bruns DFG).
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ISOLATED ROUX LOOP PANCREATICOJEJUNOSTOMY TO
PREVENT ANASTOMOTIC LEAK IN PANCREATICODUODE-
NECTOMY
R. Casadei1, N. Zanini, R. Pezzilli2, L. Calculli3, C. Ricci, N. Antonacci, R.
Giunta, F. Minni
1Departments of Surgery, Policlinico S.Orsola-Malpighi, University of
Bologna, Italy; 2Departments of Medicine, Policlinico S.Orsola-Malpighi,
University of Bologna, Italy; 3Departments of Radiology, Policlinico S.Or-
sola-Malpighi, University of Bologna, Italy
Introduction. A pancreatic fistula can be the source of considerable
morbidity and can contribute to mortality after pancreaticoduodenectomy
(PD) for pancreatic diseases. This study was conducted to evaluate the
hypothesis that isolated Roux loop pancreaticojejunostomy is safer than
pancreaticojejunostomy in a single jejunal loop.
Methods. From January to June 2006, data from 17 consecutive patients
who had PD with pancreaticojejunostomy in a separate jejunal loop, were
entered into a prospective database (group A). These patients were
compared, regarding postoperative mortality and morbidity, length of
hospital stay, operative time, blood transfusions, to an homogenous group
of 17 patients in which the treatment of the pancreatic remnant was
pancreaticojejunostomy in the same jejunal loop of the biliary and gastric
anastomosis (group B).
Results. Group A: 12 male, 5 female, median age (A˜,Aˆ9SD) 64.7 (A˜,Aˆ9
9.8) years . Histologic examination: 7 pancreatic cancers, 4 ampullary
cancers, 3 cystic pancreatic tumors, 1 chronic pancreatitis, 1 metastasis
from renal cancer and 1 inflammatory lesion. Surgical procedure: 3 PD with
distal gastrectomy, 14 pylorus-preserving PD. Mean operative time (A˜,Aˆ9
SD) 322A˜,Aˆ967.2 min., blood replacement in 7 patients. Length of hospital
stay (A˜,Aˆ9SD): 16.4A˜,Aˆ99.0 days. No postoperative deaths and 2
pancreatic fistulas (11.8%). Group 2: 11 male, 6 female, median age
(A˜,Aˆ9SD) 60.5A˜,Aˆ99.1 years, 6 pancreatic cancers, 5 ampullary cancers,
2 neuroendocrine tumors, 2 chronic pancreatitis and 2 bile duct cancers. 2
PD with distal gastrectomy, 15 pylorus-preserving PD. Mean operative time
(A˜,Aˆ9SD) 339A˜,Aˆ961.8 min., blood replacement in 8 patients. Length of
hospital stay (A˜,Aˆ9SD): 17.6A˜,Aˆ912 days. One postoperative death and 5
pancreatic fistulas (29.4%).
Conclusions. Isolated Roux loop pancreaticojejunostomy after PD is simple
and safe. Regarding operative time, blood replacement and length of hospital
stay there is no differences with pancreaticojejunostomy in the same loop. In
our study isolated Roux loop pancreaticojejunostomy decreased the incidence
of pancreatic fistulas.
229
NEOADJUVANT CHEMORADIOTHERAPY IN BORDERLINE RE-
SECTABLE PANCREATIC CANCER: A CASE-REPORT
R. Casadei1, N. Zanini, R. Pezzilli2, L. Calculli3, C. Ricci, T. Grottola, R.
Giunta, F. Minni
1Departments of Surgery, Policlinico S.Orsola-Malpighi, University of
Bologna, Italy; 2Departments of Medicine, Policlinico S.Orsola-Malpighi,
University of Bologna, Italy; 3Departments of Radiology, Policlinico S.Or-
sola-Malpighi, University of Bologna, Italy
Introduction. Pancreatic cancer resection represents the only chance of cure
but it can be performed only in localized cancer. Herein we report the case of
a patient with locally advanced pancreatic cancer who underwent neoadju-
vant chemo-radiation therapy followed by surgical resection with no residual
tumour (R0).
Case report. A 50-year-old man was referred to our team for the presence of
jaundice. A CT showed a mass in the head of the pancreas with an
encasement of at least 50% of the circumference of the superior mesenteric
vein (SMV). The involvement of the SMV was considered a relative
contraindication to surgery. The patient underwent an ERCP and a biliary
stent was left in the common bile duct. Diagnosis of pancreatic ductal
adenocarcinoma was done after a trans-abdominal US-guided fine-needle
aspiration.
PET showed an high metabolic activity area in the pancreatic head region.
The patient started 8 cycles of chemotheraphy with gemcitabine and
oxaliplatan then he underwent a chemio-radiation treatment of 6 week. A
re-staging was then performed. CT revealed a decrease of the size of the
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tumour. There was no involvement of the SMV. PET showed a completely
remission of disease.
In relation to these changes the patient was considered for surgical R0
resection. A pylorus-preserving pancreaticoduodenectomy with tangential
resection of the SMV was performed. Postoperative course was uneventful.
Histological examination of the resected specimen showed microscopic
ductal adenocarcinoma of the pancreas without neoplastic involvement of
the lymph nodes; resection margins and vein wall tissue were cancer free
(R0).
At 27 months from diagnosis the patient is alive and well, and he remains free
of recurrence or metastatic disease.
Conclusions. According to the evidence of our and other cases we suggest to
perform neoadjuvant chemo-radiation treatment in all patients affected by
‘‘borderline resectable’’ pancreatic cancer.
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SURGICAL TREATMENT OF PANCREATOBLASTOMA IN
ADULTS: RESULTS AFTER RADICAL RESECTION IN OUR
EXPERIENCE AND LITERATURE REVIEW
Alvise Cavallini1, Giovanni Butturini, Claudio Bassi, Camilla Cena, Paola
Capelli2, Paolo Pederzoli
1Surgical and Gastroenterological Dept, ?GB Rossi? Hospital, University of
Verona, Italy; 2Pathological Dept, ?GB Rossi? Hospital, University of Verona,
Italy
Introduction. pancreatoblastoma (PB) occurring in adults is extremely rare
and could mimick others solid pancreatic tumors. Methods: We describe SC,
a 26-year-old man with a PB of the head of pancreas, and MU, a 69-year-old
man with a PB localized in the body-tail of pancreatic gland. SC presented
upper abdominal pain related with the meal and was found on abdominal
ultrasound (US), computed tomography (CT) and magnetic resonance
(MR) scans to have a well delineated, vascularizated 5 cm cefalic mass which
was adherent to superior mesenteric vein. Tumor markers (alfa-AFP, CEA,
Ca19.9, e CA 125) were normal excepted Cromogranin A (272 ng/mL). A
percutaneous US guided fine needle aspiration (FNA) showed a low grade
neoplastic epithelial process, suspicious for neuroendocrine tumor (NET).
Octreoscan† was negative The patient underwent successful pancreatico-
duodenectomy. On pathologic examination the tumor formed acinar and
glandular structures and contained many squamoid corpuscles, a defining
feature of PB. The second case, MU, presented a solid mass of 6 cm in
diameter involving the body of the pancreas, revealed by US with contrast,
CT and MR scans. The mass was loculated and vascularizated. No symptom
was reported and serous tumor markers were normal (CEA, Ca19.9 and CA
125). In the suspicion of a cystic NET a distal pancreatectomy was
performed. Definitive histologic report demonstrated a PB. Results: An
extensive review of the literature avoidance only 20 patients affected by this
neoplasm in adult life. At follow up we report a disease-free survival of 45
months and 7 months respectively. The first one is the longer follow-up of a
patient disease-free reported in literature. Conclusion: diagnosis may be
difficult especially when PB affected adults. As demonstrated in our
experience, FNA might be false positive for other tumors such as NET. A
definitive diagnosis of PB relies on the histologic identification.
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THE ROLE OF TUMORSUPPRESSOR GENES IN PANCREATIC
CANCERS
Francesco Cetta1, Giuliana Malagnino, Armando Dhamo, Federico Mariani,
Giulia Calamati, Andrea Cariati2
1Department of Surgery, University of Siena, Italy; 2Policlinico di Genova
Ductal adenocarcinoma of the pancreas (DPC) is not a single entity, but
likely includes different types of tumors with different pathogenesis,
biological behaviour and prognosis. Less than 10% of patients have presently
good chances of being long-term survivals.
More than 10% of DPC are related to familial syndromes. They include
familial atypical multiple mole-melanoma syndrome (FAMM), determined
by germ-line mutation of p16 INK4, mapped at 9p2, (which is also
frequently altered in sporadic DPC), coding for a member of the pathway
p16, cyclinD1-CDK4, RB, that is crucial for cellular cycle, Li Fraumeni
Syndrome (p53 mapped at 17p13, involved in cell cycle control in the
pathway p53-p21, bax-bcl2), Lynch Syndrome (BRCA2) hereditary pan-
creatitis, and Peutz-Jeghers syndrome (PJS) (STKB11 mapped at 19p13.3,
causing a 136 folds increased risk for DPC), coding for a dual phosphatase,
that is crucial for AMP phosphorylation and apoptosis, inducing p21, by a
p53 independent mechanism.
Evidence has been accumulated that pancreatic tumors, both esocrine and
endocrine, derive from the same stem cell, and that rare acinar tumors and
related cancers show significant biological differences in terms of K-ras or
p53 mutations, in comparison with the more frequent DPC. Interestingly,
more than 50% of DPC show alterations of SMAD4/DPC4, a gene rarely
mutated elsewhere, that is crucial in the TGF/beta pathway, also involved, as
p53, and p16INK4A, in cell cycle control.
40 patients with DPC, 10 with IPMT have been recruited, in addition to still
alive long-term surviving (6 and 8 years, respectively) patients, one of whom
also had a single metachronous liver metastasis. Cell-lines from these patients
have been established. At the moment, no germ-line mutations have been
found in these patients or in siblings from their kindreds in the following
genes: APC, RB, SKTB11, PTEN, P53, BRCA2.
The study will focus on genetic and molecular differences among various
groups, in particular comparing patients having common DPC with poor
prognosis Vs those with long term survival and typical mature DPC Vs IPMT
or tumors of acinar origin, including the morular variant of pancreatoblas-
toma, which seems to be related to disruption of the Wnt pathway by APC or
beta- catenin mutations.
Carcinoma of the pancreas is unique in that al least 2 (not just one) major
tumor suppressor genes controlling the cell cycle seem to be involved in
tumor progression.
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SPECTRUM OF GEP-NET TUMORS
Deepak Chhabra1, Shashank Joshi2, Prashant Lad2, Suresh Navadgi3, Rajiv
Shah2, P Jagannath2
1Lilavati Hospital and Reearch Centre; 2Lilavati Hospital and Research
Centre; 3Asian Institute of Oncology
Background. Neuroendocrine tumors of the pancreas and peripancreatic
area are rare entities with a wide spectrum of clinical presentation. The
prognosis for non-functional tumors is poorer than that of functional tumors.
We studied the the spectrum of Neuroendocrine tumors of gastro-entero-
pancreatic system (NET-GEP) presented to the surgical oncology depart-
ment of our hospital.
Methods. Forty three patients (26 males, 17 females) of Neuroendocrine
tumors who were treated over 40 months (July 2003 -Dec 2006) were
analysed. Tumors were classified as per functional status, cells of origin and
WHO classification system. The following factors were evaluated for disease-
specific mortality: age, sex, primary tumor location, functional status, type of
primary tumor treatment, presence or absence of liver metastases, Surgical
procedure, pathologic characteristics, complications, mortality rates, and
disease-free survival.
Results. The mean age of patients was 52.5 years. 21patients (48.8%) had
nonfunctional tumors, whereas 22 patients (51.2%) who had functional
tumors: {13 insulinomas, 04 gastrinomas, 02 glucagonomas, one calcitonin
secreting tumor and one functional carcinoid} presented with appropriate
symptoms of hormonal excess. CT scan correctly localized the tumor in 39
(90.7%) of 43 patients. 07 of these 39 patients (18%) were incidentally
detected. 29 of 43 patients (67.4%) had a positive biopsy diagnosis. Most
common operative procedures were 12 pancreaticoduodenectomies, 08 distal
pancreatectomies and 04 tumor enucleation. Of the 32 patients who
underwent surgery, 27 (84.3%) underwent curative resection, 04 (12.5%),
underwent palliative resection and cytoreduction, while cytoreduction was
not possible in 1 patient. Five (15.6%) patients had postoperative complica-
tions: 4 patients had a low output pancreatic fistula while one patient
developed hypocalcemia and hypomagnesemia. There were no hospital
deaths. At a median follow up of 28 months, 06 (14%) patients are dead.
37 (86%) patients are alive: 27 patients are alive and disease free, 09 patients
are alive with disease. One patient was lost to follow up. 05 patients are being
treated with Long acting Octreotide (Sandostatin LAR R, Novartis India
Ltd). The overall survival at median follow up of 28 months is 83.7%.
Conclusions. This single-institution experience documents zero surgical
mortality and low morbidity for patients treated surgically for pancreatic and
peripancreatic neuroendocrine tumors. Surgery is the mainstay of manage-
ment, potentially curative in locally confined disease and useful for palliation
by possible cytoreductuion
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NON FUNCTIONAL PARAGANGIOMA OF THE PANCREAS:
CASE REPORT
Ettore Colangelo1, Edoardo Liberatore2, Marino Nardi2, Enzo Montefer-
ante2, Nicola Pitrelli2, Andrea Ricci3, Valerio Caracino2, Massimo Basti3,
Giuseppe Colecchia*
1s.spirito hospital pescara III unit Dept of surgery; 2s.spirito hospital III unit
Dept. of surgery; 3s.spirito hospital III unit dept. of surgery; *s.spirito
hospital III unit Dept. of. surgery
Background. Paraganglioma of the pancreas arise from paraganglia and is
histologically akin to chemodectomas. Paragangliomas are neural cells that
have separated from developing autonomic ganglia.. Lihe autonomic ganglia
paraganglia are also found with organs. A paraganglioma arising from a
visceral organ is exceedingly rare.
Paraganglioma arise from paraganglia and are histologically akin chemodec-
tomas.
Paraganglia are neural cells that have separated from developing autonomic
ganglia.
Like autonomic ganglia paraganglia are also found within organs.
A paraganglioma arising from a visceral organ is exceedingly rare.
We found only few cases (9) reports of paragangliomas arising from the
pancreas , excluding gangliocytic paragangliomas.
Case report. a 65 old man was admitted in our unit for gastric (body)
cancer( G3 T3-N1-M0). During preoperative staging TC scan showed a
mass (65 cm) of the head of the pancreas asintomatic and not infiltrating,
without dilatation of either the biliary or pancreatic ducts. Histological
examination preoperative performed after FNAB showed ‘‘neuroendocrine
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tumor like paraganglioma with immunohistochemical reaction positive for
GFAP, chromogranine, synaptofhisine and NSE.
Laparotomy confirmed the radiological findings. The mass was highly
vascular and the frozen section interpretation was a neuroendocrine tumor.
Patient underwent total gastrectomy with D2 linfectomy however pancreatic
tumor was not removed for three reaasons:a Wipple procedure and not a
enucleation have been necessary for radical surgery; histologically it was a
neuroendocrine tumor with a benign behavior; the unfavourable prognosis of
the gastric cancer.
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COMBINING CLINICAL, LABORATORY AND TOMOGRAPHIC
ASPECTS TO PREDICT MORTALITY IN ACUTE PANCREATITIS
Tercio De Campos1, Laise Kuryura, Jose Cesar Assef, Stanley Nigro,
Adhemar Pacheco Jr., Rodrigo Altenfelder Silva, Samir Rasslan
1Santa Casa School of Medical Sciences
Introduction and Aim. Mortality in severe acute pancreatitis varies from
10% to 20%. It is essential to recognize patients with higher risk of
complications to treat them properly. The aim of this study is to identify
the predictors of mortality in patients with AP.
Methods. Patients with acute pancreatitis (AP) were evaluated prospectively,
using the Atlanta criteria to determine the severity of the disease. Those
patients considered as severe were submitted to CT scan. Antibiotics were
administered when necrosis was confirmed by CT. The data analyzed were
age, gender, jaundice, fever, peritonitis, hemoglobin, leukocytosis, creatinin,
GOT, GPT, bilirubin, bicarbonate, base deficit, calcium, C-reactive protein
(CRP), APACHE II, CT scan. We compared the variables between the
survivors and the patients who died. Student’s t test and Chi square were
used for statistical analysis considering pB0.05 as significant.
Results. There were 172 patients with AP, 165 survivors (Group I) and
seven who died (4,1%) (Group II). According to Atlanta classification, 48
(27.9%) patients had severe AP. The mean APACHE II in Group I was 4.59
4.2 and 7.495.4 in Group II (p0.131). Jaundice (p0.041), leukocytosis
19,000/mm3 (p0.049), glycemia 185 mg/dl (p0.030) and base excess
B4 mEq/l (p0.019) were predictors of mortality. Pancreatic necrosis (p
0.036), fluid collections (p0.019) and severity tomographic index 2
(0.005) were also related to mortality.
Conclusion. Jaundice, leukocytosis, hyperglycemia and base deficit asso-
ciated to fluid collections and necrosis on CT scan are capable to predict
mortality in AP.
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PANCREATIC CANCER PATIENTS DON’T SHOW ELEVATED
SERUM LEVELS OF INSULIN-LIKE GROWTH FACTOR-I
Luca Degrate1, Cinzia Nobili, Claudio Franciosi, Roberto Caprotti, Mattia
Garancini, Fabio Uggeri, Franco Uggeri
1Department of Surgery, San Gerardo Hospital, University of Milano-
Bicocca, Monza, Italy
Introduction. Insulin-like Growth Factor-I (IGF-I) is the leading Growth
Hormone mediator: it strongly influences cell proliferation and it plays a
critical role in the development and progression of human cancer. High
IGF-I serum concentrations are indeed associated with an increased risk of
breast, prostate, colorectal and lung cancers. Particularly, IGF-I has been
implicated in the pathogenesis of pancreatic cancer due to its mitogenic
and proangiogenic action. The purpose of this study is to assess serum
levels of IGF-I in pancreatic cancer patients as compared to a healthy
control group.
Methods. From September 2002 to September 2006 IGF-I serum levels
were measured by RIA in 36 patients (21 males, 15 females, mean age67
years) with histological diagnosis of pancreatic adenocarcinoma and com-
pared to those of 23 age- and sex-matched healthy control subjects. 25
patients underwent radical surgery (17 pancreaticoduodenectomies and 8
splenopancreatectomies), while the other patients were judged unresectable
because of metastatic or locally advanced disease.
Results. The IGF-I serum levels evaluated in the patients with pancreatic
adenocarcinoma were significantly lower than the levels measured in the
control group (101,5966,6 ng/ml vs 136,3961,7 ng/ml, pB0,05).
Conclusions. Till now it has been observed that patients with different solid
neoplasms show high serum levels of IGF-I. Conversely this study demon-
strates that IGF-I serum values in pancreatic adenocarcinoma patients are
lower than the ones obtained in healthy subjects. These findings can be
explained by a predominant paracrine action played by IGF-I in pancreatic
cancer.
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EN-BLOC RESECTION OF SUPERIOR MESENTERIC VESSELS
AND MESENTERIC ROOT FOLLOWED BY INTESTINAL AUTO-
TRASPLANTATION FOR LOCALLY ADVANCED PANCREATIC
CANCER: A PILOT EXPERIENCE
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Vittorio Perrone, Niccola Funel2, Daniela Campani2, Carla Cappelli3,
Salvatore Mazzeo3, Franco Mosca
1University of Pisa-Regional Referral Center for Pancreatic Disease; 2Uni-
versity of Pisa-Division of Pathology; 3University of Pisa-Department of
Radiology
Introduction. Despite seemingly localized, pancreas cancers invading the
superior mesenteric artery and vein are associated to deep spread into the
mesenteric root and usually are deemed unresectable. However, the avail-
ability of newer and more efficient chemotherapy agents has recently allowed
the resection of some of these tumors with promising survival results.
Aim. Describe the outcome of a pilot experience with en-bloc resection of
superior mesenteric vessels and mesenteric root in the treatment of locally
advanced pancreatic cancer.
Methods. A retrospective analysis of our Institutional experience revealed
that 163 patients had received a pancreatectomy associated to resection of at
least one large peripancreatic vessels. Simultaneous resection of superior
mesenteric artery and vein en-bloc with the mesenteric root, followed by
intestinal auto-transplantation, was carried in 7 of these 163 patients (4.3%).
This analysis focuses on the six patients (5 women and 1 men) diagnosed
with ductal adenocarcinoma of the pancreas. The decision to proceed with
resection was based only on technical grounds (n3) in the first period of
our experience (19871998) (group 1), while subsequently only patients
(n3) showing a positive response to neoadjuvant treatments were con-
sidered (19992006) (group 2).
Results. Five patients (83.3%) underwent total splenopancreatectomy and
one (16.7%) pancreatoduodenectomy. A total of 16 vascular segments were
resected: in 4 patients (66.7%), besides superior mesenteric vessels, the
celiac trunk and/or hepatic artery were also ablated. Two patients (33.3%)
developed post-operative ( upper digestive bleeding and laminar portal
thrombosis, respectively) that were either treated conservatively. There were
no post-operative deaths. At pathology tumor infiltration of the superior
mesenteric vein was confirmed in none of the patients from group 1 and in
all of those form group 2. The superior mesenteric artery was involved in 2
patients from group 1 (2/3) and in none from group 2. Overall, 1-year
survival was 75% (65% in group 1 vs. 100% in group 2; pNS). All
patients from group 1 died from liver metastasis after a mean survival
period of 25.3 months. Two patients from group 2 are still alive, and
seemingly disease free at the time of this writing. The remaining patient
died from tumor recurrence at multiple distant sites 16 months after
resection.
Conclusions. En-bloc resection of superior mesenteric vessels and mesen-
teric root, followed by intestinal autotransplantation, can be done with an
acceptable operative risk in appropriate candidates. The sometimes striking
efficacy of newer neoajuvant medical treatments might constitute an
incentive to proceed with this formidable operation. In this perspective, our
preliminary results, although encouraging, clearly need to be verified in a
larger and well-standardized study, possibly including patients randomized as
controls without extended resection.
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ABSTRACT: NEOADJUVANT CHEMORADIOTHERAPY (GE-
MOX) PHASE II TRIAL FOR NOT RESECTABLE PANCREATIC
CANCER PATIENTS. PRELIMINARY RESULTS
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Background and Aims. Pancreatic adenocarcinoma is the fifth leading
cause of cancer-related death in the West Countries. Only in 10 20 % of
patients is achievable a surgical treatment at first time of the diagnosis.
Several trials based on preoperative chemo-radioterapy has been carried out
trying to improve resecability. Association of Gemcitabine-Oxalipatine and
focused radiotherapy, due to the improved radiation-sensitizing effects on the
primary tumor, may lead to an increase of the operable patients after
neoadjuvant treatment.
Methods. From August 2004 to August 2006 eleven patients with not
resectable local advanced pancreatic cancer were prospectively enrolled in a II
phase trial. All patients received neo-adjuvant chemo-radiotherapy: Gemci-
tabine (GEM) 1000 mg/m2/h and Oxaliplatine (OX) 100 mg/m2 /2h for 2
days each cycle. Radiotherapy was administered to all patients 15 days after
fourth cycle of chemotherapy. Follouw up has been conducted for all
patients.
Results. The Patients received 6 to 12 cycles of GEM-OX and 25 Gy
Radiation. Median time of treatment length was 161 days (range:76 175).
Six of eleven (54%) patients had clinical signs of toxicity that required
temporary discontinuation of therapy. After treatment, 5 of 11 patients
underwent had reduction in size and vascular infiltration of pancreatic tumor.
These patients underwent surgical laparotomy: 3 radical pancreatic resection
(27%) (1 spleno-pancreasectomy; 2 total pancreatectomy), 2 esplorative
laparotomy. R0 margin was achieved in 2 cases, the remnant patient was R1.
One patient (9.2%) is alive without sign of recurrence after 2 years of radical
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pancreatectomy, other patients are died for distant metastases after 7 and 6
months of surgical procedure.
Conclusions. These preliminary data are promising and confirm the
importance of neoadjuvant treatment to improve operability in unresectable
pancreatic cancer patients. Due to the small number of patients is necessary
re-evaluate these results after increase of study population.
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CHANGING TRENDS IN DISTAL PANCREATECTOMY DURING
21-YEARS: A SINGLE INSTITUTION EXPERIENCE WITH 232
CONSECUTIVE RESECTIONS
Brian Goh1, Yu Meng Tan2, Peng Chung Cheow, Yaw Fui Chung, Weng
Hoong Chan, Hock Soo Ong, Pierce Chow, Khee Chee Soo2, Wai Keong
Wong, London Ooi2
1Singapore General Hospital; 2National Cancer Centre Singapore
Aim. To examine trends in patient characteristics, surgical indications,
surgical technique and postoperative outcomes in patients undergoing distal
pancreatectomy at a single institution during a 21-year period.
Methods. Between 1986 and 2006, 232 consecutive patients who underwent
DP at a single institution were reviewed. Comparison of outcomes such as
indications for surgery, surgical technique, morbidity, mortality, duration of
hospitalization, readmissions and reoperations in patients over 3 time periods
was conducted (Period 1:1986 1992, Period 2: 19931999 and Period 3:
20002006).
Results. Nineteen DPs were performed in period 1, 50 in period 2 and 163
in period 3. Over time, the volume of DPs performed increased from an
average rate of 3 per year (period 1) to 7 per year (period 2) to 23 per year
(period 3). Resections were increasingly performed for incidental lesions
(11% to 41%, PB.001) and lesions resected were increasingly smaller in size
(median size, 108 (10240) mm to 45 (1240) mm, PB.001). Patients
undergoing DP had increasing ASA scores, P.014. Operation time, blood
loss and requirement for perioperative blood transfusions remained un-
changed. Over the time period, surgical practice changed with a trend
towards the decreasing use of sutured closure and increasing use of stapled
combined with sutured closure of the pancreatic stump, PB.001. There was
also a decreasing trend in the practice of ligation of the main pancreatic duct
after parenchymal transaction (39% to 30% to13%, P.002. However, there
was no change in the mortality, morbidity, pancreatic fistula, reoperation and
readmission rates. There was a decrease in the median length of postoperative
hospitalization from 8 (range, 545) days to 8 (range, 347 days), P.003
and need for immediate postoperative intensive care unit, 37% to 15%, P
.044.
Conclusions. DPs are increasingly performed for incidental and smaller
lesions. Although patients with increasing ASA scores are undergoing
resection, morbidity and mortality remains unchanged and the length of
hospitalization and need for intensive care unit stay are decreasing.
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OUR EXPERIENCES IN POSTOPERATIVE COMPLICATIONS OF
CEPHALIC DUODENOPANCREATECTOMY
Srbislav Knezevic1, Zoran Djordjevic, Igor Ignjatovic, Djordje Knezevic,
Slavenko Ostojic, Ivana Pavlovic, Slavko Matic
1Institute for digestive diseases, Clinical Centre of Srebia
Methodology. In a retrospective study in our department during the period
from 20002005 we have operated on 206 patients for different periampul-
lary malignancies. Standard Whipple’s procedure was done in 72 (35%),
radical Whipple’s procedure in 80 (39%) and PPDP in 54 (26%).
Results. Complications were observed in 81 patients among whom 26
patients required relaparotomy with 9 postoperative lethal outcomes.
Pancreatico-jejunal anastomotic leakages (pancreatic fistula) occurred in 40
patients resulting in 4 deaths. Postoperative bleeding as a complications was
seen in 12 patients. In 4 patients we manage to control bleeding with
endoscopic methods while 8 patients underwent reoperation which result in 1
postoperative lethal outcome. Two patients developed biliary fistula which
responded well on conservative treatment.
Conclusion. Control and treating of the complications require adequate
preoperative care sometimes including endoscopic transpapilary decompres-
sion, precise and standardized surgical technique and continuited post-
operative observation in intensive care unit. All this should lead to an early
detection of complications and early reoperation if necessary which sig-
nificantly improve the outcome of this patients.
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SURGICAL THERAPY FOR PSEUDOCYSTS OF THE PANCREAS
Djordje Knezevic1, Zoran Djordjevic, Igor Ignjatovic, Srbislav Knezevic,
Slavenko Ostojic, Ivana Pavlovic
1Institute for digestive diseases, Clinical Centre of Srebia
Background/Aims. A pancreatic pseudocyst is an incapsulated collection of
pancreatic juice, enclosed by non epithelial elements, containing a high
concentration of pancreatic enzymes, bicarbonates and necrotic detritus. It is
a common complication of acute pancreatitis and trauma of the pancreas.
Methodology. In the period between 2000 and 2005, 70 surgical procedures
were performed for pancreatic pseudocyst at the Institute for Digestive
Diseases (First Surgical University hospital) 49 male (70%) and 21 female
patients (30%) underwent surgery.
Results. In 52 (74%) patients the method of choice was cystojejunostomy by
Roux, 7 (10%) distal pancreatectomy for pseudocyst localized within the
pancreatic tail, 3 (4.3%) complete pseudocyst excision, 3 (4.3%) complete
pseudocyst excision combined with cystojejnostomy, 3 (4.3%) cystogastrost-
omy and drainage and 2 (3.1%) partial cystectomy and drainage.
Conclusion. Surgical internal drainage is the method of choice for the
treatment of pancreatic pseudocysts, involving low morbidity and mortality
rates.
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CAN WE PREDICT RISK FACTORS OF SERIOUS PANCREATIC
FISTULA AFTER PANCREATICODUODENECTOMY?
Fuks David1, Chatelain Denis2 Brehant Olivier, Dumont Frederic, Browet
Francois, Bartoli Eric3, Brazier Franck3, Yzet Thierry*, Delcenserie Ri-
chard3, Regimbeau Jean-Marc
1Department of Surgery CHU Amiens France; 2Department of Pathology
CHU Amiens France; 3Department of Gastroenterology CHU Amiens
France; *Department of Radiology CHU Amiens France
Background. Pancreatic fistula (PF) is a major complication following
pancreaticoduodenectomy (PD). The purpose of this study was to evaluate
risk factors of serious (Grade B and C) (1) PF after PD which require
interventional procedures.
Methods and patients. From 2003 to 2005, 56 patients were undertaken
in CHU of Amiens for pancreaticogastrostomy following pancreaticoduo-
denectomy. Patients with PF were divided in group 1 (grade A PF without
clinical impact) and group 2 (Grade B and C PF). Each group was
compared regarding preoperative (aetiology, loss of weight, BMI, jaundice,
prosthesis, tobacco), intraoperative (consistency of pancreas), and patholo-
gical (inflammation, fibrosis, fatty involution, chronic pancreatitis) out-
comes
Results. 22 patients (39%) had PF: 11 group 1 and 11 group 2. Mortality
rate was 3.8%. Among patients of group 2, 81% needed percutaneous
drainage and 13% needed a reintervention. Univariate analysis found that
preoperative loss of weight is a risk factors of pancreatic fistula grade B or C
(pB0.05). Major chronic pancreatitis lesions on pancreatic sump are a factor
protecting from PF: none patients with major chronic pancreatitis lesions had
PF. Others outcomes were not significantly different.
Conclusion. Serious (Grade B and C) PF after PD require interventional
procedures and are responsible of a significant increase in length of stay. The
knowledge of risk factors of serious (Grade B and C) PF after PD would help
to optimize management of patients at risk. Although a small number of
patientsBin our study, loss of weight seems to be a risk factors of serious PF.
1. Bassi C et al, Postoperative pancreatic fistula: an international study group
(ISGPF) definition. Surgery 2005 .
242
CLINICAL ANALYSIS OF 34 CASES SOLID-PSEUDOPAPILLARY
TUMORS OF THE PANCREAS
Tae Jin Lim1, Koo Jeong Kang, Yong Hoon Kim
1Department of Surgery, Keimyung University School of Medicine
Introduction. Solid-pseudopapillary tumors of the pancreas have been
reported as rare lesions with low grade malignant potential and usually
found in young women. The prognosis of this lesion is reported to be much
more favorable than other pancreatic neoplasms.
Methods. A retrospective review and analysis of 34 patients who had SPTs
from January 1996 to December 2005 were done. The clinical characteristics
and surgical strategy on 34 cases of SPT of the pancreas in Daegu area are
discussed. Despite an increase in recognition of the disease, there is still lack
of detailed reports about its surgical treatment.
Results. Of the 34 patients, 31 were female and 3 were male and their
mean age was 30.1 years with the range between 12 and 66 years of age.
The median size of the lesions were 7.4cm and tumors were located in the
head 9 patient, body 9 patients, tail 14 patients and combind body and tail
1 patient.
Correct diagnosis was 22 cases (64.8%) out of 34 cases. PPPD was done in 5
cases and distal pancreatectomy was performed in 26 cases.
Cystic nature was 17 cases and solid nature was 17 in gross appearances. Five
cases (14.7%) were confirmed as malignant tumors by pathology.
Conclusions. SPT occurs predominantly in female with relatively young age
group. Surgical resection is the most favorable in the treatment of SPT, which
has excellent prognosis. The choice of the local tumor resection depend on
the judgment of the tumor’s boundary, whereas operative types in radical
resection depend on the tumor position of the pancreas. SPT that has
infiltrated contiguous vessels, organs, even with local liver metastasis should
not be regarded as operative contraindication.
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SCORING SYSTEM FOR THE PREDICTION OF THE PROG-
NOSIS OF INFECTED PANCREATIC NECROSIS
Abstracts 61
Oleg Jarikov1, Andrey Litvin, Shadi Mauda2, Gennadiy Senchuk2, Abdulaziz
Ali2
1Gomel Regional Clinical Hospital; 2Gomel State Medical University
Background. In infected pancreatic necrosis (IPN), it is important clinically
to predict the prognosis at the time of admission. Most scoring systems for
severity of acute pancreatitis consist of multiple factors and are complicated.
Aim. This investigation aimed to propose a scoring system for the prediction
of the prognosis of IPN.
Patients and Methods. Prognostic factors were evaluated by receiver
operator characteristic curve analyses, multivariate analysis and artificial
neural network from data that were obtained on admission of 291 patients
with severe acute pancreatitis. A simple scoring system with 12 most useful
factors was made, and its usefulness was investigated in comparison with
conventional scoring systems.
Results. Twelve prognostic factors were selected: 1) type of hospitalization in
a hospital: transfer from other hospital or hospitalization «on first aid»; 2) age
of the patient  55 years; 3) body-mass index 25 kg/m2; 4) temperature 
38.08?; 5) heart rate 90 beats/min; 6) respiratory rate breath/min; 7)
WBC 12109 cells/L; 8) intra-abdominal hypertension determined within
24 hours from the beginning of disease 25 mm Hg; 9) extrapancreatic fluid
collection determined within the first 24 hours from the beginning of disease;
10) serum blood urea nitrogen 12 mmol/L; 11) glucose 7 mmol/L; 12)
absence of improvement of the patient within 24 hours of intensive therapy.
When usefulness of our scoring systems was compared with conventional
scoring systems, the area under the curve by receiver operator characteristic
curve analyses in our systems was 0.83; APACHE II was 0.58, and the
Glasgow score was 0.66.
Conclusion. This scoring system that comprised 12 items is simple, is
feasible for the prediction of prognosis and conventional scoring systems, and
is useful for the selection of the extremely severe patients with prognosis of
IPN on admission.
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PERCUTANEOUS DRAINAGE FOR ACUTE FLUID COLLEC-
TION AND PANCREAS ABSCESS IN SEVERE ACUTE PANCREA-
TITIS
Gennadiy Senchuk1, Andrey Litvin2, Shadi Mauda, Oleg Jarikov2, Abdulaziz
Ali
1Gomel State Medical University; 2Gomel Regional Clinical Hospital
Background. Percutaneous drainage is a possible therapy for the treatment
of peripancreatic fluid collection (PFC) and pancreatic abscess (PA) in severe
acute necrotizing pancreatitis.
Aim. To assess patient’s selection, techniques and results of PFC and PA
treatment using ultrasound guided percutaneous catheter drainage (PCD).
Patients and Methods. We treated 291 patients (222 male, 69 female) with
severe necrotizing pancreatitis. The most common cause of the pancreatitis
were alcohol abuse and gallstone disease (62.5% and 20.6%). Beside
antibiotic prophylaxis, selective gut decontamination, early naso-jejunal
feeding was executed and delayed operations for at least 14 days after the
admission were preferred. Percutaneous drainage was used for those patients,
with 23 cm or wider peripancreatic fluid collection (72 patients) or
pancreatic abscess (15 patients). Multivariate regression analysis determined
predictors of PCD success. Variables entered into the analysis included: type,
diameter, and location, complexity of PFC and PA, and drainage technique
(Seldinger or Trocar).
Results. No complications were found related to this intervention. Fifty
patients with PFC (69.4%) were recovered without surgery after a 14.8 days
average time of drainage. The remaining 22 patients with PFC underwent a
late (1430 days of admission) operations. Twelve patients with PA were
recovered without surgery.
Conclusions. We suggest the percutaneous peripancreatic drainage as a first
intervention for acute fluid collection or pancreas abscess in patients with
severe pancreas necrosis. If septic symptoms or MOF developed in spite of
drainage operation is mandatory. In these cases the advantage of the drainage
is to avoid the early operation. PCD should be considered as the initial
therapy in selected patients with PFC and PA, and as a staging method for
the resolution of sepsis prior to surgery.
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CURCUMIN AS A POTENTIAL CHEMOTHERAPEUTIC AGENT
FOR THE TREATMENT OF PANCREATIC ADENOCARCINOMA
Chris Mann1, Christopher P Neal, Anita Mitra2, Ashley Dennison, Margaret
Manson2, David Berry
1Department of Hepatobiliary and Pancreatic Surgery, University Hospitals
of Leicester; 2Cancer and Biomarkers Prevention Group, Department of
Cancer Studies and Molecular Medicine, University of Leicester
Background. Curcumin is a polyphenol derived from Curcuma Longa
present in the spice turmeric. It has been shown to have antiproliferative and
proapoptotic effects in a variety of human malignancies. The aim of this study
was to assess the effects of curcumin on human pancreatic adenocarcinoma
cells.
Methods. The effects of curcumin (0.130?M) on two human pancreatic
adenocarcinoma cell lines were studied in vitro. BxPC-3 is a cell line derived
from a patient with primary pancreatic adenocarcinoma, and AsPC-1 is
derived from ascites of a patient with metastatic pancreatic adenocarcinoma.
The effects of curcumin on apoptosis was assessed using an Annexin V assay.
Western blot analysis was used to determine effect of curcumin on several
regulators of apoptosis. All experiments were repeated in triplicate.
Results. Curcumin resulted in a reduction in viable cells after 24 hours of
treatment. 50% reduction in viable cells was seen with 2?M in BxPC-3 and
5?M in AsPC-1. Apoptosis was seen with doses as low as 0.1?M. At doses
exceeding 5?M in BxPC-3 and 10?M in AsPC-1, the majority of cells were
necrotic. The effects were more pronounce after 48 hours of treatment.
Western blot analysis demonstrated that these effects were associated with a
reduction in the levels of the anti-apoptotic proteins Bcl-2 and Bcl-xL and an
increase in the pro-apoptotic Bax.
Conclusion. Curcumin induces apoptosis in human pancreatic adenocarci-
noma cells. The chemotherapeutic in pancreatic cancer warrants further
consideration.
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HYPERAMYLASAEMIA FOLLOWING CARDIAC SURGERY IS
NOT USUALLY DUE TO ACUTE PANCREATITIS
U Minhas1, G Morris-Stiff, R Basir, P A O’Keefe1, M C A Puntis
1Department of HPB Surgery, University Hospital of Wales; 2Deaprtment of
Cardiothoracic Surgery, University Hospital of Wales
Background. Hyperamylasaemia has been reported as a common finding
following cardiac surgery although its aetiology and clinical significance has
been debated. The prevalence of acute pancreatitis is less well documented
with a recent study of 8709 patients reporting a prevalence of 0.05%. The
aim of this study was to document the prevalence of hyperamylasaemia
following cardiac surgery and to determine its clinical relevance.
Methods. The study group consisted of all patients undergoing cardiothror-
acic surgery during the period 2004 2006. A cohort of patients with
hyperamylasaemia consistent with a diagnosis of acute pancreatitis (serum
amlylase 400 IU/L), were identified from the biochemistry department
database. Patient demographics were determined and details of the operative
and postoperative course obtained from review of a prospectively maintained
database.
Results. 46 patients were identified with a serum amylase 400 IU/L
consisting of 30 males and 16 females with a mean age of 67.9 years. The
most common procedures were valve replacement (n28) and coronary
artery bypass grafting (n27), with some individuals undergoing combined
procedures. The median amylase level was 891 IU/L with a range from 409
2515 IU/L. The elevation in serum amylase was recorded at a median of 2
days postoperatively (range: 115 days). There was no relationship between
the development of hyperamylasaemia and the use of cardiopulmonary
bypass, use of inotropic support or the requirement of haemofiltration. All
patients were assessed clinically and 6 underwent radiological investigation
consisting of ultrasound (n3) or computed tomography (n3), the later
identifying the presence of acute pancreatitis in 2 cases. Both patients were
managed conservatively. One patient with confirmed acute pancreatitis on
day 12, whilst ventilated in the intensive care unit as a result of multi-organ
failure died on the 21st postoperative day. The second patient, whose amylase
rose on day 2 made a full recovery. A further 10 patients subsequently died of
which 7 were within 30 days of surgery. All 7 early deaths underwent post-
mortem examination and no pancreatic or other gastrointestinal pathology
was identified. The remaining 3 died at 32, 55, and 81 days following
identification of hyperamylasaemia, of cardio-respiratory causes and had not
reported any abdominal symptoms in the interim.
Conclusions. Whilst a significant hyperamylasaemia is not uncommon
following cardiothoracic surgery, in the vast majority of cases there is no
clinical or radiological evidence of acute pancreatitis and no indication of
other intra-abdominal pathology.
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PATIENTS WITH NON-DIAGNOSTIC HYPERAMYLASAEIMA
BUT APPROPRIATE CLINICAL SIGNS SHOULD BE INVESTI-
GATED AND MANAGED AS PER ACUTE PANCREATITS
G Morris-Stiff1, U Minhas, N Jardine, M C A Puntis
1Department of HPB Surgery, University Hospital of Wales
Background. The identification of hyperamylasaemia insufficient to afford a
diagnosis of acute pancreatitis poses a clinical dilemma. If the clinical
presentation is consistent with acute pancreatitis, the reasons for the sub-
diagnostic amylase may simply be that there has been a delay in presentation,
but if not, other causes of hyperamylasaemia will have to be considered. The
aim of this study was to identify a cohort of patients with hyperamylasaemia
together with appropriate clinical features and to determine the aetiology of
their elevated amylase.
Methods. The biochemical definition of acute pancreatitis was based on that
recommended by the British Society of Gastroenterology guidelines namely a
serum amlylase 400 IU/L. All patients admitted through the emergency
surgical intake of the University Hospital of Wales during 2003 and found to
have a hyperamylasaemia of B400 IU/L (normal range: B100 IU/L) were
identified from the biochemistry department database. In all cases, demo-
graphic characteristics were collected and case notes were reviewed as were
results of all subsequent radiological and biochemical investigations.
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Results. 25 patients were identified consisting of 21 men and 4 women with
a mean age of 46.7 years. The median amylase level was 230 IU/L with a
range from 102358 IU/L. Twenty two patients underwent transabdominal
radiography at the time of admission with gallstones identified in 9 cases. The
remaining 3 patients were known to have gallstones and were awaiting
elective surgery. Of the 13 patients with no evidence of cholelithiasis, 6
patients were taking medications that cause pancreatitis [statins (n3);
sodium valproate (n1); azathioprine (n1); and prednisolone (n1)].
Seven patients underwent diagnostic CT scans which identified chronic
pancreatitis in 3 cases and in 4 they were non-diagnostic. These 4 patients
underwent endoscopic ultrasound evaluation of the biliary tree to exclude
microlithiasis, this being positive in 1 instance. Patients with gallstones were
managed by ERCP/cholecystectomy. None of the patients without a
diagnosis have represented with abdominal pain during the subsequent 3
years. 6 of 25 patients had a Glasgow score of 3 or more consistent with a
severe attack of pancreatitis including 3 of 13 with confirmed cholelithiasis.
Conclusions. Patients with hyperamylasaemia not diagnostic of pancreatitis
should be carefully investigated as gallstones will be identified in at least half
of the cases. Failure to do so will lead to an underestimation of the prevalence
and importance of gallstone pancreatitis and will also mean that these
patients will miss out on definitive treatment and will be at risk for further
exacerbations. An accurate drug history is also invaluable to identify potential
aetiological agents as increasing numbers of patients are prescribed medica-
tions that may induce pancreatitis.
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PROGNOSIS OF BORDERLINE RESECTABLE PANCREATIC
CANCER IN THE ERA OF MULTIDISCIPLINARY APPROACH
Paolo Massucco1, Enrico Sgotto2, Roberto Lotesoriere2, Alfredo Mellano,
Lorenzo Capussotti
1Istituto Per La Ricerca E La Cura Del Cancro; 2Ospedale Mauriziano
‘‘Umberto I’’
Aim. To evaluate prognostic factors for survival of locally advanced border-
line respectable pancreatic cancers (BRPC) treated with chemoradiation with
or without surgical resection and to compare them with resectable (RPC) and
locally advanced unresectable (UPC) cases consecutively observed in the
same time period.
Patients and methods. From 6/1999 to 6/2005, we treated 89 patients with
non-metastatic biopsy proven pancreatic ductal cancer. According to the
pattern of vascular involvement on pre-treatment CT scan, they were
classified as 48 RPC, 25 BRPC and 16 UPC. BRPC and UPC patients
were enrolled for institutional phase II protocols of chemoradiation based on
gemcitabine alone or in combination with oxaliplatin. Patients showing PR or
SD with normalisation of CA19.9 were surgically explored. RPC were
proposed with adjuvant chemotherapy or chemoradiation based on the same
drugs. A survival analysis for BRPC was performed including sex, age 65
years, site of tumor (head/tail), diameter 3cm, CA199 300U/ml,
ECOG PS at diagnosis, pain at diagnosis, radiological response (PR vs SD/
PD) and resection.
Results. Eleven BRPC and one UPC were successfully resected. Among
RPC, 17 patients received a full course of adjuvant treatment. Median overall
survivals from treatment start were 14, 13.8 and 13 months and 2-year
actuarial survivals 34%, 35% and 0% for RPC, BRPC and UPC, respectively.
A survival exceeding 2 years was observed only among resected patients. At
univariate analysis, objective response (pB0.05) and resection (pB0.01)
resulted significant prognostic factors for BRPC. At multivariate analysis,
only resection retained significance. Median and 2-year overall survivals were
25.2 months and 57% for BRPC successfully resected (p0.23 vs RPC).
Median and 2-year disease-free survivals were 13 and 8.2 months and 25%
and 23% for resected BRPC and RPC, respectively (p0.37).
Conclusions. Patients presenting with a locally advanced pancreatic cancer
(either BRPC or UPC) and enrolled for multidisciplinary treatment protocols
experienced the same median survival as RPC. Nonetheless, only patients
successfully resected could survive beyond 2 years. Pancreatic resection was
the most powerful predictor of survival for BRPC. Patient resected after
chemoradiation had at least the same overall and disease-free survival than
RPC.
249
CHYLOUS ASCITES AFTER PANCREATODUODENECTOMY
van der Gaag Niels A1, Verhaar Andries C, Haverkort Elisabeth B2, Busch
Olivier RC, van Gulik Thomas M, Gouma Dirk J
1Academic Medical Center, department of surgery; 2Academic Medical
Center, department of dietetics
Introduction. Chyle leakage or chylous ascites is a well-recognized
complication following thoracic and abdominal surgery. Chylous ascites
(CA) is usually recognized after provocation by enteral feeding and
characterized by its milky appearance and raised triglyceride (TG) level
(1.2 mmol/L). The incidence, management, impact on outcome and
possible predisposing factors of CA after pancreatoduodenectomy (PD) for a
suspected periampullary malignancy is unclear and has never been described
before.
Objective. The aim of this study is to evaluate the incidence and manage-
ment of CA after (PP)PD, to evaluate the impact on patient outcome and to
investigate possible predisposing factors.
Methods. Data was collected from a consecutive series of 518 patients who,
in the period 19962005, had undergone a PD for a suspected periampullary
malignancy. Routinely a silicone drain was placed dorsally of the PJ
anastomosis. Patients who had a significant drain output with milky
appearance and a raised triglyceride (TG) level (1.2 mmol/L), were
included for analysis (group A). They were compared with patients without
significant drain production or a low TG level (group B). Patients with
(concomitant) anastomotic leakage were excluded for analysis. Management
of patients with isolated CA was reviewed.
Results. Fifty-eight patients (11%, 58/518) had isolated CA (group A), 383
patients did not have CA (group B) and 77 patients were excluded for
analysis. CA was almost always diagnosed between the 39 postoperative
day. Introduction of a polymeric, Low Chain Triglyceride (LCT)-containing
diet provoked the occurence of CA. Patients with CA were in 83% of the
cases successfully treated with a Medium-Chain Triglyceride (MCT) diet. An
expectative approach was followed in 17%. None of the patients required
Total Parenteral Nutrition. After a median of 3 days (range 16) CA had
resolved. Isolated CA was an independent variable for a prolonged hospital
stay (p0.002). No differences between groups or possible predisposing
factors for CA development could be identified.
Conclusion. Isolated CA occurs in 11% of the patients after PPPD. This
rather high rate might be due to the increasingly employed concept of fast
track surgery, which encompasses early introduction of enteral feeding.
However, CA poses a relatively mild complication, which can be adequately
treated with a MCT-diet. Isolated CA is an independent variable for a
prolonged hospital stay. No predisposing factors could be identified.
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SURGICAL TREATMENT OF CHRONIC CEPHALIC PANCREA-
TITIS
Iliya Buriev1, Victor Tsvirkun2, Elena Guzeeva, Oxana Paklina2, Galiya
Setdikova2
1Medical Center of MFA of Russia, Moscow, Russia; 2Clinical Hospital 119
of FMBA of Russia, Moscow, Russia
Background. Chronic abdominal pain, weight loss, obstruction of biliary
and pancreatic ducts, duodenal obstruction, stenosis and thrombosis of
peripancreatic blood vessels, and other complications of chronic pancreatitis,
occurred consequently of invariable morphological changes, such as pseu-
docysts, fibrosis, calculesis, is an indication for surgical treatment.
Aim. Evaluation of experience in total and partial resection of head of
pancreas for treatment of chronic pancreatitis.
Methods. Authors posses personal experience of 177 proximal resections of
pancreas for treatment of chronic cephalic pancreatitis (CCP): 38 
gastropancreatoduodenal resection (Whipple), 46  pyloruspreserving pan-
creatoduodenal resection (PDR). Partial resections of head of pancreas have
been recently: local resection of head of pancreas combined with longitudinal
pancreaticojejunostomy (Frey) 35, subtotal resection of head of pancreas
combined with terminolateral pancreaticojejunostomy (Beger)-31, atypical
resection (usually one of segments of head of pancreas) of head of pancreas
combined with pancreaticojejunostomy-18, atypical resection of head of
pancreas without pancreaticojejunostomy-9. Under the obligatory intrao-
perative and following morphological investigation traditional and immuno-
gistochemical methods of research including the special study of pancreatic
intraepithelial neoplasia (PanIN) (HER-2\neu, MUC1, MUC2, MUC5A,
p16, p53, Ki-67, PCNA) were used.
Results. The most informative preoperative method of diagnostics was CT
with bolus contrast enhancement and 3D reconstruction, which gives a
possibility to differentiate changes with tumors and forecast performing of
surgery. Postoperative morbidity after PDR  4,8% (4), mortality  1,9%
(1); after partial resections of head of pancreas suitability  3,2% (3) ? 0%. In
6 cases of special morphological investigation the changes are revealed which
should be considered as PanIN 3 (carcinoma in situ).
Conclusion. Partial resections of head of pancreas for treatment of CCP are
radical, less traumatic organpreserving procedures. The required condition of
performing these operations is accurate preoperative diagnosis and morpho-
logical identification.
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PANCREATOGENIC ASCITES AGGRAVATED THE CLINICAL
COURSE OF NECROTIZING PANCREATITIS
Andre Perejaslov1, Serge Chooklin, Taras Ivankiv, Oleg Granat
1Medical University
Multiple-organ dysfunction syndrome (MODS) often determined the
mortality in patients with necrotizing pancreatitis. Pancreatogenic ascites
and pancreatitis-associated fluid accompanied the clinical course of necrotiz-
ing pancreatitis in 3050% of patients. Experimental studies confirmed the
role of pancreatitis-associated fluid in aggravation of MODS. Unfortunately,
the studies about the influence of pancreatogenic ascites on clinical course of
necrotizing pancreatitis in humans are limited.
Results of treatment of 127 patients with confirmed necrotizing pancreatitis
were evaluated. All patients were divided on two groups: 1st group compiled
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37 patients without removing pancreatogenic ascites, in the 2nd group
included 90 patients in the complex management of whom the removing of
fluid were applied. Evacuation of the ascites or fluid collections was
performed within 48 hours after admission. Patients of both groups received
the identical conventional treatment. Using the ELISA technique levels of
interleukins 1, 6, 8, and 18 in plasma and ascites were measured in 69
patients. Severity of MODS determined according SOFA score.
Severity of MODS had no difference in both groups at the time of admission.
At the same time, increased levels of all cytokines were noted in all patients.
Levels of interleukins in ascites exceeded its levels in plasma (pB0.05). The
gradually elevation, up to the seventh day, of interleukins’ level was noted in
the 40.5% of patients of the first group what correlated with the MODS
progression. Evacuation of ascites or fluid collections determined the
decrease of interleukins’ concentration in systemic circulation started at the
third day after fluid removing with the improving of clinical course.
Progression of MODS was observed only in 7.8% patients of the main
group. The further spreading of necrotic process was noted in 45.9% patients
of the control group, while in 63.3% patients of the second group the necrotic
process was stabilized and in 24.4%-was noted the diminish of the necrotic
changes.
Thus, the evacuation of pancreatogenic ascites and acute fluid collections
improve the clinical course of necrotizing pancreatitis.
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N-ACETYLCYSTEINE IN THE COMPLEX MANAGEMENT OF
NECROTIZING PANCREATITIS
Taras Ivankiv1, Serge Chooklin, Andre Perejaslov, Oleg Granat
1Medical University
Multiple-organ dysfunction syndrome (MODS) is characterizes by general-
ized inflammation and tissue damage, and often determines the mortality in
severe pancreatitis. Pro-inflammatory mediators (cytokines and reactive
oxygen species) play an important role in the development and progression
of MODS. The theoretical intervention points for MODS therapy directed at
inflammatory mediator reduction and cell adhesion retardation.
The goal of this study was to determine the place of N-acetylcysteine (NAC)
in the complex management MODS in necrotizing pancreatitis.
In this study enrolled 105 patients with severe pancreatitis who admitted in
clinic not later than 48 h after onset of the symptoms. All patients were
divided on two groups: 1st  40 patients, which received standard therapy
and 2nd  65 patients who beside conventional therapy received intravenous
NAC. Levels of interleukins (IL) 6, 8, 17, 18 and adhesion molecules  E-
selectin, ICAM-1 were measured in all patients.
Increased levels of all mediators were noted in all patients at the time of
admission. During first week, mediators’ concentration significantly raised in
patients of the first group what correlated with the worsening of clinical
course (elevation of APACHE II score and increased CRP level). Insignif-
icant increase of mediators’ level was noted in patients of the second group
and started from the third day its levels decreased in 56.9% of them.
Accordingly, the decrease of APACHE II score and improving of CT picture
was observed in these patients. Mediators’ level stabilized in 26.2% of
patients and only in 16.9%  further elevation of mediators’ concentration
was noted.
Thus, our study shown, that applying NAC, which has plural potential
action, in the complex management of necrotizing pancreatitis, decreased
circulating levels of cytokines and improved clinical course of severe
pancreatitis.
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REGIONAL INTRA-ARTERIAL THERAPY IN THE MANAGE-
MENT NECROTIZING PANCREATITIS
Serge Chooklin1, Andre Perejaslov, Taras Ivankiv, Oleg Granat
1Medical University
Despite recent advances in intensive care management, the mortality rate of
severe necrotizing pancreatitis remains high. Prophylactic antibiotics given
intravenously have been demonstrated to be beneficial in reducing the rate of
pancreatic infection, but their survival benefit remains unclear. The goal of
this study was to compare the results of the traditional intravenous and
regional intra-arterial infusions in the complex management severe necrotiz-
ing pancreatitis.
Results of treatment of 78 patients with necrotizing pancreatitis were
analyzed. All patients were divided on two groups: 1st group-38 patients
who received conventional intravenous therapy and the 2nd  40 patients in
whom, besides intravenous infusions, the intra-arterial administration of
remedies (antibiotics, and proteases’ inhibitor) was applied.
Ranson, APACHE II, and Balthazar score had no significant differences in
both groups of patients at the time of admission. Subsequently, the further
spreading of the necrotic process was established in 36.8% of patients of the
first group and 22.5%  of the second group. Started at the fifth day the
gradually decrease of necrotic foci was observed in 26.3% patients of
the main group. The early contamination was noted in 15.8% patients of
the control group, while among patients of the second group there were no
cases of early contamination. In general, the total contamination level among
patients, which treated by intravenous infusions, was higher than in patients
treated by intra-arterial antibiotic administration. Accordingly, mortality in
the second group was lower than in first group.
Thus, the intra-arterial infusions are the effective for the controlling of the
necrotic process and prevention of septic complications in patients with
necrotizing pancreatitis.
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ORAL REFEEDING IN ACUTE PANCREATITIS: A REVIEW OF
LITERATURE
Maxim Petrov1, Hjalmar Van Santvoort, Marc Besselink, Geert Cirkel, Eric
Buskens2, Hein Gooszen
1Department of Surgery, University Medical Center Utrecht, Utrecht, The
Netherlands; 2Julius Center for Health Sciences and Primary Care, Uni-
versity Medical Center Utrecht, The Netherlands
Introduction. Oral refeeding in patients recovering from acute pancreatitis
may cause pain relapse. Patients with pain relapse may ill for prolonged
periods, thereby consuming additional health care resources. We aimed to
determine the incidence and risk factors of pain relapse on the basis of
reviewing all studies on oral refeeding in acute pancreatitis.
Methods. Relevant literature cited in three electronic databases (Cochrane
Central Register of Controlled Trials, EMBASE and Medline) was reviewed
for studies on oral refeeding in acute pancreatitis. Outcome measures studied
were the incidence of pain relapse and length of hospital stay.
Results. A total of 3 studies containing 274 patients with acute pancreatitis
were analyzed. Sixty of 274 patients (21.9%) presented pain relapse during
the course of acute pancreatitis. All three trials found a significant increase in
the length of hospital stay in patients with pain relapse. There were no reliable
predictive factors of pain relapse after oral refeeding in acute pancreatitis.
Conclusion. The incidence of pain relapse after oral refeeding in acute
pancreatitis is relatively high. Thereby, the quest for new therapeutical
modalities which can prevent pain relapse is of current importance.
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INFLAMMATION IN PATIENTS WITH ACUTE AND CHRONIC
PANCREATITIS: THE ROLE OF TUMOR-NECROSIS FACTOR,
INTERLEUKINS 4 AND 10
Viktoria Petrushenko1
1Department of Surgery, National Medical University, Vinnitsa, Ukraine
The aim of the study was to investigate cytokine-mediated mechanisms of
inflammation in patients with chronic pancreatitis. 57 patients with acute
alcoholic and relapsing alcoholic forms of chronic pancreatitis were included
in trial. The first (I) group consisted of 29 patients with acute alcoholic
pancreatitis while the second (II)  of 28 patients with chronic alcoholic
pancreatitis. Each group was divided into A and B subgroups according to
the severety of exacerbation. 16 donors served as controls. TNF alpha, IL-4
and IL-10 levels were evaluated in blood sera, IL-10 concentration was also
measured in blood cell culture supernatants. The investigations were
performed on the first and sixth days of exacerbation. ELISA method was
used to evaluate cytokines’ levels. In group I, high levels of TNF alpha and
IL-4 in blood sera and high level of IL-10 in cultural fluid (but not in sera)
were revealed on the 1st day of the exacerbation with rapid decrease of
cytokines’ levels found at the 6th day of the exacerbation. In group II, signs of
delayed cytokines’ synthesis were found: on the 6th day of exacerbation TNF-
alpha level in A subgroup was 4,6-fold higher and in B-subgroup  18,1-fold
higher than in controls. Intensive IL-4 production on the 6th day of
exacerbation was revealed only in IIB subgroup; its level significantly
correlated with the severety of the disease. During remission, in IIB subgroup
of patients with signs of biliar-pancreatic regurgitation TNF-alpha level was
14-fold higher than in those without regurgitation. That fact can be explained
by higher inflammation activity in patients with biliar-pancreatic reflux.
Conclusion. In patients with chronic pancreatitis signs of cytokines’
disbalance were revealed. Levels of TNF-alpha and IL-4 can be considered
as criteria of exacerbation and severety of acute alcoholic and relapsing
pancreatitis. That’s why dynamics of these cytokines levels should be also
investigated
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ANALYSIS OF CLINICAL COURSE IN SEVERE ACUTE BILIARY
AND NON BILIARY PANCREATITIS: A COMPARATIVE STUDY
Ra˜3bert Kota˜in1, JA˜inos Pa˜3sa˜in, Zsolt Szentkereszty, Pa˜#ter Sa˜ipy
1University of Debrecen, Medical and Health Science Center Department of
Surgery Augusta Surgery Center
Introduction. The acute pancreatitis is a relative common disease with
incidence of between 5 and 80 people per 100000 of the population. The
number of new cases in the last years has steadily increased. The two main
ethiological factors are alcohol and cholelithiasis. The incidence of alcoholic
pancreatitis is higher in male, and the incidence of gallstone pancreatitisis
higher in female.
Goals. The aim of this study is to summarise the difference beetween the
clinical course of biliary and not biliary type of severe acute pancreatitis by
analising the data of these patients.
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Patients and Methods. The 139 patients treated with severe acute
pancreatitis were divided in two groupes: biliary and non biliary in oroigin.
The two goup was compared on the basis of sex and age, mortality,
morbidity, number of surgery and hospital stay. I¨%2 probe was used for the
statistical analysis.
Results. The complications in the biliary group were more serious. The
mortality was 15,1% in all cases and was 17.8% in the group A and 13.8% in
the group B. The mortality rate of the female were significantly higher in the
group A.
Conclusion. There are higher morbidity and mortality rate by the female
patients suffered from severe biliary acute pancreatitis. Therefore in old
female patients with serious comorbidity and gallstones, before developing
the complications an elective cholecystectomy is suggested.
Key words. severe acute pancreatitis, gallstone pancreatitis, elective chole-
cystectomy
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ROLE OF D-DIMER IN EARLY PREDICTION OF SEVERITY IN
ACUTE PANCREATITIS
Dejan Radenkovic1, Djordje Bajec, Vasilije Jeremic, Natasa Milic2, Aleksan-
dar Karamarkovic, Nenad Ivancevic, Vladimir Djukic, Pavle Gregoric,
Branislav Stefanovic
1Center for Emergency Surgery, Clinical Center of Serbia and School of
Medicine, University of Belgrade, Serbia; 2Institut for Medical Statisctics,
University of Belgrade, Serbia
Introduction. Clinical studies in acute pancreatitis (AP) suggest activation
of haemostatic system. Early, accurate and reliable prediction of severity in
AP is very important in the clinical practice. Aim of this prospective study
was to assess whether early haemostatic abnormalities play a role in
prediction of severity in AP.
Methods. From January 2004 until April 2005 a total of 91 patients with AP
treated in our Institution were included. Measurement of coagulation,
anticoagulation and fibrinolysis parameters: prothrombin time, activated
partial thromboplastin time, fibrinogen, antithrombin III, protein C,
plasminogen activator inhibitor-1, d-dimer, alpha2-antiplasmin and plasmi-
nogen were done on admission and 24h after. The severity of AP was defined
according to the Atlanta classification system. At the end of study, groups of
33 patients with severe and 58 patients with mild form of disease were
compared.
Results. On admission, the mean d-dimer concentration was 682 ?g/l
(sd.460) for severe and 258 ?g/l (sd. 182) for mild disease (pB0,001). On
first day after admission respective values were 835 ?g/l (sd.428) and 336 ?g/l
(sd.206 pB0,001). The sensitivity, specificity, positive predictive, and
negative predictive values of the test to show severe AP compared with
mild AP on admission (414,00 ?g/l or 1,7 fold higher than uperr limit),
were 73 %, 91 %, 83 %,and 82 % respectively, and 24h after admission (
525,50 ?g/l or 2,1 fold higher than upper limit), were 76%, 82%, 72.%, and
82 %. The levels of all other measured parameters were significantly different
between the patients with severe and mild AP, but all values were within
physiological limits.
Conclusions. Prediction of severity is already possible on patients admission
to the hospital with high sensitivity and specificity. D-dimer as single test
parameter significantly contributes to an improved stratification of patients at
risk to develop severe AP and deserves routine clinical application.
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THE USE OF ENFORCEMENT MATERIALS FOR WHIPPLE
PROCEDURE
Alexey Severtsev1, Dimitry Tchudaev2, Vladimir Ovtchinnikov2, Vera Se-
vertseva2
1Central Clinical Hospital #1 of the LLC ‘‘Russian Railways’’; 2Central
Clinical Hospital#1 of the LLC ‘‘Russian Railways’’
Background. The pancreatico-jejuno anastomosis is most weak milestone of
the Whipple procedure. There are many different techniques and materials
were used to do this anastomosis safer and warranted. One of the prospective
methods is to use intraoperative adhesive materials like fibrin sealant and
TachoComb.
Aim. The purpose of this study was to assess the use of these two very close
materials for the enforcement of pancreatico- jejunoanastomosis during
Whipple procedure.
Methods. From December 1998 till October 2006 39 patients had Whipple
procedure with the use of fibrin glue or TachoComb in the site of
pancreatico- jejunoanastomosis (15 and 24 patients respectively). All patients
had the cancer of pancreatic head. The mean age, sex ratio, disease history
and concomitant diseases, and the technique of pancreato-jejunoanasomosis
(end-to side, two layers) in the both groups were similar. During surgery were
used 5 ml of sealant or 1 large fleece of TachoComb.
Results. The intraoperative time for additional manipulation was high for
sealant group (1,5 times in comparison to TachoComb). The intraoperative
adhesion and sealing was better for sealant group (in 12 cases of TachoComb
the material was not fixed to the line of anastomosis; no such cases in the
sealant group). There were 2 cases of pancreatico-jejuno anastomosis leakage
in the TachoComb group, and the absence in the fibrin glue group. The first
postoperative day of mean amylase level from the site of surgery (drainage
fluid from the abdominal cavity) was 3 times high for TachoComb (66000 IU
for TachoComb and 21500 IU for fibrin glue).
Conclusions. These results show that if the surgeon decided to use any
adhesive materials (as TachoComb or fibrin sealant) for the enforcement of
pancreatico-jejunoanastomosis during Whipple procedure, the use of sealant
is more preferable because its plasticity and temporary-time liquid condition,
which help this material to penetrate to any deep layers of anastomosis.
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CLINICAL VALUE OF DYNAMIC CONTRAST ENCHANCEMENT
COMPUTER TOMOGRAPHY IN MANAGEMENT OF NECROTIZ-
ING PANCREATITIS
Alexey Shabunin1, Dmitry Shikov, Michael Tavobilov, Andrey Lukin,
Shorensho Shotemor, Galina Shustrova
1Botkin’s Memorial Hospital
Botkin’s Clinical State Hospital
Department of general, laser, and endoscopic surgery
Unit of Hepato Pancreato Billary surgery, Moscow, Russia.
Background. The results of treatment of necrotizing pancreatitis (NP) are
still unsatisfactory, despite the use of modern principals of conservative
therapy and surgery. It’s obvious that timely and precise assessment of
character and degree of pancreas and parapancreatic fat damage plays the
leading role in determination of medical approach, which cosequently
influences on the outcome.
Aim. We have put the task to assess the role of Dynamic Contrast
Enhancement Computed Tomography (DCECT) in combination with
ultrasound (US) monitoring in defining the surgical management.
Materials and Methods. 246 patients with PN, which were presented of
two groups, have been retrospectively analyzed during the period from 2002
to 2005. All patients had the same clinical data(Ranson3, APACHE9)
and all cases were underwent different kind of surgery. Group 1 consisted of
125 patients (20022003), group 2  of 121(20042005). In group 1 the
main role in diagnostic algorythm played US monitoring and native CT,
basically at the late period of treatment. All patients from group 2 were
performed, in case of contraindications absence, DCECT on 35 days from
the onset of desease or on the admission in case of delay hospitalization with
following CECT monitoring every 710 days. The choice of way and kind of
surgery based on clinical data and results of CECT. We assessed the results of
CECT in accordance to Balthazar. Patients which had CT index of C and D
and volume of necrosis (VN).
B30% were underwent endoscopic surgery US-guided percutaneus drain,
mainly in cases with peripancreatic fluid collections40 ml. In some cases
these methods were performed like a first step with following open surgery
(necrosectomy). If CT index was grade E (VN  3050%,50%) such
patients were mainly underwent open surgery.
Results. Endoscopic surgery and US-guided drain were performed as a first
and final stage of treatment in 56 (44,8%) cases of group 1 and in 98 (81,1%)
of group 2. Endoscopic surgery and US-guided drain with following open
surgery were performed in 23 (18,4%) cases of group 1 and in 14 (11,5%)
cases of group 2. Open surgery, as a single surgical method, was performed.
In 45 (36,8%) cases of group 1 and in 9 (7,4%) cases of group 2. The
mortality range in fisrt group was 35,2% and 16,9%  in second (p0.005).
Conclusion. DCECT is one of the most effective diagnostic methods that
plays the leading role in management of necrotizing pancreatitis and allow to
perform flexible approach.
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PANCREAS HEAD CANCER WITH WERNERS SYNDROME: A
CASE REPORT
Takayuki Shiraki1, Mitsugi Shimoda, Rie Yamazaki, Akihito Abe, Masato
Katoh, Keiichi Kubota
1Second Department of Surgery, Dokkyo University School of Medicine
A 60-year-old woman with Werner’s syndrome (WS) was admitted to our
department with a complain of jundice. In a patient with WS was reduced
life-span of her fibroblasts in virto. The genotype of this patient was
heterozygote with mutation 1 in the WS gene, suggesting to be a compound
heterozygote. Her laboratory data showed sever liver dysfunction with high
serum levels of total bilirubine. Computed tomography showed a dilatation of
intrahepatic bile duct and main bile duct. MRCP showed a sever stricture in
the lower bile duct. Under a diagnosis of lower bile duct cancer, the patient
successfully underwent pancreato-duodenectomy. Histological findings
showed that main tumor was well-differentiated adenocarcinoma of the
pancreas. Ten per cent of all patients with WS develop some forms of
malignant disease, half of them sarcomas. Here we report a first successful
resected case of WS with pancreas cancer.
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INTERFERON-ALPHA ENHANCES ANTI-TUMOUR EFFECT OF
CHEMOTHERAPY IN AN ORTHOTOPIC MOUSE MODEL FOR
PANCREATIC ADENOCARCINOMA
Zhu Yvan1, Tibensky Igor, Schmidt Jan, Hackert Thilo, Ryschich Eduard,
Jaeger Dirk2, Buechler Markus W., Maerten Angela2
Abstracts 65
1Department of Surgery, University of Heidelberg, Germany; 2National
Centre for Tumor Diseases, University of Heidelberg, Germany
Objectives. Data from a phase II trial combining chemoradiotherapy with
IFN-alpha (CapRI scheme) for adjuvant treatment of pancreatic carcinoma
are very encouraging. Here, we try to evaluate the effect of IFN-alpha in this
combined treatment scheme.
Design. Mice were inoculated with syngeneic cells in the pancreas. After 5
days animals were treated with 5-FU, CDDP, radiation and IFN-alpha.
Tumour growth and immune responses were determined and adoptive cell
transfer experiments performed. The impact of IFN-alpha treatment on
leukocyte-endothelium interactions was assessed by intravital microscopy.
Results. Addition of IFN-alpha to chemo- or radiotherapy had a significant
life-prolonging effect (22 days CI 21; 23 for control animals compared to 32
days CI 24; 40 for 5-FUIFN-alpha animals). Regimens including IFN-
alpha showed in average 70% less metastases than monotherapy. T cells and
dendritic cells infiltrated tumours significantly more in 5-FUIFN-alpha
animals and these T cells secreted IFN-gamma tumour-specifically (pB
0.02). Anti-tumour response could be transferred by injection of leukocytes
from 5-FUIFN-alpha treated mice into treatment-naive animals (pB0.05).
The transferred cells homed to the tumours and proliferated there.
Furthermore, significant more leukocytes were rolling and sticking to the
endothelium (pB0.01).
Conclusions. IFN-alpha significantly improves chemo- and radiotherapy.
This is mainly mediated by immunomodulation with improved adherence of
leukocytes to the endothelium, infiltration and lysis. Although IFN-alpha acts
unspecifically an additional specific immune response could be demon-
strated.
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INTRATUMORAL INJECTION OF MACROPHAGE-ACTIVATING
LIPOPEPTIDE IN PATIENTS WITH PANCREATIC CARCINOMA:
A PHASE I/II TRIAL
Schmidt Jan1, Welsch Thilo, Jaeger Dirk2, Muehlradt Peter F.3, Buechler
Markus W., Maerten Angela2
1Department of Surgery, University of Heidelberg, Germany; 2National
Centre for Tumor Diseases, University of Heidelberg, Germany; 3Wound
Healing Research Group, BioTec Gruenderzentrum, Braunschweig, Ger-
many
Objective. This phase I/II trial examined safety and efficacy of the toll-like
receptor 2/6 agonist MALP-2 in combination with gemcitabine in patients
with incompletely resectable pancreas carcinomas.
Summary Background Data: MALP-2 acts an immunological adjuvant and
has been described recently to prolong survival in a mouse model of an
orthotopic, syngeneic pancreas tumor.
Methods. Men and women with incompletely resectable pancreas carcino-
mas were eligible while patients with R0 or R1 resections or with peritoneal
carcinosis were excluded. Ten patients were injected intratumorally during
surgery with 2030ug MALP-2 followed by postoperative chemotherapy.
Samples were taken from peripheral blood and wound secretion, and assayed
for cell content, cytokine and CRP levels, and NK activity.
Results. A MALP-2 dose of 20ug given to 5 patients was well tolerated. In
two out of three patients treated with 25ug MALP-2 and in one out of two
patients treated with 30ug serious adverse events occurred (asystole,
myocardial infarction and endotoxin-like shock). They recovered completely.
Clear signs of local MALP-2 effects were: influx of lymphocytes and
monocytes in wound secretions, and abolishment of inhibition of NK activity.
The actual mean survival is 16.393.8 months; the median survival being 9.3
months. Three patients are still alive after 26 months.
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INTERFERON-ALPHA IN COMBINATION WITH CHEMOTHER-
APY HAS POTENT ANTI-ANGIOGENIC PROPERTIES IN AN
ORTHOTOPIC MOUSE MODEL FOR PANCREATIC ADENO-
CARCINOMA
Zhu Yvan1, Tibensky Igor, Schmidt Jan, Hackert Thilo, Ryschich Eduard,
Jaeger Dirk2, Buechler Markus W., Maerten Angela2
1Department of Surgery, University of Heidelberg, Germany; 2National
Centre for Tumor Diseases, University of Heidelberg, Germany
Objectives. There are clinical data showing encouraging results for
combining chemoradiotherapy with IFN-alpha (CapRI scheme) for treat-
ment of pancreatic carcinoma.
Design. Here, we try to evaluate the anti-angiogenic effect of IFN-alpha in
combination with chemotherapy. Mice were inoculated with syngeneic cells
in the pancreas and treated with 5-FU9IFN-alpha. Tumour growth, VEGF
serum levels, VEGF-R expression, vessel density and mRNA levels of RGS-5,
an angiogenic pericyte marker were analyzed.
Results. Addition of IFN-alpha to 5-FU-treatment decreased tumour
volume, serum level of VEGF and expression of VEGF-receptor significantly.
Furthermore, we observed a decrease in vessel density in animals treated with
combination therapy. RGS-5 a protein involved in angiogenic tumour
vasculature was down-regulated in animals treated with combination therapy.
Conclusions. IFN-alpha significantly improves 5-FU-therapy for pancreatic
carcinoma. This is at least partly mediated by anti-angiogenic properties.
IFN-alpha together with 5-FU acts on the VEGF system, vessel density and
on RGS-5 expression in pericytes.
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THE INDICATIONS AND RESULTS OS PERCUTANEOUS DRAI-
NAGE OF STERILE FLUID COLLECTIONS IN SEVERE ACUTE
PANCREATITIS
Robert Kotan1, Szentkereszty Zsolt, Janos Posan, Laszlo Sasi Szabo, Judit
Hallay2, Peter Sapy
1University of Debrecen, Medical Health Science Center, Inst. of Surgery,
Auguszta Surgical Center; 2University of Debrecen, Medical Health Science
Center, Inst. of Anaesthesiology and Intensive Care
Aims. The percutaneous drainage of sterile fluid collections in severe acute
pancreatitis is not a widely used method. The authors present their
experiences of this therapeutic possibility.
Patients and methods. In a 12 year period 137 patients (67.8% male,
32.2% female, mean age of 49.2 years) were treated with severe acute
pancreatitis. Besides naso-jejunal feeding, preventative antibiotics and
delayed surgery in 22 cases percutaneous drainage was performed because
of advanced, sterile peripancreatic fluid collection.
Results. Of the 22 patients 6 (27.3%) were recovered without surgery. The
remaining 16 (72.7%) underwent one or more operations after unsuccesful
drainage. The initially sterile fluid collection was turned into infected
collection in 6 (27.3%) cases. The overall mortality rate in the 137 patients
was 14.6% and it was 9.1% in the patients who underwent percutaneous
drainage of sterile fluid collection.
Conclusions. The percutaneous drainage of sterile fluid collections in severe
acute pancreatitis plays a big role in the delaying of operation. 27.3% of the
drained patients recovered without surgery. The rate of superinfection was
27.3%.
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PERSISTING ELEVATION OF C-REACTIVE PROTEIN AFTER
PANCREATIC RESECTIONS INDICATES INFECTIOUS COMPLI-
CATIONS
Welsch Thilo1, Kleeff Joerg2, Friess Helmut2, Buechler Markus W.2, Schmidt
Jan2
1University of Heidelberg; 2University of Heidelberg, Dept. of Surgery
Background. Serum C-reactive protein (CRP) is an established discrimi-
nating factor for necrotizing pancreatitis. In this study the CRP response with
respect to infectious postoperative complications (IPCs) was examined in a
large homogeneous series of pancreatic resections in order to define a relevant
clinical parameter for early detection of IPCs.
Methods. 688 consecutive pancreatic resections with jejunal anastomosis
were screened for IPCs based on a prospective database. 89 patients had at
least one IPC and were compared to a subgroup of 60 consecutive patients
with uneventful postoperative courses.
Results. In the postoperative setting following pancreatic resection, CRP
peaked on postoperative day (POD) 3 with a median serum CRP of 132 mg/
L, and gradually declined thereafter in uncomplicated cases. In complicated
cases (with the exception of cholangitis), CRP elevation was significantly
higher, peaked on POD 3 (median CRP 173 mg/L), and persisted thereafter,
whereas white blood cell (WBC) count and body temperature did not differ
significantly from uneventful courses until POD 6. The median day of
diagnosis of IPCs was POD 9. A cutoff CRP value of 140 mg/dL on POD 4
yielded a positive predictive value of 89.1% (adjusted to the prevalence of
IPCs: 48.7%) with a specificity of 87.1% and a sensitivity of 69.5% for IPCs.
Conclusion. Persistence of CRP elevation above 140 mg/dL on POD 4 is
predictive of IPCs and should prompt an intense clinical search for major
infectious processes (e.g. pancreatic fistula or abscess) if pneumonia and
wound infection are unlikely or excluded.
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EXPRESSION AND POTENTIAL FUNCTION OF THE TWO
NOVEL CHEMOKINES CXCL14 AND CXCL16 IN PANCREATIC
CANCER
Moritz N. Wente1, Matthias M. Gaida, Christine Mayer, Christoph W.
Michalski, Frank Bergmann2, Nathalia A. Giese, Markus W. Bu¨chler,
Helmut Friess
1Department of Surgery, University of Heidelberg; 2Institute of Pathology,
University of Heidelberg
Background. CXC chemokines and their receptors have been shown to
influence angiogenesis, growth, and metastatic potential of a variety of
malignant tumors.
Aim. To evaluate the expression and functional role of CXCL14 and
CXCL16, recently described CXC chemokine family members, in human
pancreatic cancer (PaCa).
Methods. For expression analysis in human tissue and serum of patients with
PaCa, qPCR, immunohistochemistry, and ELISA were used; healthy donors
served as controls. Human PaCa cell lines were used for in vitro studies.
Effects on cell viability were tested by exposure to CXCL14 and CXCL16
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using MTT assays. In a standardized Matrigel assay, the effects of the two
chemokines on invasiveness of PaCa cells were evaluated.
Results. CXCL14 and CXCL16 are expressed by PaCa cell lines on the
mRNA and protein level. MTT showed no significant changes in cell viability
in chemokine concentrations below 25 ng/ml, whereas higher doses of
CXCL16 decreased cell viability. CXCL14 and CXCL16 significantly
increased the invasiveness of PaCa cells. qPCR of tissue samples showed a
significant increase of CXCL14 and CXCL16 in PaCa versus normal.
Immunohistochemical analyses revealed an inconsistent expression of
CXCL14 and CXCL16 especially on the invasive front of PaCa and in
non-neoplastic exocrine pancreatic tissues; however, strong expression of
CXCL14 and CXCL16 was detected in non-neoplastic pancreatic tissues
which had been altered by inflammation. Serum analysis by ELISA showed a
2-fold increase of CXCL16 expression in PaCa patients, whereas no increase
of CXCL14 was seen.
Conclusion. CXCL14 and CXCL16 are expressed by PaCa cell lines.
Upregulation of CXCL14 and CXCL16 in inflammatory areas in PaCa
supports the idea of an immune-cancer interaction regulated by chemokines,
influencing the invasiveness of PaCa.
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OPERATIVE PROCEDURES FOR CHRONIC PANCREATITIS:
ARE WE DOING THE RIGHT THING?
Tim White1, Dan Fielding, Victoria Glover, Ian Beckingham2, Brian Row-
lands, Dileep Lobo
1Dept. of Surgery, Queen’s Medical Centre, Nottingham University Hospi-
tals; 2Dept of Surgery, Queen’s Medical Centre, Nottingham University
Hospitals
Objective. We aimed to review all the operative procedures performed for
chronic pancreatitis at a single, tertiary unit between 19952005 inclusive.
Methods. Patients undergoing these procedures were sought from hospital
electronic data sources, ERCP and histopathology reporting. A retrospective
case note review was performed.
Results. Forty-eight patients (median age 50 yrs, range 1382 yrs, 37 male)
underwent an operative procedure. The median number of hospital admis-
sions for chronic pancreatitis prior to an operation was 2 (range 015). 37
patients underwent ERCP pre operatively, 15 of these had either CBD/
pancreatic duct stent insertion, (10 successfully) and 1 a PTC with drain
insertion to relieve bilary obstruction. A wide range of indications for
operation was noted-Pain alone (16), obstructions of the pancreatic duct
(8), CBD (14), and gastric outlet (4). Others  pseudocyst (3), indetermi-
nate mass (3), weight loss (2), recurrent pancreatitis (1) & persistent
pancreatic fistula (1). Twenty-one bypass procedures were performed,
various forms of pancreatic resection / pancreaticojejunostomy (17)
transduodenal sphincteroplasty & transampullary septectomy (4), cystogas-
trostomy (2), cyst excision (1) and choledochotomy & T-tube insertion (1).
22 patients were admitted to Intensive Care post-operatively (median stay 3
days). 19 patients developed post-operative complications, 18 being major, (2
requiring relaparotomy -small bowel perforation & bleeding respectively). In-
hospital post-op mortality was 4.2% (30-day mortality-2.1%). 2 others died
within 12 months from previously undiagnosed carcinomatosis. As a
consequence of operation, 7 patients required insulin replacement, 21
required pancreatic enzyme supplementation (Creon) and 7 increased
analgesia. At follow up, 36 patients claimed they had improved symptoms,
with 4 claiming they were symptomatically worse off.
Conclusion. 75% of this selected group of patients with chronic pancrea-
titics benefited from surgery. Successful outcomes in these patients demand
good selection and attention to operative and general management.
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CARCINOMA OF THE PANCREATIC HEAD INFILTRATING
MAJOR BLOOD VESSELS: IS IT WORTHY TO OPERATE?
Bogoevski Dean1, Izbicki Jakob R.2, Cataldegirmen Guelle2, Kunze C.2,
Kaifi Jussuf2, Vashist Yogesh2, Schurr Paulus2, Liebl Lena2, Gawad Karim2,
Yekebas Emre2
1Dept. of General Surgery, University Hospital Hamburg-Eppendorf,
Martinistrasse 52, 20246 Hamburg, Germany; 2Dept. of General Surgery,
University Hospital Hamburg-Eppendorf,Martinistrasse 52, 20246 Ham-
burg, Germany
Background. Evidence is growing that carcinoma of the pancreatic head
infiltrating major blood vessels (portal vein, superior mesenteric vein, hepatic
or mesenteric artery) can be safely treated by pancreatoduodenectomy with
en-bloc resection of the infiltrated vessels. Prognosis of these patients is a
matter of debate.
Methods. Morbidity, mortality, and long-term survival in patients under-
going pancreatoduodenectomy with or without vascular resections (VR) were
investigated. Between 1994 and 2005, 524 pancreato-duodenectomies were
performed for malignancies. One-hundred patients (19.1%) had additional
VR. 58 patients underwent venous resection with tangential excision with
direct suture, 8 patients tangential excision with patch, 14 segmental
resection with end-to-end anastomosis, 14 segmental resection with graft
interposition and 6 patients different arterial resections. Additionally, 20
patients had vascular resections for benign and borderline dignities.
Results. Long-term survival was analyzed in 77 patients with pancreatic, in
12 patients with ampullary and in 11 patients with distal bile duct cancers
using univariate (log-rank) and multivariate (Cox regression) methods. In 68
among 100 patients with VR, histopathology showed true tumor involve-
ment. In the complete study group, negative resection margins (R0) were
obtained in 85% of patients with VR and in 86% of patients without VR. No
statistical difference was detected between both groups when comparing
median operative time (350 VR versus 360 minutes w/o VR), and median
volume of intraoperatively transfused blood units (3 units in both groups).
Postoperative surgical complications/mortality occurred in 26%/7% (VR)
versus 31%/5% (no VR, n.s.). Analysis of long-term survival in all 424
patients without VR revealed five-year survival probability of 16% compared
to 4% in patients with VR (median overall survival 14 vs. 13 months; p
0.27). In multivariate modelling, resection margin and histological grading
significantly influenced survival.
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SALVAGE AFTER PRIMARY TREATMENT FAILURE OF SUR-
GERY FOR TREATMENT OF CHRONIC PANCREATITIS
Izbicki Jakob R.1, Vashist Yogesh, Cataldegirmen Guelle, Bogoevski Dean2,
Kaifi Jussuf, Mann Oliver, Gawad Karim, Schneider Claus, Zehler Oliver,
Liebl Lena, Yekebas Emre
1Dept. of General Surgery, University Hospital Hamburg-Eppendorf,Marti-
nistrasse 52, 20246 Hamburg, Germany; 2Dept. of General Surgery,
University Hospital Hamburg-Eppendorf,Martinistrasse 52, 20246 Ham-
burg, Germany
Background. Pain relief is the primary goal of surgery for chronic
pancreatitis. Salvage in case of inadequate relief, persistence or recurrence
of pain after surgical treatment include both ‘redo’-surgery and non-surgical
interventions. Here, we report on our institutional experience with respect to
surgical salvage after primary treatment failure.
Methods. Between 1992 and 2005, among 702 patients treated surgically for
chronic pancreatitis, 27 presented with pain recurrence and subsequently
underwent different redo-procedures depending on individual pathologies
detected in a standardized diagnostic work-up including M(E)RCP and/ CT
scanning. For measurement of quality of life, a validated EORTC-ques-
tionnaire including a pain score was used. The number of re-operations
varied between 2 and 5 operations. Follow-up ranged from 12 to 126 months
after the redo-operations.
Results. The entire cohort of 27 patients had primarily undergone
duodenum-preserving pancreas head resection in different modifications
(‘Frey’, ‘Beger’ procedure or extended drainage procedure). After primary
surgery, median global pain score did not adequately decrease. Imaging
evaluation showed at least one of the following pathologies: recurrence of
inflammatory mass in the pancreatic head (n20), stenosis or stones in the
pancreatic duct remnant (n15), and parenchymal calcifications and
pseudocysts in the body and tail (n9). In 22 patients organ preserving
pancreatic redo-resections preserving adjacent organs were carried out, while
in 2 patients classical resectional procedures and in 3 patients stepwise near
subtotal pancreatectomy had to be performed. No perioperative mortality
was registered. Following redo-operation, surgical morbidity accounted for
22% (6/27), while medical morbidity accounted for additional two patients
(7.5%). No statistical difference in morbidity was detected between the index
and redo-procedures. Endocrine insufficiency impaired in one patient after
redo-resection. Median pain score decreased significantly after redo-proce-
dures from 86 median (range: 62100) to 25 (range1046; p0.0001; t-
test) compared to the status after the index operation.
Conclusion. Therapeutic nihilism after failure of primary surgical treatment
in chronic pancreatitis patients is not justifiable. Based on the individual
complaints and morphological findings in imaging investigations, surgical
salvage procedures offer reasonable chances to achieve pain relief as the
eventual success parameter of any treatment for chronic pancreatitis.
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MANAGEMENT OF FOCAL CENTRAL PANCREATIC LESIONS
OF QUESTIONABLE DIGNITY-COMPARISON BETWEEN OR-
GAN SPARING VS. CLASSICAL RESECTIONAL SURGERY
Cataldegirmen Guelle1, Izbicki Jakob R., Bogoevski Dean2, Schneider Claus,
Vashist Yogesh, Schurr Paulus, Kaifi Jussuf, Koenig Alexandra, Mann Oliver,
Yekebas Emre
1Dept. of General Surgery, University Hospital Hamburg-Eppendorf,Marti-
nistrasse 52, 20246 Hamburg, Germany; 2Dept. of General Surgery,
University Hospital Hamburg-Eppendorf,Martinistrasse 52, 20246 Ham-
burg, Germany
Background. It is unclear whether patients with focal pancreatic lesions of
borderline dignitiy can be treated with organ sparing pancreatic segmental
resections (OSPSR), rather than with classical resectional procedures (CRP).
This surgical approach would theoretically not compromise functional
results.
Methods. Between 1992 and 2005, a total of 1467 patients were operated
because of various pancreatic diseases. Of these, 74 patients were treated
surgically for different focal pancreatic lesions of benign or borderline dignity.
Indications for OSPSR were cystadenomas, benign or borderline neuroendo-
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crine tumors, pancreatitis and secondary metastasis in 43 patients. The rest
of 31 patients were treated with CRP.
Results. No perioperative mortality was registered in the 43 patients with
OSPSR unlike to CRP with a mortality rate of 3%. Thirty day-morbidity was
23.2% (18.6% Surgical; 4.6% non-surgical) in OSPSR, compared to 41.9%
in CRP (32.2% surgical and 9.6% non-surgical). After a median follow up of
60 months, 33 patients (83.7%) with OSPSR are free of recurrence
compared to 24 (80%) patients in the CRP after a median follow up of 24
months.
Conclusion. OSPSR in focal pancreatic lesions of borderline dignity is a
valuable alternative with good results, and even lower morbidity and
mortality rates and in the same time not compromising pancreatic function
and above all showing comparable recurrence rates and survival.
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DEEP MYCOSIS AFTER THE PANCREAS SURGERY
Yukihiro Iso1, Tokihiko Sawada, Mitsugi Shimoda, Junji Kita, Hiroaki
Kijima, Keiichi Kubota
1Dokkyo University Hospital, HPB Surgery
Objective. In this study, we retrospectively evaluated whether deep mycosis
affect the clinical course after pancreas surgery.
Method. Between January 2005 and December 2006, 60 patients underwent
pancreatic surgery at our department. There were 38 males (63.3%) and 22
females (36.7%) with a mean age of 64.2 years. Diagnosis included cancers of
papilla of Vaters (n9), pancreas head cancers (n16), pancreas tail cancers
(n3), bile duct cancers (n14), duodenal cancers (n3), and others (n
15). Procedure included Pancreatico-duodenectomy (PD) (n38), PD with
portal vein resection (n7), hepato-PD (n4), diatal pancrectomy (n7),
total pancrectomy (n2), and Puestow procedure (n2). Patients who were
positive for any of CAND-TEC, ?-D-glucan, bacterial culture for mycosis,
were classified into G1 (n10), there who were negative for the examina-
tions were classified into G2 (n50). perioperative and postoperative data
were compared between G1 and G2. The antifungal drug was given to G1
patients.
Results. Operation times in G1 and G2 were 486.0 min and 520.0 min,
respectively (p0.65), and intraoperative blood losses in G1 and G2 were
579.5 ml and 524.0 ml, respectively (p0.38). Postoperative complications
included pneumonia, pleural effusion, ascites, and pancreatic juice leakage.
All the G1 patients were treated the antifungal drug was given for 7.8 days.
Postoperative hospital stays in G1 and G2 were 39.0 days and 37.0 days,
respectively (p0.97), and mean survival time in G1 and G2 were 7.5
months and 8.0 months (p0.75).
Conclusions. The deep mycosis still occurs after pancreas surgery, but early
diagnosis and accurate antifungal therapy enabled to minimize morbidity.
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THE SAFETY OF PANCREATICO-DUODENECTOMY IN ELDER
PATIENTS
Takayuki Shiraki1, Yukihiro Iso, Tokihiko Sawada, Junji Kita, Mitsugi
Shimoda, Kyu Rokkaku, Masato Kato, Keiichi Kubota
1Dokkyo University Hospital, HPB Surgery
Objective. Pancreatico-duodenectomy (PD) is a standard method to remove
pancreatico-biliary tumor. However, it carries considerable risk due to
extensive resection, especially in elderly patients. In this study, we retro-
spectively evaluated the safety of PD in patients over 65-years old.
Methods. Between April 2000 to December 2006, 70 PD were performed
for patients over 65-years at our department (G1). Diagnosis included
cancers of papilla of Vaters (n11), pancreas head cancers (n19), bile duct
cancers (n22), gall bladder cancers (n2), duodenal cancers (n7), and
others (n10). Operative data (time, blood loss), and postoperative data
(complications, hospital stay, survival months) were compared with those
under 64 years (G2:n45). Risk Index (RI) for postoperative death,
postulated by Lloyd et al. (Br J Surg 92, 2005) was calculated in G1 and G2.
Results. Operation times of G1 and G2 were 595.2 min and 626.8 min,
respetively (p0.18), and intraoperative blood losses of G1 and G2 were
724.2 ml and 792.1 ml, respectively (p0.43). Postoperative complications
included pneumonia, pleural effusion, ascites, bile leakage, and pancreatic
juice leakage. However, there was no difference in morbidity between the two
groups (p0.45). Postoperative hospital stays and survival periods of G1 and
G2 were 54.0 days and 45.5 days, respectively (p0.043), and 18.0 months
and 20.4 months (p0.43). RI of G1 and G2 was 0.19 and 0.09, respectively
(p0.049). RI of 0.19 means that 19% of operation-related death could have
occured, however, there was no operation-related death in both G1 and G2.
Conclusions. PD can be performed safely in elder patients as in younger
patients, as long as PD is performed with adequate operative procedure and
peri- and post-operative management.
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XANTHOGLANULOMATOUS LESION OF THE PANCREAS
WITH INTRADUCTAL PAPILLARY MUCINOUS TUMOR
Yukihiro Iso1, Tokihiko Sawada, Junji Kita, Hiroaki Kijima, Keiichi Kubota
1Dokkyo University Hospital, HPB Surgery
Objective. We experienced xanthogranulomatous lesion of the pancreas
(XGP) with intraductal papillary mucinous tumor (IPMT). In this study, we
report a very rare case of XGP with IPMT.
Clinical course. An 82-year-old male was admitted to our hospital because
of the body weight loss. Laboratory test showed mild inflamation. PET scan
showed the positive uptake in pancreas head, tail and spleen. CT scan
showed the tumor located in pancreas tail, extending to the spleen. MRCP
showed that main pancreatic duct dilatated from the tail to Santorini duct.
Duodenal scopy revealed the mucin excretion from Vater’s papilla and ERCP
showed the obstruction of the main pancreatic duct at the tail portion and
dilatated Santorini duct. Intraductal Ultrasonography detected the tumor
only in pancreas tail. Preoperative diagnosis was IPMT in pancreas tail, with
metastasis to the spleen, and operation was performed. Operative findings
revealed that the tumor located in the pancreas tail and head. In considera-
tion of the patient’s age and patient’s family opinion, distal pancrectomy and
splenectomy were performed. A microscopic examination revealed that the
tumor was XGP, extending to the spleen. The patient’s postoperative course
was uneventful, and he was discharged from our hospital 22 days after the
operation.
Discussion. There have been 5 reported cases of XGP in the world. All cases
were male patients and mean age was 58.2 years old. The most frequent
symptom was upper abdominal pain (80.0%). All cases were diagnosed as
pancreas carcinomas preoperatively and underwent operations. But XGP is a
benign disease, the prognosis was good.
Conclusion. The diagnosis of XGP can’t be established on clinical grounds
alone. This very rare case will be reported with some bibliographical
comments.
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MULTI-VISCERAL EN BLOC PANCREATIC RESECTIONS FOR
MALIGNANT TUMOURS OF THE PANCREAS
Mohammed Abu-Hilal1, Colin Johnson, Mark McPhail, Bashar Zeidan, Neil
Pearce
1Southampton University Hospital
Introduction. Orthodox surgical teaching states that pancreatic resection
should not be contemplated when malignancies arise in the pancreas and
involve other organs. Less aggressive, non-ductal adenocarcinomas, however,
may achieve useful palliation by surgical resection.
Methods. Twenty-seven patients -16 male: 11 female, median age 64 (40
76) years-, underwent multi-visceral en bloc resections for malignant
tumours involving the pancreas, between 1994 and 2006. Seventeen patients
had locally advanced peri-pancreatic primary malignancy; ten patients had
secondary cancers involving the pancreas. The surgical intention was radical
resection in all cases. Patients’ data was analyzed by an independent
statistician. Survival rates were calculated from the date of operation using
the Kaplan-Meier (KM) method with statistical significance required at the
95% level. Post-operative death was defined as occurring within ninety days
of operation.
Results. Eight patients underwent pancreaticoduodenectomy; nineteen
patients had left sided pancreatic resections. They had a median of 2 (range
14) additional organs resected. There was one post-operative death, 5
patients had a major complication and in 11 patients, 23 minor complications
were observed. There was no correlation between the number of organs
resected, operative time, intra-operative blood loss, and number of complica-
tions or length of hospital stay. Median follow up was 18 months (1150)
months, seven patients have died (5 of recurrent disease) and two patients are
alive with recurrent disease, one patient with recurrent neuroendocrine
tumour was lost from follow up after 30 months. Median overall survival was
41 months and disease free survival 34 months.
Conclusion. En bloc multi-visceral resection for selected locally advanced
malignancy involving the pancreas is technically feasible and in specialist
centers can be achieved with low mortality and acceptable morbidity, offering
good disease free and overall survival.
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RESECTION MARGIN INVOLVEMENT AND SURVIVAL AFTER
PANCREATICODUODENECTOMY FOR ADENOCARCINOMA
OF THE HEAD OF THE PANCREAS.
Sohayl Mukhtar1, Mohammed Abu-Hilal, Rami Kallala, Bashar Zeidan,
Mark McPhail, Neil Pearce, Colin Johnson
1Southampton University Hospital
Objectives. For a long time, the status of resection margins (RM) has been
considered an important prognostic factor following pancreatico duodenect-
omy (PD) for resectable pancreatic adenocarcinoma. Recently, Verbeke et al
suggested that closer histopathological re-examination of the tissue samples
increases significantly the number of positive resection margins putting the
impact of negative RMs on survival following PD under discussion.
Aims. To examine the relationship of involved pancreaticoduodenectomy
(PD) resection margins to survival.
Methods. We reviewed records of patients who had PD for adenocarcinoma
between 1995 and 2005. Data were collected for the age, sex, maximum
tumour diameter, differentiation, number of nodes, resection margins,
perineural and perivascular invasion, tumour type, operation date, post-op
chemotherapy and last recorded clinical encounter. Median and 1-year
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survivals were calculated and compared using the log-rank test or with Cox
proportional regression modeling.
Results. 92 patients underwent PD, for pancreatic intraductal adenocarci-
noma in this period (50 males (54%) and 42 (46%) females), median age was
65 (IQR 5873) years and median diameter of tumor was 30 (IQR 2035)
mm. Median survival was 579 days (IQR 415743), with a one year survival
rate of 83%. Using Kaplan-Meier analysis there was no difference in median
survival for patients with clear (665 days) or with involved margins (501
days); p0.152, log-rank test). Multivariate analysis of survival in the PA
group including age, sex, tumour size, perineural or perivascular involve-
ment, lymph node status and adjuvant chemotherapy as covariates confirmed
that margin status did not influence survival (p0.463).
Conclusion. No significant survival difference was found between patients
with positive or clear resection margins. This supports the doubts about the
significant importance of resection margin involvement as a prognostic factor
after PD for pancreatic adenocarcinoma.
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IS T-TUBE DRAINAGE AFTER CBD EXPLORATION NECES-
SARY?
Irfan Ahmed1, C Pradhan, Ayo Meduoye, Ian J Beckingham, Brian J
Rowlands, Dileep N Lobo
1Nottingham University Hospitals
Aim. To review the complications associated with T-tube drainage after
common bile duct (CBD) exploration and to determine whether primary
closure of the bile duct reduces postoperative morbidity.
Methods. A retrospective audit was performed on patients undergoing CBD
exploration between July 1997 and August 2006, identified from the hospital
theatre database. Intra-operative findings and postoperative complications
were recorded from the clinical notes.
Results. During the study period 140 (88 female) patients with a median
(range) age of 65 (2590) years underwent CBD exploration. A T-tube was
inserted in 80 patients (Group I) and the CBD was closed primarily in 60
(Group II).
One or more biliary complications occurred in a total of 25 (18%) patients:
19 (24%) in Group I and 6 (10%) in Group II (p0.04). In Group I, 12
had a biliary leak, (3 were re-explored), 6 had peri-tubal infection, 2 had
accidental slippage of the tube and 2 a trapped T-tube which was removed
after 3 months (after absorption of the sutures). In Group II, 6 patients had
biliary leakage, 2 of whom were re-explored. There were 4 deaths, 3 in Group
I (1 T tube related) and 1 in Group II).
Conclusion. Bile duct exploration is associated with significant morbidity.
Primary bile duct closure is associated with a decreased morbidity when
compared with insertion of a T-tube.
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SURGICAL AMPULLECTOMY : A SURE TREATMENT OF PRE-
SUMED BENIGN AMPULLOMAS
Sauvanet Alain1, Couvelard Anne2, Ponsot Philippe3, Aubert Alain3, Cazals-
Hatem Dominique2, Ruszniewski Philippe3, Belghiti Jacques
1APHP, Department of HPB Surgery, Hospital Beaujon, University Paris
VII; 2APHP, Department of Pathology, Hospital Beaujon, University Paris
VII; 3APHP, Department of Gastroenterology, Hospital Beaujon, University
Paris VII
Aim. Presumed benign ampullomas (PBA) can be treated either by
pancreaticoduodenectomy (PD), endoscopic ampullectomy, or surgical
ampullectomy (SA). SA needs previous assessment to eliminate invasive
carcinoma and must obtain tumor-free margins. The aim of this work was to
evaluate feasibility and results of SA.
Methods. from 1995 to 2006, 31 patients (age : 3879 years) underwent SA
for PBA revealed by biliary pain / cholangitis (n10), pancreatitis (n4),
fortuitously (n16) or during endoscopic follow-up after SA performed
elsewhere. Preoperatively, all 31 patients underwent duodenoscopy with
biopsies (11 after endoscopic sphincterotomy) and endoscopic ultrasound
(EUS). Biopsies had revealed: adenoma with low-grade dysplasia (LGD; n
21) or high-grade dysplasia (HGD; n4), or inflammatory/normal mucosa
(n6). At EUS, the ampulloma was always classified as an uT1N0 lesion.
Frozen section was routinely done, on the only resection margins. All patients
were informed of the need for PD in case of invasive carcinoma.
Results. One patient (3%) underwent immediate conversion to PD (firm
and suspect papilla, due to invasive carcinoma). Peroperatively, a technical
problem occurred in 7 patients (3 partial duodenal desinsertions, 3 difficult
localizations of a Wirsung duct B1 mm, one pancreas divisum unknown
preoperatively) but was treated succesfully in all 7. At frozen section, the first
biliary (n5) or pancreatic (n2) margin was tumoral in 7 patients but all
had additional ductal resection with tumor-free margin at the second
examination ; all duodenal margins were tumor-free. PBA size ranged from
8 to 65mm (mean : 20 mm). There was no mortality. Postoperative course
was uneventful in 22 patients (73%). Main complications were: 2 cholangitis,
one fistula of the cystic duct (reoperation), one upper GI bleeding (this
patient was the only one tranfused), one abdominal abscess without fistula,
and one mild onset of pancreatitis (in the patient with pancreas divisum). On
definitive pathologic examination, there was 19 adenomas (12 LGD, 7
HGD), 5 microinvasive intra-ampullry carcinomas (not extending through
the Oddi’s muscle, therefore without risk of lymph node metastasis), one
carcinoma invading the duodenal submucosa (PD contra-indicated to due
general condition), and 5 other benign lesions (including 3 adenomyomas).
All margins were tumor-free. With a 22 months median follow-up (range: 3
72), 3 (10%) patients had symptoms: cholangitis (n2) or epigastric pain.
Tumor recurrence was observed in 3 (10%) patients : one presumed ductal
cephalic adenocarcinoma, one distal cholangiocarcinoma, one LGD ade-
noma (routine biopsies).
Conclusions. SA combined with frozen section can treat PBA with
acceptable morbidity (less than observed after PD) and tumor-free margins,
particularly on the common bile duct. After complete endoscopic assess-
ment, the probability to perform immediatly or secondarily a PD is less
than 10%.
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APPLICATIONS OF LAPAROSCOPIC HEPATICOJEJUNOSTOMY
Saleh Baghdadi1, K A Abdul Aziz, B J Ammori
1Manchester Royal Infirmary
Background. Hepaticojejunostomy (HJ) is conventionally constructed at
laparotomy either to bypass benign or malignant biliary strictures, or
following hepatobiliary or pancreatic resections. The role of the laparoscopic
approach to HJ, however, remains under evaluation.
Methods. The feasibility and safety of the laparoscopic approach to HJ were
prospectively evaluated.
Results. Between 2002 and 2006, 10 selected patients with a median age of
64 (range, 3881) years underwent laparoscopic Roux-en-Y HJ (end-to-side,
n6; side-to-side, n4). The HJ was constructed to bypass benign (n1)
and malignant (n4; three combined with gastrojejunostomy) biliary
strictures, and following laparoscopic Whipple’s procedure (n4) or excision
of choledochal cyst (n1). All procedures were completed laparoscopically.
The median operative times for bypass surgery and for pancreatobiliary
resections were 320 and 600 minutes respectively. One patient developed a
pancreatic fistula. There were no biliary leaks or strictures, no re-operations,
and no perioperative deaths. The median postoperative hospital stay after
bypass and choledochal surgery was 6 days and after Whipple’s was 13 days.
No biliary strictures were encountered at a median (range) follow up of 6 (3
36) months.
Conclusions. Laparoscopic HJ is feasible and safe. Expansion of
experience is required to refine the operative technique and establish long-
term results.
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SYSTEMATIC EVALUATION OF LITH MOUSE CANDIDATE
GENES IN HUMAN GALLSTONE DISEASE
Schniewind Bodo1, Brosch Mario, Foelsch Ulrich, Fandrich Fred, Hampe
Jochen, Tepel Juergen
1Universtiy hospital Schleswig Holstein
Background and Aims. Cholelithiasis is a frequent and economically highly
relevant health problem in industrialized countries. Genetic predisposition
has been demonstrated by familial clustering (familial relative risks between 3
and 7). The familial relative risk is further increased in patients with a young
age of onset to 3040 for patients with an age of onset under 40 years. In
twin studies, MZ concordances around 4056% versus 0-8% in DZ twins
have been reported. Over 20 mouse ‘‘Lith’’ loci have been identified by
genome-wide QTL mapping in inbred mouse strains. This study was
undertaken to investigate the human othologs of five attractive positional
and functional candidate genes that are located in three major murine
gallstone susceptibility loci as candidate genes for gallstone disease in humans.
Methods. Over 2500 patients who had undergone cholecystectomy for
symptomatic gallstone disease below the age of 66 years were recruited using
the POPGEN infrastructure. A high-risk patient sample (n810; median age
of onset, 50 years) were compared with 718 sonographically gallstone free,
sex-matched (50% males) control individuals. Haplotype tagging and all
known coding single nucleotide polymorphisms (SNPs) were genotyped for
Lith1 ABCB11(n29), LXRA(n11); Lith2 ABCC2(n20; controls, n
516) and Lith6 PPARG(n28), APOBEC1 (n11).
Results. The investigated patient sample provides a power of greater than
80% for the detection of odds ratios down to 1.55.) No evidence of
association of the five genes in the single point tagging markers, coding
variants and in the sliding window haplotype analysis was detected (all
nominal single point p-values 0.06).
Conclusions. This investigation is the first association approach to the
molecular genetic investigation of the general ‘‘gallstone’’ trait in humans.
Systematic fine mapping of the investigated murine ‘‘Lith’’ regions are
required to identify the causative genetic variants for gallstone disease in mice
and humans.
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GALLBLADDER METASTASIS FROM BREAST CANCER: CASE
REPORT
Abstracts 69
Ettore Colangelo1, Edoardo Liberatore2, Andrea Ricci3, Marino Nardi2,
Massimo Basti3, Nicola Pitrelli2, Enzo Monteferante2, Valerio Caracino2,
Giuseppe Colecchia*
1S.Spirito Hospital Pescara III Unit Dept of Surgery; 2S.Spirito Hospital III
Unit Dept. of Surgery; 3S.Spirito Hospital III Unit Dept. of Surgery;
*S.Spirito Hospital III Unit Dept. of. Surgery
Background. Metastatic breast carcinoma to the galbladder is rare and only
few cases have been reported in the literature.
In our review the malignancies most likely to metastasize to the galbladder are
melanoma, gastric, pancreatic , colonic, renal and cervical carcinomas.
We report a 78 years old woman that was admitted in our unit for acute
pancreatitis and cholecystitis . She underwent modified radical mastectomy
five years ago for breast carcinoma. With a preoperative diagnosis of acut
biliry pancreatitis she underwent ERCP and seven days after laparotomic
colecystectomy.
Histopatological examination revealed galbladder metastasis from breast
carcinoma.
Case report: A 78 -years old-woman was admitted in our unit for a 34
days history of right upper quadrant and epigastric pain with her back
irradiation. Abdominal examination showed high epigastric pain , positive
bowel sounds and no masses or organomegaly.Laboratory values included
amylase 876 l WBC 17.000,alkaline phosphatase 564.
Abdominal US showd gallbladder without stones with thickcned wall. MRI
cnfirmed these data and revealed moderate dilatation of common bile duct.
The medical history was positive for diabetes, gastric antrectomy for bleeding
ulcera (1975) and breast cancer which had been treated with radical
mastectomy( 2001) and adjuvant chemotherapy.
With a preoperative diagnosis of acute (biliary) pancreatis the patient
underwent ERCP with biliary sfincterotomy and seven days after laparotomic
cholecystectomy was performed.
Histopatological examination revealed metastatic breast carcinoma (like
ductal-lobuar infiltrating carcinoma ) with malignant cells present in
submucosa. Himmunohistochemical reactions wer positive for EMA, Cher-
atine, P53,Estrogeni (100%) C-erb-b2.
No adjuvant therapy was performed.
Conclusions. Breast carcinoma usually metastasizes to bone, lungs and the
liver. Signet ring cell carcinoma ( a morfhologic variant of infiltrating lobular
carcinoma) has a poor prognosis.
The occurrence of matastases of the galbladder is rare and few cases have
been reported in the literature.
They often arise from malignant melanoma, renal and cervical carcinomas.
Breast carcinoma metastatic is extremely rare. Primary tumors can metasta-
size to galbladder either by direct invation of the porta hepatis or by
hematogenous spread. It usually leads to symptoms of abdominal pain
mimicking acute cholecistitis . The prognosis is poor.
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MALPRACTICE LITIGATION AFTER BILE DUCT INJURY
de Reuver Philip1, Wind Jan, Cremers Jan2, Busch Olivier, van Gulik
Thomas, Gouma Dirk
1Amsterdam Medical Center; 2Medirisk
Background. Bile duct injury (BDI) is associated with high rates of litigation
claims in the United States. The prevalence of litigation claims and factors
associated with the outcome of the verdict are unreported in Europe.
Aim. To analyse the outcome of BDI litigation claims, filed at the largest
Dutch hospital insurer, and specifically to assess the influence of patient
characteristics, informed consent procedures, and operation characteristics
on the outcome of the verdict and the amount of euros paid for financial
compensation.
Results. Between 1993 and 2006, 2578 claims were filed after surgical
procedures performed by general surgeons in the Netherlands. Two hundred
and ten claims involved laparoscopic procedures of which 133 (63%) were
submitted after the occurrence of BDI, with a total financial compensation of
1 million euros. BDI related death occurred in 12 patients (9%). Currently,
88 claims are closed after a mean duration of 2.4 years (range 5 months  6.5
years). In 61 cases (69%) the verdict was in the defendants favour and in 16
cases (18%) the verdict was in the plaintiffs favour. The mean financial
compensation was @euro@16.476,76 (range @euro@361,20 
@euro@55.301.06). In 11 cases the claim was settled.
Factors associated with a verdict in the plaintiffs favour or settlement, were:
patient employment (p0.05), and death of a patient (p0.01). Factors
associated with amount of euros paid for financial compensation are delay
in diagnostic imaging (p0.033), delay in diagnosis (p0.009), and
relaparotomy with repair in the initial hospital (p0.028). The percentage
of rejected claims increased from 50% in the first 22 claims to 82% in the
last 22 claims (p0.023). Informed consent and documented commu-
nication between surgeon and patient did not influence the verdict
outcome.
Conclusion. Sixty three percent of all medical liability claims, involving
laparoscopic procedures performed by general surgeons, is filed after the
occurrence of BDI. In almost 9% of these cases, a patient died due to the
injury. Two thirds of the claims are rejected.
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MANSOURA EXPERIENCE WITH ENDOSCOPIC TREATMENT
OF CBD STONES
Gamal El-Ebidy1, Mohamad El-Shobari, Tharwat Kandiel2, Niazy Selim3,
Ahmad Abd El-Raouaf3, Tarek Salah2
1Gastroenterology Surgical Center; 2Gastroenterolgy Surgical Center; 3Gas-
troenterlogy Surgical Center
Introduction. Common bile duct stones are a challenging problem which
needs multidisciplinary approach.
Aim. Evaluation of our results of endoscopic treatment of CBD stones
Patients and Methods. In the period between 3/92-11/2006, 2601
patients with CBD stones were referred to our center, 1359 males
(52.2%) and 1242 Females (47.8%), mean age 55.7 y (797y) SD
15.2. Presentation include jaundice in 72%, pain in 71.5%, and fever in
19%, mean serum bilirubin 7.2 mg/dl ,SGOT 92.4 IU, SGPT 87.1 IU and
Alkaline phosphates 32.3 K.A.U.
Results. Cannulation was successful in 97.6%, precut was needed in
35.7%.success rate of stone extraction 77%. Cholangiography revealed single
stone in 49.4% & multiple in 50.6%, large stones in 45.3%, and small stone
in 36.3%. Complications occurred in 5.1%, pancreatitis 1.7%, cholangitis
0.4%, basket impaction 0.6%, duodenal perforation 0.2%, CBD perforation
in one patient, mortality 0.4%.
Conclusion. Endoscopic treatment of CBD stones has excellent success rate
of clearance with low morbidity & mortality and should be used initially
especially in old unfit patients.
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INCIDENCE OF IGG4- RELATED SCLEROSING DISEASE IN
PATIENTS RESECTED FOR SUSPICIOUS PROXIMAL BILE
DUCT STRICTURES
D. Erdogan1, F.J. ten Kate2, J. Kloek, O.R.C. Busch, D.J. Gouma, T.M. van
Gulik
1Academic Medical Center, Department of Surgery, Amsterdam, The
Netherlands; 2Academic Medical Center, Department of Pathology, Am-
sterdam, The Netherlands
The main cause of proximal bile duct strictures is hilar cholangiocarcinoma
(HCCA). Recently, IgG4-related lymphoplasmacytic sclerosing pancreatitis
(LPSP) has been described mimicking distal cholangiocarcinoma. The aim of
this study was to assess the role of IgG4-related sclerosing disease in patients
with benign diseases after resection for suspicious proximal bile duct
strictures. Furthermore, the long term follow-up of these patients was
assessed.
A total of 185 consecutive patients underwent resection on the suspicion of
HCCA between January 1984 and June 2005. In 32 patients (17.3%), a
benign stricture was found on histopathological examination of the specimen.
These lesions were analysed by histological and immunohistochemical
analysis.
Of 32 patients, the most common presenting symptoms were obstructive
jaundice in 25 patients (78%) and malaise in 19 patients (59%). Surgical
procedures included common bile duct resection in 29 patients (91%), which
was combined with liver resection in 7 patients. Histologically, the bile duct
walls in 15 patients (47%) showed diffuse, moderate/severe lymphoplasma-
cytic infiltration with marked fibrosis. Of these, 14 pts (93%) showed
moderate/severe CD3-T lymphocyte infiltrates compared to moderate/severe
CD20-B lymphocyte in 9 pts (75%). In the T lymphocyte population, 11 pts
(73%) showed moderate/severe CD4 cells whereas 7 pts (47%) had
moderate/severe CD8 cells. IgG-plasma cell staining showed moderate
infiltration in 7 of 15 patients (47%) and was negative in one patient.
Abundant IgG4-bearing plasma cell infiltration around the bile duct lesions
was seen in 2 of the 15 patients (13%) with moderate/high suspicion of an
autoimmune disease. In 5 patients IgG4-plasma cell staining was negative
and the remaining 8 patients showed slight infiltration of IgG4-plasma cells.
In one patient, the IgG-bearing plasma cells were completely composed of
IgG4-bearing plasma cells. Long-term complications occurred in 11 patients.
Patients with high suspicion of an autoimmune disease showed more
recurrent biliary complications compared to patients without features of an
autoimmune disease (50% vs. 27%, respectively; P0.250).
Conclusions. Features of autoimmune disease were seen in 47% of patients
with benign hilar strictures resected for presumed HCCA. IgG4-related
sclerosing disease was found in 6.3% of patients with benign hilar strictures.
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TOTALLY LAPAROSCOPIC MANAGEMENT OF CHOLEDO-
CHAL CYSTS USING A FOUR-HOLE METHOD
Jin-Young Jang1, Hoseong Han2, Sun-Whe Kim
1Department of Surgery, Seoul National University Hospital; 2Department
of Surgery, Seoul National University
Background. Choledochal cyst is a rare benign disease of the biliary tract.
However, once diagnosed, it must be excised with the gallbladder because of
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the risk for cancer developing in the biliary tree, including the gallbladder.
This report introduces a new surgical technique for totally laparoscopic
excision of choledochal cyst and hepaticojejunostomy using a four-hole
method.
Methods. Between October 2003 and 2006, the authors performed totally
laparoscopic choledochal cyst excision for 18 patients. All the patients except
one were women, and the mean age was 37.3 years (range, 17 62 years).
According to the Todani classification, there were eight type Ia cases, four
type Ic cases, and six type IV cases. Choledochal cyst excision and Roux-en-Y
hepaticojejunostomy were performed laparoscopically using the four-port
technique.
Results. The mean operation time was 220 min (range, 150 330 min). No
operative or postoperative transfusion was required. An oral diet was started
on postoperative day 3. The average length of hospital stay was 5.8 days.
There was no major complication associated with anastomosis leakage or
obstruction. No patient had an adverse response, as determined by clinical or
laboratory evaluation during a 2- to 19-month follow-up period.
Conclusions. Considering that choledochal cyst is common among young
women, who are especially interested in cosmetic results in addition to
complete resolution of medical problems, the laparoscopic management of
choledochal cyst may be an attractive treatment option.
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ROUX-EN-Y DUODENOJEJUNOSTOMY AFTER BLEEDING
CONTROL OF AMPULLA OF VATER
Sun Hyung Joo1, Kwang Ro Joo2, Hyoung Min Seo3, Sung Il Choi3, Jeong
Yoon Song3, Suk Hwan Lee3
1Kyung Hee University, Dept. of Surgery, College of Mecicine; 2Kyung Hee
University, Dept. of Medicine, College of Medicine; 3Kyung Hee University,
Dept. of Surgery, College of Medicine
Introduction. Bleeding is a serious complication after ERCP (endoscopic
retrograde cholangio pancreatography) following EST (endoscopic sphinc-
terotomy). Most of cases are improved without further active treatment. But
in a few cases, other treatment modalities such as angiographic embolization
or surgical exploration are needed. Case report: We report a case of ampulla
of Vater bleeding after ERCP following EST, which is treated successfully by
duodenotomy with bleeding control and Roux-en-Y duodenojejunostomy. A
57-year-old woman is referred with impression of biliary stone disease. ERCP
is performed to evaluate of jaundice by expert medical doctor. Unexpected
bleeding after ERCP is developed and 2 times of endoscopic bleeding
controls are tried but failed because of bad endoscopic field. Gastroduodenal
artery embolization is carried out by angiographic intervention, but bleeding
is not controlled. After Kocherization, longitudinal duodenotomy by 5 cm in
length is performed and active bleeding artery is suture ligated. Considering
of poor blood supply of duodenum due to previous embolization, primary
closure can be dangerous. Roux-en-Y duodenojejunostomy is done by
retorcolic fashioned. The patient recovered without any other complication
and discharged. We think that Roux-en-Y duodenojejunostomy is a safe
method to repair the compromised duodenum. Retrocolic loop duodenoje-
junostomy also can be an alternative.
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TRAUMATIC NEUROMA OF THE COMMON BILE DUCT
Sang Kwon Yun1, Yang Seok Koh, Jung Chul Kim, Chol Kyoon Cho, Hyun
Jong Kim
1Division of Hepatobiliary and pancreatic surgery, Department of Surgery,
Chonnam National University Medical School, Gwangju, Korea
Traumatic neuroma is the nonneoplastic proliferative mass of Schwann cells
and neurites that may develop at the end of a severed or injured nerve. The
usual location of traumatic neuroma is in amputated extremites. However,
traumatic neuroma of the bile duct can occur following cholecystectomy due
to a reactive proliferation of pericholangial nerve tissue induced by injury.
We present the case of 76 year-old man presenting, 17 years after
cholecystectomy, with a common bile duct mass. He was treated by surgical
resection of the common bile duct at the mass site, and Roux-en-Y
hepaticojejunostomy. Postoperative course was uneventful. Histologic exam-
ination revealed a traumatic neuroma.
Although traumatic neuroma in the bile duct was very rare, it should be
included in the differential diagnosis of bile duct mass in patients with a
history of cholecystectomy.
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A CASE OF PREDUODENAL PORTAL VEIN AND COMMON
BILE DUCT ASSOCIATED WITH CHOLEDOCHAL CYST
Kuniaki Kojima1, Masahiko Urao2, Minoru Fujisawa2, Yoshio Ishibiki2,
Toshiaki Kitabatake2, Toshio Machida2
1Juntendo University Nerima Medical Center; 2Juntendo University Nerima
Medical center
A preduodenal position of the portal vein(PDPV) and common bile duct
(PDCBD) is a very rare congenital anomaly. We experienced this particularly
rare case which is associated with choledochal cyst.
Our patient, a 35-years-old female, was diagnosed to have choledochal cyst
and cholecyst-choledocholithiasis. The PDPV and PDCBD was discovered
during the resection of the extrahepatic biliary tract including choledochal
cyst, and Roux-en-Y hepaticojejunostomia.
This anomaly was not diagnosed preoperatively, but it could have been.
Although embryological anomalies of the portal venous system and biliary
duct system, such as prepancreatic portal vein(PPPV) and PDPV, PDCBD,
are rarely encountered in abdominal surgery, surgeons must be aware of their
possibility and be able to recognize them to avoid major intraoperative injury.
The case is being reported because of the rarity of this condition and also to
stress the importance of accurately recognizing this anomaly when treating
the concomitant diseases, particularly when surgical implications are
involved.
We also discuss the anatomy and embryology of these structures and briefly
review the patterns of previously reported cases that we found.
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MANAGEMENT OF BENIGN BILIARY STRICTURE: REVISITED
Andrea Lauretta1, Osama Damrah, Peter Sipos2, Devinder Bansi3, Andy
Thillainayagam*, Long Jiao, Nagy Habib, Ruben Canelo
1HPB Surgery Hammersmith Hospital NHS  Imperial College London;
2HPB Surgery Hammersmith Hospital; 3Gastroenterology Unit Hammer-
smith Hospital NHS  Imperial College London; *Gastroenterology Unit
Hammersmith Hospital NHS  Imperial College London
Introduction. Benign biliary stricture remains difficult management pro-
blem and a major challenge to hepatobiliary surgeons. New minimally
invasive and interventional techniques have met great interest as they avoid
difficult operations. Since there is currently no consensus on which patients
should have what type of procedure, a review of the effectiveness of all
available treatments is necessary to set a standard treatment.
Methods. The authors reviewed the treatment and outcome of all patients
with benign biliary stricture who were managed at our institution between
2002 and 2006. Demographic data and result of diagnostic and therapeutics
procedure before and after referral were obtained and analyzed. Diagnosis of
a stricture was confirmed by either endoscopic retrograde pancreatico-
cholangiography (ERCP) or percutaneus transhepatic cholangiography
(PTC). In patients with bile duct injuries recognized during the operation
intraoperative cholangiography was immediately performed and surgical
repair undertaken. The common bile duct (CBD) stricture was identified
as a narrowing of the CBD with pre-stenotic dilatation and/or delayed runoff
of contrast. The iatrogenic strictures were classified according to the Bismuth
classification. Patients were treated surgically and/or endoscopically accord-
ing to the aetiology and the degree and the level (Bismuth’s classification) of
the stricture. However the management choice was made on individual basis,
evaluating carefully the personal medical history, and evolving data with
respect to outcome after each diagnostic procedure performed.
Results. Forty-nine patients with benign biliary stricture were treated.
Causes of the stricture were chronic pancreatitis (17, 35.6%), injuries (12,
24.5%), cholangitis (8, 16.3% primary sclerosing cholangitis; 4, 8.1% other),
enterobiliary anastomosis (3, 6.1%), choledocal cyst (3, 6.1%), crohn‘s
disease of duodenum (1, 2%), aberrant anatomy (1, 2%). 28 (57.1%)
patients had only endoscopic interventions (ercp and/or ptc stenting and
balloon dilatation). 16 (32.6%) patients were treated with both surgical and
interventional procedure. 5 (10.2%) patients underwent only surgical
treatment. Repeated interventional treatments gave less complications (4/
28) than surgery alone (4/5) or surgery and interventional procedure together
(15/16); as well as were correlated to a less initial hospital stay (PB0.01) and
total hospital stay (PB0.01). Recurrence rate was less in patients treated by
surgery 18.4% (9) than in patients treated by endoscopy 22.4% (11) but not
statistically significant. Recurrent stricture after interventional treatments was
successfully treated by surgery in 7 patients (14.3%) and by repeated
minimally invasive treatments in 4 patients (0.08%). Recurrent stricture
after surgery was successfully managed by repeated interventional treatments.
There was no difference in the outcome according to the level of the stricture
and the etiology.
Conclusion. Successful management of benign biliary stricture requires a
multidisciplinary approach. Endoscopic stenting is often chosen as the initial
treatment and repeated interventional procedures are a real option. Surgery
achieves good long-term results and is indicated when interventional
procedures failed. Combination of surgical and interventional techniques
provides the best results.
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OUTCOME OF SURGICAL MANAGEMENT OF MALIGNANT
BILE DUCT STRICTURES: INSTITUTIONAL EXPERIENCE
Osama Damrah1, Andrea Lauretta, Mohammed Ghallab2, Long Jiao, Ruben
Canelo, Nagy Habib
1HPB Surgery Hammersmith Hospital NHS-Imperial College London;
2Imperial College London
Introduction. Relevant clinical experience in managing cholangiocarcinoma
has been limited to few referral centers. Fewer than 30% of patients are
suitable for formally curative resection (R0 resection). Standard treatment of
patients with unresectable cholangiocarcinoma is biliary drainage. The
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authors analyze and assess the management and outcome in patients with
cholangiocarcinoma in a single tertiary referral center.
Methods. Between 2002 and 2005, database of all patients with bile duct
cancer treated at our institution was reviewed. Demographics, results of
imaging studies, pathology, and survival were analyzed. Pre-operative biliary
drainage was achieved by endoscopic stenting and/or percutaneus transhe-
patic drains in all jaundiced patients. To assess the resectability, when CT
scan and MRI were not conclusive, selective angiogram was done. Patients
who were deemed unresectable on pre-operative imaging were managed with
metallic stent and, if having good performance status, treated with further
chemotherapy. Curative resections included hepatectomy, pancreaticoduo-
denoectomy and extra-hepatic biliary ducts excision. Patients with unresect-
able lesions based on the findings from surgery were offered surgical enteric
and biliary bypass.
Results. There were 106 patients (55 men, 51 women) with a mean age of
66.4. Sixty-nine (65.2%) patients had hilar cholangiocarcinoma (according
to the Bismuth classification 2 patients belonged to type I, 6 type II, 17 type
IIIa, 10 type IIIb, 11 type IV and 22 unclassified), twenty-five (23.5%) had
intrahepatic cholangiocarcinoma, seven (6.6%) middle cbd and five (4.7%)
lower cbd cholangiocarcinoma. Pre-operative histological diagnosis was
available in 64 patients, 42 patients had only radiological evidence of the
tumor. Eighty-seven patients required biliary drainage. 97 endoscopic
drainage procedures were performed (10 failed). 55 patients required further
monolateral ptcd and 17 bilateral ptcd. Eighty-four (79.2%) patients had
unresectable disease; 39 patients underwent surgical exploration with
curative intent. Twenty-two (20.8%) underwent resection (1 after neoadju-
vant chemotherapy): 10 had a concomitant partial hepatic resection. Sixteen
had major complication and 1 died post-operatively. The 1-year survival rate
was 78% for resected patients and 34% for those who did not undergo
resection (PB0.01). R0, R1 and R2 resection resulted in 1-year survival rates
of 100%, 83%, and 46% respectively. There was no significant difference
(P0.5) in term of survival between patients who underwent R2 resection
and patients who had not any surgical treatment. Fifty-three patients had
chemotherapy (51 adjuvant, 1 neoadjuvant and 1 neoadjuvant and adjuvant).
There was significant benefit in term of survival (the 1-year survival rate was
56% for patients who receive chemotherapy and 22% for those who did not
have any chemo).
Conclusion. Only complete tumor resection, including hepatic resection,
enables long survival for patients with cholangiocarcinoma. Percutaneus
drainage is almost always necessary as endoscopic stenting is often unable to
relieve the jaundice. Adjuvant chemotherapy after both surgical treatment
and palliative stenting has a significant benefit in term of survival rate
compared with both surgery and stenting alone.
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HILAR CHOLANGIOCARCINOMA: INSTITUTIONAL EXPERI-
ENCE
Andrea Lauretta1, Osama Damrah, Ruben Canelo, Nagy Habib, Long Jiao
1HPB Surgery Hammersmith Hospital NHS-Imperial College London
Introduction. Cholangiocarcinoma is a rare disease, accounting for less than
2% of all human malignancies. Although the entire biliary tree is potentially
at risk, tumors involving the biliary confluence or the right or left hepatic
ducts (hilar cholangiocarcinoma) are most common and account for 40% to
60% of all cases. Treatment options for these tumors may be primarily
surgical, either curative resection or palliative bypass, or non surgical using
modalities such as chemotherapy, radiotherapy, a combination of the two or
more recently photodynamic therapy. The authors analyze and assess the
management and outcome in patients with cholangiocarcinoma in a single
tertiary referral center.
Methods. All patients with the diagnosis of Hilar Cholangiocarcinoma
treated at our center between 2002 and 2005 had their records reviewed and
analyzed. Demographics, results of imaging studies, surgical findings,
pathology, management and survival were recorded. Radiological evaluation
to assess resectability and extent of involvement of the biliary tree was done
using CT scan and MRI. To assess the vascular involvement, when CT or
MRI were no conclusive, selective angiogram was done. Pre-operative biliary
drainage was often chosen as initial treatment to relieve the jaundice. It was
achieved by endoscopic stenting and, when it was inadequate, further
percutaneus transhepatic drainage was performed. When the possibility of
resection was excluded on pre-operative imaging, patients were managed
with metallic stent and, if having good performance status, treated with
further chemotherapy. Curative resection involved complete removal of all
macroscopic and microscopic disease to achieve negative histological margins
at the resected bile duct or liver margin. To achieve this scope (R0 resection)
partial hepatectomy was also performed.
Results. There were 69 patients (34 men, 35 women) with a mean age of
67.1. According to the Bismuth classification 2 (4.3%) patients belonged to
type I, 6 (13.2%) type II, 17 (36.9%) type IIIa, 10 (21.7%) type IIIb, 11 type
IV (23.9%). Thirty-three (47.82%) patients had confirmed histological
diagnosis with the remainder being diagnosed on strong radiological
evidence. Sixty-two (89.8%) patients required biliary drainage. 59 endo-
scopic drainage procedures were performed (8 failed). 40 patients required
further monolateral PTCD and 14 bilateral PTCD. Fifty-eight (84%)
patients had unresectable disease; 19 patients underwent surgical exploration
with curative intent. Two patients were offered palliative surgical bypass.
Eleven (16%) underwent resection (1 after neoadjuvant chemotherapy); 7
had a concomitant partial hepatic resection. Seven had major complication
and 1 died post-operatively (9% mortality rate). The 1-year survival rate was
81% for resected patients and 36% for those who did not undergo resection
(PB0.05). R0 and R1 resection resulted in 1-year survival rates of 100%,
82%, respectively. Thirty-five patients had chemotherapy (34 adjuvant, and 1
neoadjuvant). There was significant benefit in term of survival (the 1-year
survival rate was 59% for patients who receive chemotherapy and 22% for
those who did not have any chemo).
Conclusion. Only complete tumor resection, including hepatic resection,
increases survival in patients with hilar cholangiocarcinoma, although it
carries the risk of significant morbidity and mortality. Percutaneus drainage is
almost always necessary as endoscopic stenting is often unable to relieve the
jaundice. Adjuvant chemotherapy after both surgical treatment and palliative
stenting has a significant benefit in terms of survival rate compared with both
surgery and stenting alone.
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OPEN BILIARY BYPASS PROCEDURES AS PALLIATION FOR
UNRESECTABLE MALIGNANT DISEASE DISEASE
Chris Mann1, Sarah Thomasset, Nick Johnson, Guiseppe Garcea, Christo-
pher P Neal, Ashley Dennison, David Berry
1Department of Hepatobiliary and Pancreatic Surgery, University Hospitals
of Leicester
Introduction. Although endoscopic palliation of jaundice is increasingly
employed in the palliation of unresectable malignant disease, surgical bypass
still has a role to play in setting. This study aimed to reappraise the short and
long-term results of combined biliary/gastric bypass (hepatojejunostomy and
gastrojejunostomy) as palliation for unresectable malignant disease.
Patients and Methods. All patients undergoing simultaneous biliary and
gastric bypass procedures for unresectable malignant disease between August
2000 and January 2006 were identified and outcomes reviewed.
Results. 102 patients underwent open surgical biliary drainage procedures
for palliation of malignant disease. Underlying malignant disease included
pancreatic carcinoma (n88), duodenal adenocarcinoma (n5) and distal
cholangiocarcinoma (n3). 33 of the patients underwent a planned
palliative bypass procedure; the remainder being performed after uresect-
able disease was identified at laparotomy. Findings that precluded resection
were liver metastases (21%), peritoneal deposits (19%), metastatic lymph
nodes (19%) and unresectable vascular involvement (10%). The overall
post-operative morbidity rate was 26.4%. The post-operative mortality rate
was 5.9%, secondary to pneumonia (2), cardiac complications (2),
pulmonary embolism (1) and sepsis (1). Median hospital stay was 20
days (range 468). Median survival was 9 months. During follow-up, 3
patients developed recurrent jaundice required transhepatic stenting and 2
patients developed late gastric outlet obstruction requiring refashioning of
gastrojejunostomy.
Conclusion. Surgery prevented recurrent jaundice or gastric outlet obstruc-
tion in 95% of patients in this series. Therefore combined gastric and biliary
bypass is a safe and effective treatment for these symptoms in patients with
unresectable malignant disease.
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LONGTERM RESULTS OF BENIGN BILIARY STRICTURES RE-
CONSTRUCTION
Radoje Colovic1, Slavko Matic, Dragoljub Bilanovic2, Miodrag Jovanovic,
Nikica Grubor, Stojan Latincic
1Institute for Digestive diseases, Clinical Centre of Serbia; 2Clinical Centre
‘‘Bezanijska Kosa’’
Introduction and Aim. Operative bile ducts injuries and benign bile ducts
strictures (BBDS) continue to be a surgical challenge. We present our 30-
years experience.
Patients and Methods. Over 30-year period, 242 pts were operated for
BBDS. There were 147 female (60.74 %) and 95 male (39.26%) pts. The
average age was 48 (14-76) years. Two pts (0.83%) had congenital stricture,
2 (0.83%) posttraumatic, and 238 (98.34%) postoperative BBDS (224 after
cholecystectomy, 9 after distal gastrectomy, 4 after hydatid cyst operations
and one after hepatic debridement for blunt hepatic trauma). We had 99
(40.9%) primary repairs and 143 (59.1%) repairs after one to six previous
attempts of reconstruction. According to Bismuth’s classification, there
were 28 (11.57%) strictures of type I, 47 (19.42%) of type II, 102
(42.15%) of type III, and 65 (26.86%) of type IV. We registered more then
215 complications prior to our reconstruction: intrahepatic lythiasis (82),
liver fibrosis or cirrhosis (21), atrophy/hypertrophy complex (4), liver
abscess (8), incisional hernia (17), biliodigestive fistula (7), colonic fistula
(2), gastrojejunal fistula (1), supp. pericarditis (1), retroperitoneal biloma
(1), portal vein thrombosis (1), subhepatic abscess (4), biliary peritonitis
(12), CBD varices (1) and so on. In 80 pts, 1 to 6 attempts of
reconstruction had been performed. In 53 previously reconstructed pts
Roux-en-Y jejunal limb was not adequate. In two pts reconstruction was
technically impossible. In 234 pts hepaticojejunostomy with 75 cm long
Roux-en-Y limb, in 4 choledochoduodenostomy and in 2 choledochoplasty
were carried out.
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Results. Three pts died within first six months (two in whom the
reconstruction was impossible and one of unrelated cause), while three pts
died later due to liver cirrhosis and eight of unrelated causes. Eight pts were
lost from follow up. The rest 220 (96.69%) pts were followed up from 4
months to 30 years (median 9.3 years). Good results were achieved in 171
(77.73%), satisfactory in 45 (20.45%) and unsatisfactory in 4 (1.82%), three
of which were successfully reoperated.
Conclusion. Good or satisfactory results could be achieved in an over-
whelming majority of patients if the proper reconstruction is not performed
too late.
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SECTORAL AND SEGMENTAL BILE DUCTS INJURIES. HOW
DO WE MANAGE THEM
Radoje Colovic1, Dragoljub Bilanovic2, Slavko Matic, Nikica Grubor,
Mihajlo Jagodic, Vladimir Radak, Stojan Latincic
1Institute for Digestive diseases, Clinical Centre of Serbia; 2Clinical Centre
‘‘Bezanijska Kosa’’
Introduction. Sectoral and segmental operative bile ducts injuries, usually
related to the right lobe liver bile ducts, continue to be a challenge. Their
treatment is still controversial.
Material and Method. Over a 32 years period we treated 18 patients
with segmental bile duct injuries. In 4 patients the injury was recog-
nized during original surgery, 4 were sent for biliary peritonitis, 6 for
external biliary fistula, 3 for cholangitis, and 1 for liver abscess and
cholangitis.
Primary repair was performed in 4 patients, 3 over a T-tube, and 1 with
Roux-en-Y anastomosis. Patients with biliary peritonitis were submitted to
open surgery during which lavage and drainage were carried out and all
developed external biliary fistula. All 6 patients sent for external biliary fistula
were followed for 4-6 weeks to see whether the fistula would close
spontaneously. So, a total of 10 patients had external biliary fistula. Three
patients with ligated duct were submitted to Roux-en-Y repair and abscess
drainage. The patient with a ligated duct who developed liver abscess, wound
dehiscence and peritonitis was submitted to abscess and abdominal drainage.
Results. All 4 patients with primary repair did well with good long term
outcome. Only one patient developed incisional hernia requiring an open
surgical repair. Five out of 10 external biliary fistulas closed spontaneously
and required no further surgery. The rest 5 patients had to be submitted to
Roux-en-Y reconstruction. Two patients submitted to Roux-en-Y recon-
struction after a ligature did well with good long term outcome. Third patient
developed a stricture of the anastomosis which required reoperation with
good long term outcome. The last patient with ligated sectoral duct
developed a series of complications for which he had to be submitted to
repeated surgery and subsequently died.
Conclusion. Primary repair seems to be the best solution if the injury is
recognized at original surgery. Ligature of the injured duct can lead to serious
complications even with a fatal outcome, so that should be cautiously
indicated. External biliary fistulas should be followed for several weeks as
there is at least 50% chance to close spontaneously with good long term
outcome.
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GALLBLADDER CANCER INVADING THE PERIMUSCULAR
CONNECTIVE TISSUE: RESULTS OF RE-RESECTION AFTER
PRIOR SIMPLE CHOLECYSTECTOMY
Andrea Muratore1, Alfredo Mellano, Enrico Sgotto2, Luca Vigano?2,
Lorenzo Capussotti
1Istituto Per La Ricerca e La Cura Del Cancro; 2Ospedale Mauriziano
‘‘Umberto I’’
Aims. Most T2 gallbladder cancers are diagnosed at final pathology after
cholecystectomy. Reoperations including liver resection and regional lymph
node dissection are needed to achieve better long-term results. The aim of
this study is to evaluate long-term results of re-resections after prior non-
curative surgery for T2 carcinomas.
Patients and Methods. Single-unit, retrospective study from January 1985
to December 2006. Twenty-five out of 30 pT2 cancers were diagnosed
postoperatively after simple cholecystectomy. Twenty-one who have under-
gone re-resection (liver resection  lymph node dissection) are the basis of
our study.
Results. Four patients (Group A), who underwent simple cholecystectomy
in other hospitals, were referred to us when a local recurrence developed
during the follow-up. In the remaining patients (Group B), no visible
recurrences were shown by the preoperative staging. The mean time between
simple cholecystectomy and re-resection was 133.3 days (95% CI: 39.344
227.323): the cholecystectomy-reoperation mean time was significantly
higher in the group A (p0.005). The in-hospital mortality rate was 0%.
Median follow-up from the re-operation was 41.024 months. Overall 5-year
survival rate was 59.259% with a median survival of 63 months. Median and
5-year survival rate of the Group B patients were 70.4 months and 81.818%:
thirteen patients are actually alive without recurrence. Median survival of
Group A patients was 25 month (p0.015): all these patients have died of
recurrence within 4 years from the reoperation. At final pathology, lymph
node metastases and/or residual disease in the gallbladder bed were found in
5 patients of the Group B. No significant difference in long-term survival was
found out between patients with or without residual disease at final pathology
(p0.928).
Conclusions. T2 cancers discovered incidentally after simple cholecystect-
omy should be reoperated on as soon as possible: the appearance, before re-
operation, of a recurrence is significantly related to a dismal prognosis.
Otherwise, the finding of residual disease on the specimen does not seem to
be correlated with a worse prognosis.
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EXTRACAPSULAR LYMPH NODE INVOLVEMENT IN NODE
POSITIVE PATIENTS WITH ADENOCARCINOMA OF THE AM-
PULLA OF VATER
van der Gaag Niels A1, Lagarde Sjoerd M, Busch Olivier RC, van Gulik
Thomas M, ten Kate Fiebo JW2, Gouma Dirk J
1Academic Medical Center, department of surgery; 2Academic Medical
Center, department of pathology
The presence and extent of lymphatic dissemination is an important
predictor of survival in patients with adenocarcinoma of the ampulla of
Vater. Extracapsular lymph node involvement (LNI) and its impact on
survival have been studied for several malignancies. No available literature to
date describes the incidence of extracapsular LNI in adenocarcinoma of the
ampulla of Vater and the clinical consequences.
The aim of the present study was to assess the incidence and extent of
extracapsular LNI in a consecutive series of patients with adenocarcinoma of
the ampulla of Vater, that underwent a resection with curative intent. The
relation with tumour stage and number of positive nodes was evaluated and
the prognostic significance with respect to survival (tumour recurrence) was
analyzed.
Between Jan-1992 and Feb-2006, a consecutive series of 649 patients
underwent pancreatoduodenectomy (PD) for a suspected periampullary
malignancy. The clinicopathological data were prospectively collected.
Hundred and sixty patients had an adenocarcinoma of the ampulla of Vater,
positive lymph nodes were found in 75 patients (47%). Positive nodes were
re-examined by a pathologist, experienced in the field of gastrointestinal
malignancies. Follow-up data was collected at the outpatient clinic or by
contacting general practitioners.
For a total of 230 positive nodes, extracapsular LNI was identified in 100
(43% of the positive nodes), occurring in 44 of 75 lymph node positive
patients (59%). The median potential follow-up period for was 88 months
(11179). The median overall survival in patients with only intracapsular
LNI was 30 months (95% CI: 2040) in comparison to 18 months (95% CI:
1323) for those who had extracapsular LNI (pB0.016). Five-year overall
survival rates were for intracapsular LNI and extracapsular LNI, respectively
20% and 9%. Multivariate analysis demonstrated that for patients with
positive lymph nodes, extracapsular LNI and tumor differentiation were
independent prognostic factors for survival.
The presence of extracapsular LNI identifies, in patients with an adenocar-
cinoma of the ampulla of Vater, a subgroup with a significantly worse long-
term survival. Adjuvant therapy after resection, i.e. chemo- and/or radiation
therapy, might be considered for this particular subgroup.
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INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM(IPMN) OF
THE BILE DUCTS: THE CLINICAL FEATURES AND OUTCOME
OF 25 CASES
Kwang Yeol Paik1, Min Young Choi, Jun Chul Chung, Jin Seok Heo, Seong
Ho Choi, Dong Wook Choi, Yong Il Kim
1Samsung Medical Center
Introduction. Intraductal papillary mucinous neoplasm(IPMN) of the bile
ducts may be considered as an uncommon intraductal growing tumor
characterized by intraluminal papillary masses in association with bile duct
dilatation and obstruction. Some of these tumors secrete an mucin.
Histologically, they resemble intraductal papillary mucinous tumor of
pancreas. But their clinical features and outcomes after surgical resection
are not well known.
Objectives. The purpose of this study was to evaluate the clinical,
radiological, histopathological characteristics and the prognosis of the
IPMN of the bile ducts.
Methods. From October 1995 until August 2006, a retrospective analysis of
25 patients who underwent operation for IPMN of the bile ducts was made.
Clinical features and radiological, pathological and operative findings were
reviewed. Survival rate was analyzed in 25 patients with IPMN of the bile
ducts.
Results. The main symptoms was abdominal pain (36.0%). In 5 patients
(20.0%), the lesions were incidentally found in radiologic study. Radiologi-
cally, 23 (92.0%) dilatation of the bile ducts. 10 diffuse dilatation of entire
biliary tree with or without dilataton of the extrahepatic bile duct. 10
disproportionaly dilatation, 3 intrahepatic huge cystic dialatation of the bile
ducts. As to location of the lesion in liver was left dominant (64.0%). 7
patients were diagnosed IPMN of the bile ducts before operation. In
preoperative diagnosis: 10 cholangiocarcinoma, 4 recurrent pyogenic cho-
langitis, 2 intrahepatic duct(IHD) stone, 1 abscess, and 1 cystic neoplasm. 23
of 25 patients were performed hepatic resection with or without extrahepatic
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bile ducts resection. There was no in hospital mortality. Pathologic features of
the lesion: 1 hyperplasia, 2 adenoma, 3 moderate dysplasia (2 adenoma
background), 1 carcinoma in-situ, 18 carcinoma (6 coexist with the
hyperplasia, adenoma, in-situ). The median survival time is 59.8 month
and 1-,2-,4- year survival rate 90.5%, 84.0%, 84.0%, respectively. All 6
patients with benign IPMN of the bile ducts were still alive without
recurrence. Preoperative diagnosis of benign disease were made in 7 patients
for abscess, recurrent pyogenic cholangitis, IHD stone. These lesion were
confirmed 3 carcinoma, 1 in-situ, 2 adenoma and 1 hyperplasia, pathologi-
cally.
Conclusion. IPMN of the bile ducts is a benign to malignant disease.
Diagnosis of IPMN of the bile ducts is largely made in patients with biliary
dilatation in radiologic study. The prognosis of IPMN of the bile ducts
especially benign category is excellent. Aggressive surgical resection is a
treatment of choice for IPMN of the bile ducts.
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CHOLANGIOCARCINOMA (SINGLE HEPATIC CLINIC EXPERI-
ENCE)
Alexey Severtsev1, Dimitry Tchudaev2, Vladimir Ovtchinnikov2, Vera Se-
vertseva2, Irina Grishina2, Lali Kogonia2
1Central Clinical Hospital #1 of the LLC ‘‘Russian Railways’’; 2Central
Clinical Hospital#1 of the LLC ‘‘Russian Railways’’
Peripheral cholangiocarcinoma (ChC) is the second on frequency occurred
liver cancer. In Russia this cancer is extremely rare occured. The purpose of
the study is to estimate the clinical situation by this kind of liver cancer and to
define the prospects in its treatment. For the period from Dec. 2002 till Dec.
2005 in our hospital 12 patients with the confirmed diagnosis cholangio-
carcinoma were observed. In spite of the fact that bilobar involvement was
applied to 7 patients, surgery is executed to all patients. The volume of liver
resection was individual, but an obligatory condition was full (5 patients) or
maximal (7 patients) removal of a tumoral tissue (citoreductive surgery). All
patients in the postoperative period received immuno- and chemotherapy and
the hyperthermal intraoperative intraperitoneal chemotherapy. Perioperative
mortality was 0%. In the group without bilobar process, the minimal long
term observation has made 1 year, the maximal  up to 3years. 3 patients had
an advanced process. In the group with bilobar involvement, the minimal
long time observation has made 4 months, the maximal  up to 2 years. 2 in 7
patients have died (the period of supervision of 5 months and 1,1 year).The
received preliminary results allow to approve, that new intraoperative
techniques and oncologic methods allow to prolong substantially the life in
this group of patients.
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ACUTE CHOLECYSTITIS WITH LIVER CIRRHOSIS
Alexey Severtsev1, Dimitry Tchudaev2, Vladimir Ovtchinnikov2, Vera Se-
vertseva2
1Central Clinical Hospital #1 of the LLC ‘‘Russian Railways’’; 2Central
Clinical Hospital#1 of the LLC ‘‘Russian Railways’’
Background. Acute cholecystitis is one of the most frequent surgical
pathologies. There is no sufficient information about the course of such
acute process during the liver cirrhosis. The combination of these two
pathological conditions leads to significant stress for surgeons.
Aim. The purpose of this study is to estimate the clinical experience of the
treatment in this group of patients.
Methods. Within the period of existence of multi-specialized hepatological
department (19982005) we observed 27 patients who had such combined
pathology is exposed. The ratio of men:women was approximately identical
(15:12), the age structure was also identical (43:45). The cirrhosis was
diagnosed on the basis of standard criteria (plus biopsy). The diagnosis of an
acute cholecystitis: Visualizing techniques (US, CT), blood tests for an
inflammation, clinical course. 23 patients have been put as an acute
cholecystitis (with small calculi). Considering that it was impossible to
exclude the destruction of the wall of gall bladder, 16 patients have been
operated.
Results. In all situations it has been done the conventional cholecystectomy
(not laparoscopic one). There were technically intraoperative difficulties with
impossibility traditional suturing of gall bladder bed and long time post-
operative external drainage (abdomen). During the surgery in all acute
cholecystites (the extended adhesive process in this zone, enlarged gall
bladder walls) was visually confirmed. However biliary calculi have been
confirmed only for 1 patient. At postoperative histological investigation, the
hypertrophy of gall bladder walls without attributes of their destruction was
marked. Obtained results have allowed us to consider, that most often it take
place the mimicry of acute process on a background of strengthening of
activity of the basic process in a liver. Therefore another 11 patients with such
diagnosis got non surgical treatment only of the basic process of a liver, even
on a background expressed WBC and suspicions on the destruction of gall
bladder walls at visualizing techniques. The condition of all patients was
normalized. Besides in 1 month of dynamic follow up was observed at 7
patients from 9 (with US biliary calculi), it has not been received the
confirmation of biliary calculi.
Conclusions. Obtained data allow to refuse substantially performance of
surgery at patients with cirrhosis of a liver.
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OPERATIVE OUTCOME FOR CHOLANGIOCELLULAR CARCI-
NOMAS: SINGLE CENTER EXPERIENCE
Mitsugi Shimoda1, Masato Katoh, Junji Kita, Tokihiko Sawada, Keiichi
Kubota
1Second Department of Surgery, Dokkyo University School of Medicine
Introduction and Aim. Surgical resection of cholangiocellular carcinomas
(CCC) is the only therapy with a curative intention. This study was
conducted to clarify the efficacy of surgical resection for the treatment of
CCC during the past six years.
Patients and Methods. From April 2000 to April 2006, a total of 480
patients underwent hepatic resection at our department, among them 19
patients (2.5%) had CCC. Fourteen had periductal infiltrating or intraductal
growth type tumor. Six cases underwent extended right lobectomy with
common bile duct resection (CBD-R) after portal vein embolization (PE).
Three cases underwent extended left lobectomy with CBD-R, 2 cases
underwent left lobectomy and posterior segmentectomy, respectively, and
one underwent left trisegmentectomy with CBD-R following PE, and partial
resection and extended lateral segementectomy.
Result. Eight of 19 patients were still alive at the end of the study. The
actuarial patient survival at 1 and 3 years after resection was 55.7% and
41.8%, respectively. Fourteen of 19 patients had recurrence, most
common recurrence site was remnant liver (10 of the 14 patients). Five
patients had GEM treatment after recurrence; however, GEM did not
have a significant effect on patient survival after recurrence (GEM: 11.4/
4.1 mo vs none-GEM: 15.3/13.7 mo, P0.56). Thirteen of 19
(64.2%) cases received R0 resection by histological findings. Patient
survival at 1 and 3 years for R0 cases were 76.9% and 57.7%, respectively.
R0 resection had significant benefit on patients survival rate compared to
R1 (P0.0007).
Conclusion. Major hepatectomy with CBD resection was the only treatment
for patients with CCC with biliary invasion of IHCCC. R0 resection was
an important prognostic factor for IHCCC patients after surgery. Our data
sug gested that the effectiveness of recurrent treatment of GEM is still
unclear.
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UNUSUAL COMPLICATIONS OF GALL STONES AND LAPARO-
SCOPIC CHOLECYSTECTOMY
N. Srinivasaiah1, M. Bhojak2, N. Mathias2, R. Jackson2, S. Woodcock
1Department of surgery , North Tyneside general hospital, Tyne and Wear;
2Department of Radiology , Freeman hospital , Tyne and Wear
Introduction. Complications from gallstones and laparoscopic cholecys-
tectomy can be serious, and even fatal, if there is a delay in recognition and
treatment. We aim to present two unusual, life threatening complications as a
result of gall stones and laparoscopic cholecystectomy. Their management is
highlighted.
Case 1. Cystic arterial erosion and haemetemesis.
An 81 year old female with calculus cholecystitis had a failed ERCP for a
CBD stone. She presented 10 weeks later with left basal pneumonia. During
her stay in the hospital she developed epigastric pain, followed by
haemetemesis 2 days. She became unstable due to further haematemesis.
Patient was resuscitated and transferred to the high dependency unit. OGD
showed field full of blood making it impossible to locate the source of bleed.
Laparotomy showed adhesions and gall bladder containing a single large
stone. With no other obvious source of bleed, gall bladder was mobilised
revealing an active cystic arterial bleed which was spurting into second part of
Duodenum. Patient had subtotal cholecystectomy, duodenal defect closure,
and feeding jejunostomy. She recovered well to be discharged home 7/52
later.
Case 2. Pseudo aneurysm of right hepatic artery and haemobilia.
A 57 year male presented with right sided abdominal pain 4/52 weeks after
laparoscopic cholecystectomy. Pain was associated with haemetemesis.
Investigations revealed raising LFTS. U/S scan showed 5 cm aneurysm in
the gall bladder bed following which he was transferred to a tertiary centre for
intervention. CT demonstrated an aneurismal sac of 6.9 cms, slow to fill with
contrast and the feeding vessel could not be clearly visualized. A possibility of
a cystic artery stump or right hepatic artery aneurysm was suspected. Patient
developed near fatal haemetemesis, malena and was haemodynamically
unstable. Post resuscitation he was transferred for angiography. Angiography
showed a subtle pseudo aneurysm arising from the right hepatic artery
adjacent to two surgical clips. Embolisation of the distal and proximal ends
revealed that there was more than one bleeding point, requiring embolisation
of the whole right hepatic artery. The Patient was discharged home and is
doing well.
Conclusion. Gall stones eroding cystic artery and pseudo aneurysm causing
arteriobiliary fistula are rare complications of gall stones and laparoscopic
cholecystectomy. A high index of suspicion and timely intervention is
important in patients who present with haemetemesis and haemobilia.
Needless to say trauma to arteries should be avoided during laparoscopic
cholecystectomy.
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ACUTE CHOLECYSTITIS  SURGICAL TACTICS AND LETH-
ALITY
Sheri Tadzher1, Liubomir Svilenov2, Maksim Tadzher3, Stoyan Petrov3,
Ivanova Iskra*, Petrov Kiril*, Marinov Viktor*, Simidjiska Maria*
1For Active Treatment and Emergency Medicine ‘‘N. I. Pirogov’’- Sofia,
Bulgaria, Department of Emergency Surgery; 2Bulgaria, 1606, Sofia,
MHATEM ‘‘N. I. Pirogov’’, Emergency Surgery Department; 3Bulgaria,
1606, Sofia, MHATEM ‘‘N. I. Pirogov’’, Emergency Surgery Dept.;
*Bulgaria, 1606, Sofia, MHATEM ‘‘N. I. Pirogov’’, 21 ‘‘Totleben’’ blvd,
Third Surgery Clinic, floor 6
The early cholecystectomy tactic leads to a decrease of 1% to 10% lethality.
We have set an objective to investigate the surgical tactic and lethality in acute
cholecystitis (AC).
For a period of 6 years (20002005) in the Emergency Surgery Department
of MHATEM ‘‘N. I. Pirogov’’ 1864 patients have been operated for acute
cholecystitis, of which 704 males and 1160 females (1:1.6). Most frequently
affected age group is 6170 yrs.  517 patients (27.7%), followed by 7180
yrs.  477 (25.6%), but those over 81 yrs. make up 6% etc. Patients up to 60
yrs. who have been operated on are 758 (40.6%), while those over 61 yrs. 
1106 (59.4%). Consequently, the lethality rate is 1.3%:6.5%. The post-
operative lethality is 4.39%, and for the last two years  2.45%, but increases
several times after the 6th decade.
For the same period 265 patient have been operated for AC, complicated
with benign obstructive jaundice. 80 patients are up to 60 yrs., while 185 are
over 61 yrs. The lethality rate, consequently, is 5%:11.8%; postoperative
mortality is 9.8%.
49 patients are operated for catarrhal AC, of which up to and over 61 yrs. are
0.7%:1.8%; phlegmonose AC  1006 patients with lethality up to and over
61 yrs  0.9%:4.6%; with gangrenous AC  786, as in this age group the
lethality rate is 2.0%:8.8% and gangrenous AC with gallbladder carcinoma 
23, consequently, with a lethality 0%:15.7%.
We are supporters of the active surgical tactic with defined approach, with
definitive treatment.
We performed emergency operations (up to 6 hrs from admission) on 551
patients (29.6%). On the 1st day of admission 664 patients (35.6%) have
been operated on, on the 2nd day  394 (21.1%), on the 3rd day 207
(11.1%) and from the 4th till the 7th day  48 (2.6%), due to unsuccessful-
ness of the conservative treatment. Lethality is highest in patients who have
undergone emergency operations  8.1%, and consequently 3.7%, 1.5% and
2.8%. Of 1816 emergency operated patients (up to 3rd day of admission),
1767 (97.3%) are with destructive AC, of which up to 60 yrs. constitute 970,
while over 61yrs.  797. Lethality among this age group is 1.0%:9.0%.
It has come to our attention that there is a high frequency of the concomitant
disease.
1864 cholecystectomies have been performed, 271 of which laparoscopicaly
treated for the last two years.
The pathogenesis of the benign obstructive jaundice syndrome, constituting
14.8%, has been investigated in detail. Choledochoduodenoanastomosis
(ChDA) has been performed on 135 patients, 128 patients have Kehr-
drainage inserted and on 2 hepaticojejunoanastomosis. Formally viewed, the
lethality among patients with ChDA is 10.3%, while external drainage 
8.5%.
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INTERNAL BILIARY FISTULAS AND MIRIZZI SYNDROME  ‘‘A
TRAP’’ FOR THE SURGEON
Maksim Tadzher1, Sheri Tadzher2, Petrov Kiril3, Stoyan Petrov
1Bulgaria, 1606, Sofia, MHATEM ‘‘N. I. Pirogov’’, Emergency Surgery
Dept.; 2for Active Treatment and Emergency Medicine ‘‘N. I. Pirogov’’ 
Sofia, Bulgaria, Department of Emergency Surgery; 3Bulgaria, 1606, Sofia,
MHATEM ‘‘N. I. Pirogov’’, 21 ‘‘Totleben’’ blvd, Third Surgery Clinic,
floor 6
During 1948, Mirizzi describes the so-called functional hepatic syndrome in
jaundice patients, which is observed in 0.7% to 2.7% of cholecystctomies.
There are different views in literature with regards to the surgical treatment of
the Mirizzi syndrome.
We classify the Mirizzi syndrome into two types, as do other authors. In type
I, there is no additional communication between the gallbladder and biliary
tree. In type I A, the length of the cystic duct, which is parallel of the hepatic
duct, is more then 3 cm longer, and contains an incarcerated stone, which
compresses it. In type I B, there is a complete obstruction of the cystic duct.
Type II presents a bilio-biliary fistula between the gallbladder and common
hepatic duct with a stone, incarcerated in the fistula.
No external biliary fistulas are observed. We found internal biliary fistulas as a
complication of acute cholecystitis in 29 cases, of which 9 were cholecysto-
duodenal, 4 colo-biliary, 6 bilio-biliary and 10 Mirizzi syndrome.
In fistulas with a large defect of the choledochal duct, Mirizzi syndrome type
II, and in the case of iatrogenic lesions the method of choice is removal of the
fistula above Kehr-drainage (either through the fistula or choledochotomy) if
possible with a gallbladder lambo, but only with an absolute assurance of the
absence of the gallbladder carcinoma. A similar case of gallbladder
carcinoma, histologicaly proved, reported by Bayer. We always perform an
intraoperative cholangiography through the Kehr-drainage.
An alternative method is bilio-enteral anastomosis. However, in the cases of
severe inflammation, worn out tissues (inflammatory infiltration of the
hepatoduodenal ligament, pericholedochal lymphadenitis), anastomosis is
an extremely risky procedure-risk of anastomosis leakage, stenosis etc.
An alternative procedure is plastic of the choledochal duct with teres ligament
(even in choledochitis).
The treatment of these pathologies presents a challenge for the surgeon.
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ANALYSIS OF 71 SURGICAL BYPASS PROCEDURES FOR MA-
LIGNANT BILIARY OBSTRUCTION: A COMPARISON OF PRE-
DICTED AND ACTUAL SURVIVAL
Sarah Thomasset1, Christopher Mann, Giuseppe Garcea, Nick Johnson,
Christopher Neal, Ashley Dennison, David Berry
1Department of Hepatobiliary and Pancreatic Surgery, Leicester General
Hospital
Objective. Surgical exploration of patients with potentially resectable
malignant biliary obstruction may result in either resection or a palliative
bypass. The aim of this study was to compare actual and expected mortality
figures in patients undergoing biliary bypass and to assess whether an
aggressive surgical approach for exploration can be justified.
Methods. A retrospective study of patients undergoing biliary and gastric
bypass (hepaticojejunostomy-en-Y and gastroenterostomy) in whom explora-
tion/resection had been planned pre-operatively between September 2000
and February 2006. Case notes were reviewed and demographic details,
operative information and outcome data extracted.
Results. 71 patients were identified. Diagnoses included pancreatic cancer
(n61, 86%), duodenal carcinoma (n4, 6%) and cholangiocarcinoma (n
2, 3%). Median patient age was 66 years (range 36 to 86 years) and the median
POSSUM score for predicted mortality was 18.5% (range 6.7 to 66.2%). In
hospital and 30-day mortality was 1.4% (n1) with 66.2% of patients alive at
6 months (n47) and 46.4% of patients alive at 1 year (n32).
Conclusions. Actual mortality (1.4%) was less than predicted mortality
(18.5%) in this study. Significant numbers of patients were alive at 1 year.
These data support an aggressive policy for surgical exploration of
malignant biliary obstruction whenever there may be a possibility of curative
resection.
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LIVER TRANSPLANTATION AFTER LAPAROSCOPIC LIVER
RESECTION FOR HEPATOCELLULAR CARCINOMA
Tayar Claude1, Laurent Alexis, Cherqui Daniel
1Dept of Surgery, Hopital Henri Mondor, Creteil  France
Liver resection (LR) for solitary HCCB5 cm in Child A patient is
controversial because of associated mortality and morbidity, and increased
risk in case of subsequent liver transplantation (LT). We have shown that in
selected patients with peripheral tumors, laparoscopic LR was a safe and
efficient procedure. We report here the first patients who underwent LT after
laparoscopic LR.
Patients. Among 48 patients who underwent laparoscopic LR for HCC, 10
(21%) underwent subsequent LT. Indication for transplantation was recur-
rent HCC in 7 patients (salvage LT), second stage after neoadjuvant
resection in 2 (bridge LT) and decompensated cirrhosis in 1. All patients
had Child’s A or B cirrhosis due to hepatitis B or C in 7 patients and alcohol
in 3. Previous resection included 1 segment or less in 6 patients, left lateral
sectionectomy in 3 and right hepatectomy in 1.
Results. LTwere performed after a mean of 22 months (range 749). LTwas
performed with cadaveric donor in 9 patients and living donor in 1. All
transplantations were performed with IVC preservation with temporary
portocaval anastomosis. Laparotomy was straightforward in all cases. In 7
patients, there were no or minimal intra abdominal adhesions. In one patient
with major portal hypertension, there were hypervascular adhesions between
the omentum and the liver. LT procedures were uneventful with a mean
operative time of 7 hours (range 49). There were no postoperative deaths.
One patient died at 8 months from biliary sepsis. After a mean follow-up of 13
months (range 145), all other patients are alive and without tumor recurrence.
Conclusion. Our study shows that previous laparoscopic LR for HCC does
not impair operative and postoperative LT results. The main advantage is the
dramatic reduction of adhesion permitting straightforward laparotomy and
LT. Therefore, laparoscopic LR could have an impact on the therapeutic
strategy of HCC complicating chronic liver disease as a bridge to liver
transplantation, especially in patients with peripheral initial tumor.
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LIVING DONOR LIVER TRANSPLANTATION IN DIEGO BLOOD
DISPARITY
Takayuki Shiraki1, Tokihiko Sawada, Rie Yamazaki, Akihito Abe, Masato
Katoh, Mitsugi Shimoda, Junji Kita, Keiichi Kubota
1Second Department of Surgery, Dokkyo University School of Medicine
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Dia antigen in the Diego blood type system (DBS) is an anthropologic
marker of Mongoloids. We report the first case of liver transplantation (LT)
involving DBS disparity. The recipient was a 58-year-old woman with
fulminant hepatic failure and 32-year-old daughter was a donor. DBS were
Di (a b) in the recipient and Di (a b) in the donor. Living-related
liver transplantation was performed, and immediate graft function was
obtained. No signs of humoral rejection were observed on postoperative
days 14. Biopsy performed on postoperative day 10, 63, and 87 because of
elevation of the serum bilirubin level, showed no signs of humoral rejection.
Eighty days after the transplant operation, the patient developed severe
aspergillus pneumonia and died on post-transplantation day 120. In
conclusion, liver transplantation can be performed successfully in cases of
Diego blood type disparity.
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POST LIVER TRANSPLANT BILIARY CAST SYNDROME
N. Srinivasaiah1, R. Jackson2, B. J. Jaques3
1Department of surgery, North Tyneside general hospital, Tyne and Wear;
2Department of Radiology, Freeman hospital, Tyne and Wear; 3Hepatopan-
creatobiliary and Transplant Unit, Freeman Hospital, High Heaton, New-
castle upon Tyne
Background. Biliary casts occur as a complication of Orthotopic liver
transplantation (OLTx). Incidence varies between 3% 18%. Biliary cast
syndrome (BCS) is a clinical entity associated with casts leading to morbidity,
graft failure, need for Re-transplantation and mortality. Management of BCS
is difficult. We aim to review our experience and present a novel percutaneous
approach for duct clearance.
Methods. Retrospective review of management of 3 cases of BCS.
1) A 34 year old female after 9 months following OLTx for paracetamol
overdose developed BCS with hepatic artery occlusion (HAO). Initial ERCP
clearance helped. 6 months later, she presented with multiple liver abscesses.
She was treated with antibiotics for 3 months followed by open exploration of
the biliary tree with surgical cast removal. Further cast removal with
refashioning of a Roux en Y hepaticojujenostomy was needed 18 months
later. She remains well.
2) A 65 year old female developed BCS without HAO 3 months following
OLTX for PBC. Failed ERCP led to PTC and drainage followed by Segment
IV b resection with open cast removal and biliary reconstruction. A month
later, casts reformed leading to jaundice and sepsis. She was re listed but died
of sepsis with MODS.
3) A 9 year male had OLTx for hyperoxaluria complicated by hepatic arterial
thrombosis necessitating a second transplant. 13 years after 2nd transplant, a
3rd transplant was performed for late conduit thrombosis and chronic graft
failure. For this 3rd transplant, a new supra-renal hepatic arterial conduit was
fashioned and biliary drainage obtained using a Roux-en Y. 8 months post
OLTx, arterial conduit thrombosis occurred complicated by BCS. A 6.5 F
internal-external PTC catheter was used for biliary decompression and due
to the complicated nature of the 3rd transplant; a percutaneous approach to
cast removal was employed. The internal-external drain track was serially
dilated to 16 F. Under GA, biliary casts were removed using percutaneous
choledochoscopy. Subsequently regular saline flushes were employed to
facilitate drainage. 12 weeks later the process was repeated & all tubes were
removed. The patient remains well with normal LFT.
Conclusion. With our limited experience apart from the traditional
approaches using ERCP and surgery to remove the casts, a percutaneous
endoscopic approach is safe, and could be considered as an option before
surgery.
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CONCOMITANT PRESENCE OF CHOLANGIOCARCINOMA OF
THE DUCT CONFLUENCE COLORECTAL CARCINOMA,
BREAST CANCER AND THYROID TUMOR IN THE SAME
PATIENT: A NEW MULTITUMORAL SYNDROME?
Francesco Cetta1, Armando Dhamo, Giuliana Malagnino, Antonio Acqua-
viva2, Antonio De Martino, Leonardo Barellini, Luca Mazzarella
1Department of Surgery, University of Siena, Italy; 2Department of
Pediatrics, Obstetric and Gynecology, University of Siena, Italy
A female patient had non malignant thyroid tumor at age 22, breast ductal
cancer at age 40, cholangiocarcinoma of the hepatic duct confluence at age
62, and colon cancer (Dukes, cancer in the sigmoid colon) not associated
with FAP at age 66. In particular, the patient underwent right hepatectomy
plus caudate lobe resection and bileduct-jejunostomy and had disease free
survival greater than 7 years, dying at age 69 because of recurrence from the
colorectal malignancy.
The entire kindred, including 11 subjects spanning 4 generations, was
recruited for clinical and genetic screening. In particular, germ-line muta-
tions of the APC gene (Adenomatous Polyposis Coli), mismatch repair genes
(HNPCC), PTEN, responsible for Cowden disease, BRCA1 and BRCA2
(breast plus pancreatobiliary carcinoma), and STK11/LKB1, responsible for
Peutz-Jegher syndrome were searched, in all available subjects. No germ-line
mutation in these genes has been found up to now.
Peutz-Jeghers syndrome (PJS) is a dominantly inherited disease characterized
by hamartomatous gastrointestinal polyps and microcutaneous pigmentation
of the lips and buccosal mucosa, associated with germ-line mutations in the
STK11/LKB1 gene (19p13.3), that encodes a multifunctional serine-
threonine kinase. An increased risk of gastrointestinal, gynecologic, breast,
thyroid and pancreatic carcinomas (136 folds) has been reported. Several
reports have shown LOH on 19p in breast, colorectal and pacreatic cancer.
However, since the STK11/LKB1 gene has been cloned, evidence for biallelic
somatic inactivation of STK11 in colorectal and breast cancer is lacking.
Recent reports have shown evidence for genetic heterogeneity in PJS.
Interestingly, about 30% of patients with a clinical pathologic diagnosis of
PJS failed to show a germ-line mutation of the STK11/LKB1 gene. A second
candidate gene, possibly located at 19p14 has been hypothesized. In
particular, a very high incidence of cholangiocarcinoma (40%), possibly
located at 19p14 has been observed in PJS patients not showing germ-line
mutations of STK11/LKB1 gene.
Search for this new candidate gene is in progress.
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IS CA19.9 OF VALUE IN SCREENING FOR COLORECTAL ME-
TASTASES?
G Morris-Stiff1, S Mitchell, L Heywood, A Hassn
1Department of Surgery, Princess of Wales Hospital
Background. Carcinembryonic antigen (CEA) is regularly used in the
postoperative monitoring of patients with colorectal carcinoma in the hope of
identifying treatable liver metastases. Whilst Ca 19.9 is frequently used as a
marker of pancreaticobiliary neoplasia, there is some evidence to suggest it
may have a prognostic role in the assessment of colorectal liver metastases.
The aim of this study was to explore this role.
Methods. All patients undergoing resection of colorectal carcinomas during
the 3 year period 20032005 were identified from a prospectively maintained
database. Individuals in whom parallel CEA and Ca 19.9 measurements were
performed sequentially during follow-up were identified and the relationship
between tumour markers, clinical course and findings of computed tomo-
graphy were investigated.
Results. Ninety three patients were identified with complete follow-up. The
results are summarised in a temporal fashion in relation to the location of
metastases.
Liver Local Lung
CEA and Ca 19.9 11 3 0
CEA pre Ca 19.9 3 2 1
CEA only 1 0 1
Ca19.9 pre CEA 1 0 0
Ca 19.9 only 3 0 1
No CEA or Ca 19.9 0 3 3
Conclusions. The combination of CEA and Ca19.9 identified all patients
with liver metastases demonstrated on CT whereas CEA alone would have
missed 21% of cases suggesting that Ca 19.9 may have a role in screening of
patients. However, the fact that neither marker was reliable for local
recurrence or lung metastases means that CT will remain the modality of
choice.
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